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Carbon monoxide is arguably one of the most important feedstocks in organic 
synthesis because it enables the introduction of valuable functional groups in often a 
mild, efficient, and economical manner. Utilization of this building block in 
hydroformylation reactions or ring-expansion carbonylation reactions of heterocycles 
gives rise to value added-products. One transformation of particular importance is the 
carbonylation of epoxides to β-lactones. β-Lactones are a highly versatile set of 
compounds that can undergo numerous reactions in often a benign and economical 
fashion, thus giving rise to small molecules such as aldol-type compounds, and 
polymers such as polyesters. The use of catalysts of the form [Lewis acid]+[Co(CO)4]- 
have streamlined the synthesis of β-lactones to a point where implementation on an 
industrial scale seems feasible. Nonetheless, challenges remain in the conversion of 
epoxides to β-lactones using these catalysts. Regioselectivity in the carbonylation of 
cis- or trans-disubstituted epoxides, and enantioselectivity in general are two largely 
unsolved synthetic hurdles in this regard and await further exploration.  
The work presented herein introduces new catalyst design strategies, and 
implements them in an effort to address these remaining challenges. The result are 
four new carbonylation catalysts that enable the highly regioselective synthesis of β-
 lactones starting from cis- or trans-disubstituted epoxides. The value of the resulting 
products, and the fact that regioselective ring-opening reactions of disubstituted 
epoxides have been a long-standing challenge in the field of organic synthesis make 
this study relevant on both a practical as well as an academic level.  
In addition to the four catalysts introduced for improved regioselectivity, two 
more catalysts were synthesized and found to be competent for the formation of highly 
enantioenriched β-lactones starting from meso or racemic epoxides. Given the scarcity 
of catalysts that can affect similar transformations with equally high selectivities, this 
represents another important step forward in the field of ring-expansion carbonylation 
reactions. 
Lastly, the use of carbon monoxide in a more streamlined synthesis of a 
pharmaceutically relevant class of compounds called ampakines is explored. This new 
methodology underlines once more the synthetic potential that rests in this building 
block. 
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CHAPTER ONE 
Overview of Properties and Reactions of β-Lactones, and Current Challenges 
Associated with Their Synthesis 
 
2 
1.1 Introduction and General Properties of β-Lactones  
β-Lactones, also known as 2-oxetanones, have been known to the chemical 
community since the late 1880’s,1,2 and have been valued as a versatile class of 
compounds ever since. Despite their inherent chemical reactivity, they are readily 
isolated and characterized. As one may expect, β-lactones are composed of a planar 
four-membered ring that displays IR absorptions around 1810-1840 cm-1, which are 
characteristic of the carbonyl-functionality.3 The planar structure is supported further 
by the 1H NMR coupling constants of the two methine protons in vicinally 
disubstituted lactones, which generally follow the trend 3Jcis = 6.5 Hz > 3Jtrans = 4-4.5 
Hz.4 The inherent reactivity of this class of compounds stems from the high ring-strain 
(ca. 23 kcal/mol) of the four-membered heterocycle, and is akin to that of epoxides 
(ca. 27 kcal/mol).5 This high ring-strain, together with the ambident electrophilicity of 
β-lactones (see Section 1.2.2), is the reason why this class of compounds is so useful 
and versatile. 
3 
1.2 Significance of β-Lactones 
1.2.1 Motif in Drugs and Natural Products 
Given the delicate balance of thermodynamic instability and kinetic inertness found in 
β-lactones, it would not come as a surprise if nature also took advantage of this 
functional moiety. Indeed, many natural products containing 2-oxetanones have been 
isolated and characterized over the years (Figure 1.1).6 Just like their nitrogen-analogs, 
the β-lactams, β-lactones serve as potent electrophiles that can readily and irreversibly 
acylate critical functional groups in enzymes. Consequently, antibiotic behavior is 
often associated with such compounds.7 Interestingly, the majority of these 
compounds feature vicinally or geminally disubstituted β-lactones.6,8 This substitution 
pattern might serve as a means to regulate the inherent reactivity of these compounds 
until their deployment. 
Me
MeMe
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Me Me
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CO2H
Me
O
O
HO
Me Me
Antibiotic 1233A (2)
O
O
Me
O
Me Me
Me H
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O
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O
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O
ClMe
HO H
Salinosporamide A (4)  
Figure 1.1 Selected natural products containing a β-lactone motif 
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At least one class of naturally occurring β-lactones has been developed further 
into an approved drug named Orlistat (Tetrahydrolipostatin (6), Figure 1.2). This drug 
is available over-the-counter in the US as a treatment for obesity, and operates by 
irreversibly deactivating lipases needed to digest triglycerides, thus interfering with 
the absorption of dietary fat in the gastrointestinal tract. Efforts to develop other kinds 
of drugs based on β-lactone motifs are currently underway.9 
O
O
C6H11H23C11
O
OMe
Me NHCHO
O
O
C6H11
O
OMe
Me NHCHO
Me
Lipstatin (5) Tetrahydrolipstatin (6)  
Figure 1.2 The natural product Lipstatin (5) and its derivative Tetrahydro-
lipstatin (6), an over-the-counter anti-obesity drug 
1.2.2 Reactivity of β-Lactones 
Due to the high innate reactivity of β-lactones, they can undergo a wide range of 
transformations as seen in Scheme 1.1.3,10 Reaction with a variety of hard nucleophiles 
from groups 5 and 6 such as alcohols or amines generally leads to cleavage of the 
acyl-oxygen bond and gives rise to aldol-type carboxylic acids, esters, and amides 
(Scheme 1, route A). Given that these ring-opening reactions occur under relatively 
mild conditions with high conversions in a stereoselective manner, they represent a 
versatile and useful entry into stereopure aldol-products.11 The reaction with alkoxides 
is of particular importance as it can produce polyesters (route B) in a controlled 
fashion, provided a suitable polymerization catalyst is available.12,13 
5 
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O
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Scheme 1.1 Selected transformations and products accessible from β-lactones 
Thanks to the ambident electrophilicity of β-lactones, a second type of ring-
opening reaction is also possible. For example, cleavage of the alkyl-oxygen bond is 
observed with soft nucleophiles such as thiols or azides.11a This mode of reactivity 
leads to β-azido- and β-thiocarboxylic acids under inversion of stereochemistry (route 
G). Additionally, cuprates of the type R2CuMgBr react in the very same way, thus 
allowing stereoselective introduction of an alkyl moiety in the β-position (route E).11c 
This transformation has also been applied to 4-alkynyl-2-oxetanones, which undergo a 
SN2’-reaction, thus enabling stereoselective synthesis of highly substituted allenes 
(route C).14 Other typical reactions of β-lactones include dyotropic rearrangements to 
γ-lactones (route F),15 rearrangement to acrylate derivatives (route D),16 stereo-
selective decarboxylation to the corresponding alkene (route I),17 and α-alkylation 
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(route H).16,18 Overall, this versatility in reactivity is what makes β-lactones so 
interesting, and justifies further research endeavors aimed at their synthesis and usage. 
1.3 Synthetic Routes to β-Lactones 
1.3.1 Brief Survey of Common Approaches to β-Lactones 
In light of the diverse set of reactions that β-lactones can undergo, it seems 
somewhat surprising that only two routes are routinely used for their synthesis 
(Scheme 1.2).3 The first route consists of cyclization of an acyclic aldol-type precursor 
(Scheme 1.2a), and a variety of robust methods are available to carry out this approach 
either in situ19 or with well-defined precursors.20 Unfortunately, these routes often 
require several synthetic steps, and are not very economical because stoichiometric 
amounts of additional reagents are needed. 
O O
O
R
R1 R2 R1 R2
O
O O
alkylation
R1 OH
OOH
R2
aldol product
OO
R1
R2
•+
epimerization
cyclization
[2+2]-cyclo-
addition
class I: Fe-, Pd-, Rh-based
class II: [Lewis acid]+[Co(CO)4]-
CO
carbonylation
catalyst
O
R1 R2
cis or trans
carbonylation catalyst
a)
b)
c)
 
Scheme 1.2 Common synthetic approaches to mono- and disubstituted β-lactones 
The second approach relies on catalyzed (formal) [2+2] cycloadditions of 
carbonyl compounds with ketenes (Scheme 1.2b).21,22 If catalyzed, this route can give 
a wide range of β-lactones directly and often with good stereochemical control in the 
case of vicinally disubstituted β-lactones. On the downside, the required ketenes are 
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generally highly reactive compounds that need to be generated at low temperatures 
using basic conditions. Besides being inconvenient, this approach also introduces 
stoichiometric amounts of additional reagents. Moreover, the majority of these 
methods only produces mono- or cis-disubstituted β-lactones. On the other hand, the 
synthesis of trans-disubstituted β-lactones requires a special catalytic system (vide 
infra). At this point, it should also be noted that neither monosubstituted β-lactones 
nor cis-disubstituted β-lactones can easily be transformed into trans-disubstituted β-
lactones via alkylation or epimerization, respectively.18,23 Nevertheless, the [2+2]-
cycloaddition approach has found wide acceptance in the synthetic community and has 
been applied to several total syntheses.6a  
Ring-expansion carbonylation of epoxides (Scheme 1.2c) has recently emerged as 
a powerful, convenient, and direct method for the production of β-lactones, and has 
great potential to complement the aforementioned synthetic routes. Fundamentally, 
there are two different kinds of catalytic systems that can affect such transformations. 
The first class uses catalytic amounts of late-row transition metals such as rhodium, 
palladium, or stoichiometric amounts of iron carbonyls, and is limited to the 
carbonylation of alkenyl-substituted epoxides.24 The second class consists of a Lewis 
acid paired with a metal carbonyl anion such as [Co(CO)4]-, and was found to be more 
applicable and versatile in terms of scope then the first class. 25,26 Consequently, the 
nuances of the second class will be discussed in more detail in the subsequent sections. 
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1.3.2 Epoxide Carbonylation Using Catalysts of the Form [Lewis acid]+[Co(CO)4]- 
In 2001, Alper and coworkers showed that epoxides can be carbonylated to the 
corresponding β-lactones by using a neutral Lewis acid in combination with a salt 
containing [Co(CO)4]- as anion.26a Although this system was a major improvement 
over existing methods at that time, it still required high reaction temperatures together 
with long reaction times, and a limited substrate scope. Another major step forward 
was the introduction of catalytic systems based on frustrated ion pairs of the form 
[Lewis acid]+[Co(CO)4]- by Coates and coworkers in 2002.26b,c These systems were 
well defined, operated under milder conditions with a wide variety of epoxides, 
required only small catalyst loadings, and showed high chemoselectivity and  
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catalyst fo carbonylation
 of aziridines
catalyst for double carbonyation of
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   7 8
9 10
 
Figure 1.3 Selected carbonylation catalysts of the form [Lewis acid]+[Co(CO)4]- 
and their utility 
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functional group tolerance. Over the years, several generations of catalysts have been 
developed and optimized for different applications as can be seen in Figure 1.3.26b-e,27 
Mechanistic investigations revealed an intricate interplay between the catalytic 
system, the epoxide substrate, and the reaction solvent, as well as the SN2-mechanism 
by which the carbonylation reaction proceeds.17,28,29 A general mechanism is shown in 
Scheme 1.3.29 
Al+ LL
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Scheme 1.3 Proposed mechanism for carbonylation of epoxides using catalysts of 
the form [Lewis acid]+[Co(CO)4]- 
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The postulated catalytic cycle shows that the isolated and characterized [Lewis 
acid]+[Co(CO)4]—species (Scheme 1.3, A) is not the actual catalyst because the Lewis 
acid ions are coordinatively saturated by solvent molecules. This is also evident from 
X-ray analysis of single crystals. Consequently, the catalytically active species is 
formed initially in situ by loss of a molecule of solvent (B). The now unoccupied 
coordination site is then available for epoxide molecules. Upon coordination (C), the 
substrate becomes electrophilic enough so that the nucleophilic cobaltate-anion can 
perform a ring-opening reaction, which proceeds in an SN2-type manner. Concomitant 
with this attack is the loss of another solvent molecule from the Lewis acidic metal. 
The newly formed cobalt species D then undergoes migratory insertion of a molecule 
of carbon monoxide into the cobalt-alkyl bond to give rise to E. In the next step, a 
molecule of CO is recruited from the surrounding solution to the cobalt-center, which 
subsequently produces the cobalt-acyl species F. This intermediate is observable by in 
situ-IR and was proposed to be the resting state of this catalytic cycle. In the 
following, rate-determining step, a solvent molecule recoordinates to the Lewis acidic 
metal, which initiates the ring-closing reaction of the organic substrate to the β-lactone 
product (G). Interactions like this between solvent molecules and catalyst rationalize 
the large solvent dependence of the reaction rate as well as product selectivity, for 
example mono- vs. biscarbonylation of epoxides.27 Finally, the catalytically competent 
species B is reformed and ready to undergo another catalytic cycle. 
Despite all the advantages that catalysts of the form [Lewis acid]+[Co(CO)4]- 
introduced to the field of ring-expansion carbonylation of epoxides, one component 
that is at the heart of synthesis still needs to be addressed further by these systems, 
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namely selectivity. Although carbonylation reactions proceed with high 
chemoselectivity (cf. Section 1.4.1) and follow a stereospecific mechanism, areas such 
as regioselectivity and enantioselectivity nonetheless remain challenging. 
1.4 Selectivity in Epoxide Carbonylation Reactions Using [Lewis acid]+[Co(CO)4]- 
Catalysts: Opportunities and Challenges 
1.4.1 Chemoselectivity  
As mentioned before, carbonylation of epoxides proceeds with such high 
chemoselectivity that upon completion of the reaction the β-lactone products can often 
be isolated via simple distillation. Scheme 1.3 indicates that the formation of ketone 
side products can become a problem at certain stages in the catalytic cycle.25e For 
example, upon coordination of the epoxide to the Lewis acid (Scheme 1.3, species C) 
the epoxide is activated enough do undergo a Meinwald rearrangement30 to the 
corresponding ketone. Indeed, this reaction is observed exclusively in the presence of 
a non-nucleophilic anion such as tetraphenylborate. β-Hydride elimination from the 
intermediate cobalt-alkyl species D is another potential pathway to ketone formation, 
and can be suppressed by judicious choice of the Lewis acid or by applying pressures 
of CO exceeding 300 psi.26e 
Other potential decomposition pathways for the β-lactone product under reaction 
conditions include ring-opening polymerization to polyesters, double carbonylation of 
the β-lactone to succinic anhydrides, or decarboxylation to the underlying alkene. The 
first two routes can be suppressed by the use of the right solvent, or even promoted if 
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so desired.27,31 The degradation via decarboxylation is usually avoided by adjusting 
the reaction temperature accordingly.32 
A summary of all potential degradation pathways discussed in this section is 
provided in Scheme 1.4. 
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Scheme 1.4 Major pathways that can compromise the chemoselectivity of the 
ring-expansion carbonylation of epoxides to β-lactones 
1.4.2 Regioselectivity  
Terminal epoxides are carbonylated with excellent regioselectivities of >100 : 1 in 
favor of CO insertion at the methylene carbon (Scheme 1.5a). This steric preference is 
in line with what is expected from an SN2-mechanism. The only exception is alkenyl-
substituted epoxides such as styrene oxide, which show preferential incorporation of 
CO at the α- instead of the β-position (Scheme 1.5b).33 Tri- and tetra-substituted 
epoxides, on the other hand, are inert to carbonylation reactions (Scheme 1.5c).33 
A special scenario arises with 2,2’-disubstituted epoxides (Scheme 1.5d) Based on 
steric factors alone, one would expect exclusive carbonylation at the methylene 
carbon. However, the experimental observation is a mixture of both possible 
regioisomers.26b,c A possible explanation for this outcome lies in the very electrophilic 
nature of the Lewis acid ion. As the epoxide coordinates to the Lewis acid, it is 
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conceivable that a partial positive charge develops at the tertiary carbon of the 
epoxide. Even though orbital overlap favors attack at the methylene carbon, ionic 
interactions bias the attack of the cobalt-anion toward the tertiary carbon, which 
overall results in attack at both positions and yields the aforementioned mixture. 
O
R
O
O
R
[Lewis acid]+
[Co(CO)4]-
CO
virtually
exclusive
O
Ar
O
Ar
[Lewis acid]+
[Co(CO)4]-
CO
O
O
Ar
+
O
majorminor
O
[Lewis acid]+
[Co(CO)4]-
COR2
R1 R3
R4
R4 = R or H
O
[Lewis acid]+
[Co(CO)4]-
COR2
R1
O O+
major minor
O O
R1
R2
R1
R2
(a)
(b)
(c)
(d)
O
[Lewis acid]+
[Co(CO)4]-
CO
(e)
R2R1
O O+
O O
R1 R2 R1 R2
mixture of regiosiomers
with little to no selectivity
R1 ! R2
no reaction
cis or trans
 
Scheme 1.5 Observed regioselectivies with literature-known carbonylation 
catalysts for selected types of epoxides 
The most challenging substrates in terms of regiocontrol are unsymmetrically cis- 
or trans-disubstituted epoxides (Scheme 1.5e). This class of epoxides is particularly 
interesting because most known bioactive β-lactones consist of only a single trans-
disubstituted regioisomer (cf. Section 1.2.1). Prior to the work presented in Chapter 2 
in this thesis, only two examples regarding the carbonylation of this class of epoxides 
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were reported, and both proceeded with low regioselectivities.33 Regioselective 
intermolecular reactions of unbiased cis- or trans-disubstituted epoxides that follow by 
an SN2-mechanism are generally difficult to achieve with any sort of nucleophile.34 
Strategies to address this problem have been developed, and include a) use of epoxides 
that carry a strong electronic or steric bias,35 b) utilization of a non-SN2-mechanism 
for the ring-opening reaction,36 c) restricting the reaction to an intramolecular event,37 
or d) use of a directing group present in the epoxide.34b While these methods can 
achieve very high regioselectivities, use of a selective catalyst that only temporarily 
alters the structure of the substrate while still achieving the same selectivity would be 
more desirable. Unfortunately, such catalytic systems are very rare.38 As is often the 
case, nature has successfully taken on this problem and evolved enzymes called 
hydrolases that allow regioselective hydrolysis of vicinally disubstituted epoxides in 
mammalian cells.39 However, to date no synthetic small molecule analog of these 
enzymes exists that shows good selectivity with a variety of cis- or trans-disubstituted 
epoxides. A potentially new design strategy for such catalysts is presented in Chapter 
2, which addresses the problem of regioselective carbonylation of cis- or trans-
disubstituted epoxides for a number of substrates. 
1.4.3 Enantioselectivity 
The enantioselective synthesis of β-lactones is of great importance given the wide 
range of products and reactions derived from them. The two aforementioned main 
synthetic routes to β-lactones, namely cyclization of aldol products and [2+2]-
cycloadditions of ketenes with carbonyl compounds, can both be used to access 
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enantioenriched β-lactone products.6a,10 As far as the cyclization route is concerned, 
many diastereo- and enantioselective (aldol) methodologies exist to synthesize the 
required precursors,40,41 and some of these methods have been incorporated into 
powerful one-pot procedures.42  
In addition to the cyclization route, enantioselective variants of the 
aforementioned [2+2]-cycloadditions exist, which rely on catalysis by either an 
enantiopure Lewis acid10 or an enantiopure nucleophile.43 While enantiopure Lewis 
acids afford only moderate enantioselectivities, enantiopure nucleophilic catalysts 
have been developed into a reliable and versatile synthetic tool for the synthesis of 
enantioenriched β-lactones.44 Nonetheless, the aforementioned disadvantages 
associated with these methods still apply. Moreover, only mono- and cis-disubstituted 
β-lactone products are routinely accessible using the [2+2]-cycloaddition method. 
Direct trans-selective routes were unknown until recently,45 and still require 
refinement. 
Carbonylation of epoxides has the potential to be a very powerful approach to 
enantioenriched β-lactone products. Since stereochemistry is reliably transformed at 
the site of CO insertion during carbonylation reactions using [Lewis acid]+[Co(CO)4]--
catalysts, enantioenriched epoxides are readily converted into the corresponding 
lactone products without erosion of enantiopurity.26b The required enantioenriched 
epoxides themselves can be accessed using a host of different methods.46 
Enantioenriched terminal epoxides are especially readily available thanks to 
techniques such as hydrolytic kinetic resolution.46e Overall, this combination of 
enantioselective epoxide synthesis and subsequent carbonylation reaction provides a 
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reliable two-step entry into enantioenriched β-lactone products. Alternatively, racemic 
β-lactones can be subjected to enzymatic kinetic resolution to obtain the same 
enantioenriched β-lactones.47 
On the other hand, the synthesis of enantioenriched β-lactones starting directly 
from meso or racemic epoxides is significantly less advanced. Most of these routes 
would also have to rely on kinetic resolutions of epoxides (Scheme 1.6), yet no 
general synthetic method exists so far despite continuing efforts (see Chapter 3).48 The 
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Scheme 1.6 Potential approaches to enantioenriched β-lactone products using 
enantiopure carbonylation catalysts 
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advantage of such methods over the use of already enantioenriched epoxide substrates 
would be that all of the epoxide substrate could eventually be transformed into β-
lactone product using two rounds of carbonylation, instead of being forced to discard 
50% of the epoxide in a resolution step prior to carbonylation. Furthermore, β-lactones 
derived from meso epoxides do not have an epoxide precursor that can be produced in 
an enantioenriched form. Consequently, enantioselective carbonylation catalysts are a 
must for this class of epoxides. Given the current dearth of such enantioselective 
carbonylation catalysts, this field still awaits further exploration.49 New concepts on 
how this can potentially be achieved are presented in Chapter 3. 
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of cis- and trans-Disubstituted Epoxides to β-Lactones 
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2.1 Introduction 
The aldol reaction and its diverse array of products are of great importance in the 
synthesis of complex molecules and industrial processes.1 Noteworthy features of this 
transformation are the formation of a C–C bond, and the concomitant creation of two 
contiguous stereocenters. Aldol products derived from so-called propionate aldol 
reactions (Figure 2.1, R2 = Me) are of special interest,2 and thus many excellent 
methods for their synthesis exist.3  
R1 H
O
Aux
O
+ R1 X
OOH
X = NR2,
OR, OH
R2
- activating reagent in addition to catalyst / auxiliary (Aux) typically required
- strict control of reaction conditions often necessary
- challenge: control over diastereo- and enantioselectivity
R2 syn
R1 X
OOH
R2 anti
or
 
Figure 2.1 Generalized (stereoselective) aldol reaction and common synthetic 
characteristics associated with it  
A common deficiency of these methods, however, is the use of stoichiometric 
amounts of an activating agent, e.g. a base, to facilitate the reaction. Furthermore, 
strict control of reaction conditions and additional auxiliaries or catalysts are often 
needed to induce high levels of relative and absolute stereocontrol.3 Taken together, 
these attributes can be disadvantageous in terms of cost and operational simplicity. 
An alternative approach to the same line of aldol-type products utilizes α,β-
disubstituted β-lactones. Due to their inherent reactivities, they can easily be converted 
into a wide variety of stereochemically well-defined aldol-type compounds, or 
rearranged to structures otherwise inaccessible via aldol reactions.4,5 As mentioned 
before in Chapter 1, β-lactones also represent a valuable class of compounds due to 
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their occurrence in natural products,6 and because of their ability to serve as 
monomers in the synthesis of polyesters.7  
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Figure 2.2 Common approaches to α,β-disubstituted β-lactones and regioselective 
epoxide carbonylation as a versatile alternative  
Unfortunately, not many methods are currently available to make α,β-
disubstituted β-lactones stereoselectively in a direct and economical fashion (Figure 
2.2).8 Of the methods available, most require lactonization of a corresponding acyclic 
precursor. However, these precursors themselves are typically derived from aldol 
reactions.9 Another popular approach is the catalyzed (formal) [2+2]-cycloaddition of 
ketenes to carbonyl compounds. This transformation gives cis-β-lactones directly with 
often excellent stereoselectivity.10 Drawbacks are the need to synthesize both reaction 
partners separately, the use of stoichiometric amounts of an activating agent, and 
careful control of the reaction parameters. Moreover, only a few catalytic systems are 
known to make trans-β-lactones by this method.11 
Carbonylation of epoxides using catalysts of the form [Lewis acid]+[Co(CO)4]- 
has recently emerged as a reliable direct approach to β-lactones when using terminal 
or symmetrically cis- or trans-disubstituted epoxides as substrates.12 Consequently, 
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this route seems like an attractive alternative method to obtain the aforementioned β-
lactones and aldol-type products associated with them (Figure 2.3). The epoxide 
substrates are readily available in diastereo- and enantioenriched forms,13 and the SN2-
mechanism of the carbonylation reaction transforms existing stereochemistry 
predictably.14 
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Figure 2.3 Regioselective epoxide carbonylation and subsequent β-lactone 
funtionalization as an alternative entry into aldol-type products 
However, known carbonylation catalysts are prone to producing an unselective 
mixture of regioisomeric β-lactone products from cis- or trans-disubstituted epoxides. 
Presumably this is because of an unselective SN2-ring opening reaction between the 
epoxide and the cobaltate anion in the case of electronically or sterically unbiased 
substrates (Scheme 2.1). Unselective SN2-reactions are a general problem encountered 
with any nucleophile when trying to ring-open this class of epoxides.15 Consequently, 
very few selective catalysts exist for such a reaction based on an SN2-type 
mechanism.16,17  
With the intent to address these problems, we report in the following four new 
salen-based catalysts that carbonylate cis- and trans-disubstituted epoxides with 
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Scheme 2.1 Simplified mechanism of epoxide carbonylation using [Lewis acid]+ 
[Co(CO)4]- catalysts, and the problem of regioselectivity 
moderate to high regioselectivities. Each catalyst selectively produces a different 
isomer out of the four possible regioisomeric β-lactones. Use of these new catalysts 
consequently provides a convenient entry into a larger group of more complex α,β-
disubstituted β-lactones and the aldol-type products associated with them starting from 
readily available epoxides. Given the large number of epoxide ring-opening reactions 
that are mediated by salen-type catalysts, these new systems could also be useful for 
applications beyond just carbonylation reactions. This idea is explored further by 
applying one of the new catalyst-frameworks to the regioselective transformation of 
vicinally disubstituted epoxides into chlorohydrins. 
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2.2 Regioselective Carbonylation of trans-Epoxides to cis-β-Lactones 
2.2.1 Catalyst Development 
Initial studies focused on identifying a ligand framework for the Lewis acidic 
metal ion that could impart high degrees of regioselectivity in the carbonylation of 
trans-epoxides (Table 2.1). Methyl-substituted epoxides such as 2a were chosen as 
substrates because the resulting β-lactones 3a and 4a are both of interest. Lactone 
class 3 serves as a precursor for the aforementioned important propionate aldol 
products.2 Lactones 4 give aldol-type products based on acetaldehyde, which can be a 
troublesome electrophile in aldol reactions due to its suspected carcinogenicity and 
propensity to hydrate or oligomerize. The salen-framework seemed to be a good 
starting point for ligand development because of its highly modular nature and known 
ability to form complexes that catalyze carbonylation reactions.12,14 Previously 
reported salen-based carbonylation catalysts, however, showed poor activity at 
ambient temperature, and a modest contrasteric preference for β-lactone 4a (entries 1-
3). Consequently, a redesign of the ligand was necessary. Changing the ligand 
structure from the salen-type to a salalen-type (L2, catalyst 1e) increased the 
preference for 4a to more synthetically useful levels (entry 5). Use of a salalen-ligand 
also allowed for the incorporation of an additional pyridine donor ligand. Based on 
prior mechanistic studies,14b this was expected to facilitate the rate-determining step in 
the catalytic cycle, thus improving the low activity of catalysts such as 1a at 22 °C. 
Indeed, complete conversion of epoxide 2a and a slight increase in selectivity were 
observed with catalyst 1e after solvent optimization (Table 2.2, entries 1-7). 
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Table 2.1 Evaluation of carbonylation catalysts for the regioselective carbonyla-
tion of trans-epoxide 2aa 
N N N N N N N N
L1 L2 L4L3
rac
N
rac
N
L5amine/imine linker
N
N N
O O
Al+
R1
R2 R2
R1
1a-n
linker R1 = Me, tBu
R2 = Me, tBu,
2,6-Me2Ph (Ar1),
2,4,6-Me3Ph (Ar2),
2,6-Me2-4-tBuPh (Ar3)
[Co(CO)4]
 
O
Me nPent
O
Me nPent
O
Me nPent
+
3a 4a
racemic
catalyst (5 mol %)
2a
O O
CO (900 psi)
THF
 
entry linker R1 R2 catalyst ratiob 3a : 4a conversionb (%) 
1z L1 tBu tBu 1a 01 : 1.6 >05 
2z L3 tBu tBu 1b 01 : 1.6 >12 
3c L3 tBu tBu 1c 01 : 1.2 >10 
4z L4 tBu tBu 1d 01 : 1.3 >45 
5d L2 tBu tBu 1e 01 : 3.7 >41 
6z L1 Me Me 1f 01.4 : 1 >09 
7z L1 H Ar2 1g n. d. 0<5 
8z L1 Me Ar2 1h 10.1 : 1 >40 
9z L3 Me Ar2 1i 11.5 : 1 >23 
10 L4 Me Ar2 1j 02.3 : 1 >87 
11 L5 Me Ar2 1k 06.7 : 1 >71 
12 L1 Me Ar1 1l 11.5 : 1 >40 
13 L1 Me Ar3 1m 11.5 : 1 >95 
14 L3 Me Ar3 1n 10.1 : 1 >35 
aReaction conditions: [2a] = 0.5 M, 22 °C, 20 h. With the exception of 1a-e, catalysts were generated in situ 
(LnAlCl + NaCo(CO)4). bAs determined by 1H NMR/GC analysis from crude reaction mixture. cUse of Cr3+ 
instead of Al3+ as Lewis acidic metal ion. d7.5 mol % 1e used. n. d. = not determined. 
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Table 2.2 Evaluation of solvents in the regioselective carbonylation of trans-
epoxide 2a using optimized catalysts 1e and 1ma 
O
Me nPent
O
Me nPent
O
Me nPent
+
3a 4a
racemic
1e (7.5 mol %)
or
1m (5 mol %)
2a
N N
O O
Al
tBu
tBu tBu
tBu
rac
N
[Co(CO)4]
1e
O O
N N
O O
Al
Me Me
rac
tBu tBu
Me
Me
Me
Me
1m
[Co(CO)4]
CO (900 psi)
solvent
 
entry solvent catalyst ratiob 3a : 4a conversionb (%) 
1 THF 1e 1 : 3.7 >41 
2 1,4-dioxane 1e 1 : 4.0 >02 
3 toluene 1e 1 : 4.0 >71 
4 benzene 1e 1 : 4.0 >95 
5 xylenes 1e 1 : 4.2 >21 
6 anisole 1e 1 : 4.0 >48 
7 hexanes 1e 1 : 4.2 >60 
8 THF 1m 11.5 : 1 >95 
9 1,4-dioxane 1m 10.6 : 1 >81 
10 toluene 1m 06.9 : 1 >24c 
11 DME 1m 10.6 : 1 >95 
12 THP 1m 09.4 : 1 >25 
aReaction conditions: [2a] = 0.5 M, 22 °C, 12 h. Catalyst 1m was generated in situ (LnAlCl + NaCo(CO)4). 
bAs determined by 1H NMR/GC analysis from crude reaction mixture. cSignificant amounts of ketone as 
by-product detected. 
Catalyst 1e proved useful for the enhanced production of 4a, yet a carbonylation 
catalyst that would strongly favor formation of regioisomer 3a was still more 
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desirable. A first indication how this could be achieved came in the form of catalyst 1f 
(Table 2.1, entry 6). The small size of the substituents R1 and R2 in this catalyst gave 
rise to a small shift in selectivity toward 3a. A subsequent adjustment of the steric 
hindrance in R2 then gave rise to very good selectivity, yet catalyst activity was still 
only moderate (entry 8). Variation of the diamine-linker yielded unsatisfactory results 
(entries 9-11). However, fine-tuning the steric size of the aryl-group in R2 (entries 12 
and 13) led to catalyst 1m, which in THF showed the best activity and selectivity in 
producing 3a (Table 2.2, entries 8-12). 
To date, only low quality X-ray crystals of 1m could be obtained (Figure 2.4, R = 
0.0707, wR2 = 0.1832). Nonetheless, their analysis indicates that the ligand 
coordinates in the salen-typical trans-planar geometry around the Al3+-ion, albeit in a 
rather distorted fashion.18 
  
Figure 2.4 Low quality crystal data for catalyst 1m 
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2.2.2 Scope of the Regioselective Carbonylation Using Catalysts 1e and 1m 
Catalysts 1e and 1m were subsequently tested for the regioselective carbonylation 
of a variety of trans-disubstituted epoxides 2 (Table 2.3 and Table 2.4). GC or 1H 
NMR analysis of crude reaction mixtures indicated full conversion of starting material 
to lactone with both catalysts in almost all cases. The resulting regioisomeric β-lactone 
products 3 and 4 could be separated from one another either directly via column 
chromatography, or after converting them into the corresponding ester-derivatives 5 
and 6 using a one-pot sequence by quenching the reaction with MeOH/NaOMe. The 
latter approach showcases how the obtained β-lactones can readily be converted into 
related aldol moieties with well-defined stereochemistry. 
Table 2.3 Regioselective carbonylation of trans-disubstituted epoxides to β-
lactones using catalyst 1ea 
Me OMe
OH
Et
O
5b (ester-
derivative of 4b)
O
Me R
O
Me R
+
4
racemic
O
2
O
O
Me R
3
CO (900 psi)
benzene
preferentially 
formed
1e (7.5 mol %)
 
entry R (epoxide) ratiob 3 : 4 
isolated 
product 
isolated 
yield (%) 
1c Et (2b) 1 : 3.0 5b 63 
2c nPr (2c) 1 : 3.7 4c 60 
3c nBu (2d) 1 : 3.5 4d 65 
4c nPent (2a) 1 : 4.0 4a 68 
5c nHex (2e) 1 : 4.6 4e 71 
6c (CH2)3OTBS (2f) n. d. 4f <5b 
aReaction conditions: [2] = 0.5 M, 22 °C, 22 h. All reactions gave full conversion (GC or 1H NMR 
analysis), except for 2f (<5%). Yields refer to isolated products. bDetermined by 1H NMR analysis of 
crude reaction mixture. c5 mol % of 1e used. n. d. = not determined. TBS = tBuMe2Si. 
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Carbonylation of trans-epoxides 2 with catalyst 1e gave good preference for β-
lactones 4 (Table 2.3), with ratios 3 : 4 falling in the range from 1 : 3.0 to 1 : 4.6. 
Interestingly, 1e displayed an almost steady increase in regioselectivity for epoxides 
2a-e (entries 1-5). This seems counterintuitive because longer alkyl-chains should 
shield their side of the epoxide more from nucleophilic attacks than shorter ones. In 
line with this expectation, epoxides with sterically more demanding substituents R 
such as 2f gave no formation of any lactone when exposed to 1e (entry 6). 
Nevertheless, the contrasteric selectivities achieved with 1e are without precedence for 
this group of epoxides, and cannot readily be explained by invoking an inherent steric 
or electronic bias. 
In comparison to 1e, catalyst 1m generally showed higher regioselectivities in the 
carbonylation of trans-epoxides 2, with ratios 3 : 4 typically exceeding 10.0 : 1 in 
favor of 3 (Table 2.4). Only epoxide 2b gave a lower ratio of 6.1 : 1 (entry 1). Given 
the similarity of the epoxide substituents in 2b (Me vs. Et), this is still a very good 
ratio, and underscores the ability of 1m to effectively enhance even small degrees of 
steric bias contained in 2. In contrast to the trend observed with 1e, epoxides 2a,c-e 
showed little variation in regioselectivity as the length of the alkyl-chain was altered 
(entries 2-5). As expected, trans-epoxides 2 with sterically more demanding 
substituents R gave even better selectivities toward β-lactones 3 (entries 6-9). In case 
of 2h and i, this additional bias was strong enough to form lactones 3h and i almost 
exclusively, with only trace amounts of 4h and i being detectable via 1H NMR 
spectroscopy. However, placement of steric bulk immediately adjacent to the epoxy-
group (2j, entry 10) gave a mixture of 3 and 4 and relatively poor conversion. 
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Likewise, trans-epoxides with sterically very similar substituents gave rather low 
selectivities when using catalyst 1m. For example, trans-2-butyl-3-ethyloxirane (2k) 
gave a ratio of 2.7 : 1 of regioisomeric β-lactones, and 25% conversion with 1m under 
standard reaction conditions (1H NMR analysis). 
Table 2.4 Regioselective carbonylation of trans-disubstituted epoxides to β-
lactones using catalyst 1ma 
6 (ester-
derivative of 3)
O
Me R
O
Me R
+
4
racemic
O
2
O
O
Me R
3
CO (900 psi)
THF
preferentially 
formed
R
O
Me
OH
MeO1m (5 mol %)
 
entry R (epoxide) 
ratiob 
3 : 4 
isolated 
product 
isolated 
yield (%) 
1d Et (2b) 06.1 : 1 6b 60x 
2d nPr (2c) 11.5 : 1 6c 68x 
3d nBu(2d) 13.3 : 1 6d 74x 
4d nPent (2a) 11.5 : 1 6a 79x 
5d nHex (2e) 13.3 : 1 6e 85x 
6d (CH2)3OTBS (2f) 19.0 : 1 6f 75x 
7c (CH2)2OTBS (2g) 24.0 : 1 6g 81x 
8d CH2OTBS (2h)  >50 : 1 3h 92c 
9d CH2Ph (2i)  >50 : 1 3i 84c 
10d iPr (2j) 10.1 : 1 3j + 4jb 45b 
aReaction conditions: [2] = 0.5 M, 22 °C, 20 h. All reactions gave full conversion (GC or 1H NMR 
analysis), except for 2j (45%). Yields refer to isolated products. bDetermined by 1H NMR analysis of 
crude reaction mixture. c7.5 mol % 1m used. d10 mol % 1m used. TBS = tBuMe2Si. 
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2.2.3 Regioselective Carbonylation of Enantiopure Epoxides using Catalyst 1m 
Given the good performance of 1m, its ability to regioselectively carbonylate 
enantioenriched trans-epoxides was investigated next. The use of enantioenriched 
epoxides is very attractive because several excellent methods for their preparation 
exist,13 and stereochemistry is reliably converted during carbonylation reactions.14 A 
potential pitfall, however, lies in the fact that 1m is typically used as a racemate. This 
can lead to matched/mismatched combinations19 between the enantioenriched epoxide 
and the two enantiomers of the racemic catalyst, thus potentially diminishing the good 
selectivities observed before with racemic epoxides. To explore this scenario, highly 
enantioenriched (S,S)-2e (>95% ee) and (S,S)-2i (99% ee) were synthesized and 
carbonylated using racemic versions of 1m (Table 2.5). 
The good regioselectivities and activities were retained with both enantioenriched 
epoxides when using rac-1m (entries 1-2, and 5-6). These results indicate that 1m is 
well suited for the regioselective carbonylation of enantioenriched trans-epoxides, 
which ultimately leads to enantioenriched aldol-type products. The use of enantiopure 
catalyst also allowed for the identification of matched/mismatched-pairs between the 
epoxide and the carbonylation catalyst. As Table 2.5 shows, trans-epoxides with (S,S)-
configuration constitute a mismatched pair with (S,S)-1m, leading to significantly 
reduced selectivity and activity (entries 3 and 7). The matched case with (R,R)-1m, 
however, improves further on the already good selectivity and produced the preferred 
regioisomer 3 almost exclusively (entries 4 and 8). 
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Table 2.5 Regioselective carbonylation of enantioenriched trans-disubstituted 
epoxides (S,S)-2e and i using catalyst 1ma 
1m (5 mol %)O
Me R
O
Me R
+
(3R,4S)-4
enantioenriched
O
(S,S)-2
O
O
Me R
(3R,4S)-3
CO (900 psi)
THF
preferentially 
formed
 
entry R (epoxide) catalyst 
ratiob 
3 : 4 
conversionb 
(%) 
1 nHex (rac-2e) rac-1m 13.3 : 1 >95 
2 nHex (S,S-2e) rac-1m 13.3 : 1 >95 
3 nHex (S,S-2e) (S,S)-1m 01.6 : 1 >80 
4 nHex (S,S-2e) (R,R)-1m 32.3 : 1 >95 
5 CH2Ph (rac-2i) rac-1m >50 : 1 >95 
6 CH2Ph (S,S-2i) rac-1m >50 : 1 >95 
7 CH2Ph (S,S-2i) (S,S)-1m 13.4 : 1 >56 
8 CH2Ph (S,S-2i) (R,R)-1m >50 : 1 >95 
aReaction conditions: [2] = 0.5 M, 22 °C, 20 h. bConversion to lactone, determined by 1H NMR analysis 
of crude reaction mixture. 
It is currently unclear, why (R,R)-1m preferentially interacts with (S,S)- instead of 
(R,R)-trans-epoxides 2, and how the catalyst is able to induce such high levels of 
regioselectivity. Steric interactions presumably play a major role in both processes. 
Moreover, it is reasonable to assume that binding of epoxide 2 to the sterically 
encumbered Lewis acid restricts the number of conformations that its substituent R 
can adopt (Figure 2.5a). Similar levels of conformational restriction are probably 
absent when less sterically bulky Lewis acids are used (Figure 2.5b). The effect of 
such restrictions would then be that substituent R is confined to conformations that 
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shield its corresponding epoxy-methine-carbon from nucleophilic attacks, thus 
strongly favoring ring opening of the epoxide at the observed position.  
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Figure 2.5 Proposed effect of salen-ligand framework on epoxide conformation 
and resulting regioselectivity  
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2.2.4 Conclusion 
In summary, two new carbonylation catalysts 1e and 1m are reported that convert 
trans-disubstituted epoxides 2 into the corresponding regioisomeric β-lactones 3 and 
4. Due to the excellent regioselectivities displayed by 1e and 1m, only one of the two 
β-lactone regioisomers is predominantly produced in these reactions. Moreover, the 
two catalysts show opposing regioselectivities, and thus provide access to a large 
variety of α,β-disubstituted β-lactones starting from readily available epoxides and 
carbon monoxide. In addition, these features are retained with enantiopure epoxides, 
and regioselectivity can be improved even further by matching enantiomers of catalyst 
and epoxide.  
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2.3 Regioselective Carbonylation of cis-Epoxides to trans-β-Lactones 
2.3.1 Catalyst Development 
A great number of naturally occurring β-lactones are α,β-disubstituted, exist as a 
single regioisomer, and display trans-configuration.20 Consequently, carbonylation of 
cis-disubstituted epoxides would be of great value if it could be performed in such a 
way that the resulting trans-configured β-lactones where produced with high 
regioselectivity. Unfortunately, the catalysts introduced for the regioselective 
carbonylation of trans-epoxides, 1e and 1m, gave unsatisfactory selectivities with cis-
disubstituted epoxides such as 9a (Table 2.6, entries 1 and 2). As a result, two 
additional catalysts had to be found that show high activities and opposing 
regioselectivities for the carbonylation of cis-disubstituted epoxides to the 
corresponding trans-β-lactones. 
Given the success of salen-based ligands in the regioselective carbonylation of 
trans-epoxides, we felt confident that analogous frameworks could also yield highly 
active and selective catalysts for cis-epoxides. Consequently, a variety of salen based-
carbonylation catalysts were screened for the selective synthesis of regioisomer 10a 
starting from cis-epoxide 9a (Table 2.6). The resulting β-lactones 10 would give rise 
to potentially useful propionate aldol-type motifs commonly found in natural products 
synthesis.2 Test reactions using literature-known catalysts 1a-c already yielded good 
conversions and selectivities for lactone 10a (entries 3-5). Interestingly, the use of 
chromium as Lewis acidic metal ion produced a more active yet less selective catalyst 
in comparison to the aluminum-based systems, and thus was not pursued further. 
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Table 2.6 Evaluation of carbonylation catalysts for the regioselective carbonyla-
tion of cis-disubstituted epoxides to trans-β-lactonesa 
N
N
N
N Al
Cl
Cl
Cl
Cl
N N
O O
Al
tBu
tBu tBu
tBu
N
[Co(CO)4]rac
diamine-linker:
1e
[Co(CO)4]
8
substituents R1, R2:
iPr
iPr
iPr
N N
L1
N N
L2
rac
N N
L3
N N
L4
N N
O O
Al+
R1
R2 R2
R1
1
linker
rac
tBu
tBu
Ar4
[Co(CO)4] Me, tBu
Me
Me
tBu
Me
Me Ar1
Ar2
Ar3
 
O
Me nBu
catalyst (5 mol %) O
Me nBu
+
10a
racemic
9a
O
O
O
Me nBu
11a
CO (900 psi)
THF
 
entry Linker R1 R2 catalyst ratiob 10a : 11a conv.b (%) 
1h - tBu tBu 1e 1 : 1.30 >95 
2h L2 Me Ar2 1m 3.0 : 10 072c 
3d L1 tBu tBu 1c 2.1 : 10 >95 
4c L1 tBu tBu 1b 3.0 : 10 >74 
5c L2 tBu tBu 1a 2.7 : 10 >72 
6c L3 tBu tBu 1d 3.3 : 10 >95 
7c L3 tBu Me 1o 2.0 : 10 >95 
8c L3 Me Me 1p 2.1 : 10 >95 
9c L3 Me H 1q 2.1 : 10 >95 
10c L3 Ar3 tBu 1r 2.1 : 10 >95 
11c L2 Me Ar1 1l 1.6 : 10 >74 
12e L4 Me Ar4 7a 1 : 11.5 >63 
13e - - - 8 2.9 : 10 >95 
aReaction conditions: [9a] = 0.5 M, 22 °C, 20 h. bConversion to lactone and ratio of regioisomers 
determined by GC or 1H NMR analysis of crude reaction mixture. cThe remainder was 3-heptanone. dCr3+ 
used as Lewis acidic metal ion. e2 mol % of 8 used All catalysts except 1d,e,m and 8 were prepared in situ 
(LnAlCl + NaCo(CO)4). 
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Changing the diamine-linker to 2,3-dimethylbutane-2,3-diamine (L3) preserved the 
good regioselectivity observed with linkers L1 and L2, and further increased the 
activity of the catalytic system (entry 6). Variation of the steric size of substituents R1 
and R2 had no beneficial effect in terms of selectivity (entries 7-10), consequently 1d 
was the catalyst of choice (Figure 2.6). 
When testing catalysts akin to 1l and 1m that featured 1,1’-binaphtyl-2,2’-diamine 
(DABN) as the diamine-linker, a reversal in regioselectivity in favor of lactone 11a 
was noted. Use of this moiety together with 3,5-tBu-phenyl as substituent R2 then gave 
rise to catalyst 7a (entry 12), which displayed excellent contrasteric regioselectivity. 
Use of 1,4-dioxane instead of THF as solvent enhanced the selectivity for lactone 11a 
even further (Table 2.7). 
Table 2.7 Evaluation of solvents in the regioselective carbonylation of cis-epoxide 
9a using catalyst 7aa 
O
Me nBu
7a (5 mol %) O
Me nBu
+
10a
racemic
9a
O
O
O
Me nBu
11a
CO (900 psi)
solvent
 
entry solvent ratiob 10a : 11a conv.b (%) 
1 THF 1 : 11.5 >63 
2 1,4-dioxane 1 : 24.0 >95 
3 THP 1 : 10.1 >41 
4 Et2O 1 : 7.30 >95 
aReaction conditions: [9a] = 0.5 M, 22 °C, 20 h. bConversion to lactone and ratio of regioisomers 
determined by GC or 1H NMR analysis of crude reaction mixture. Catalyst 7a prepared in situ (LnAlCl 
+ NaCo(CO)4). 
With two competent and complementary carbonylation catalysts in hand (Figure 
2.6), the scope of each catalytic system was investigated. 
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Figure 2.6 Optimized catalysts 1d and 7a for the regioselective carbonylation of 
cis-disubstituted epoxides 
 
45 
2.3.2 Scope of the Regioselective Carbonylation Using Catalysts 1d and 7a 
Cis-epoxides 9 typically gave synthetically useful regioselectivities of greater 
than 3.0 : 1 in favor of lactones 10 when using catalyst 1d (Table 2.8). It is worth 
noting that epoxides 9 with linear alkyl chains as substituent R showed good 
selectivities in the range of 2.9 to 3.8 : 1 irrespective of the length of the alkyl chain 
(entries 1-5). In the case of epoxides with sterically more demanding substituents R,  
Table 2.8 Regioselective carbonylation of cis-disubstituted-epoxides 9 yielding β-
lactones 10 using catalyst 1da 
O
Me R
1d (5 mol %) O
Me R
+
11
O
O
O
Me R
10
CO (900 psi)
THF
preferentially 
formed
racemic
9  
entry R (epoxide) ratiob 10 : 11 isol. product isol. yield (%) 
1c Et (9b) 03.2 : 1 10b + 11b 66 
2c nPr (9c) 02.9 : 1 10c + 11c 62 
3c nBu (9a) 03.3 : 1 10a + 11a 80 
4c nPent (9d) 03.8 : 1 10d + 11d 74 
5c nHex (9e) 03.5 : 1 10e + 11e 91 
6c CH2Cy (9f) 05.7 : 1 10f + 11f 88 
7c CH2Ph (9g) 19.0 : 1 10g + 11g 90 
8c (CH2)2Ph (9h) 03.5 : 1 10h + 11h 86 
9c (CH2)2iPr (9i) 03.3 : 1 10i + 11i 90 
10c (CH2)2OTBS (9j) 04.0 : 1 10j + 11j 87 
11c (CH2)3OTBS (9k) 02.7 : 1 10k + 11k 92 
aReaction conditions: [9] = 0.5 M, 22 °C, 20 h. All reactions gave full conversion (GC or 1H NMR 
analysis). bAs determined by 1H NMR analysis of crude reaction mixture. c7.5 mol % of 1d used. TBS = 
tBuMe2Si. 
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one would predict an increase in selectivity due to a stronger inherent steric bias. 
Indeed, such additional bias benefited selectivity as long as it was situated close to the 
epoxide (entries 6 and 7). Distancing it further away, however, made it ineffective 
quickly (entries 8-11), and the obtained selectivities resembled those achieved with 
epoxides 9a-e. Interestingly, epoxides 9f and 9g gave very different ratios of 10 and 
11 despite their structural similarity. 
The two resulting lactones 10 and 11 could generally not be separated 
quantitatively from one another using column chromatography. Therefore, a mixture 
of the two lactones was isolated in all cases in yields usually exceeding 80%. The 
somewhat lower yields in entries 1 and 2 can be attributed to the volatility of the 
lactone products. It should be noted that ring-opening of 10 and 11 to the 
corresponding aldol-type methyl-esters by quenching the reaction with 
MeOH/NaOMe allowed for facile separation of the two regioisomers as is shown for 
catalyst 7a in the following Table 2.9. 
Selective formation of lactones 11 using catalyst 7a proceeded extremely well, 
with ratios in favor of 11 exceeding 10.0 : 1 for nearly all cis-epoxides 9 tested (Table 
2.9). Even the simple cis-epoxide 9b gave a very good selectivity of 10.1 : 1 (entry 1), 
and better ratios were achieved for epoxides with longer alkyl-chains (entries 2-5). 
Similar to 1d, catalyst 7a did not show much variance in selectivity as the length of 
the linear alkyl-chain in substituent R was altered, the only exception being 9b. It is 
also worth noting that racemic 7a carbonylated enantioenriched epoxides such as 
(2R,3S)-heptene oxide ((2R,3S)-9a) with regioselectivities similar to those obtained  
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Table 2.9 Regioselective carbonylation of cis-disubstituted epoxides yielding β-
lactones 11 and methyl-esters 12 using catalyst 7aa 
12 (ester-
derivative of 11)
O
Me R
7a (5 mol %) O
Me R
+
11
racemic
9
O
O
O
Me R
10
CO (900 psi)
1,4-dioxane
Me
O
R
OH
OMe
preferentially 
formed
 
entry R (epoxide) ratiob 10 : 11 isol. product isol. yield (%) 
1c Et (9b) 1 : 10.1 12b >70d 
2c nPr (9c) 1 : 15.7 12c >77d 
3c nBu (9a) 1 : 24.0 10a + 11a >69d 
4c nPent (9d) 1 : 24.0 10d + 11d >74d 
5c nHex (9a) 1 : 19.0 10e + 11e >72d 
6c nBu (2R,3S-9a) 1 : 24.0 10a + 11a >95d 
7c CH2Cy (9f) 1 : 04.9 10f + 11f >83d 
8c CH2Ph (9g) 1 : 01.3 10g + 11g >18d 
9c (CH2)2Ph (9h) 1 : 32.3 12h >83d 
10c (CH2)2iPr (9i) 1 : 19.0 12i >78d 
11c (CH2)2OTBS (9j) 1 : 24.0 12j >81d 
12c (CH2)3OTBS (9k) 1 : 13.3 12k >80d 
13c (CH2)3OAc (9l) 1 : 10.1 10l + 11l >82d 
aReaction conditions: [9] = 0.5 M, 22 °C, 20 h. All reactions gave full conversion (GC or 1H NMR 
analysis), except for 9f and 9g. bAs determined by 1H NMR analysis of crude reaction mixture. 
c(2R,3S)-heptene oxide (99% ee) was used. d% Conversion to β-lactone (1H NMR analysis). Catalyst 7a 
prepared in situ (LnAlCl + NaCo(CO)4). TBS = tBuMe2Si. 
with rac-9a (entry 6). Given the availability of enantioenriched epoxides,13 this makes 
for a convenient entry into enantioenriched β-lactones and aldol-type products. 
Epoxides 9 with additional steric hindrance in R also underwent regioselective 
carbonylation reactions with catalyst 7a, and still yielded the contrasteric lactone 11 
preferentially (entries 7-13). Interestingly, the selectivities observed with these 
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epoxides were comparable to those achieved with the less hindered epoxides 9a-e, and 
even ratios as high as 32.3 and 24.0 : 1 (entries 9 and 11) were obtained. The only 
limitation arose when steric bulk was situated very close to the epoxide (entries 7 and 
8). Nevertheless, the observed ratios of 4.9 and 1.3 : 1 in favor of lactones 11f and g 
respectively are still good given how sterically shielded the corresponding methine-
carbon is from nucleophilic attacks. This fact is also reflected in the high selectivity 
with which lactones 10f and g are formed when using catalyst 1d (Table 2.8, entries 6 
and 7). Lastly, cis-epoxides with sterically very similar substituents were carbonylated 
with low regioselectivity by 7a. For example, cis-2-butyl-3-ethyloxirane gave a ratio 
of 2.2 : 1 of regioisomeric β-lactones, and 30% conversion (1H NMR analysis). 
As before with catalyst 1d (Table 2.8), the resulting trans-β-lactones were 
isolated as mixtures in good yields, except for those derived from the sterically 
encumbered epoxides 9f and g. As was mentioned before in the discussion of the 
results for catalyst 1d, conversion of the lactones into aldol-type methyl-esters using a 
one-pot procedure allowed for facile separation of the two regioisomers. Equally good 
yields were obtained using this approach, which is shown for a selected range of 
epoxides in Table 2.9 (entries 1-2, and 9-12). 
2.3.3 Regioselective Chlorohydrin Formation Using Catalyst 7b 
Lastly, use of a different nucleophile in the regioselective ring-opening of cis-
epoxides 9 was explored. The synthesis of vicinally disubstituted chlorohydrins 
seemed particularly attractive because they are important functional groups,21 yet 
methods for their selective synthesis are scarce.22 Moreover, compounds of the type 
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[LnAl]-Cl are commonly used as precursors in the synthesis of carbonylation catalysts, 
and seemed like ideal catalysts for the regioselective formation of chlorohydrins. 
Indeed, complex 7b (Table 2.10), the immediate precursor to 7a, turned out to be a 
selective and active catalytic system. For example, addition of 2,4,6-Me3-pyridine 
(2,4,6-collidine) hydrochloride as an HCl-surrogate to cis-epoxide 9a in THF in the 
presence of 7b led to complete conversion of 9a within 48 hours. Chlorohydrin 14a 
was formed preferentially, and THF was the best solvent tested for this transformation 
(Table 2.10). The contrasteric selectivity in favor of 14a is consistent with the 
carbonylation results obtained with 7a in Table 2.9. 
Table 2.10 Evaluation of solvents in the regioselective formation of chlorohydrin 
14a from cis-disubstituted epoxide 9a using catalyst 7ba 
N N
Me
OAlOMe
tButBu
tBu
tBu
rac7b
O
Me nBu
7b (5 mol %)
2,4,6-collidine•HCl 
(1.1 equiv.)
solvent
Me
HO Cl
nBu
14a
Me
Cl OH
nBu
13a
+
preferentially 
formed
racemic
9a Cl
 
entry solvent ratiob 13a : 14a conv.b (%) 
1 THF 1 : 6.7 >95 
2 1,4-dioxane 1 : 2.5 >53 
3 2-methyl-THF 1 : 2.3 >64 
4 diglyme 1 : 1.3 >67 
5 dimethyl carbonate 1 : 1.5 >14 
6 THP 1 : 4.9 >78 
aReaction conditions: [9a] = 0.5 M, 22 °C, 48 h. bAs determined by GC analysis of crude reaction mixture. 
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In order to ensure, that the obtained selectivities were a result of the use of 7b and 
did not stem from either an inherent quality of epoxide 9a or a background reaction 
involving 2,4,6-collidine hydrochloride, several control experiments were performed 
(Table 2.11). 
Table 2.11 Control experiments concerning the regioselective formation of 
chlorohydrin 14a from cis-disubstituted epoxides 
entry reaction 
ratioa  
13a : 14a 
conv.a 
(%) 
1 
O
Me nBu
2,4,6-collidine•HCl 
(1.1 equiv.)
Me
HO Cl
nBu
14a
Me
Cl OH
nBu
13a
+
9a
(0.5 M)
N2, THF
22 °C, 48 h
 
1 : 1.2 0<5 
2 
9a
(1 M)
O
Me nBu
HCl
(2 M, Et2O,1.1 equiv.)
Me
HO Cl
nBu
14a
Me
Cl OH
nBu
13a
+
Et2O
0 °C, 15 min
 
1 : 1.1 >95 
3 
9a
(1 M)
O
Me nBu
nBu4N+Cl- 
(anhydr., 1.2 equiv.)
p-toluenesulfonic acid 
(anhydr., 1.2 equiv.)
Me
HO Cl
nBu
14a
Me
Cl OH
nBu
13a
+
N2, THF
22 °C, 48 h
 
1 : 1.0 >95 
4 
N
N
N
O O
Cl
Cl
Cl
(0.46 equiv.)
acetone/water 
(2 : 1, v/v)
22 °C, 12 h(0.3 M)
Me
HO Cl
nBu
14a
Me
Cl OH
nBu
13a
+Me nBu
 
1 : 1.9 >95 
aAs determined by 1H NMR analysis of crude reaction mixture. 
Entry 1 shows that the background reaction between 9a and 2,4,6-collidine 
hydrochloride in the absence of 7b is negligible, because less than 5% conversion 
were detected after 48 h. The low conversion can mainly be attributed to the observed 
low solubility of collidine hydrochloride in THF, which impedes the reaction with 9a 
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in the absence of catalyst 7b. Entries 2 and 3 examined the formation of chlorohydrins 
13a and 14a using more soluble sources of HCl. Complete conversion of 9a to 
chlorohydrin was observed in both cases, however the resulting product was a mixture 
of 13a and 14a in a ratio of almost 1 : 1. Lastly, the synthesis of chlorohydrins 13a 
and 14a starting from the olefin oxidation level was investigated using trichloroiso-
cyanuric acid as a source of electrophilic chloronium-species. Indeed, the resulting 
chlorohydrins formed with excellent conversion and a slight preference in favor of 
14a, yet this outcome was still inferior to the transformation using 7b (entry 4). 
Having established the feasibility of selective chlorohydrin formation using 7b, a 
number of epoxides 9 were surveyed (Table 2.12). Epoxides with linear or branched  
Table 2.12 Regioselective formation of chlorohydrins 14 from cis-disubstituted 
epoxides using catalyst 7ba 
O
Me R
7b (5 mol %)
2,4,6-collidine•HCl 
(1.1 equiv.)
THF Me
HO Cl
R
14
Me
Cl OH
R
13
+
preferentially 
formed
racemic
9  
entry R (epoxide) ratio 13 : 14 isol. product isol. yield (%) 
1c nBu (9a) 1 : 6.7b 14a 68 
2c nPent (9d) 1 : 6.1b 14d 70 
3c nHex (9e) 1 : 6.1c 14e 77 
4d CH2Ph (9g) 1 : 2.8c 14g 55 
5c (CH2)2Ph (9h) 1 : 4.9c 14h 75 
6c (CH2)2iPr (9i) 1 : 6.7b 14i 68 
aReaction conditions: [9] = 0.5 M, 22 °C, 48 h. All reactions gave full conversion (GC or 1H NMR 
analysis). bAs determined by GC analysis of crude reaction mixture. cAs determined by 1H NMR 
analysis of crude reaction mixture. d7.5 mol % 7b used.  
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alkyl-chains as substituent R showed ratios in favor of 14 exceeding 6.0 : 1 entries (1-
3, and 6). However, in cases where the steric bulk was located too close to the epoxy-
group (entry 4), or became too large (entry 5), regioselectivity dropped to lower levels. 
Nevertheless, chlorohydrins 14 were readily isolatable in good yields. 
2.3.4 Conclusion 
In conclusion, two new catalysts 1d and 7a were introduced for the regioselective 
carbonylation of racemic and enantioenriched cis-disubstituted epoxides 9. Due to the 
opposing regiopreference of 1d and 7a, either one of the two regioisomeric trans-β-
lactones 10 and 11 could be accessed in high yield and with good selectivity. 
Furthermore, ring-opening of the lactone products using a one-pot procedure gave rise 
to anti-aldol-type compounds that were readily separable by column chromatography. 
Lastly, a structurally related catalyst 7b was applied to the regioselective synthesis of 
vicinally disubstituted chlorohydrins 14 from cis-epoxides 9. Similar to the 
carbonylation reactions with 7a, this transformation also proceeded with synthetically 
useful yields and contrasteric regioselectivities. 
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2.4 Synopsis 
Four new carbonylation catalysts were developed (Figure 2.7) and shown to be 
able to convert trans- and cis-disubstituted epoxides into the corresponding β-lactones 
with good to excellent regioselectivities and yields. Each catalyst was optimized to 
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catalyst 7a
N N
O O
Al
tBu
tBu tBu
tBu
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N
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tBu tBu
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Me
Me
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[Co(CO)4]
 
Figure 2.7 New carbonylation catalysts for the regioselective carbonylation of cis- 
and trans-disubstituted epoxides to β-lactones 
selectively produce one different isomer out of the overall four possible isomeric β-
lactones (Figure 2.8). Given these complimentary selectivities, the four catalysts 
provide access to an increased variety of more complex vicinally disubstituted β-
lactones in a direct and synthetically useful manner starting from readily available cis- 
and trans-disubstituted epoxides. Overall, this study not only increases the range of 
available lactones, but also constitutes significant progress towards regioselective 
intermolecular SN2-ring-opening reactions of cis- or trans-disubstituted epoxides, a 
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transformation that has eluded synthetic chemists for the longest time. Future studies 
will focus on enantiopure versions of these catalysts for the synthesis of enantio-
enriched β-lactones via carbonylative kinetic resolution of cis- or trans-disubstituted 
epoxides. 
O
Me
catalyst 1mO
Me R
major isomer
up to >50 : 1
O
RCO
transcis
catalyst 1e O
RMe
major isomer
up to 5 : 1
O
CO
cis
O
Me
catalyst 1dO
Me R
major isomer
up to 19 : 1
O
RCO
cistrans
catalyst 7a O
RMe
major isomer
up to 32 : 1
O
CO
trans
 
Figure 2.8 Selectivities and products achieved with each new carbonylation 
catalyst
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2.5 Experimental Procedures 
2.5.1 General Considerations 
Methods and Instruments 
Unless stated otherwise all synthetic manipulations were carried out using 
standard Schlenk techniques under a nitrogen atmosphere or in an MBraun Unilab 
glovebox under an atmosphere of purified nitrogen. Reactions were carried out in 
oven-dried glassware cooled under vacuum. High-pressure reactions were performed 
in a custom-designed and -fabricated, six-chamber, stainless steel, high-pressure 
reactor.23 The reactor design allowed for incorporation of six 2 fluid dram glass vials. 
Unless stated otherwise flash column chromatography was performed with silica 
gel (particle size 40-64 µm, 230-400 mesh) using either mixtures of ethyl acetate and 
hexanes or mixtures of diethylether and pentane as eluent. IR spectra were recorded on 
a Nicolet 380 FT-IR spectrometer. 1H NMR and 13C NMR spectra were recorded on a 
Varian 300, 400 or 500 MHz instrument at 22 °C (unless indicated otherwise) with 
shifts reported relative to the residual solvent peak (CDCl3: 7.26 ppm (1H), and 77.16 
ppm (13C); C6D6: 7.16 ppm (1H) and 128.06 ppm (13C)). NMR solvents were 
purchased from Cambridge Isotope Laboratories and stored over activated 4Å 
molecular sieves (C6D6) or K2CO3 (CDCl3). GLC analyses were performed on a 
Hewlett Packard 6890 gas chromatograph equipped with a Supelco b-Dex225 column 
and a flame ionization detector. Helium (Airgas, UHP grade) was used as carrier gas. 
Elemental analyses were performed at Midwest Microlab, LLC. High-resolution mass 
spectrometry (HRMS) analyses were performed at the Mass Spectrometry Laboratory 
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at the University of Illinois at Urbana-Champaign. Optical rotations were measured on 
a Perkin-Elmer 241 polarimeter. 
 
Chemicals 
Anhydrous 1,4-dioxane, anhydrous dimethyl carbonate, anhydrous diethylene-
glycoldimethyl ether (diglyme), and anhydrous tetrahydropyran (THP) were purchased 
from Sigma-Aldrich and degassed via three freeze-pump-thaw cycles prior to use. 
Anhydrous dichloromethane (DCM), toluene, hexanes and tetrahydrofuran (THF) 
were purchased from Fischer Scientific and sparged vigorously with nitrogen for 40 
minutes prior to first use. The solvents were further purified by passing them under 
nitrogen pressure through two packed columns of neutral alumina (THF was also 
passed through a third column packed with activated 4Å molecular sieves) or through 
neutral alumina and copper(II) oxide (for toluene and hexanes). THF and DCM were 
degassed via three freeze-pump-thaw cycles prior to use. 2-Methyl-tetrahydrofuran, 
diethylether, 1,2-dimethoxyethane (DME), xylenes, anisole, and benzene were dried 
over sodium/benzophenone and degassed via three freeze-pump-thaw cycles prior to 
use. All other solvents were reagent grade or better and used as received. 
Triethylamine was dried over calcium hydride and degassed via three freeze-pump-
thaw cycles prior to use. All epoxides used in this study were dried over calcium 
hydride and degassed via three freeze-pump-thaw cycles prior to use. Carbon 
monoxide (Airgas, 99.99% min. purity) was used as received. All other chemicals 
were purchased from Aldrich, Alfa-Aesar, Acros, TCI or GFS Chemicals, and used as 
received unless stated otherwise. 
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The following compounds were prepared according to literature procedures:  
a) Catalyst-precursors: rac-2,4-di-tert-butyl-6-((E)-(((1S,2S)-2-((pyridin-2-yl-
methyl)amino)-cyclohexyl)imino)methyl)phenol,24 rac-6,6'-((1E,1'E)-((1S,2S)-
cyclohexane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2,4-dimethyl-
phenol),25 (4-(tert-butyl)-2,6-dimethyl-phenyl)magnesium bromide,26 2,3-
dimethylbutane-2,3-diamine,27 3',5'-di-tert-butyl-2-hydroxy-5-methyl-[1,1'-biphenyl]-
3-carbaldehyde,28 5-(tert-butyl)-2-hydroxy-3-methylbenzaldehyde,29 2,4,6-trimethyl-
pyridine hydrochloride,30 4-bromo-2-(tert-butyl)phenol.31 
b) Catalysts: NaCo(CO)4,32 [rac-salcyAl(THF)2]+ [Co(CO)4]- (1a, salcy = N,N'-
bis(3,5-di-tert-butyl-salicyl-idene)-1,2-cyclohexanediamine),14a [salphAl(THF)2]+ 
[Co(CO)4]- (1b, salph = 6,6'-((1E,1'E)-(1,2-phenylenebis(azanylylidene))bis(meth-
anylylidene))bis(2,4-di-tert-butylphenolate)),12a [salphCr(THF)2]+[Co(CO)4]- (1c, 
salph = 6,6'-((1E,1'E)-(1,2-phenylenebis(azanylylidene))bis(methanylylidene))bis(2,4-
di-tert-butylphenolate)),33 [ClTPPAl(THF)2]+ [Co(CO)4]- (8, ClTPP = meso-tetra(4-
chlorophenyl)porphyrinato).34 
c) Epoxide-precursors: (2S,3R)-2-(Benzyloxy)nonan-3-ol,35 (E)-but-2-en-1-
ylbenzene,36 (E)-hex-4-en-1-ol,37 (E)-pent-3-en-1-ol,38 (S)-2-(benzyloxy)-1-
(pyrrolidin-1-yl)propan-1-one,39 (Z)-tert-butyldimethyl(pent-3-en-1-yloxy)silane,40 
(Z)-but-2-en-1-ylbenzene,41 (Z)-1-phenyl-3-pentene.42 
d) Epoxides: rac-(2S,3S)-2-ethyl-3-methyloxirane (2b),43 rac-(2S,3S)-2-butyl-3-
methyloxirane (2d),44 rac-(2S,3S)-2-butyl-3-ethyloxirane (2k),45 rac-(2S,3S)-2-
methyl-3-pentyloxirane (2a),44 rac-(2S,3S)-2-hexyl-3-methyl-oxirane (2e),44 rac-tert-
butyldimethyl(((2S,3S)-3-methyloxiran-2-yl)methoxy)-silane (2h),46 rac-(2S,3S)-2-
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isopropyl-3-methyloxirane (2j),47 rac-(2S,3R)-2-ethyl-3-methyloxirane (9b),48 rac-
(2R,3S)-2-methyl-3-propyloxirane (9c),48 rac-(2R,3S)-2-butyl-3-methyloxirane (9a),49 
(2R,3S)-2-butyl-3-methyloxirane ((2R,3S)-9a),48 rac-(2R,3S)-2-butyl-3-ethyloxirane,50 
rac-(2R,3S)-2-methyl-3-pentyloxirane (9d),48 rac-(2S,3R)-2-hexyl-3-methyloxirane 
(9e),48 rac-(2S,3R)-2-isopentyl-3-methyloxirane (9i),48 rac-tert-butyldimethyl(3-
((2S,3R)-3-methyloxiran-2-yl)propoxy)silane (9k),48 rac-cis-1-acetoxy-4,5-
epoxyhexane (9l).51 
2.5.2 Synthetic Procedures 
2.5.2.1 General Procedures 
General procedure A: Epoxidation of alkenes to epoxides using mCPBA 
mCPBA (Aldrich, ≤ 77%) was added in portions at 0 °C under air to a solution of 
the corresponding alkene in DCM, and the resulting mixture was stirred at the same 
temperature until TLC analysis indicated complete consumption of the alkene. After 
destroying excess mCPBA by adding aqueous NaHSO3 at 0 °C, the reaction mixture 
was filtered, the organic phase washed with NaHCO3 (aq., sat., 3x), then dried with 
sodium sulfate, filtered and concentrated under reduced pressure. The residue was 
purified either via distillation or flash column chromatography. 
 
General procedure B: Kumada coupling of aryl-Grignard reagents with 2-
bromo-phenols 
The appropriate bromophenol (distilled or sublimed prior to use) was added in 
small portions to a mixture of sodium hydride (Aldrich, dry, 95%) and THF at 0 °C, 
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followed by stirring at 22 °C for 10 minutes. Pd(acac)2 (Strem) or Pd(OAc)2 (Strem) 
was added, followed by the appropriate Grignard reagent, and the resulting mixture 
was refluxed for 12 h. Upon cooling to 0 °C, H2O was carefully added to destroy 
residual Grignard reagent and sodium hydride. HCl (aq., 2 M) was added followed by 
celite, and the resulting mixture was filtered through a pad of celite. The resulting 
phases were separated and the aqueous phase extracted with Et2O (3x). The combined 
organic layers were washed with brine, dried with sodium sulfate, filtered and 
concentrated under reduced pressure. The resulting residue was purified via flash 
column chromatography. 
 
General procedure C: Formylation of 2-arylphenols to the corresponding 
salicylaldehyde derivatives 
Methylmagnesium bromide (Acros, Et2O, 3 M) was added slowly to the 
appropriate 2-arylphenol in THF at 0 °C. After warming to 22 °C, toluene, 
triethylamine and paraformaldehyde were added, and the resulting reaction mixture 
stirred at 80 °C for 12 h. After cooling to 0 °C, H2O and then HCl (aq., 2 M) were 
added, and the resulting phases were separated. The aqueous phase was extracted with 
Et2O (3x). The combined organic layers were washed with brine, dried with sodium 
sulfate, filtered and concentrated under reduced pressure. The residue was purified via 
flash column chromatography. 
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General procedure D: Assembly of salen-compounds via imine-condensation 
The appropriate salicylaldehyde derivative was mixed under air with either 
methanol or ethanol at the indicated temperature. The appropriate diamine was added 
and the reaction mixture stirred at the same temperature for the time indicated. The 
reaction mixture was allowed to reach 22 °C, and the resulting precipitate was isolated 
by filtration, followed by washings with small amounts of cold methanol or ethanol to 
give the corresponding salen-compound after drying in vacuo at 80 °C. 
 
General procedure E: Metallation of salen-compounds using Et2AlCl 
The appropriate salen-compound was dissolved in the indicated amount of DCM 
and cooled to 0 °C. Et2AlCl (Aldrich, 1.0 M, hexanes, pyrophoric) is added in one 
portion under vigorous stirring at 0 °C, and the resulting solution was stirred at 22 °C 
for 12 h. The resulting metal-complex was then isolated as indicated. 
 
General procedure F: Regioselective carbonylation of trans-epoxides 2 using 
catalyst 1e 
In a glove box, a 2 fluid dram glass vial equipped with a Teflon-coated magnetic 
stir bar was charged with the appropriate amount of catalyst 1e and benzene. The vial 
was then placed in a custom-made 6-well high-pressure reactor which itself was 
placed in a glove box freezer at -34 °C for 30 minutes. The appropriate amount of 
epoxide (also cooled to -34 °C) was then added to the vial, the reactor removed from 
the freezer, subsequently sealed, taken out of the glove box, placed in a well-ventilated 
hood and pressurized with carbon monoxide (900 psi). It is important to keep the 
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temperature of the reactor below 0 °C once it is removed from the freezer to minimize 
isomerization of the epoxide to ketone products. The reactor was then placed in a 22 
°C water bath, and the reaction mixture stirred for 22 h. The reactor was carefully 
vented in a well-ventilated hood, the crude reaction mixture concentrated under 
reduced pressure and then purified further via flash column chromatography unless 
indicated otherwise. 
 
General procedure G: Regioselective carbonylation of trans-epoxides 2 using 
catalyst 1m prepared in situ 
In a glove box, a 2 fluid dram glass vial equipped with a Teflon-coated magnetic 
stir bar was charged with MF9 (the precursor to 1m) and a stocksolution of 
NaCo(CO)4 in THF. After 1 minute of stirring at 22 °C, the vial was placed in a 
custom-made 6-well high-pressure reactor which itself was placed in a glove box 
freezer (-34 °C) for 30 minutes. The appropriate amount of epoxide (also cooled to -34 
°C) was then added to the vial, the reactor removed from the freezer, subsequently 
sealed, taken out of the glove box, placed in a well-ventilated hood and pressurized 
with carbon monoxide (900 psi) It is important to keep the temperature of the reactor 
below 0 °C once it is removed from the freezer to minimize isomerization of the 
epoxide to ketone products. The reactor was then placed in a 22 °C water bath, and the 
reaction mixture stirred for 20 h. The reactor was carefully vented in a well-ventilated 
hood and the product purified as indicated. 
Note: No significant difference was observed when conducting regioselective 
carbonylations of trans-epoxides 2 using isolated batches of catalyst 1m instead of in 
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situ prepared 1m. Overall, in situ formation was found to be more convenient because 
the precursor MF9 is significantly less sensitive to oxygen and can be stored at 22 °C. 
 
General procedure H: Regioselective carbonylation of cis-epoxides using catalyst 
1d 
In a glove box, a 2 fluid dram glass vial equipped with a Teflon-coated magnetic 
stir bar was charged with catalyst 1d and THF. The vial was then placed in a custom-
made 6-well high-pressure reactor which itself was placed in a glove box freezer at -
34 °C for 30 minutes. The appropriate epoxide (also cooled to -34 °C) was then added 
to the vial, the reactor removed from the freezer, subsequently sealed, taken out of the 
glove box, placed in a well-ventilated hood and pressurized with carbon monoxide 
(900 psi). It is important to keep the temperature of the reactor below 0 °C once it is 
removed from the freezer to minimize isomerization of the epoxide to ketone products. 
The reactor was then sealed again, placed in a 22 °C water bath, and stirred for the 
time indicated. The reactor was carefully vented in a well-ventilated hood, the crude 
reaction mixture concentrated under reduced pressure and the product isolated as 
indicated. 
 
General procedure I: Regioselective carbonylation of epoxides with in situ 
formation of catalyst 7a 
In a glove box, a 2 fluid dram glass vial equipped with a Teflon-coated magnetic 
stir bar was charged with 7b (the precursor to 7a), NaCo(CO)4, and dioxane. The vial 
was then placed in a custom-made 6-well high-pressure reactor, which itself was 
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placed in a glove box freezer at -34 °C for 30 minutes. The appropriate epoxide (also 
cooled to -34 °C) was added to the vial, the reactor removed from the freezer, 
subsequently sealed, taken out of the glove box, placed in a well-ventilated hood and 
pressurized with carbon monoxide (900 psi). It is important to keep the temperature of 
the reactor below 0 °C once it is removed from the freezer to minimize isomerization 
of the epoxide to ketone products. The reactor was then sealed again, placed in a 22 °C 
water bath and stirred for the time indicated. The product was then isolated as 
indicated. 
 
General procedure J: Regioselective chlorohydrin formation using catalyst 7b 
In a glove box, a 2 fluid dram glass vial equipped with a Teflon-coated magnetic 
stir bar was charged with catalyst 7b, 2,4,6-trimethylpyridine hydrochloride, THF, and 
the appropriate epoxide. The vial was sealed with a Teflon-coated cap, and the 
reaction mixture stirred at 22 °C for 48 h. The crude reaction mixture was 
concentrated under reduced pressure and the product isolated as indicated. 
2.5.2.2 Synthesis of Starting Materials 
rac-(2S,3S)-2-Methyl-3-propyloxirane (2c) 
Following general procedure A, (E)-hex-2-ene (4.70 g, 55.8 mmol) was reacted 
with mCPBA (17.0 g) in DCM (135 ml) to give 2c (1.77 g, 32%) as a colorless liquid. 
The analytical data was in accordance with that reported in the literature.52 1H NMR 
(300 MHz, CDCl3): δ 2.72 (qd, J = 5.3, 2.3 Hz, 1H), 2.61 (dt, J = 5.6, 2.5 Hz, 1H), 
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1.51–1.39 (m, 4H), 1.28 (d, J = 5.2 Hz, 3H), 0.93 (t, J = 7.3 Hz, 3H). 13C NMR (126 
MHz, CDCl3): δ 59.8, 54.7, 34.2, 19.4, 17.8, 14.0. 
(2S,3S)-2-Hexyl-3-methyloxirane ((2S,3S)-2e) 
(2S,3R)-2-(Benzyloxy)nonan-3-ol35 (3.59 g, 14.3 mmol) was dissolved in pyridine 
(18 ml), and para-toluenesulfonylchloride (7.69 g, 40.3 mmol) was added. After 
stirring at 40 °C for 24 hours, ethylene glycol (7.5 ml) was added at 22 °C, followed 
by stirring at 22 °C for one hour to destroy excess para-toluenesulfonylchloride. The 
reaction mixture was then diluted with Et2O, washed with hydrochloric acid (aq., 1 M, 
3x), dried with sodium sulfate, filtered and concentrated under reduced pressure. The 
crude product was filtered through silica gel using a 10:1-mixture of hexanes and 
Et2O, and the filtrate concentrated under reduced pressure. The residue was taken up 
in methanol (100 ml), palladium on carbon (Strem, 5% Pd, 1.33 g) was added, and the 
resulting suspension stirred vigorously at 22 °C under an atmosphere of hydrogen (1 
atm) for five hours. The reaction mixture was diluted with Et2O, filtered through a pad 
of celite, and then concentrated. The residue was taken up in methanol (25 ml), 
potassium carbonate (11.4 g, 82.5 mmol) was added, and the resulting mixture stirred 
at 22 °C for 90 minutes. The supernatant was decanted, and the remaining solid 
washed repeatedly with DCM. The combined organic phases were washed with water, 
then brine, dried with sodium sulfate, filtered and concentrated under reduced 
pressure. The residue was purified via flash column chromatography to give (2S,3S)-
2e (1.41 g, 71% over three steps) as a colorless liquid. The NMR-spectroscopic data 
was in accordance with that reported in the literature for the racemic compound.44 1H 
NMR (500 MHz, CDCl3): δ 2.71 (qd, J = 5.2, 2.3 Hz, 1H), 2.60 (td, J = 5.6, 2.2 Hz, 
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1H), 1.52–1.26 (m, 10H), 1.27 (d, J = 5.2 Hz, 3H), 0.87 (t, J = 7.0 Hz, 3H). 13C NMR 
(126 MHz, CDCl3): δ 60.0, 54.7, 32.2, 31.9, 29.2, 26.1, 22.7, 17.8, 14.2. Specific 
rotation: [α]22D = -48 (c = 3.3, pentanes). 
Using an NMR shift-reagent,53 the enantiomeric ratio (er) of (2S,3S)-2e was 
determined to be 2.3 : 97.7 by 1H NMR analysis in comparison to authentic racemic 
material. NMR samples were prepared by mixing 26 mg of the respective epoxide 
with 7.7 mg of europium(III) tris[3-(trifluoromethylhydroxymethylene)-(+)-
camphorate] as shift-reagent in 0.6 ml C6D6.  
 
rac-Tert-butyldimethyl(3-((2S,3S)-3-methyloxiran-2-yl)propoxy)silane (2f) 
To a solution of (E)-hex-4-en-1-ol37 (2.57 g, 8.32 mmol), DCM (20 ml) and 1-
methyl-1H-imidazole (2.03 g, 24.7 mmol) was added a solution of tert-
butylchlorodimethylsilane (1.74 g, 11.5 mmol) in DCM (6 ml) at 22 °C. The reaction 
mixture was stirred for 19 h, then washed with water, dried with sodium sulfate, 
filtered and concentrated under reduced pressure. The crude product was filtered 
through silica gel using a 95:5-mixture of hexanes and ethylacetate, and the filtrate 
concentrated under reduced pressure. The residue was then taken up in DCM (20 ml), 
mCPBA (Aldrich, ≤ 77%, 2.50 g) was added in portions at 0 °C, and the resulting 
mixture stirred at the same temperature for 4 h. After destroying excess mCPBA by 
adding aqueous NaHSO3 at 0 °C, DCM was added, and the organic phase washed with 
NaHCO3 (aq., sat., 3x), then dried with sodium sulfate, filtered and concentrated under 
reduced pressure. The residue was purified via flash column chromatography to give 
2f (6.35 g, 76%) as a colorless liquid. 1H NMR (400 MHz, CDCl3): δ 3.67–3.58 (m, 
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2H), 2.74 (qd, J = 5.2, 2.3 Hz, 1H), 2.64 (ddd, J = 6.2, 4.8, 2.3 Hz, 1H), 1.71–1.48 (m, 
4H), 1.28 (d, J = 5.2 Hz, 3H), 0.87 (s, 9H), 0.03 (s, 6H). 13C NMR (75 MHz, CDCl3): 
δ 62.8, 59.7, 54.8, 29.3, 28.7, 26.1, 18.5, 17.8, -5.2. IR (neat, cm-1): 2929, 2857, 1472, 
1254, 1093, 833, 773. HRMS (ESI) m/z calculated for C12H27O2Si+ (M + H+) 
231.1775, found 231.1790. 
 
rac-Tert-butyldimethyl(2-((2S,3S)-3-methyloxiran-2-yl)ethoxy)silane (2h) 
To a solution of (E)-pent-3-en-1-ol38 (1.94 g, 6.58 mmol), DCM (16 ml) and 1-
methyl-1H-imidazole (1.61 g, 19.6 mmol) was added a solution of tert-
butylchlorodimethylsilane (1.38 g, 9.09 mmol) in DCM (5 ml) at 22 °C. The reaction 
mixture was stirred for 19 h, then washed with water, dried with sodium sulfate, 
filtered and concentrated under reduced pressure. The crude product was filtered 
through silica gel using a 95:5-mixture of hexanes and ethylacetate, and the filtrates 
concentrated under reduced pressure. The residue was then taken up in DCM (16 ml), 
mCPBA (Aldrich, ≤ 77%, 2.00 g) was added in portions at 0 °C, and the resulting 
mixture stirred at the same temperature for 4 h. After destroying excess mCPBA by 
adding aqueous NaHSO3 at 0 °C, DCM was added, and the organic phase washed with 
NaHCO3 (aq., sat., 3x), then dried with sodium sulfate, filtered and concentrated under 
reduced pressure. The residue was purified via flash column chromatography to give 
2h (0.790 g, 55%) as a colorless liquid. 1H NMR (400 MHz, CDCl3): δ 3.74 (dd, J = 
6.9, 5.4 Hz, 2H), 2.80–2.73 (m, 2H), 1.79–1.64 (m, 2H), 1.30 (d, J = 5.2 Hz, 3H), 0.88 
(s, 9H), 0.05 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 60.1, 57.5, 54.9, 35.6, 26.0, 18.4, 
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17.8, -5.3. IR (neat, cm-1): 2928, 2857, 1472, 1252, 1097, 832, 773. HRMS (ESI) m/z 
calculated for C11H25O2Si+ (M + H+) 217.1618, found 217.1625. 
rac-(2S,3S)-2-Benzyl-3-methyloxirane (2i) 
Following general procedure A, (E)-but-2-en-1-ylbenzene36 (2.15 g, 16.3 mmol) 
was reacted with mCPBA (4.90 g) in DCM (40 ml) to give 2i (1.73 g, 78%) as a 
colorless liquid. The analytical data was in accordance with that reported in the 
literature.20 1H NMR (400 MHz, CDCl3): δ 7.34–7.29 (m, 2H), 7.26–7.22 (m, 3H), 
2.94–2.78 (m, 4H), 1.31 (d, J = 5.2 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 137.6, 
129.1, 128.7, 126.7, 59.8, 54.7, 38.6, 17.7. 
 
(2R,3S)-3-(Benzyloxy)-1-phenylbutan-2-ol (SM1) 
Adapting a published procedure,54 (S)-2-(benzyloxy)-1-(pyrrolidin-1-yl)propan-1-
one39 (4.63 g, 19.8 mmol) was dissolved in THF (20 ml) and cooled to -20 °C. 
Benzylmagnesium chloride (Aldrich, Et2O, 1.0 M, 40 ml, 40.0 mmol) was added 
dropwise at -20 °C, the resulting mixture stirred at the same temperature for 30 
minutes, followed by addition of ammonium chloride (aq., sat.). The reaction mixture 
was then extracted with Et2O (3x). The combined organic phases were dried with 
sodium sulfate, filtered and concentrated under reduced pressure. The residue was 
subjected to flash column chromatography to give (S)-3-(benzyloxy)-1-phenylbutan-2-
one (ca. 3.74 g, ca. 74%) as a colorless liquid. Note: The isolated material contained 
ca. 0.900 g of (S)-2-benzyl-3-(benzyloxy)-1-phenylbutan-2-ol as an inseparable 
impurity, and was used in the next step without further purification. NMR-
spectroscopic data for the main component is provided: 1H NMR (500 MHz, CDCl3): 
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δ 7.39–7.20 (m, 10H), 4.52 (d, J = 11.7 Hz, 1H), 4.48 (d, J = 11.7 Hz, 1H), 4.04 (q, J 
= 6.9 Hz, 1H), 3.89 (d, J = 15.8 Hz, 1H), 3.88 (d, J = 15.8 Hz, 1H), 1.39 (d, J = 6.8 
Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 209.9, 137.6, 133.9, 129.8, 128.7, 128.6, 
128.0, 128.0, 127.0, 80.2, 72.0, 44.6, 17.5. 
The impure (S)-3-(benzyloxy)-1-phenylbutan-2-one (ca. 3.74 g, ca. 14.7 mmol) 
was added to a suspension of lithium bis((trifluoromethyl)sulfonyl)amide (4.47 g, 17.9 
mmol) in DCM (45 ml) and cooled to -78 °C. Sodium triethylborohydride (Aldrich, 
toluene, 1.0 M, 29 ml, 29.0 mmol) was added dropwise at -78 °C, and the resulting 
reaction mixture stirred at -78 °C for one hour. Ammonium chloride (aq., sat.) was 
added, followed by hydrochloric acid (aq., 1 M), and the resulting mixture was then 
extracted with DCM (3x). The combined organic phases were dried with sodium 
sulfate, filtered and concentrated under reduced pressure. The residue was subjected to 
flash column chromatography to give SM1 (1.32 g, 26% over two steps) as a colorless 
liquid. 1H NMR (300 MHz, CDCl3): δ 7.35–7.20 (m, 10H), 4.62 (d, J = 11.5 Hz, 1H), 
4.50 (d, J = 11.6 Hz, 1H), 4.02–3.95 (m, 1H), 3.58–3.50 (m, 1H), 2.86–2.70 (m, 2H), 
2.01 (d, J = 3.6 Hz, 1H), 1.27 (d, J = 6.3 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 
138.7, 138.6, 129.4, 128.6, 128.5, 127.78, 127.76, 126.5, 77.3, 74.5, 70.9, 39.0, 14.1. 
IR (neat, cm-1): 3455, 3027, 2686, 14958, 1453, 1070, 1028. HRMS (ESI) m/z 
calculated for C17H21O2+ (M + H+) 257.1536, found 257.1541. Specific rotation: 
[α]22D = +39.5 (c = 0.35, CHCl3). 
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(2S,3S)-2-Benzyl-3-methyloxirane ((2S,3S)-2i) 
(2R,3S)-3-(Benzyloxy)-1-phenylbutan-2-ol (SM1, 1.32 g, 5.15 mmol) was 
dissolved in pyridine (6.5 ml), and para-toluenesulfonylchloride (3.44 g, 18.0 mmol) 
was added. After stirring at 40 °C for 24 hours, ethylene glycol (2.7 ml) was added at 
22 °C, followed by stirring at 22 °C for one hour to destroy excess para-
toluenesulfonylchloride. The reaction mixture was then diluted with Et2O, washed 
with hydrochloric acid (aq., 1 M, 3x), dried with sodium sulfate, filtered and 
concentrated under reduced pressure. The crude product was filtered through silica gel 
using a 6:1-mixture of hexanes and Et2O, and the filtrate concentrated under reduced 
pressure. The residue was then taken up in a mixture of methanol (35 ml) and 
ethylacetate (15 ml), palladium on carbon (Strem, 5% Pd, 1.33 g) was added, and the 
resulting suspension stirred vigorously at 22 °C under an atmosphere of hydrogen (1 
atm) for five hours. The reaction mixture was diluted with Et2O, filtered through a pad 
of celite, and then concentrated. The residue was then taken up in methanol (8 ml), 
potassium carbonate (3.86 g, 27.9 mmol) was added, and the resulting mixture stirred 
at 22 °C for 90 minutes. The supernatant was decanted, and the remaining solid 
washed repeatedly with DCM. The combined organic phases were washed with water, 
then brine, dried with sodium sulfate, filtered and concentrated under reduced 
pressure. The residue was purified via flash column chromatography to give (2S,3S)-2i 
(0.495 g, 65% over three steps) as a colorless liquid. The analytical data was in 
accordance with that reported in the literature.55 1H NMR (500 MHz, CDCl3): δ 7.33–
7.30 (m, 2H), 7.26–7.23 (m, 3H), 2.94–2.79 (m, 4H), 1.31 (d, J = 5.2 Hz, 3H). 13C 
NMR (126 MHz, CDCl3): δ 137.6, 129.1, 128.7, 126.7, 59.8, 54.7, 38.6, 17.7. 
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Specific rotation: [α]22D = -21 (c = 0.61, CHCl3). The enantiomeric ratio (er) was 
determined to be >99.5 : 0.5 by GLC analysis (b-Dex225 column) in comparison to 
authentic racemic material. 
 
rac-(2S,3R)-2-(Cyclohexylmethyl)-3-methyloxirane (9f) 
Methyllithium (Acros, 1.6 M, Et2O, 21.5 ml, 34.4 mmol) was added dropwise at -
78 °C to a solution of prop-2-yn-1-ylcyclohexane (3.81 g, 31.2, mmol) in THF (55 
ml), and the resulting solution stirred at -78 °C for 0.5 h. Methyl iodide (10.5 g, 74.0 
mmol) was added dropwise at -78 °C, the reaction mixture slowly warmed to 22 °C 
and stirred for 12 h. NaHCO3 (sat., aq.) was added and the aqueous phase extracted 
with pentane. The combined organic layers were dried with sodium sulfate, filtered 
and concentrated under reduced pressure. THF (14 ml) was added to the residue and 
the resulting solution degassed by two freeze-pump-thaw cycles. The solution was 
then added to a solution of 9-BBN (0.5 M, THF, 72 ml) at 0 °C, and the resulting 
reaction mixture stirred at 22 °C until TLC analysis indicated complete disappearance 
of the alkyne. Methanol (1.0 ml) was added, then glacial acetic acid (20.0 mg) as a 
solution in methanol (2.6 ml), and the resulting mixture stirred for 2 h at 22 °C. 
Pentane was added, followed by controlled addition of NaOH (1 M, aq., 40 ml) and 
H2O2 (30%, aq., 20 ml) under ice cooling. The aqueous layer was extracted with 
pentane, and the combined organic layers washed with NaHCO3 (aq., sat.), then dried 
with sodium sulfate, filtered and concentrated under reduced pressure. The crude 
product was filtered through a plug of silica gel using pentane, and the filtrates 
concentrated under reduced pressure.  
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Following general procedure A, the residue was reacted with mCPBA (9.00 g) in 
DCM (40 ml) to give 9f (1.12 g, 23%) as a colorless liquid. 1H NMR (400 MHz, 
CDCl3): δ 3.02 (dtd, J = 5.3, 4.3 Hz, 1H), 2.94 (td, J = 6.0, 4.2 Hz, 1H), 1.79–1.62 (m, 
5H), 1.51–1.33 (m, 3H), 1.30–1.08 (m, 3H), 1.25 (d, J = 5.5 Hz, 3H), 1.04–0.89 (m, 
2H). 13C NMR (75 MHz, CDCl3): δ 56.0, 52.7, 36.2, 35.0, 33.8, 33.3, 26.6, 26.41, 
26.38, 13.5. IR (neat, cm-1): 2921, 2851, 1448, 1390, 961, 889, 819, 783. HRMS 
(ESI) m/z calculated for C10H19O+ (M + H+) 155.1430, found 155.1443. 
 
rac-(2S,3R)-2-Benzyl-3-methyloxirane (9g)  
Following general procedure A, (Z)-but-2-en-1-ylbenzene41 (0.446 g, 3.37 mmol) 
was reacted with mCPBA (0.960 g) in DCM (17 ml) to give 9g (0.390 g, 78%) as a 
colorless liquid. The analytical data was in accordance with that reported in the 
literature.56 1H NMR (400 MHz, CDCl3): δ 7.35–7.31 (m, 2H), 7.27–7.23 (m, 3H), 
3.18–3.11 (m, 2H), 2.94 (dd, J = 14.7, 5.8 Hz, 1H), 2.79 (dd, J = 14.7, 6.3 Hz, 1H), 
1.41 (d, J = 5.4 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 137.9, 128.9, 128.7, 126.6, 
57.4, 53.0, 34.2, 13.6. 
 
rac-(2R,3S)-2-Methyl-3-phenethyloxirane (9h) 
Following general procedure A, (Z)-1-phenyl-3-pentene42 (2.71 g, 18.5 mmol) 
was reacted with mCPBA (5.50 g) in DCM (45 ml) to give 9h (2.19 g, 73%) as a 
colorless liquid. The analytical data was in accordance with that reported in the 
literature.42 1H NMR (400 MHz, CDCl3): δ 7.31–7.28 (m, 2H), 7.22–7.18 (m, 3H), 
3.04 (qd, J = 5.5, 4.2 Hz, 1H), 2.95 (td, J = 6.3, 4.3 Hz, 1H), 2.85 (ddd, J = 14.6, 9.2, 
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5.8 Hz, 1H), 2.74 (ddd, J = 13.9, 8.9, 7.4 Hz, 1H), 1.93–1.69 (m, 2H), 1.19 (d, J = 5.5 
Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 141.5, 128.55, 128.55, 126.2, 56.6, 53.0, 
32.8, 29.6, 13.3. 
 
rac-Tert-butyldimethyl(2-((2S,3R)-3-methyloxiran-2-yl)ethoxy)silane (9j) 
Following general procedure A, (Z)-tert-butyldimethyl(pent-3-en-1-yloxy)silane40 
(2.74 g, 13.7 mmol) was reacted with mCPBA (4.10 g) in DCM (35 ml) to give 9j 
(2.34 g, 79%) as a colorless liquid. 1H NMR (300 MHz, CDCl3): δ 3.80–3.75 (m, 2H), 
3.09–3.03 (m, 2H), 1.82–1.63 (m, 2H), 1.26 (d, J = 5.4 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 
6H). 13C NMR (75 MHz, CDCl3): δ 60.6, 54.8, 52.7, 31.2, 26.1, 18.5, 13.6, -5.2. IR 
(neat, cm-1): 2929, 2857, 1472, 1254, 1094, 829, 774. HRMS (ESI) m/z calculated for 
C11H24NaO2Si+ (M + Na+) 239.1438, found 239.1445. 
 
2',5,6'-Trimethyl-[1,1'-biphenyl]-2-ol (SM2) 
Following general procedure B, 2-bromo-4-methylphenol (3.77 g, 20.2 mmol) 
was treated with sodium hydride (0.70 g, 29.2 mmol) in THF (40 ml), followed by 
addition of Pd(acac)2 (0.302 g, 0.991 mmol, 4.90 mol %), and 2,6-xylylmagnesium 
bromide (Aldrich, THF, 1.0 M, 30 ml, 30 mmol) to give SM2 (3.16 g, 74%) as a 
colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.36–7.24 (m, 3H), 7.17 (d, J = 8.2 Hz, 
1H), 7.00 (d, J = 8.3 Hz, 1H), 6.92 (s, 1H), 4.55 (s, 1H), 2.40 (s, 3H), 2.15 (s, 6H). 13C 
NMR (101 MHz, CDCl3): δ 150.1, 138.0, 135.1, 130.2, 130.0, 129.6, 128.4, 128.0, 
126.3, 115.1, 20.7, 20.5. IR (neat, cm-1): 3493, 2919, 1496, 1461, 1274, 1187, 1036, 
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816, 771. HRMS (ESI) m/z calculated for C15H17O+ (M + H+) 212.1201, found 
212.1207. 
 
2-Hydroxy-2',5,6'-trimethyl-[1,1'-biphenyl]-3-carbaldehyde (SM3) 
Following general procedure C, 2',5,6'-trimethyl-[1,1'-biphenyl]-2-ol (SM2, 3.14 
g, 14.8 mmol) was treated with methylmagnesium bromide (6.0 ml, 18.0 mmol) in 
THF (40 ml), followed by addition of toluene (75 ml), triethylamine (3.6 ml, 25.8 
mmol), and paraformaldehyde (1.26 g, 42.0 mmol) to give SM3 (2.91 g, 87%) as a 
colorless solid. MP 64–65 °C. 1H NMR (500 MHz, CDCl3): δ 10.96 (s, 1H), 9.93 (s, 
1H), 7.39–7.38 (m, 1H), 7.21 (dd, J = 8.3, 6.7 Hz, 1H), 7.18 (d, J = 2.3 Hz, 1H), 7.14 
(d, J = 7.4 Hz, 2H), 2.39 (s, 3H), 2.06 (s, 6H). 13C NMR (126 MHz, CDCl3): δ 196.8, 
156.7, 139.3, 136.7, 135.9, 132.9, 129.7, 129.2, 127.9, 127.4, 120.7, 20.6, 20.5. IR 
(neat, cm-1): 2919, 2850, 1643, 1439, 1315, 1261, 1220, 1123, 975, 869, 774. HRMS 
(ESI) m/z calculated for C16H17O2+ (M + H+) 241.1223, found 241.1228. 
 
2',4',6'-Trimethyl-[1,1'-biphenyl]-2-ol (SM4) 
Following general procedure B, 2-bromophenol (3.13 g, 18.1 mmol) was treated 
with sodium hydride (0.61 g, 25.4 mmol) in THF (35 ml), followed by addition of 
Pd(acac)2 (0.258 g, 0.847 mmol, 4.68 mol %), and mesitylmagnesium bromide 
(Aldrich, THF, 1.0 M, 28 ml, 28.0 mmol) to give SM4 (3.77 g, 98%) as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ 7.29 (ddd, J = 8.8, 6.8, 2.1 Hz, 1H), 7.04–6.97 (m, 
5H), 4.64 (s, 1H), 2.36 (s, 3H), 2.04 (s, 6H). 13C NMR (101 MHz, CDCl3): δ 152.6, 
138.2, 137.9, 131.7, 130.2, 129.0, 128.9, 126.5, 120.8, 115.2, 21.2, 20.3. IR (neat, cm-
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1): 3491, 2918, 1580, 1474, 1334, 1227, 1185, 1005, 851, 753. HRMS (EI) m/z 
calculated for C15H16O+ (M+) 212.1201, found 212.1205. 
 
2-Hydroxy-2',4',6'-trimethyl-[1,1'-biphenyl]-3-carbaldehyde (SM5) 
Following general procedure C, 2',4',6'-trimethyl-[1,1'-biphenyl]-2-ol (SM4, 3.74 
g, 17.6 mmol) was treated with methylmagnesium bromide (7.0 ml, 21.0 mmol) in 
THF (45 ml), followed by addition of toluene (84 ml), triethylamine (4.0 ml, 28.7 
mmol), and paraformaldehyde (1.34 g, 44.6 mmol) to give SM5 (3.76 g, 89%) as a 
colorless solid. MP 95–97 °C. 1H NMR (500 MHz, CDCl3): δ 11.15 (s, 1H), 9.98 (s, 
1H), 7.61 (dd, J = 7.7, 1.7 Hz, 1H), 7.36 (dd, J = 7.4, 1.7 Hz, 1H), 7.12 (t, J = 7.5 Hz, 
1H), 6.99 (s, 2H), 2.36 (s, 3H), 2.04 (s, 6H). 13C NMR (126 MHz, CDCl3): δ 196.8, 
158.9, 138.6, 137.6, 136.6, 133.1, 132.8, 130.0, 128.3, 120.9, 120.0, 21.3, 20.4. IR 
(neat, cm-1): 2917, 2883, 1656, 1614, 1433, 1392, 1295, 1218, 1057, 907, 823, 743. 
HRMS (ESI) m/z calculated for C16H17O2+ (M + H+) 241.1223, found 241.1232. 
 
2',4',5,6'-Tetramethyl-[1,1'-biphenyl]-2-ol (SM6) 
Following general procedure B, 2-bromo-4-methylphenol (2.33 g, 12.4 mmol) 
was treated with sodium hydride (0.380 g, 15.8 mmol) in THF (20 ml), followed by 
addition of Pd(acac)2 (0.170 g, 0.558 mmol, 4.50 mol %), and mesitylmagnesium 
bromide (Aldrich, THF, 1.0 M, 18 ml, 18.0 mmol) to give SM6 (2.78 g, 99%) as an 
off-white solid. MP 66–67 °C. 1H NMR (300 MHz, CDCl3): δ 7.08 (d, J = 8.4 Hz, 
1H), 7.00 (s, 2H), 6.91 (d, J = 8.1 Hz, 1H), 6.82 (s, 1H), 4.49 (d, J = 0.9 Hz, 1H), 2.35 
(s, 3H), 2.32 (s, 3H), 2.04 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 150.3, 138.0, 137.8, 
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132.0, 130.5, 129.9, 129.5, 128.8, 126.3, 114.9, 21.2, 20.7, 20.4. IR (neat, cm-1): 3477, 
2917, 1478, 1436, 1272, 1230, 1161, 1031, 819. HRMS (ESI) m/z calculated for 
C16H18NaO+ (M + Na+) 249.1250, found 249.1259.  
2-Hydroxy-2',4',5,6'-tetramethyl-[1,1'-biphenyl]-3-carbaldehyde (SM7) 
Following general procedure C, 2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol (SM6, 
3.78 g, 16.7 mmol) was treated with methylmagnesium bromide (6.5 ml, 19.5 mmol) 
in THF (40 ml), followed by addition of toluene (80 ml), triethylamine (2.76 g, 27.3 
mmol), and paraformaldehyde (1.28 g, 42.6 mmol) to give SM7 (3.32 g, 78%) as an 
off-white solid. MP 105–106 °C. 1H NMR (300 MHz, CDCl3): δ 10.95 (s, 1H), 9.93 
(s, 1H), 7.37 (d, J = 2.3 Hz, 1H), 7.18 (d, J = 2.2 Hz, 1H), 6.97 (s, 2H), 2.39 (s, 3H), 
2.34 (s, 3H), 2.03 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 196.8, 156.9, 139.5, 137.4, 
136.6, 132.9, 132.8, 129.8, 129.2, 128.3, 120.6, 21.3, 20.45, 20.42. IR (neat, cm-1): 
2917, 1643, 1454, 1320, 1224, 1103, 971, 850, 798, 742. HRMS (ESI) m/z calculated 
for C17H19O+ (M + H+) 255.1380, found 255.1383. 
 
4'-(Tert-butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-2-ol (SM8) 
Following general procedure B, 2-bromo-4-methylphenol (3.88 g, 20.7 mmol) 
was treated with sodium hydride (0.680 g, 28.3 mmol) in THF (40 ml), followed by 
addition of Pd(OAc)2 (0.220 g, 0.980 mmol, 4.73 mol %), and (4-(tert-butyl)-2,6-
dimethyl-phenyl)magnesium bromide26 (THF, 1.0 M, 40 ml) to give SM8 (4.58 g, 
83%) as a thick yellow oil. 1H NMR (400 MHz, CDCl3): δ 7.18 (s, 2H), 7.08 (dd, J = 
8.3, 2.2 Hz, 1H), 6.91 (d, J = 8.2 Hz, 1H), 6.85 (d, J = 2.3 Hz, 1H), 4.51 (s, 1H), 2.31 
(s, 3H), 2.08 (s, 6H), 1.37 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 151.2, 150.4, 137.5, 
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131.9, 130.4, 129.8, 129.5, 126.4, 125.1, 114.9, 34.6, 31.5, 20.8, 20.7. IR (neat, cm-1): 
3543, 2962, 1606, 1481, 1362, 1227, 1186, 1035, 869, 815. HRMS (ESI) m/z 
calculated for C19H24NaO+ (M + Na+) 291.1719, found 291.1730. 
4'-(Tert-butyl)-2-hydroxy-2',5,6'-trimethyl-[1,1'-biphenyl]-3-carbaldehyde (SM9)  
Following general procedure C, 4'-(tert-butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-2-
ol (SM8, 4.40 g, 16.4 mmol) was treated with methylmagnesium bromide (6.5 ml, 
19.5 mmol) in THF (40 ml), followed by addition of toluene (80 ml), triethylamine 
(2.90 g, 28.7 mmol), and paraformaldehyde (1.33 g, 44.3 mmol) to give SM9 (4.36 g, 
90%) as a yellow oil. 1H NMR (400 MHz, CDCl3): δ 10.99 (s, 1H), 9.92 (s, 1H), 7.37 
(m, 1H), 7.19 (m, 1H), 7.14 (s, 2H), 2.37 (s, 3H), 2.06 (s, 6H), 1.35 (s, 9H). 13C NMR 
(126 MHz, CDCl3): δ 196.8, 156.9, 150.4, 139.7, 136.1, 132.9, 132.8, 129.9, 129.1, 
124.5, 120.6, 34.5, 31.5, 20.8, 20.5. IR (neat, cm-1): 2949, 2863, 1648, 1455, 1322, 
1263, 1219, 968, 867. HRMS (ESI) m/z calculated for C20H25O2+ (M + H+) 297.1849, 
found 297.1850. 
 
5-(Tert-butyl)-4-hydroxy-2’,4’,6’-triisopropyl-[1,1’-biphenyl]-3-carbaldehyde 
(SM10) 
4-Bromo-2-(tert-butyl)phenol31 (1.6 g, 7.0 mmol) was added in small portions to a 
mixture of sodium hydride (Aldrich, 95%, dry, 0.23 g, 9.6 mmol) and THF (7 ml) at 0 
°C, followed by stirring at 22 °C for 10 minutes. Pd(OAc)2 (Strem, 0.107 g, 0.351 
mmol) was added, followed by 2,4,6-triisopropylphenylmagnesium bromide (Aldrich, 
0.5 M, THF, 30 ml, 15 mmol), and the resulting mixture was refluxed for 12 h. Upon 
cooling to 0 °C, H2O was carefully added to destroy residual Grignard reagent and 
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sodium hydride. HCl (2 M, aq.) was added followed by celite, and the resulting 
mixture was filtered through a pad of celite. The resulting phases were separated and 
the aqueous phase extracted with Et2O (3x). The combined organic layers were 
washed with brine, dried with sodium sulfate, filtered and concentrated under reduced 
pressure. The resulting residue was subjected to flash column chromatography. The 
isolated product (1.88 g) was contaminated with approximately 5% of 2-(tert-
butyl)phenol, and was used without further purification in the next step. 1H NMR data 
for the main component, 3-(tert-butyl)-2’,4’,6’-triisopropyl-[1,1’-biphenyl]-4-ol, is 
provided: 1H NMR (400 MHz, CDCl3): δ 7.06 (s, 1H), 7.05 (s, 2H), 6.88–6.85 (m, 
1H), 6.68 (d, J = 7.9 Hz, 1H), 4.72 (s, 1H), 2.94 (p, J = 6.9 Hz, 1H), 2.70–2.50 (m, 
2H), 1.41 (d, J = 1.3 Hz, 9H), 1.31 (d, J = 6.9 Hz, 6H), 1.09 (d, J = 6.7 Hz, 6H), 1.07 
(d, J = 6.8 Hz, 6H). 
Methylmagnesium bromide (Acros, 3 M, Et2O, 2.2 ml, 6.6 mmol) was added 
slowly to 3-(tert-butyl)-2’,4’,6’-triisopropyl-[1,1’-biphenyl]-4-ol (1.88 g, ca. 5 mmol) 
in THF (13 ml) at 0 °C. After warming to 22 °C, toluene (26 ml), triethylamine (1.3 
ml, 9.3 mmol) and paraformaldehyde (0.42 g, 14 mmol) were added, and the resulting 
reaction mixture stirred at 80 °C for 12 h. After cooling to 0 °C, H2O and then HCl (2 
M, aq.) were added, and the resulting phases were separated. The aqueous phase was 
extracted with Et2O (3x). The combined organic layers were washed with brine, dried 
with sodium sulfate, filtered and concentrated under reduced pressure. The residue 
was subjected to flash column chromatography, followed by recrystallization from 
methanol to give SM10 (1.32 g, 50% over two steps) as an off-color solid. MP 144–
143 °C (methanol). 1H NMR (500 MHz, CDCl3): δ 11.80 (s, 1H), 9.87 (s, 1H), 7.36 
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(d, J = 2.2 Hz, 1H), 7.22 (d, J = 2.1 Hz, 1H), 7.08 (s, 2H), 2.96 (hept, J = 6.9 Hz, 1H), 
2.61 (hept, J = 6.9 Hz, 2H), 1.43 (s, 9H), 1.32 (d, J = 6.9 Hz, 6H), 1.12 (d, J = 6.9 Hz, 
6H), 1.09 (d, J = 6.9 Hz, 6H). 13C NMR (126 MHz, CDCl3): δ 197.4, 160.0, 148.4, 
147.1, 137.9, 136.3, 135.9, 132.4, 131.6, 120.9, 120.4, 35.1, 34.5, 30.5, 29.55, 29.55, 
24.5, 24.23, 24.20. IR (neat, cm-1): 2958, 2868, 1638, 1436, 1264, 1166, 881, 787. 
HRMS (EI) m/z calculated for C26H26O2+ (M+) 380.2715, found 380.2709. 
2.5.2.3 Synthesis of Salen-Compounds 
rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis(meth-
anyly-lidene))bis(2',4',6'-trimethyl-[1,1'-biphenyl]-2-ol) (LF1) 
Following general procedure D, 2-hydroxy-2',4',6'-trimethyl-[1,1'-biphenyl]-3-
carbaldehyde (SM5, 360 mg, 1.50 mmol), racemic trans-cyclohexane-1,2-diamine 
(85.0 mg, 0.744 mmol) and methanol (2.5 ml) were mixed and then stirred at 65 °C for 
7 h. Following filtration and drying in vacuo, LF1 (311 mg, 75%) was obtained as a 
yellow powder. MP 184–185 °C. 1H NMR (500 MHz, CDCl3): δ 13.57 (s, 2H), 8.27 
(s, 2H), 7.12 (d, J = 6.3 Hz, 2H), 7.06 (d, J = 6.2 Hz, 2H), 6.98 (s, 4H), 6.86 (t, J = 7.5 
Hz, 2H), 3.24 (d, J = 9.5 Hz, 2H), 2.36 (s, 6H), 2.06 (s, 6H), 1.98 (d, J = 13.4 Hz, 2H), 
1.90 (s, 6H), 1.88 (d, J = 9.8 Hz, 2H), 1.78–1.60 (m, 2H), 1.46 (t, J = 9.9 Hz, 2H). 13C 
NMR (126 MHz, CDCl3): δ 165.0, 158.2, 136.9, 136.7, 136.5, 134.3, 133.5, 130.5, 
128.8, 128.3, 128.2, 118.6, 118.5, 73.0, 32.9, 24.2, 21.3, 20.5, 20.3. IR (neat, cm-1): 
2933, 2859, 1611, 1441, 1264, 1065, 850, 749. HRMS (ESI) m/z calculated for 
C38H43N2O2+ (M + H+) 559.3319, found 559.3311. 
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rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis(meth-
anylyli-dene))bis(2',5,6'-trimethyl-[1,1'-biphenyl]-2-ol) (LF2) 
Following general procedure D, 2-hydroxy-2',5,6'-trimethyl-[1,1'-biphenyl]-3-
carbaldehyde (SM3, 359 mg, 1.49 mmol), racemic trans-cyclohexane-1,2-diamine 
(84.0 mg, 0.736 mmol) and ethanol (7 ml) were mixed and then stirred at 80 °C for 7 
h. Following filtration and drying in vacuo, LF2 (318 mg, 77%) was obtained as a 
yellow powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): δ 13.32 (s, 2H), 8.20 (s, 
2H), 7.20–7.13 (m, 6H), 6.91 (s, 2H), 6.88 (s, 2H), 3.21 (d, J = 9.6 Hz, 2H), 2.26 (s, 
6H), 2.08 (s, 6H), 1.99–1.95 (m, 2H), 1.95 (s, 6H), 1.87 (d, J = 8.6 Hz, 2H), 1.69 (q, J 
= 12.1 Hz, 2H), 1.44 (t, J = 9.8 Hz, 2H). 13C NMR (126 MHz, CDCl3): δ 165.1, 155.7, 
137.4, 136.69, 136.66, 133.9, 130.7, 128.5, 127.42, 127.39, 127.3, 127.2, 118.4, 73.1, 
32.9, 24.3, 20.6, 20.43, 20.42. IR (neat, cm-1): 2919, 2856, 1628, 1453, 1265, 1151, 
1056, 981, 867, 763. HRMS (ESI) m/z calculated for C38H43N2O2+ (M + H+) 
559.3319, found 559.3322. 
 
rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis(meth-
anylyli-dene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) (LF3) 
Following general procedure D, 2-hydroxy-2',4',5,6'-tetramethyl-[1,1'-biphenyl]-
3-carbaldehyde (SM7, 381 mg, 1.50 mmol), racemic trans-cyclohexane-1,2-diamine 
(83.0 mg, 0.729 mmol) and ethanol (4 ml) were mixed and then stirred at 80 °C for 7 
h. Following filtration and drying in vacuo, LF3 (338 mg, 79%) was obtained as a 
yellow powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): δ 13.28 (s, 2H), 8.19 (s, 
2H), 6.96 (s, 4H), 6.89 (d, J = 2.1 Hz, 2H), 6.86 (d, J = 2.1 Hz, 2H), 3.19 (d, J = 9.7 
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Hz, 2H), 2.34 (s, 6H), 2.25 (s, 6H), 2.04 (s, 6H), 1.95 (d, J = 14.5 Hz, 2H), 1.91 (s, 
6H), 1.84 (d, J = 8.8 Hz, 2H), 1.70–1.63 (m, 2H), 1.44 (t, J = 9.8 Hz, 2H). 13C NMR 
(126 MHz, CDCl3): δ 165.1, 155.9, 136.8, 136.6, 136.5, 134.4, 134.1, 130.6, 128.6, 
128.2, 128.1, 127.3, 118.3, 73.1, 32.9, 24.3, 21.3, 20.6, 20.5, 20.3. IR (neat, cm-1): 
2918, 2856, 1628, 1599, 1451, 1261, 1105, 981, 849, 794. HRMS (ESI) m/z 
calculated for C40H47N2O2+ (M + H+) 587.3632, found 587.3646. 
 
3,3''-((1E,1'E)-(1,2-Phenylenebis(azanylylidene))bis(methanylylidene))-
bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) (LF4) 
2-Hydroxy-2',4',5,6'-tetramethyl-[1,1'-biphenyl]-3-carbaldehyde (SM7, 254 mg, 
1.00 mmol), benzene-1,2-diamine (54.1 mg, 0.744 mmol) and methanol (5 ml) were 
mixed and then stirred at 65 °C for 12 h. The reaction mixture was cooled to -20 °C, 
and the resulting precipitate isolated by filtration, followed by two washings with 
small amounts of cold methanol to give LF4 (178 mg, 62%) as an orange powder. MP 
>200 °C. 1H NMR (400 MHz, CDCl3): δ 12.76 (s, 2H), 8.59 (s, 2H), 7.32–7.29 (m, 
2H), 7.17–7.15 (m, 2H), 7.13 (s, 2H), 6.96 (s, 2H), 6.92 (s, 4H), 2.32 (s, 12H), 1.96 (s, 
12H). 13C NMR (126 MHz, CDCl3): δ 164.5, 156.4, 142.7, 136.8, 135.7, 134.3, 131.6, 
129.3, 128.10, 128.08, 127.8, 127.5, 120.8, 119.1, 21.3, 20.6, 20.5. IR (neat, cm-1): 
2916, 1616, 1595, 1447, 1265, 1212, 1108, 981, 848, 754. HRMS (ESI) m/z 
calculated for C40H41N2O2+ (M + H+) 581.3163, found 581.3156. 
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3,3''-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanylyli-
dene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) (LF5) 
Following general procedure D, 2-hydroxy-2',4',5,6'-tetramethyl-[1,1'-biphenyl]-
3-carbaldehyde (SM7, 254 mg, 0.999 mmol), 2,3-dimethylbutane-2,3-diamine18 (58.6 
mg, 0.504 mmol) and methanol (5 ml) were mixed and then stirred at 65 °C for 7 h. 
Following filtration and drying in vacuo, LF5 (235 mg, 80%) was obtained as a faint 
yellow powder. MP >200 °C. 1H NMR (300 MHz, CDCl3): δ 13.74 (s, 2H), 8.31 (s, 
2H), 7.01 (d, J = 1.7 Hz, 2H), 6.98 (s, 4H), 6.92 (d, J = 2.0 Hz, 2H), 2.35 (s, 6H), 2.30 
(s, 6H), 2.06 (s, 12H), 1.36 (s, 12H). 13C NMR (126 MHz, CDCl3): δ 162.1, 156.3, 
136.8, 136.6, 134.6, 134.3, 131.0, 128.7, 128.2, 127.2, 118.7, 65.3, 23.3, 21.3, 20.6, 
20.5. IR (neat, cm-1): 2973, 2917, 1622, 1597, 1456, 1378, 1259, 1139, 1101, 975, 
848, 832. HRMS (ESI) m/z calculated for C40H49N2O2+ (M + H+) 589.3789, found 
589.3779. 
 
3,3''-((1E,1'E)-((2-Methylpropane-1,2-diyl)bis(azanylylidene))bis(methanylyli-
dene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) (LF6) 
Following general procedure D, 2-hydroxy-2',4',5,6'-tetramethyl-[1,1'-biphenyl]-
3-carbaldehyde (SM7, 635 mg, 2.50 mmol), 2-methylpropane-1,2-diamine (121.0 mg, 
1.37 mmol) and methanol (4 ml) were mixed and then stirred at 65 °C for 12 h. 
Following filtration and drying in vacuo, LF6 (635 mg, 91%) was obtained as an off-
color powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): δ 13.80 (s, 1H), 13.08 (s, 
1H), 8.31 (s, 1H), 8.27 (s, 1H), 7.02 (d, J = 2.0 Hz, 1H), 7.00 (d, J = 1.8 Hz, 1H), 6.97 
(s, 4H), 6.92 (s, 2H), 3.68 (s, 2H), 2.35 (s, 6H), 2.31 (s, 6H), 2.03 (s, 6H), 2.03 (s, 6H), 
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1.40 (s, 6H). 13C NMR (126 MHz, CDCl3): δ 167.0, 161.8, 156.3, 156.0, 136.9, 136.8, 
136.60, 136.56, 134.6, 134.5, 134.4, 134.2, 130.9, 130.8, 128.8, 128.7, 128.3, 128.2, 
127.5, 127.3, 118.49, 118.47, 70.8, 60.4, 25.5, 21.26, 21.25, 20.54, 20.52, 20.51, 
20.49. IR (neat, cm-1): 2975, 2916, 1629, 1602, 1456, 1387, 1263, 1110, 1064, 849. 
HRMS (ESI) m/z calculated for C38H45N2O2+ (M + H+) 561.3476, found 561.3481. 
 
rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis-(methany-
lylidene))bis(4'-(tert-butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-2-ol) (LF7) 
Following general procedure D, 4'-(tert-butyl)-2-hydroxy-2',5,6'-trimethyl-[1,1'-
biphenyl]-3-carbaldehyde (SM9, 444 mg, 1.50 mmol), racemic trans-cyclohexane-
1,2-diamine (84.9 mg, 0.743 mmol) and methanol (2.5 ml) were mixed and then 
stirred at 64 °C for 1 h. Following filtration and drying in vacuo, LF7 (368 mg, 74%) 
was obtained as a yellow powder. MP >200 °C. 1H NMR (400 MHz, CDCl3): δ 13.35 
(s, 2H), 8.18 (s, 2H), 7.14 (s, 4H), 6.89 (s, 4H), 3.18 (m, 2H), 2.24 (s, 6H), 2.08 (s, 
6H), 1.96 (s, 6H), 1.96 (m, 2H), 1.85 (m, 2H), 1.66 (s, 2H), 1.45–1.39 (m, 2H), 1.36 
(s, 18H). 13C NMR (126 MHz, CDCl3): δ 165.2, 155.9, 149.8, 136.1, 136.0, 134.4, 
134.3, 130.6, 128.7, 127.4, 124.4, 124.3, 118.3, 73.1, 34.4, 32.9, 31.6, 24.3, 21.0, 20.8, 
20.4. IR (neat, cm-1): 2945, 2861, 122, 1453, 1262, 1097, 862. HRMS (ESI) m/z 
calculated for C46H59N2O2+ (M + H+) 671.4571, found 671.4574. 
The synthesis of (S,S)- and (R,R)-LF7 is analogous to that of the racemic 
compound. Specific rotation of (S,S)-LF7: [α]22D = +425 (c = 0.56, CHCl3). 
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3,3''-((1E,1'E)-(1,2-Phenylenebis(azanylylidene))bis(methanylylidene))bis(4'-(tert-
butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-2-ol) (LF8) 
Following general procedure D, 4'-(tert-butyl)-2-hydroxy-2',5,6'-trimethyl-[1,1'-
biphenyl]-3-carbaldehyde (SM9, 444 mg, 1.50 mmol), benzene-1,2-diamine (81.1 mg, 
0.750 mmol) and methanol (2.5 ml) were mixed and then stirred at 65 °C for 7 h. 
Following filtration and drying in vacuo, LF8 (336 mg, 67%) was obtained as an 
orange powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): δ 12.84 (s, 2H), 8.61 (s, 
2H), 7.32 (dd, J = 5.9, 3.4 Hz, 2H), 7.19 (dd, J = 5.8, 3.4 Hz, 2H), 7.16 (d, J = 2.0 Hz, 
2H), 7.14 (s, 4H), 7.02 (d, J = 2.2 Hz, 2H), 2.33 (s, 6H), 2.02 (s, 12H), 1.38 (s, 18H). 
13C NMR (126 MHz, CDCl3): δ 164.6, 156.4, 149.7, 142.7, 136.3, 135.9, 134.3, 
131.6, 129.4, 127.8, 127.5, 124.3, 120.7, 119.1, 34.4, 31.6, 20.9, 20.5. IR (neat, cm-1): 
2959, 2865, 1614, 1575, 1445, 1270, 1214, 1097, 861. HRMS (ESI) m/z calculated for 
C46H53N2O2+ (M + H+) 665.4102, found 665.4122. 
 
rac-2,4-Di-tert-butyl-6-((E)-(((1S,2S)-2-((3,5-di-tert-butyl-2-hydroxybenzyl)(pyri-
din-2-ylmethyl)amino)cyclohexyl)imino)methyl)phenol (LF9) 
rac-2,4-Di-tert-butyl-6-((E)-(((1S,2S)-2-((pyridin-2-ylmethyl)amino)cyclohexyl)-
imino)-methyl)phenol12 (4.95 g, 11.7 mmol), paraformaldehyde (0.42 g, 14.0 mmol), 
2,4-di-tert-butylphenol (2.41 g, 11.7 mmol), and toluene (13 ml) were mixed in air and 
stirred at 100 °C for 22 h. Upon cooling to 22 °C, volatiles were removed in vacuo and 
the residue was purified via flash column chromatography (using neutral alumina) to 
afford LF9 (1.17 g, 16%) as a yellow powder. MP >200 °C. 1H NMR (500 MHz, 
CDCl3): δ 13.33 (s, 1H), 10.40 (s, 1H), 8.53–8.45 (m, 1H), 8.33 (s, 1H), 7.70 (td, J = 
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7.7, 1.9 Hz, 1H), 7.52 (d, J = 7.9 Hz, 1H), 7.40 (d, J = 2.4 Hz, 1H), 7.18 (ddd, J = 7.5, 
4.9, 1.2 Hz, 1H), 7.13 (d, J = 2.4 Hz, 1H), 7.01 (d, J = 2.4 Hz, 1H), 6.90 (d, J = 2.4 
Hz, 1H), 4.19 (d, J = 13.5 Hz, 1H), 3.92 (d, J = 13.9 Hz, 1H), 3.79 (d, J = 13.9 Hz, 
1H), 3.56 (d, J = 13.5 Hz, 1H), 3.38 (td, J = 10.6, 4.3 Hz, 1H), 2.91 (ddd, J = 12.8, 
10.1, 3.3 Hz, 1H), 2.26 (d, J = 12.5 Hz, 1H), 1.91–1.87 (m, 1H), 1.76–1.72 (m, 2H), 
1.53 (s, 9H), 1.47–1.33 (m, 4H) 1.30 (s, 9H), 1.27 (s, 9H), 1.09 (s, 9H). 13C NMR 
(126 MHz, CDCl3): δ 167.0, 158.5, 158.1, 154.1, 148.7, 140.4, 139.8, 137.2, 136.4, 
135.7, 126.8, 126.1, 124.3, 124.1, 123.0, 122.4, 121.0, 118.4, 69.9, 63.2, 56.1, 53.3, 
35.7, 35.2, 34.8, 34.3, 34.2, 31.8, 31.7, 29.8, 29.5, 25.3, 24.9, 22.4. IR (neat, cm-1): 
2951, 1629, 1438, 1360, 1238, 986, 878, 756. HRMS (ESI) m/z calculated for 
C42H62N3O2+ (M + H+) 640.4837, found 640.4839. 
 
2,2’-((1E,1’E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanyl-
ylidene))bis(4-methylphenol) (LF10) 
Following general procedure D, 2-hydroxy-5-methylbenzaldehyde (204 mg, 1.50 
mmol), 2,3-dimethylbutane-2,3-diamineS18 (87.0 mg, 0.749 mmol), and methanol (4.5 
ml) were mixed and then stirred at 70 °C for 11 h. Following filtration and drying in 
vacuo, LF10 (189 mg, 72%) was obtained as a yellow powder. MP 198–199 °C. 1H 
NMR (500 MHz, CDCl3): δ 13.81 (s, 2H), 8.32 (s, 2H), 7.11 (dd, J = 8.3, 2.2 Hz, 2H), 
7.06 (d, J = 2.3 Hz, 2H), 6.85 (d, J = 8.3 Hz, 2H), 2.28 (s, 6H), 1.37 (s, 12H). 13C 
NMR (126 MHz, CDCl3): δ 161.7, 159.3, 133.1, 131.9, 127.6, 118.7, 116.9, 65.3, 
23.2, 20.5. IR (neat, cm-1): 2978, 1625, 1590, 1492, 1278, 1133, 822. HRMS (ESI) 
m/z calculated for C22H29N2O2+ (M + H+) 353.2224, found 353.2225. 
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6,6'-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanyl-
ylidene))bis(2,4-dimethylphenol) (LF11) 
Following general procedure D, 2-hydroxy-3,5-dimethylbenzaldehyde (225 mg, 
1.50 mmol), 2,3-dimethylbutane-2,3-diamineS18 (87.0 mg, 0.749 mmol), and methanol 
(4.5 ml) were mixed and then stirred at 70 °C for 12 h. Following filtration and drying 
in vacuo, LF11 (228 mg, 80%) was obtained as a yellow powder. MP 178–179 °C. 1H 
NMR (500 MHz, CDCl3): δ 14.07 (s, 2H), 8.33 (s, 2H), 7.01 (s, 2H), 6.92 (s, 2H), 
2.26 (s, 12H), 1.39 (s, 12H). 13C NMR (126 MHz, CDCl3): δ 161.9, 157.7, 134.4, 
129.5, 127.0, 125.8, 117.9, 65.2, 23.3, 20.5, 15.6. IR (neat, cm-1): 2971, 2913, 1627, 
1601, 1473, 1377, 1264, 1133, 863, 838. HRMS (ESI) m/z calculated for C24H33N2O2+ 
(M + H+) 381.2537, found 381.2538. 
 
6,6'-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanyl-
ylidene))bis(4-(tert-butyl)-2-methylphenol) (LF12) 
Following general procedure D, 5-(tert-butyl)-2-hydroxy-3-methylbenzaldehyde29 
(384 mg, 2.00 mmol), 2,3-dimethylbutane-2,3-diamine27 (116 mg, 0.998 mmol), and 
methanol (6.0 ml) were mixed and then stirred at 70 °C for 8 h. Following filtration 
and drying in vacuo, LF12 (362 mg, 78%) was obtained as a yellow powder. MP 
171–173 °C. 1H NMR (500 MHz, CDCl3): δ 14.1 (s, 2H), 8.40 (s, 2H), 7.23 (s, 2H), 
7.12 (s, 2H), 2.30 (s, 6H), 1.40 (s, 12H), 1.31 (s, 18H). 13C NMR (126 MHz, CDCl3): 
δ 162.2, 157.7, 140.7, 130.9, 125.8, 125.4, 117.5, 65.2, 34.0, 31.6, 23.3, 15.9. IR 
(neat, cm-1): 2965, 1630, 1479, 1380, 1274, 1135, 1040, 979, 861. HRMS (ESI) m/z 
calculated for C30H45N2O2+ (M + H+) 465.3476, found 465.3471. 
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5,5''-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanyl-
ylidene))bis(3-(tert-butyl)-2',4',6'-triisopropyl-[1,1'-biphenyl]-4-ol) (LF13) 
Following general procedure D, SM10 (381 mg, 1.00 mmol), 2,3-dimethylbutane-
2,3-diamine27 (58 mg, 0.50 mmol), and methanol (15 ml) were mixed and then stirred 
at 70 °C for 12 h. Following filtration and drying in vacuo, LF13 (319 mg, 76%) was 
obtained as a yellow powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): δ 14.51 (s, 
2H), 8.45 (s, 2H), 7.14 (d, J = 2.1 Hz, 2H), 7.08 (s, 4H), 6.97 (d, J = 2.1 Hz, 2H), 2.97 
(hept, J = 6.9 Hz, 2H), 2.70 (hept, J = 6.8 Hz, 4H), 1.47 (s, 12H), 1.45 (s, 18H), 1.33 
(d, J = 6.9 Hz, 12H), 1.13 (d, J = 6.9 Hz, 12H), 1.09 (d, J = 6.8 Hz, 12H). 13C NMR 
(126 MHz, CDCl3): δ 162.5, 159.4, 147.8, 147.2, 137.1, 136.9, 131.5, 130.6, 129.9, 
120.7, 118.5, 65.4, 35.1, 34.4, 30.4, 29.7, 24.7, 24.3, 23.5. IR (neat, cm-1): 2957, 1630, 
1433, 1384, 1267, 1131, 876. HRMS (ESI) m/z calculated for C58H85N2O2+ (M + H+) 
841.6606, found 841.6605. 
 
3,3''-((1E,1'E)-([1,1'-Binaphthalene]-2,2'-diylbis(azanylylidene))bis(methanylyli-
dene))bis(3',5'-di-tert-butyl-5-methyl-[1,1'-biphenyl]-2-ol) (BinamSal, LF14) 
3',5'-Di-tert-butyl-2-hydroxy-5-methyl-[1,1'-biphenyl]-3-carbaldehyde28 (324 mg, 
0.999 mmol), racemic [1,1'-binaphthalene]-2,2'-diamine (142 mg, 0.499 mmol) and 
ethanol (8 ml) were mixed and then refluxed for 12 h. After allowing the reaction 
mixture to reach 22 °C, the resulting precipitate was isolated by filtration, washed with 
a small amount of ethanol and finally pentane to give LF14 (372 mg, 83%) as a 
powder of orange color. MP 196–198 °C. 1H NMR (400 MHz, CDCl3): δ 12.36 (s, 
2H), 8.62 (s, 2H), 8.01 (d, J = 8.8 Hz, 2H), 7.89 (d, J = 8.2 Hz, 2H), 7.56 (d, J = 8.8 
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Hz, 2H), 7.38 (dt, J = 8.1, 4.0 Hz, 2H), 7.33 (t, J = 1.8 Hz, 2H), 7.26 (d, J = 1.8 Hz, 
2H), 7.22 (d, J = 3.2 Hz, 2H), 7.14 (d, J = 2.1 Hz, 2H), 6.92 (d, J = 2.2 Hz, 2H), 2.24 
(s, 6H), 1.35 (s, 36H). 13C NMR (101 MHz, CDCl3): δ 162.6, 156.2, 150.0, 144.4, 
136.6, 135.0, 133.4, 132.5, 131.6, 130.09, 130.05, 129.3, 128.3, 127.6, 127.0, 126.6, 
125.8, 123.8, 121.0, 119.4, 117.3, 35.0, 31.8, 20.5. IR (neat, cm-1): 2962, 1582, 1462, 
1362, 1259, 967, 865, 742, 714. HRMS (ESI) m/z calculated for C64H69N2O2+ (M + 
H+) 897.5354, found 897.5382.  
2.5.2.4 Metallation of Salen-Compounds 
6,6'-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanylyli-
dene))bis(2,4-di-tert-butylphenolate)aluminum chloride (MF2, precursor to 1d)  
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 600 µl, 0.600 
mmol) was added to 6,6'-((1E,1'E)-((2,3-dimethylbutane-2,3-diyl)bis(azanylylidene))-
bis(methanylylidene))bis(2,4-di-tert-butylphenol) (TCI, 277 mg, 0.505 mmol) in 
DCM (3.0 ml). After stirring at 22 °C, volatiles were removed in vacuo. The residue 
was broken up and further dried in vacuo at 80 °C for 1 h to give MF2 (236 mg, 77%) 
as a fluorescent yellow powder. MP >200 °C. 1H NMR (500 MHz, C6D6): δ 8.04 (s, 
2H), 7.84 (s, 2H), 7.15 (s, 2H), 1.88 (s, 18H), 1.39 (s, 18H), 0.96 (s, 6H), 0.53 (s, 6H). 
13C NMR (126 MHz, C6D6): δ 167.4, 163.8, 142.0, 138.8, 131.4, 128.1, 119.5, 65.9, 
36.2, 34.3, 31.7, 30.4, 24.8, 23.8. IR (neat, cm-1): 2952, 1616, 1541, 1472, 1391, 1258, 
1153, 854, 756. HRMS (ESI) m/z calculated for C36H54AlN2O2+ (M - Cl)+ 573.3995, 
found 573.3990. 
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[Me4SalAl(THF)2]+[Co(CO)4]- (1d)  
NaCo(CO)4 (33.4 mg, 0.172 mmol), 6,6'-((1E,1'E)-((2,3-dimethylbutane-2,3-
diyl)bis(azanylylidene))bis(methanylylidene))bis(2,4-di-tert-butylphenolate)aluminum 
chlorideS16 (100 mg, 0.164 mmol) and THF (2.5 ml) were mixed and stirred for 12 h at 
22 °C. The reaction mixture was filtered through a 0.45 µm teflon syringe filter, the 
filtrate carefully layered with hexane and then placed in a freezer at -34 °C for a day. 
The resulting crystals were isolated by filtration, washed with hexanes and then dried 
in vacuo to give 1d (118 mg, 81%) as yellow crystals. 1H NMR (400 MHz, C6D6): δ 
8.75 (s, 2H), 7.87 (d, J = 2.6 Hz, 2H), 7.78 (d, J = 2.5 Hz, 2H), 3.47–3.23 (m, 8H, 
THF), 1.65 (s, 18H), 1.43 (s, 18H), 1.18 (s, 12H), 1.20–1.15 (m, 8H, THF). 13C NMR 
(126 MHz, C6D6 + THF-d8, (1:1, v/v)): δ 171.0, 162.4, 139.4, 132.2, 130.5, 119.9, 
67.9, 35.8, 34.5, 31.5, 29.8, 26.3, 25.9. IR (neat, cm-1): 2953, 1862 ν(C=O), 1613, 1401, 
1259, 1149, 1019, 848, 760. 
 
rac-2,4-Di-tert-butyl-6-((E)-(((1S,2S)-2-((3,5-di-tert-butyl-2-hydroxybenzyl)(pyri-
din-2-ylmethyl)amino)cyclohexyl)imino)methyl)phenolaluminum chloride (1e) 
Et2AlCl (Aldrich, hexanes, 1.0 M, 715 µl, 0.715 mmol) was added to a solution of 
rac-2,4-di-tert-butyl-6-((E)-(((1S,2S)-2-((3,5-di-tert-butyl-2-hydroxybenzyl)(pyridin-
2-ylmethyl)amino)cyclohexyl)imino)methyl)phenol (LF9, 352 mg, 0.550 mmol) in 
DCM (2.5 ml) at 0 °C. The resulting solution was stirred at 22 °C for 24 h, followed 
by removal of all volatiles in vacuo. NaCo(CO)4 (107 mg, 0.552 mmol) and THF (1.5 
ml) were added to the residue and stirred for 12 h at 22 °C. The reaction mixture was 
then filtered through a 0.45 µm teflon syringe filter and concentrated in vacuo. The 
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residue was taken up in a minimum amount of Et2O and the solution placed in a 
freezer at -34 °C. The resulting precipitate was isolated by filtration to give 1b (173 
mg, 35%) as a powder of yellow to orange color. The powder can be dissolved in 
toluene followed by layering with hexanes to give a crystalline yellow solid. No 
significant difference in terms of activity and selectivity was noted when using the 
recrystallized species. Catalyst 1e was stored under nitrogen at -34 °C. 1H NMR (300 
MHz, C6D6): δ 8.83 (d, J = 4.9 Hz, 1H), 7.97 (s, 1H), 7.83 (d, J = 2.6 Hz, 1H), 7.65 (d, 
J = 7.8 Hz, 1H), 7.45 (d, J = 2.5 Hz, 1H), 7.22–7.14 (m, 2H), 6.84 (d, J = 2.4 Hz, 1H), 
6.46 (t, J = 6.7 Hz, 1H), 5.19 (d, J = 17.1 Hz, 1H), 3.84 (m, 2H), 3.81 (d, J = 16.7 Hz, 
1H), 3.31 (d, J = 13.4 Hz, 1H), 3.11 (d, J = 13.4 Hz, 1H), 2.49 (t, J = 10.9 Hz, 1H), 
1.87–1.60 (m, 4H), 1.73 (s, 9H), 1.55–1.44 (m, 1H), 1.39 (s, 9H), 1.32 (s, 9H), 1.27 (s, 
9H), 0.73–0.58 (m, 1H), 0.25–0.04 (m, 1H). 13C NMR (126 MHz, C6D6): δ 172.6, 
162.6, 155.5, 154.9, 147.7, 144.3, 141.2, 140.6, 140.1, 138.6, 133.2, 129.8, 126.1, 
125.3, 124.8, 124.7, 120.4, 119.3, 61.6, 59.3, 56.5, 52.8, 35.6, 35.3, 34.4, 34.3, 31.9, 
31.4, 30.4, 29.7, 28.8, 24.0, 23.7, 23.2. IR (neat, cm-1): 1875 ν(C=O). 
 
rac-6,6'-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis(methan-
ylylidene))bis(2,4-dimethylphenolate)aluminum chloride (MF1, precursor to 1f) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 520 µl, 0.520 
mmol) was added to rac-6,6'-((1E,1'E)-((1S,2S)-cyclohexane-1,2-diylbis-
(azanylylidene))bis(methanylylidene))bis(2,4-dimethylphenol)25 (174 mg, 0.460 
mmol) in DCM (2.0 ml). After stirring at 22 °C, the supernatant was removed via 
filtration, and the residue washed once with 1,4-dioxane. The residue was dried in 
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vacuo at 80 °C for 1 h to give MF1 (137 mg, 68%) as a yellow powder. MP >200 °C. 
1H NMR (400 MHz, CDCl3): δ 8.31 (d, J = 1.9 Hz, 1H), 8.13 (d, J = 2.0 Hz, 1H), 7.18 
(s, 2H), 6.92 (d, J = 2.1 Hz, 1H), 6.88 (d, J = 1.8 Hz, 1H), 3.93 (t, J = 10.7 Hz, 1H), 
3.13 (t, J = 11.1 Hz, 1H), 2.55 (d, J = 12.0 Hz, 1H), 2.45 (d, J = 12.0 Hz, 1H), 2.35 (s, 
3H), 2.33 (s, 3H), 2.25 (s, 3H), 2.24 (s, 3H), 2.11–2.07 (m, 2H), 1.61–1.38 (m, 4H). 
The very low solubility of MF1 in both CDCl3 and C6D6 interfered with collection of 
a 13C NMR spectrum in a reasonable amount of time. IR (neat, cm-1): 2946, 1625, 
1602, 1557, 1351, 1346, 1265, 1037, 824, 764. HRMS (ESI) m/z calculated for 
C24H28AlN2O2+ (M - Cl)+ 403.1966, found 403.1964. 
 
rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis(meth-
anyly-lidene))bis(2',4',6'-trimethyl-[1,1'-biphenyl]-2-olate)aluminum chloride 
(MF4, precursor to 1g) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 630 µl, 0.630 
mmol) was added to rac-3,3''-((1E,1'E)-((1S,2S)-cyclohexane-1,2-diylbis(aza-
nylylidene))bis(methanyly-lidene))bis(2',4',6'-trimethyl-[1,1'-biphenyl]-2-ol) (LF1, 
311 mg, 0.558 mmol) in DCM (2.5 ml). After stirring at 22 °C, the supernatant was 
removed via filtration, and the residue washed with DCM once. The residue was dried 
in vacuo at 80 °C for 1 h to give MF4 (292 mg, 84%) as a yellow-white powder. MP 
>200 °C. 1H NMR (500 MHz, CDCl3): δ 8.40 (d, J = 1.9 Hz, 1H), 8.18 (d, J = 2.1 Hz, 
1H), 7.30 (dd, J = 7.7, 1.9 Hz, 1H), 7.23 (dd, J = 5.8, 1.8 Hz, 1H), 7.21 (dd, J = 6.2, 
1.8 Hz, 1H), 7.17 (dd, J = 7.2, 1.9 Hz, 1H), 6.99 (s, 1H), 6.97 (s, 1H), 6.85 (t, J = 7.5 
Hz, 1H), 6.79 (s, 1H), 6.78 (t, J = 7.5 Hz, 1H), 6.61 (s, 1H), 3.87 (t, J = 10.7 Hz, 1H), 
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3.14 (t, J = 10.1 Hz, 1H), 2.56 (d, J = 11.4 Hz, 1H), 2.50 (s, 3H), 2.46 (d, J = 10.7 Hz, 
1H), 2.39 (s, 3H), 2.10–2.05 (m, 2H), 2.08 (s, 3H), 1.91 (s, 3H), 1.78 (s, 3H), 1.75 (s, 
3H), 1.58–1.38 (m, 4H). 13C NMR (126 MHz, CDCl3): δ 169.0, 164.2, 162.3, 161.6, 
138.73, 138.69, 137.9, 137.7, 136.4, 135.52, 135.51, 135.3, 135.1, 134.4, 134.1, 
133.42, 133.40, 132.5, 128.20, 128.19, 127.8, 127.7, 119.4, 118.8, 117.3, 116.9, 65.8, 
62.3, 28.6, 27.2, 24.1, 23.6, 21.5, 21.5, 21.3, 20.7, 20.2, 19.6. IR (neat, cm-1): 2936, 
1613, 1556, 1432, 1398, 1232, 1106, 933, 853, 759. HRMS (ESI) m/z calculated for 
C38H40AlN2O2+ (M - Cl)+ 583.2905, found 583.2906. 
 
rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis(meth-
anylyli-dene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-olate)aluminum chloride 
(MF5, precursor to 1h) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 1.1 ml, 1.1 
mmol) was added to rac-3,3''-((1E,1'E)-((1S,2S)-cyclohexane-1,2-diylbis(aza-
nylylidene))bis(methanylylidene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) (LF3, 
587 mg, 1.00 mmol) in DCM (8.0 ml). After stirring at 22 °C, the supernatant was 
removed via filtration, and the residue washed with DCM once. The residue was dried 
in vacuo at 80 °C for 1 h to give MF5 (362 mg, 56%) as a yellow-white powder. MP 
>200 °C. 1H NMR (400 MHz, CDCl3): δ 8.35 (d, J = 1.9 Hz, 1H), 8.14 (d, J = 2.0 Hz, 
1H), 7.08 (d, J = 0.8 Hz, 1H), 7.06 (d, J = 2.4 Hz, 1H), 7.00 (s, 2H), 6.98 (s, 1H), 6.96 
(s, 1H), 6.79 (s, 1H), 6.59 (s, 1H), 3.87–3.82 (m, 1H), 3.16–3.11 (m, 1H), 2.54 (d, J = 
13.4 Hz, 1H), 2.50 (s, 3H), 2.47 (d, J = 10.6 Hz, 1H), 2.39 (s, 3H), 2.28 (s, 3H), 2.24 
(s, 3H), 2.09 (s, 3H), 2.05 (d, J = 21.4 Hz, 2H), 1.93 (s, 3H), 1.79 (s, 3H), 1.77 (s, 3H), 
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1.57–1.37 (m, 4H). 13C NMR (101 MHz, CDCl3): δ 168.6, 162.4, 162.2, 159.6, 140.2, 
139.1, 138.7, 137.6, 136.4, 135.6, 135.4, 135.2, 134.9, 134.5, 133.8, 133.1, 132.6, 
132.0, 128.2, 128.1, 127.8, 127.7, 126.0, 125.5, 119.0, 118.4, 65.7, 62.3, 28.6, 27.3, 
24.1, 23.6, 21.53, 21.48, 21.2, 20.8, 20.4, 20.3, 20.2, 19.6. IR (neat, cm-1): 2950, 2921, 
1621, 1557, 1448, 1227, 836, 786. HRMS (ESI) m/z calculated for C40H44AlN2O2+ (M 
- Cl)+ 611.3218, found 611.3223. 
 
3,3''-((1E,1'E)-(1,2-Phenylenebis(azanylylidene))bis(methanylylidene))bis-
(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-olate)aluminum chloride (MF3, 
precursor to 1i) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 400 µl, 0.400 
mmol) was added to 3,3''-((1E,1'E)-(1,2-phenylenebis(azanylylidene))bis(methanylyl-
idene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) (LF4, 178 mg, 0.307 mmol) in 
DCM (4.0 ml). After stirring at 22 °C, the supernatant was removed via filtration, and 
the residue washed with DCM once. The residue was dried in vacuo at 80 °C for 1 h to 
give MF3 (53.7 mg, 27%) as an orange powder. MP >200 °C. 1H NMR (500 MHz, 
C6D6): δ 8.06 (s, 2H), 7.03 (s, 2H), 7.00 (d, J = 2.3 Hz, 2H), 6.96 (s, 2H), 6.89–6.85 
(m, 2H), 6.84–6.81 (m, 2H), 6.66 (dd, J = 2.3, 1.1 Hz, 2H), 2.53 (s, 6H), 2.32 (s, 6H), 
2.09 (s, 6H), 2.08 (s, 6H). 13C NMR (126 MHz, CDCl3): δ 163.2, 161.7, 141.5, 138.2, 
137.9, 135.9, 135.6, 135.4, 134.7, 132.9, 128.7, 128.1, 127.9, 126.2, 119.2, 115.7, 
21.7, 20.9, 20.7, 20.2. IR (neat, cm-1): 2916, 1616, 1551, 1459, 1347, 1214, 833, 752. 
HRMS (ESI) m/z calculated for C40H38AlN2O2+ (M - Cl)+ 605.2749, found 605.2748. 
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3,3''-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanylyli-
dene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-olate)aluminum chloride (MF6, 
precursor to 1j) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 450 µl, 0.450 
mmol) was added to 3,3''-((1E,1'E)-((2,3-dimethylbutane-2,3-diyl)bis(azanylyl-
idene))bis(methanylyli-dene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) (LF5, 230 
mg, 0.391 mmol) in DCM (6.0 ml). After stirring at 22 °C, volatiles were removed in 
vacuo. The residue was broken up and further dried in vacuo at 80 °C for 1 h to give 
MF6 (187 mg, 74%) as a yellow powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): 
δ 8.40 (s, 1H), 7.07 (d, J = 2.4 Hz, 1H), 7.03 (d, J = 2.5 Hz, 1H), 6.89 (s, 1H), 6.76 (s, 
1H), 2.41 (s, 3H), 2.27 (s, 3H), 1.93 (s, 3H), 1.91 (s, 3H), 1.53 (s, 3H), 1.31 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.7, 161.2, 139.7, 138.6, 135.7, 135.5, 135.1, 
133.4, 132.4, 128.1, 128.0, 125.7, 119.2, 66.2, 25.4, 24.4, 21.3, 21.2, 20.30, 20.29. IR 
(neat, cm-1): 2913, 1619, 1556, 1461, 1300, 1232, 1155, 829. HRMS (ESI) m/z 
calculated for C40H46AlN2O2+ (M - Cl)+ 613.3375, found 613.3369. 
 
3,3''-((1E,1'E)-((2-Methylpropane-1,2-diyl)bis(azanylylidene))bis(methanylyli-
dene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-olate)aluminum chloride (MF7, 
precursor to 1k) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 1.1 ml, 1.1 
mmol) was added to 3,3''-((1E,1'E)-((2-methylpropane-1,2-diyl)bis(azanylylidene))-
bis(methanylyli-dene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) (LF6, 561 mg, 
1.00 mmol) in DCM (7.5 ml). After stirring at 22 °C, volatiles were removed in vacuo. 
94 
 
The residue was broken up and further dried in vacuo at 80 °C for 1 h to give MF7 
(597 mg, 96%) as a yellow powder. MP >200 °C. 1H NMR (500 MHz, C6D6): δ 7.80 
(s, 1H), 7.47 (s, 1H), 7.10 (s, 1H), 7.00 (s, 1H), 6.98 (dd, J = 6.7 Hz, 2.5 Hz, 2H), 6.97 
(s, 1H), 6.93 (s, 1H), 6.70 (dd, J = 2.4, 1.0 Hz, 1H), 6.63 (d, J = 2.2 Hz, 1H), 3.77 (d, J 
= 11.6 Hz, 1H), 2.49 (s, 6H), 2.41 (s, 3H), 2.36 (d, J = 12.2 Hz, 1H), 2.30 (s, 3H), 2.10 
(s, 3H), 2.08 (s, 3H), 2.06 (s, 3H), 2.05 (s, 3H), 0.86 (s, 3H), 0.46 (s, 3H). 13C NMR 
(126 MHz, CDCl3): δ 168.1, 167.4, 162.5, 161.6, 140.1, 139.8, 138.6, 137.9, 136.2, 
135.9, 135.7, 135.5, 135.3, 135.2, 134.6, 134.3, 132.6, 131.8, 128.8, 128.40, 128.35, 
128.1, 125.6, 125.3, 119.11, 119.07, 65.0, 59.8, 27.6, 24.8, 21.61, 21.59, 21.4, 21.1, 
20.7, 20.6, 20.3, 20.2. IR (neat, cm-1): 2916, 1621, 1557, 1443, 1277, 1232, 841. 
HRMS (ESI) m/z calculated for C38H42AlN2O2+ (M - Cl)+ 585.3062, found 585.3062. 
 
rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis-
(methanylyli-dene))bis(2',5,6'-trimethyl-[1,1'-biphenyl]-2-olate)aluminum 
chloride (MF8, precursor to 1l) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 1.15 ml, 1.15 
mmol) was added to rac-3,3''-((1E,1'E)-((1S,2S)-cyclohexane-1,2-diylbis(aza-
nylylidene))bis(methanylyli-dene))bis(2',5,6'-trimethyl-[1,1'-biphenyl]-2-ol) (LF2, 
554 mg, 1.00 mmol) in DCM (7.0 ml). After stirring at 22 °C, the supernatant was 
removed via filtration, and the residue washed with DCM once. The residue was dried 
in vacuo at 80 °C for 1 h to give MF8 (347 mg, 56%) as a yellow powder. MP >200 
°C. 1H NMR (400 MHz, C6D6): δ 7.62 (d, J = 1.8 Hz, 1H), 7.54 (d, J = 2.2 Hz, 1H), 
7.33 (d, J = 7.3 Hz, 1H), 7.29–7.25 (m, 2H), 7.23 (d, J = 7.7 Hz, 1H), 7.19–7.17 (m, 
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1H), 7.11 (d, J = 7.3 Hz, 1H), 6.98 (d, J = 2.5 Hz, 1H), 6.92 (d, J = 2.4 Hz, 1H), 6.80 
(d, J = 2.4 Hz, 1H), 6.71 (d, J = 1.8 Hz, 1H), 3.54 (t, J = 11.1 Hz, 1H), 2.47 (s, 3H), 
2.30 (s, 3H), 2.14 (s, 3H), 2.11 (s, 6H), 2.07 (s, 3H), 2.03–2.00 (m, 1H), 1.48–1.43 (m, 
2H), 1.36 (d, J = 11.3 Hz, 2H), 0.82–0.42 (m, 4H). 13C NMR (126 MHz, CDCl3): δ 
168.5, 162.4, 162.1, 159.6, 139.8, 138.8, 138.5, 137.5, 137.3, 136.4, 135.0, 133.8, 
133.2, 132.7, 132.1, 127.8, 127.4, 126.9, 126.83, 126.75, 126.6, 126.3, 126.0, 125.6, 
118.9, 118.5, 65.7, 62.3, 28.6, 27.3, 24.1, 23.6, 21.5, 20.8, 20.4, 20.3, 20.2, 19.7. IR 
(neat, cm-1): 2959, 1618, 1552, 1443, 1226, 862, 839, 764. HRMS (ESI) m/z 
calculated for C38H40AlN2O2+ (M - Cl)+ 583.2905, found 583.2907. 
 
rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis-(methany-
lylidene))bis(4'-(tert-butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-2-olate)aluminum 
chloride (MF9, precursor to 1m) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 625 µl, 0.625 
mmol) was added to rac-3,3''-((1E,1'E)-((1S,2S)-cyclohexane-1,2-diylbis(aza-
nylylidene))bis-(methanylylidene))bis(4'-(tert-butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-
2-ol) (LF7, 360 mg, 0.527 mmol) in DCM (2.5 ml). After stirring at 22 °C, the 
supernatant was removed via filtration, and the residue washed with DCM once. The 
residue was dried in vacuo at 80 °C for 1 h to give MF9 (229 mg, 58%) as a 
fluorescent yellow powder. MP >200 °C. 1H NMR (500 MHz, C6D6): δ 7.70 (s, 1H), 
7.67 (s, 1H), 7.51 (d, J = 2.1 Hz, 1H), 7.41 (s, 1H), 7.33 (s, 1H), 7.23 (s, 1H), 7.03 (d, 
J = 2.3 Hz, 1H), 6.95 (d, J = 2.4 Hz, 1H), 6.85 (d, J = 2.5 Hz, 1H), 6.69 (d, J = 2.0 Hz, 
1H), 3.47 (t, J = 10.9 Hz, 1H), 2.56 (s, 3H), 2.27 (s, 3H), 2.24 (s, 3H), 2.15 (m, 1H), 
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2.14 (s, 3H), 2.13 (s, 3H), 2.09 (s, 3H), 1.56 (s, 9H), 1.55 (s, 9H), 1.55–1.50 (m, 1H), 
1.43 (d, J = 10.9 Hz, 1H), 1.32 (d, J = 13.4 Hz, 1H), 1.24 (d, J = 13.2 Hz, 1H), 0.86–
0.67 (m, 1H), 0.66–0.53 (m, 1H), 0.53–0.40 (m, 1H), 0.35 (m, 1H). 13C NMR (126 
MHz, C6D6): δ 168.6, 163.3, 161.4, 160.4, 149.1, 148.9, 140.1, 139.6, 139.5, 137.8, 
136.49, 136.47, 136.0, 135.4, 134.9, 133.8, 132.6, 132.0, 125.9, 125.3, 124.7, 124.6, 
124.4, 124.1, 119.9, 118.6, 65.3, 61.8, 34.74, 34.70, 32.1, 32.0, 27.8, 26.6, 23.9, 23.3, 
22.2, 21.8, 21.2, 20.33, 20.31, 20.1. IR (neat, cm-1): 2966, 1644, 1616, 1552, 1444, 
1225, 859, 837. HRMS (ESI) m/z calculated for C46H56AlN2O2+ (M - Cl)+ 695.4152, 
found 695.4146. Elemental analysis: C46H56AlClN2O2 (731.38), calculated C 75.54, 
H 7.72 N 3.83; found C 75.39, H 7.73, N 3.84. 
The synthesis of (S,S)- and (R,R)-MF9 is analogous to that of the racemic 
compound. 
 
rac-3,3''-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-diylbis(azanylylidene))bis-(methany-
lylidene))bis(4'-(tert-butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-2-olate)aluminum 
cobaltate (1m) 
NaCo(CO)4 (46.4 mg, 0.239 mmol), MF9 (166 mg, 0.228 mmol) and THF (1.5 
ml) were mixed and stirred for 12 h at 22 °C. The reaction mixture was filtered 
through a 0.45 µm teflon syringe filter, the filtrate carefully layered with hexanes, and 
then placed in a freezer at -34 °C for one day. The resulting crystals were isolated by 
filtration, washed with hexanes and then dried in vacuo to give 1m (132 mg, 57%) as 
yellow crystals. The product was stored under nitrogen at -34 °C. 1H NMR (500 MHz, 
C6D6): δ 8.24 (s, 2H), 7.47 (s, 2H), 7.20 (s, 2H), 7.13 (s, 2H), 6.87 (s, 2H), 3.17 (s, 
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2H), 2.49 (d, J = 12.1 Hz, 2H), 2.12 (s, 6H), 2.04 (s, 2H), 1.97 (s, 6H), 1.94 (s, 6H), 
1.64 (s, 2H), 1.59–1.43 (m, 2H), 1.51 (s, 18H). 13C NMR (126 MHz, C6D6): δ 168.6, 
159.9, 149.7, 140.4, 137.5, 136.1, 135.5, 134.0, 132.9, 127.5, 124.6, 124.3, 119.2, 
64.9, 34.7, 31.9, 28.1, 24.0, 21.30, 20.2, 20.1. IR (neat, cm-1): 2950, 2865, 1866 ν(C=O), 
1621, 1558, 1448, 1231, 1018, 860. 
The synthesis of (S,S)- and (R,R)-1m is analogous to that of the racemic 
compound. 
 
3,3''-((1E,1'E)-(1,2-Phenylenebis(azanylylidene))bis(methanylylidene))bis(4'-(tert-
butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-2-olate)aluminum chloride (MF10, 
precursor to 1n) 
Following general procedure E, Et2AlCl (Aldrich, hexanes, 1.0 M, 610 µl, 0.610 
mmol) was added to 3,3''-((1E,1'E)-(1,2-phenylenebis(azanylylidene))bis(methanylyl-
idene))bis(4'-(tert-butyl)-2',5,6'-trimethyl-[1,1'-biphenyl]-2-ol) (LF8, 360 mg, 0.505 
mmol) in DCM (2.5 ml). After stirring at 22 °C, the supernatant was removed via 
filtration, and the residue washed with DCM once. The residue was dried in vacuo at 
80 °C for 1 h to give MF10 (277 mg, 58%) as an orange powder. MP >200 °C. 1H 
NMR (500 MHz, C6D6): δ 8.07 (s, 2H), 7.45 (d, J = 2.0 Hz, 2H), 7.37 (d, J = 2.1 Hz, 
2H), 6.97 (dd, J = 2.4, 0.7 Hz, 2H), 6.85–6.82 (m, 2H), 6.81–6.78 (m, 2H), 6.68 (d, J = 
2.4 Hz, 2H), 2.38 (s, 6H), 2.13 (s, 6H), 2.07 (s, 6H), 1.58 (s, 18H). 13C NMR (126 
MHz, CDCl3): δ 163.1, 161.3, 149.2, 141.6, 138.4, 138.0, 136.1, 135.9, 134.5, 132.8, 
127.8, 126.3, 124.6, 124.5, 119.5, 115.7, 34.8, 32.1, 21.4, 20.8, 20.2. IR (neat, cm-1): 
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2965, 1617, 1547, 1455, 1216, 861, 838, 746. HRMS (ESI) m/z calculated for 
C46H50AlN2O2+ (M - Cl)+ 689.3688, found 689.3689. 
 
6,6'-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanylyli-
dene))bis(4-(tert-butyl)-2-methylphenolate)aluminum chloride (MF11, precursor 
to 1o) 
Following general procedure E, Et2AlCl (Aldrich, 1.0 M, hexanes, 950 µl, 0.950 
mmol) was added to 6,6'-((1E,1'E)-((2,3-dimethylbutane-2,3-diyl)bis(azanylylidene))-
bis(methanylylidene))bis(4-(tert-butyl)-2-methylphenol) (LF12, 360 mg, 0.775 mmol) 
in DCM (5.0 ml). After stirring at 22 °C, the volatiles were removed in vacuo. The 
residue was broken up and dried in vacuo at 80 °C for 1 h to give MF11 (276 mg, 
68%) as a yellow powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): δ 8.45 (s, 2H), 
7.42 (d, J = 1.5 Hz, 2H), 7.10 (d, J = 2.6 Hz, 2H), 2.39 (s, 6H), 1.55 (s, 6H), 1.34 (s, 
6H), 1.31 (s, 18H). 13C NMR (126 MHz, CDCl3): δ 167.1, 162.3, 139.3, 135.0, 130.4, 
126.7, 117.5, 66.3, 34.0, 31.5, 25.8, 24.4, 16.4. IR (neat, cm-1): 2952, 2863, 1618, 
1560, 1392, 1275, 1153, 843. HRMS (ESI) m/z calculated for C30H42N2O2+ (M - Cl)+ 
489.3056, found 489.3065. 
 
6,6'-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanyl-
ylidene))bis(2,4-dimethylphenolate)aluminum chloride (MF12, precursor to 1p) 
Following general procedure E, Et2AlCl (Aldrich, 1.0 M, hexanes, 750 µl, 0.750 
mmol) was added to 6,6'-((1E,1'E)-((2,3-dimethylbutane-2,3-diyl)bis(azanylylidene))-
bis(methanylylidene))bis(2,4-dimethylphenol) (LF11, 228 mg, 0.599 mmol) in DCM 
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(4.0 ml). After stirring at 22 °C, the volatiles were removed in vacuo. The residue was 
broken up and dried in vacuo at 80 °C for 1 h to give MF12 (193 mg, 73%) as a 
yellow powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): δ 8.40 (s, 2H), 7.20 (s, 
2H), 6.95 (s, 2H), 2.36 (s, 6H), 2.26 (s, 6H), 1.54 (s, 6H), 1.33 (s, 6H). 13C NMR (126 
MHz, CDCl3): δ 166.8, 162.2, 138.3, 130.7, 130.4, 125.8, 118.1, 66.3, 25.7, 24.3, 
20.4, 16.0. IR (neat, cm-1): 2973, 1621, 1602, 1556, 1301, 1262, 1156, 1138, 834. 
HRMS (ESI) m/z calculated for C24H30N2O2+ (M - Cl)+ 405.2117, found 405.2122. 
 
2,2'-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanyl-
ylidene))bis(4-methylphenolate)aluminum chloride (MF13, precursor to 1q) 
Following general procedure E, Et2AlCl (Aldrich, 1.0 M, hexanes, 650 µl, 0.650 
mmol) was added to 2,2’-((1E,1’E)-((2,3-dimethylbutane-2,3-diyl)bis(azanylylidene))-
bis(methanylylidene))bis(4-methylphenol) (LF10, 188 mg, 0.533 mmol) in DCM (4.0 
ml). After stirring at 22 °C, the volatiles were removed in vacuo. The residue was 
broken up and dried in vacuo at 80 °C for 1 h to give MF13 (170 mg, 78%) as a 
yellow powder. MP >200 °C. 1H NMR (500 MHz, CDCl3): δ 8.43 (s, 2H), 7.28 (dd, J 
= 8.7, 2.4 Hz, 2H), 7.15–7.11 (m, 2H), 7.10 (s, 1H), 7.08 (s, 1H), 2.28 (s, 6H), 1.55 (s, 
6H), 1.32 (s, 6H). 13C NMR (126 MHz, CDCl3): δ 166.9, 163.4, 137.9, 133.1, 126.6, 
122.6, 118.8, 66.5, 25.6, 24.4, 20.3. IR (neat, cm-1): 2978, 1624, 1602, 1547, 1390, 
1306, 1152, 827. HRMS (ESI) m/z calculated for C22H26N2O2+ (M - Cl)+ 377.1804, 
found 377.1813. 
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5,5''-((1E,1'E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanyl-
ylidene))bis(3-(tert-butyl)-2',4',6'-triisopropyl-[1,1'-biphenyl]-4-olate)aluminum 
chloride (MF14, precursor to 1r) 
Following general procedure E, Et2AlCl (Aldrich, 1.0 M, hexanes, 650 µl, 0.650 
mmol) was added to a suspension of 5,5''-((1E,1'E)-((2,3-dimethylbutane-2,3-diyl)bis-
(azanylylidene))bis(methanylylidene))bis(3-(tert-butyl)-2',4',6'-triisopropyl-[1,1'-
biphenyl]-4-ol) (LF13, 281 mg, 0.334 mmol) in DCM (7.0 ml). After stirring at 22 °C, 
the volatiles were removed in vacuo. The residue was broken up and dried in vacuo at 
80 °C for 1 h to give MF14 (254 mg, 84%) as a yellow powder. MP >200 °C. 1H 
NMR (500 MHz, CDCl3): δ 8.44 (s, 2H), 7.33 (d, J = 2.3 Hz, 2H), 7.09 (d, J = 4.8 Hz, 
4H), 6.99 (d, J = 2.2 Hz, 2H), 2.97 (hept, J = 6.9 Hz, 2H), 2.79 (p, J = 6.9 Hz, 2H), 
2.78 (p, J = 6.9 Hz, 2H), 1.61 (s, 6H), 1.58 (s, 18H), 1.41 (s, 6H), 1.34 (d, J = 6.9 Hz, 
12H), 1.17 (d, J = 6.9 Hz, 6H), 1.16 (d, J = 6.9 Hz, 6H), 1.12 (d, J = 6.8 Hz, 6H), 1.10 
(d, J = 6.8 Hz, 6H). 13C NMR (126 MHz, CDCl3): δ 167.6, 163.6, 147.9, 147.6, 147.2, 
141.4, 136.8, 135.7, 132.3, 129.0, 120.8, 120.6, 119.3, 66.4, 35.7, 34.4, 30.5, 30.4, 
30.0, 25.8, 24.79, 24.77, 24.6, 24.33, 24.32, 24.27, 24.25. IR (neat, cm-1): 2957, 2866, 
1616, 1540, 1409, 1153, 876, 841, 758. HRMS (ESI) m/z calculated for C58H82N2O2+ 
(M - Cl)+ 865.6186, found 865.6186. 
 
BinamSalAlCl (7b, precursor to 7a) 
Following general procedure E, Et2AlCl (Aldrich, 1.0 M, hexanes, 950 µl, 0.950 
mmol) was added to a solution of 3,3''-((1E,1'E)-([1,1'-binaphthalene]-2,2'-
diylbis(azanylylidene))bis(methanylylidene))bis(3',5'di-tert-butyl-5-methyl-[1,1'-
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biphenyl]-2-ol) (BinamSal, LF14, 774 mg, 0.863 mmol) in DCM (8.0 ml) at 0 °C. 
After stirring at 22 °C for 12 h, approximately half of the solvent was removed in 
vacuo. The remainder was cooled to 0 °C, and the precipitate isolated by filtration. 
The solid, still kept at 0 °C, was washed with cold DCM, then cold pentane, and 
subsequently dried in vacuo at 80 °C for 1 h to give BinamSalAlCl (7b, 549 mg, 66%) 
as a yellow powder. MP >200 °C. 1H NMR (500 MHz, CDCl3, -55 °C): δ 8.20 (s, 
1H), 7.96 (s, 1H), 7.82 (d, J = 8.7 Hz, 1H), 7.76 (d, J = 8.3 Hz, 1H), 7.69–7.67 (m, 
2H), 7.62 (s, 2H), 7.57 (d, J = 8.6 Hz, 1H), 7.30 (t, J = 7.7 Hz, 1H), 7.27–7.24 (m, 
2H), 7.21 (s, 1H), 7.13 (s, 1H), 7.11–7.03 (m, 4H), 6.98–6.95 (m, 3H), 6.86 (d, J = 8.7 
Hz, 1H), 6.67 (s, 2H), 1.99 (s, 3H), 1.97 (s, 3H), 1.01 (s, 18H), 0.83 (s, 18H). 13C 
NMR (126 MHz, CDCl3, -55 °C): δ 174.1, 168.9, 162.8, 159.3, 149.5, 149.4, 144.2, 
143.9, 140.8, 138.9, 136.6, 136.5, 134.0, 133.2, 133.0, 132.45, 132.40, 132.3, 131.8, 
131.7, 130.5, 129.4, 128.6, 128.4, 127.2, 127.0, 126.9, 126.8, 126.5, 126.28, 126.25, 
126.23, 126.0, 125.9, 125.8, 125.24, 125.22, 124.9, 124.48, 124.45, 124.12, 124.05, 
120.6, 120.2, 119.3, 118.7, 34.9, 34.6, 31.5, 31.2, 20.5, 20.4. IR (neat, cm-1): 2951, 
1582, 1548, 1462, 1259, 1220, 985, 860, 745. HRMS (ESI) m/z calculated for 
C64H66AlN2O2+ (M - Cl)+ 921.4934, found 921.4906. 
2.5.2.5 Regioselective Carbonylation of trans-Epoxides Using Catalyst 1e 
rac-(2R,3S)-Methyl 2-ethyl-3-hydroxybutanoate (5b) 
General procedure F was followed using 1e (27.3 mg, 0.0301 mmol, 7.49 mol %), 
rac-(2S,3S)-2-ethyl-3-methyloxirane43 (2b, 34.6 mg, 0.402 mmol) and benzene (0.8 
ml). The crude reaction mixture was treated with methanol (0.5 ml) and sodium 
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methoxide (ca. 25.2 mg, ca. 0.466 mmol), stirred for 5 minutes at 22 °C and then 
concentrated under reduced pressure. The residue was subjected to flash column 
chromatography to give 5b (36.9 mg, 63%) as a colorless oil. The analytical data was 
in accordance with that reported in the literature.57 1H NMR (500 MHz, CDCl3): δ 
3.98 (q, J = 5.7 Hz, 1H), 3.71 (s, 3H), 2.38–2.34 (m, 2H), 1.75–1.63 (m, 2H), 1.18 (d, 
J = 6.2 Hz, 3H), 0.93 (t, J = 7.5 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 175.7, 68.2, 
54.1, 51.7, 20.7, 20.5, 12.3. 
 
rac-(3S,4R)-4-Methyl-3-propyloxetan-2-one (4c) 
Following general procedure F using 1e (27.3 mg, 0.0301 mmol, 7.34 mol %), 
rac-(2S,3S)-2-methyl-3-propyloxirane (2c, 41.1 mg, 0.413 mmol), and benzene (0.8 
ml) gave 4c (31.5 mg, 60%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 4.74 (p, 
J = 6.4 Hz, 1H), 3.61 (ddd, J = 8.6, 7.6, 6.3 Hz, 1H), 1.81–1.72 (m, 1H), 1.64–1.36 
(m, 3H), 1.46 (d, J = 6.4 Hz, 3H), 0.95 (t, J = 7.3 Hz, 3H). 13C NMR (126 MHz, 
CDCl3): δ 172.1, 71.8, 52.7, 26.0, 20.8, 15.8, 14.0. IR (neat, cm-1): 2961, 2875, 1808, 
1387, 1288, 1120, 1019, 823. HRMS (ESI) m/z calculated for C7H13O2+ (M + H+) 
129.0910, found 129.0920. 
 
rac-(3S,4R)-3-Butyl-4-methyloxetan-2-one (4d) 
Following general procedure F using 1e (27.3 mg, 0.0301 mmol, 7.60 mol %), 
rac-(2S,3S)-2-butyl-3-methyloxirane44 (2d, 45.2 mg, 0.396 mmol), and benzene (0.8 
ml) gave 4d (36.7 mg, 65%) as a colorless oil. 1H NMR (500 MHz, CDCl3): δ 4.73 (p, 
J = 6.4 Hz, 1H), 3.58 (td, J = 8.2, 6.3 Hz, 1H), 1.81–1.73 (m, 1H), 1.64–1.57 (m, 1H), 
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1.51–1.42 (m, 1H), 1.45 (d, J = 6.4 Hz, 3H), 1.39–1.30 (m, 3H), 0.91 (t, J = 7.1 Hz, 
3H). 13C NMR (126 MHz, CDCl3): δ 172.2, 71.9, 52.9, 29.6, 23.7, 22.6, 15.7, 13.9. 
IR (neat, cm-1): 2958, 2864, 1809, 1463, 1387, 1285, 1120, 1019, 821. HRMS (EI) 
m/z calculated for C8H14O2+ (M+) 142.0988, found 142.0990. 
 
rac-(3S,4R)-4-Methyl-3-pentyloxetan-2-one (4a) 
Following general procedure F using 1e (26.3 mg, 0.0290 mmol, 7.58 mol %), 
rac-(2S,3S)-2-methyl-3-pentyloxirane44 (2a, 49.0 mg, 0.382 mmol), and benzene (0.8 
ml) gave 4a (40.3 mg, 68%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 4.74 (p, 
J = 6.4 Hz, 1H), 3.59 (ddd, J = 8.6, 7.8, 6.3 Hz, 1H), 1.82–1.72 (m, 1H), 1.65–1.55 
(m, 1H), 1.54–1.43 (m, 1H), 1.45 (d, J = 6.4 Hz, 3H), 1.42–1.25 (m, 5H), 0.89 (t, J = 
6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 172.2, 71.9, 53.0, 31.6, 27.2, 24.0, 22.5, 
15.8, 14.1. IR (neat, cm-1): 2932, 2861, 1812, 1460, 1386, 1286, 1120, 1020, 824. 
HRMS (ESI) m/z calculated for C9H17O2+ (M + H+) 157.1223, found 157.1236. 
 
rac-(3S,4R)-3-Hexyl-4-methyloxetan-2-one (4e) 
Following general procedure F using 1e (27.3 mg, 0.0301 mmol, 7.48 mol %), 
rac-(2S,3S)-2-hexyl-3-methyloxirane44 (2e, 57.0 mg, 0.401 mmol) and benzene (0.8 
ml) gave 4e (48.5 mg, 71%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 4.74 (p, 
J = 6.4 Hz, 1H), 3.59 (ddd, J = 8.5, 7.8, 6.4 Hz, 1H), 1.82–1.73 (m, 1H), 1.65–1.56 
(m, 1H), 1.53–1.42 (m, 1H), 1.46 (d, J = 6.4 Hz, 3H), 1.39–1.25 (m, 7H), 0.87 (t, J = 
6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 172.2, 71.9, 52.9, 31.6, 29.1, 27.4, 24.0, 
22.7, 15.8, 14.1. IR (neat, cm-1): 2929, 2859, 1813, 1460, 1386, 1285, 1120, 1020, 
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823. HRMS (ESI) m/z calculated for C10H18O2Na+ (M + Na+) 193.1199, found 
193.1209. 
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2.5.2.6 Regioselective Carbonylation of trans-Epoxides using Catalyst 1m 
rac-(2R,3S)-Methyl 3-hydroxy-2-methylpentanoate (6b) 
General procedure G was followed using 1m (11.4 mg, 0.0156 mmol, 5.15 mol 
%), NaCo(CO)4 (THF, 0.05 M, 320 µl, 0.0160 mmol, 5.28 mol %), and rac-(2S,3S)-2-
ethyl-3-methyloxirane43 (2b, THF, 1.01 M, 300 µl, 0.303 mmol). The crude reaction 
mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 19.0 mg, ca. 
0.352 mmol), stirred for 5 minutes at 22 °C and then concentrated under reduced 
pressure. The residue was subjected to flash column chromatography to give 6b (26.6 
mg, 60%) as a yellow oil. The analytical data was in accordance with that reported in 
the literature.58 1H NMR (400 MHz, CDCl3): δ 3.80 (tt, J = 8.5, 4.0 Hz, 1H), 3.69 (s, 
3H), 2.65–2.38 (m, 2H), 1.62–1.34 (m, 2H), 1.16 (d, J = 7.2 Hz, 3H), 0.95 (t, J = 7.4 
Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 176.7, 73.4, 51.9, 44.0, 26.9, 10.7, 10.5. 
 
rac-(2R,3S)-Methyl 3-hydroxy-2-methylhexanoate (6c) 
General procedure G was followed using 1m (7.3 mg, 0.010 mmol, 5.1 mol %), 
NaCo(CO)4 (THF, 0.05 M, 200 µl, 0.0100 mmol, 5.05 mol %) and rac-(2S,3S)-2-
methyl-3-propyloxirane (2c, THF, 0.992 M, 200 µl, 0.198 mmol). The crude reaction 
mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 14.0 mg, ca. 
0.259 mmol), stirred for 5 minutes at 22 °C and then concentrated under reduced 
pressure. The residue was subjected to flash column chromatography to give 6c (21.8 
mg, 68%) as a colorless oil. The analytical data was in accordance with that reported 
in the literature.59 1H NMR (400 MHz, CDCl3): δ 3.91–3.87 (m, 1H), 3.70 (d, J = 1.3 
Hz, 3H), 2.52 (qd, J = 7.2, 3.6, Hz, 1H), 2.49 (d, J = 4.6 Hz, 1H), 1.56–1.40 (m, 2H), 
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1.39–1.28 (m, 2H), 1.18 (d, J = 7.2 Hz, 3H), 0.92 (t, J = 7.1 Hz, 3H). 13C NMR (75 
MHz, CDCl3): δ 176.8, 71.6, 51.9, 44.3, 36.1, 19.3, 14.1, 10.8. 
 
rac-(2R,3S)-Methyl 3-hydroxy-2-methylheptanoate (6d) 
General procedure G was followed using 1m (7.3 mg, 0.010 mmol, 5.0 mol %), 
NaCo(CO)4 (THF, 0.05 M, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2S,3S)-2-
butyl-3-methyloxirane44 (2d, THF, 1.00 M, 200 µl, 0.200 mmol). The crude reaction 
mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 14.0 mg, ca. 
0.259 mmol), stirred for 5 minutes at 22 °C and then concentrated under reduced 
pressure. The residue was subjected to flash column chromatography to give 6d (25.7 
mg, 74%) as a colorless oil. The analytical data was in accordance with that reported 
in the literature.26 1H NMR (500 MHz, CDCl3): δ 3.87 (dt, J = 8.3, 4.1 Hz, 1H), 3.69 
(s, 3H), 2.55–2.50 (m, 2H), 1.49–1.24 (m, 6H), 1.17 (d, J = 7.2 Hz, 3H), 0.89 (t, J = 
7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 176.8, 71.9, 51.9, 44.3, 33.6, 28.3, 22.7, 
14.1, 10.7. 
 
rac-(2R,3S)-Methyl 3-hydroxy-2-methyloctanoate (6a) 
General procedure G was followed using 1m (7.3 mg, 0.010 mmol, 5.0 mol %), 
NaCo(CO)4 (THF, 0.05 M, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2S,3S)-2-
methyl-3-pentyloxirane44 (2a, THF, 0.998 M, 200 µl, 0.200 mmol). The crude reaction 
mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 14.0 mg, ca. 
0.259 mmol), stirred for 5 minutes at 22 °C and then concentrated under reduced 
pressure. The residue was subjected to flash column chromatography to give 6a (29.8 
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mg, 79%) as a colorless oil. The analytical data was in accordance with that reported 
in the literature.60 1H NMR (500 MHz, CDCl3): δ 3.88 (dq, J = 8.3, 4.1 Hz, 1H), 3.70 
(s, 3H), 2.54 (qd, J = 7.2, 3.5 Hz, 1H), 2.48 (d, J = 4.4 Hz, 1H), 1.50–1.42 (m, 2H), 
1.40–1.24 (m, 6H), 1.18 (d, J = 7.3 Hz, 3H), 0.88 (t, J = 6.8 Hz, 3H). 13C NMR (75 
MHz, CDCl3): δ 176.8, 71.9, 51.9, 44.3, 33.9, 31.9, 25.8, 22.7, 14.2, 10.7. 
 
rac-(2R,3S)-Methyl 3-hydroxy-2-methylnonanoate (6e) 
General procedure G was followed using 1m (7.3 mg, 0.010 mmol, 4.9 mol %), 
NaCo(CO)4 (THF, 0.05 M, 200 µl, 0.0100 mmol, 4.85 mol %), rac-(2S,3S)-2-hexyl-3-
methyloxirane44 (2e, 29.3 mg, 0.206 mmol) and THF (0.2 ml). The crude reaction 
mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 14.0 mg, ca. 
0.259 mmol), stirred for 5 minutes at 22 °C and then concentrated under reduced 
pressure. The residue was subjected to flash column chromatography to give 6e (35.6 
mg, 85%) as a colorless oil. 1H NMR (500 MHz, CDCl3): δ 3.87 (ddd, J = 8.3, 4.4, 
3.4 Hz, 1H), 3.70 (s, 3H), 2.55–2.50 (broad s, 1H), 2.52 (tt, J = 7.2, 3.6 Hz, 1H), 1.49–
1.41 (m, 2H), 1.40–1.21 (m, 8H), 1.17 (d, J = 7.2 Hz, 3H), 0.88–0.85 (m, 3H). 13C 
NMR (126 MHz, CDCl3): δ 176.8, 71.9, 51.9, 44.3, 33.9, 31.9, 29.3, 26.1, 22.7, 14.2, 
10.7. IR (neat, cm-1): 3444, 2930, 2857, 1736, 1458, 1198, 1166, 1037. HRMS (ESI) 
m/z calculated for C11H22NaO3+ (M + Na+) 225.1461, found 225.1471. 
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rac-(2R,3S)-Methyl 6-((tert-butyldimethylsilyl)oxy)-3-hydroxy-2-methylhexanoate 
(6f) 
General procedure G was followed using 1m (7.3 mg, 0.010 mmol, 5.0 mol %), 
NaCo(CO)4 (THF, 0.05 M, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-tert-
butyldimethyl(3-((2S,3S)-3-methyloxiran-2-yl)propoxy)silane (2f, THF, 0.998 M, 200 
µl, 0.200 mmol). The crude reaction mixture was treated with methanol (0.4 ml) and 
sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), stirred for 5 minutes at 22 °C and 
then concentrated under reduced pressure. The residue was subjected to flash column 
chromatography to give 6f (43.5 mg, 75%) as a colorless oil. 1H NMR (500 MHz, 
CDCl3): δ 3.86 (dq, J = 8.3, 4.1 Hz, 1H), 3.69 (s, 3H), 3.65 (t, J = 5.7 Hz, 2H), 3.09 (d, 
J = 4.3 Hz, 1H), 2.54 (qd, J = 7.1, 4.4 Hz, 1H), 1.71–1.45 (m, 4H), 1.19 (d, J = 7.1 Hz, 
3H), 0.88 (s, 9H), 0.05 (s, 6H). 13C NMR (126 MHz, CDCl3): δ 176.5, 71.9, 63.3, 
51.8, 44.8, 31.3, 29.4, 26.0, 18.4, 11.4, -5.2. IR (neat, cm-1): 2952, 2857, 1737, 1254, 
1094, 833, 774. HRMS (ESI) m/z calculated for C14H31O4Si+ (M + H+) 291.1986, 
found 291.1994. 
 
rac-(2R,3S)-Methyl 5-((tert-butyldimethylsilyl)oxy)-3-hydroxy-2-methylpentan-
oate (6g) 
General procedure G was followed using 1m (11.0 mg, 0.0150 mmol, 7.30 mol 
%), NaCo(CO)4 (THF, 0.05 M, 300 µl, 0.0150 mmol, 7.28 mol %), rac-tert-
butyldimethyl(2-((2S,3S)-3-methyloxiran-2-yl)ethoxy)silane (2g, 44.6 mg, 0.206 
mmol) and THF (100 µl). The crude reaction mixture was treated with methanol (0.4 
ml) and sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), stirred for 5 minutes at 22 
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°C and then concentrated under reduced pressure. The residue was subjected to flash 
column chromatography to give 6g (46.4 mg, 81%) as a colorless oil. 1H NMR (500 
MHz, CDCl3): δ 4.06–4.02 (m, 1H), 3.87 (ddd, J = 10.2, 5.7, 4.5 Hz, 1H), 3.80 (ddd, J 
= 10.2, 8.1, 4.1 Hz, 1H), 3.68 (s, 3H), 3.52 (d, J = 2.9 Hz, 1H), 2.54 (qd, J = 7.1, 5.4 
Hz, 1H), 1.72–1.65 (m, 1H), 1.63–1.57 (m, 1H) 1.21 (d, J = 7.1 Hz, 3H), 0.88 (s, 9H), 
0.06 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 176.0, 72.2, 62.3, 51.8, 45.3, 36.0, 26.0, 
18.3, 12.1, -5.4. IR (neat, cm-1): 3497, 2953, 2857, 1737, 1253, 1081, 832, 775. 
HRMS (ESI) m/z calculated for C13H29O4Si+ (M + H+) 271.1830, found 277.1835. 
 
rac-(3R,4R)-4-(((Tert-butyldimethylsilyl)oxy)methyl)-3-methyloxetan-2-one (3h) 
General procedure G was followed using 1m (14.6 mg, 0.0200 mmol, 9.85 mol 
%), NaCo(CO)4 (THF, 0.05 M, 400 µl, 0.0200 mmol, 9.85 mol %) and rac-tert-
butyldimethyl(((2S,3S)-3-methyloxiran-2-yl)methoxy)silane46 (2h, 41.0 mg 0.203 
mmol). The crude reaction mixture was concentrated under reduced pressure and then 
subjected to flash column chromatography to give 3h (43.0 mg, 92%) as a colorless 
liquid. 1H NMR (500 MHz, CDCl3): δ 4.52 (dt, J = 6.7, 4.9 Hz, 1H), 3.97–3.90 (m, 
2H), 3.81–3.75 (m, 1H), 1.34 (d, J = 7.7 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 6H). 13C NMR 
(126 MHz, CDCl3): δ 172.4, 74.0, 61.3, 47.2, 25.9, 18.3, 8.3, -5.35, -5.42. IR (neat, 
cm-1): 2930, 2858, 1823, 1463, 1253, 1104, 1016, 829, 776. HRMS (ESI) m/z 
calculated for C11H23O3Si+ (M + H+) 231.1411, found 231.1418. 
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rac-(3R,4S)-4-Benzyl-3-methyloxetan-2-one (3i) 
General procedure G was followed using 1m (7.3 mg, 0.010 mmol, 5.0 mol %), 
NaCo(CO)4 (THF, 0.05 M, 200 µl, 0.0100 mmol, 4.95 mol %) and rac-(2S,3S)-2-
benzyl-3-methyloxirane (2i, THF, 1.01 M, 200 µl, 0.202 mmol). The crude reaction 
mixture was concentrated under reduced pressure and then subjected to flash column 
chromatography to give 3i (29.5 mg, 84%) as an off-white solid. MP 60–62 °C. 1H 
NMR (400 MHz, CDCl3): δ 7.35–7.30 (m, 2H), 7.28–7.2 (m, 3H), 4.80 (ddd, J = 8.8, 
6.3, 5.0 Hz, 1H), 3.82 (qd, J = 7.8, 6.3 Hz, 1H), 3.12 (dd, J = 14.8, 8.8 Hz, 1H), 2.99 
(dd, J = 14.8, 5.0 Hz, 1H), 1.37 (d, J = 7.8 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 
172.3, 136.1, 129.0, 128.9, 127.1, 75.8, 47.8, 36.4, 8.5. IR (neat, cm-1): 2968, 1808, 
1454, 1382, 1263, 1146, 1014, 830, 701. HRMS (ESI) m/z calculated for C11H13O2+ 
(M + H+) 177.0910, found 177.0917. 
2.5.2.7 Regioselective Carbonylation of cis-Epoxides Using Catalyst 1d 
rac-(3R,4R)-4-Ethyl-3-methyloxetan-2-one (10b) and rac-(3R,4R)-4-methyl-3-
propyloxetan-2-one (11b) 
General procedure H was followed using 1d (18.6 mg, 0.0209 mmol, 7.21 mol 
%), THF (0.6 ml), and rac-(2S,3R)-2-ethyl-3-methyloxirane48 (9b, 25.0 mg, 0.290 
mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was subjected to 
bulb-to-bulb distillation to give a mixture of 10b and 11b (22.0 mg, 66%) as a yellow 
oil. Analytical data for 10b61 and 11b62 has previously been reported. 1H NMR (400 
MHz, CDCl3): δ 4.41 (qd, J = 6.1, 4.0 Hz, 1H, 11b), 4.13 (td, J = 6.6, 4.0 Hz, 1H, 
10b), 3.22 (qd, J = 7.5, 4.0 Hz, 1H, 10b), 3.13 (ddd, J = 8.4, 6.7, 4.0 Hz, 1H, 11b), 
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1.94–1.73 (m, 4H), 1.55 (d, J = 6.1 Hz, 3H, 11b), 1.39 (d, J = 7.5 Hz, 3H, 10b), 1.03 
(t, J = 7.5 Hz, 3H, 10b), 1.00 (t, J = 7.6 Hz, 3H, 11b). 13C NMR (126 MHz, CDCl3): δ 
172.1 (10b), 171.2 (11b), 80.6 (10b), 74.2 (11b), 59.0 (11b), 50.4 (10b), 27.3 (10b), 
21.0 (11b), 20.4 (11b), 12.7 (10b), 11.2 (11b), 9.1 (10b). 
 
rac-(3R,4R)-3-Methyl-4-propyloxetan-2-one (10c) and rac-(3R,4R)-3-ethyl-4-
methyloxetan-2-one (11c) 
General procedure H was followed using 1d (18.6 mg, 0.0209 mmol, 6.74 mol 
%), THF (0.6 ml), and rac-(2R,3S)-2-methyl-3-propyloxirane48 (9c, 31.0 mg, 0.310 
mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was subjected to 
flash column chromatography to give a mixture of 10c and 11c (22.0 mg, 66%) as a 
yellow oil. Analytical data for 10c61 and 11c63 has previously been reported. 1H NMR 
(300 MHz, CDCl3): δ 4.40 (qd, J = 6.1, 3.9 Hz, 1H, 11c), 4.18 (ddd, J = 7.3, 6.2, 4.0 
Hz, 1H, 10c), 3.24–3.14 (m, 2H), 1.89–1.78 (m, 2H), 1.76–1.65 (m, 2H), 1.55 (d, J = 
6.1 Hz, 3H, 11c), 1.50–1.34 (m, 4H), 1.38 (d, J = 7.5 Hz, 3H, 10c), 0.98 (t, J = 7.5 Hz, 
3H, 10c), 0.95 (t, J = 7.3 Hz, 3H, 11c). 13C NMR (126 MHz, CDCl3): δ 172.2 (10c), 
171.4 (11c), 79.5 (10c), 74.7 (11c), 57.5 (11c), 50.8 (10c), 36.2 (10c), 29.8 (11c), 20.4 
(11c), 20.3 (11c), 18.5 (10c), 13.80 (10c), 13.79 (11c), 12.6 (10c). 
 
rac-(3R,4R)-4-Butyl-3-methyloxetan-2-one (10a) and rac-(3R,4R)-3-butyl-4-
methyloxetan-2-one (11a) 
General procedure H was followed using 1d (13.3 mg, 0.0150 mmol, 4.93 mol 
%), THF (0.6 ml), and rac-(2R,3S)-2-butyl-3-methyloxirane49 (9a, 34.7 mg, 0.304 
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mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was subjected to 
flash column chromatography to give a mixture of 10a and 11a (34.7 mg, 80%) as a 
colorless oil. Analytical data for 10a61 and 11a48 has previously been reported. 1H 
NMR (400 MHz, CDCl3): δ 4.38 (qd, J = 6.1, 4.0 Hz, 1H, 11a), 4.15 (ddd, J = 7.2, 
6.3, 4.0 Hz, 1H, 10a), 3.20 (qd, J = 7.5, 4.0 Hz, 1H, 10a), 3.17–3.12 (m, 1H, 11a), 
1.90–1.68 (m, 2H + 2H, 10a + 11a), 1.53 (d, J = 6.1 Hz, 3H, 11a), 1.37 (d, J = 7.5 Hz, 
3H, 10a), 1.48–1.26 (m, 4H + 4H, 10a + 11a), 0.93–0.88 (m, 3H + 3H, 10a + 11a). 
13C NMR (126 MHz, CDCl3): δ 172.2 (10a), 171.5 (11a), 79.7 (10a), 74.7 (11a), 57.7 
(11a), 50.8 (10a), 33.9 (10a), 29.1 (11a), 27.5 (11a), 27.2 (10a), 22.5 (11a), 22.4 
(10a), 20.4 (11a), 14.0 (10a), 13.9 (11a), 12.6 (10a). 
 
rac-(3R,4R)-3-Methyl-4-pentyloxetan-2-one (10d) and rac-(3R,4R)-4-methyl-3-
pentyloxetan-2-one (11d) 
General procedure H was followed using 1d (17.8 mg, 0.0200 mmol, 6.58 mol 
%), THF (0.6 ml), and rac-(2R,3S)-2-methyl-3-pentyloxirane48 (9d, 39.0 mg, 0.304 
mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was subjected to 
flash column chromatography to give a mixture of 10d and 11d (35.2 mg, 74%) as a 
colorless oil. Analytical data for 10d64 and 11d48 has previously been reported. 1H 
NMR (400 MHz, CDCl3): δ 4.38 (qd, J = 6.1, 3.9 Hz, 1H, 11d), 4.16 (td, J = 6.7, 4.0 
Hz, 1H, 10d), 3.20 (qd, J = 7.6, 4.0 Hz, 1H, 10d), 3.16 (ddd, J = 8.9, 6.5, 3.9 Hz, 1H, 
11d), 1.89–1.79 (m, 2H), 1.78–1.6 (m, 2H), 1.54 (d, J = 6.0 Hz, 3H, 11d), 1.48–1.24 
(m, 12H), 1.38 (d, J = 7.5 Hz, 3H, 10d), 0.90–0.86 (m, 6H). 13C NMR (75 MHz, 
CDCl3): δ 172.2 (10d), 171.5 (11d), 79.7 (10d), 74.8 (11d), 57.7 (11d), 50.8 (10d), 
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34.2 (10d), 31.50 (11d), 31.46 (10d), 27.7 (11d), 26.6 (11d), 24.7 (10d), 22.54 (10d), 
22.46 (11d), 20.4 (11d), 14.04 (11d), 14.02 (10d), 12.6 (10d). 
 
rac-(3R,4R)-4-Hexyl-3-methyloxetan-2-one (10e) and rac-(3R,4R)-3-hexyl-4-
methyloxetan-2-one (11e) 
General procedure H was followed using 1d (13.3 mg, 0.0150 mmol, 5.02 mol 
%), THF (0.6 ml), and rac-(2S,3R)-2-hexyl-3-methyloxirane48 (9e, 42.5 mg, 0.299 
mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was subjected to 
flash column chromatography to give a mixture of 10e and 11e (48.3 mg, 95%) as a 
colorless oil. Analytical data for 10e65 and 11e48 has previously been reported. 1H 
NMR (300 MHz, CDCl3): δ 4.38 (qd, J = 6.1, 4.0 Hz, 1H, 11e), 4.15 (td, J = 6.6, 3.9 
Hz, 1H, 10e), 3.20 (qd, J = 7.5, 4.0 Hz, 1H, 10e), 3.14 (ddd, J = 8.9, 6.5, 3.9 Hz, 1H, 
11e), 1.88–1.78 (m. 2H), 1.78–1.65 (m. 2H), 1.54 (d, J = 6.1 Hz, 3H), 1.47–1.21 (m, 
16H), 1.37 (d, J = 7.6 Hz, 3H), 0.89–0.85 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 
172.2 (10e), 171.5 (11e), 79.7 (10e), 74.7 (11e), 57.7 (11e), 50.8 (10e), 34.2 (10e), 
31.7 (10e), 31.6 (11e), 29.00 (11e), 28.96 (10e), 27.8 (11e), 26.9 (11e), 25.0 (10e), 
22.60 (11e), 22.57 (10e), 20.4 (11e), 14.11 (11e), 14.11 (10e), 12.6 (10e). 
 
rac-(3R,4R)-4-(Cyclohexylmethyl)-3-methyloxetan-2-one (10f) and rac-(3R,4R)-3-
(cyclohexylmethyl)-4-methyloxetan-2-one (11f) 
General procedure H was followed using 1d (8.9 mg, 0.0100 mmol, 4.98 mol %), 
THF (0.4 ml), and (2S,3R)-2-(cyclohexylmethyl)-3-methyloxirane (9f, 31.0 mg, 0.201 
mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was subjected to 
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flash column chromatography to give a mixture of 10f and 11f (32.3 mg, 88%) as a 
colorless oil. Only analytical data for 10f is provided: 1H NMR (300 MHz, CDCl3): δ 
4.28–4.23 (m, 1H), 3.23–3.14 (m, 1H), 1.83–1.53 (m, 7H), 1.39 (d, J = 7.6 Hz, 3H), 
1.50–1.34 (m, 1H), 1.32–1.12 (m, 3H), 1.08–0.89 (m, 2H). 13C NMR (126 MHz, 
CDCl3): δ 172.3, 78.4, 51.3, 42.0, 34.9, 33.5, 33.1, 26.4, 26.2, 26.1, 12.6. IR (neat, 
cm-1): 2922, 2851, 1818, 1449, 1125, 947, 859, 806. HRMS (ESI) m/z calculated for 
C11H19O2+ (M + H+) 183.1380, found 183.1390. 
 
rac-(3R,4R)-4-Benzyl-3-methyloxetan-2-one (10g) and rac-(3R,4R)-3-benzyl-4-
methyloxetan-2-one (11g) 
General procedure H was followed using 1d (13.2 mg, 0.0148 mmol, 7.33 mol 
%), THF (0.4 ml), (2S,3R)-2-benzyl-3-methyloxirane (9g, 30.0 mg, 0.202 mmol). 
After stirring at 22 °C for 21 h, the crude reaction mixture was subjected to flash 
column chromatography to give a mixture of 10g and 11g (31.8 mg, 90%) as a 
colorless oil. Only analytical data for 10g is provided: 1H NMR (400 MHz, CDCl3): δ 
7.36–7.27 (m, 3H), 7.23–7.20 (m, 2H), 4.40 (td, J = 6.5, 4.0 Hz, 1H), 3.33 (qd, J = 7.5, 
4.0 Hz, 1H), 3.20 (dd, J = 14.2, 6.4 Hz, 1H), 3.04 (dd, J = 14.3, 6.5 Hz, 1H), 1.30 (d, J 
= 7.6 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 171.6, 135.3, 129.2, 128.9, 127.3, 
79.0, 50.5, 40.1, 12.5. IR (neat, cm-1): 3030, 2936, 1816, 1455, 1125, 1053, 884, 812, 
699. HRMS (ESI) m/z calculated for C11H13O2+ (M + H+) 177.0910, found 177.0919. 
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rac-(3R,4R)-3-Methyl-4-phenethyloxetan-2-one (10h) and rac-(3R,4R)-4-methyl-
3-phenethyloxetan-2-one (11h) 
General procedure H was followed using 1d (13.2 mg, 0.0149 mmol, 7.30 mol 
%), THF (0.4 ml), and (2R,3S)-2-methyl-3-phenethyloxirane (9h, 33.1 mg, 0.204 
mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was subjected to 
flash column chromatography to give a mixture of 10h and 11h (33.5 mg, 86%) as a 
colorless oil. Analytical data for 10h has previously been reported in the literature.66 
1H NMR (500 MHz, CDCl3): δ 7.33–7.30 (m, 2H + 2H, 10h + 11h), 7.25–7.19 (m, 
3H + 3H, 10h + 11h), 4.32 (qd, J = 6.1, 3.9 Hz, 1H, 11h), 4.17 (ddd, J = 7.7, 5.8, 3.9 
Hz, 1H, 10h), 3.20 (qd, J = 7.5, 4.0 Hz, 1H, 10h), 3.15 (ddd, J = 9.1, 6.5, 4.0 Hz, 1H, 
11h), 2.83 (ddd, J = 14.2, 8.8, 5.5 Hz, 1H + 1H, 10h + 11h), 2.71 (dt, J = 13.9, 8.0 Hz, 
1H + 1H, 10h + 11h), 2.23–2.16 (m, 1H + 1H, 10h + 11h), 2.12–2.05 (m, 1H + 1H, 
10h + 11h), 1.43 (d, J = 6.1 Hz, 3H, 11h), 1.33 (d, J = 7.6 Hz, 3H, 10h). 13C NMR 
(126 MHz, CDCl3): δ 171.9 (10h), 171.2 (11h), 140.2 (11h), 140.1 (10h), 128.67 
(10h), 128.66 (11h), 128.5 (11h), 128.4 (10h), 126.5 (11h), 126.4 (10h), 78.7 (10h), 
75.0 (11h), 56.8 (11h), 50.9 (10h), 35.8 (10h), 33.1 (11h), 31.3 (10h), 29.5 (11h), 
20.1 (11h), 12.5 (10h). IR (neat, cm-1): 3027, 2935, 1816, 1455, 1386, 1125, 841, 747, 
699. HRMS (ESI) m/z calculated for C12H15O2+ (M + H+) 191.1067, found 191.1080. 
 
rac-(3R,4R)-4-Isopentyl-3-methyloxetan-2-one (10i) and rac-(3R,4R)-3-isopentyl-
4-methyloxetan-2-one (11i) 
General procedure H was followed using 1d (13.2 mg, 0.0149 mmol, 5.16 mol 
%), THF (0.6 ml), and rac-(2S,3R)-2-isopentyl-3-methyloxirane48 (9i, 37.0 mg, 0.289 
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mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was subjected to 
flash column chromatography to give a mixture of 10i and 11i (40.9 mg, 91%) as a 
colorless oil. Analytical data for 10i and 11i has previously been reported in the 
literature.48 1H NMR (400 MHz, CDCl3): δ 4.39 (qd, J = 6.1, 3.9 Hz, 1H, 11i), 4.13 
(td, J = 6.7, 4.0 Hz, 1H, 10i), 3.21 (qd, J = 7.5, 4.0 Hz, 1H, 10i), 3.12 (ddd, J = 8.9, 
6.5, 3.9 Hz, 1H, 11i), 1.88–1.80 (m, 2H), 1.78–1.69 (m, 2H), 1.62–1.51 (m, 2H), 1.55 
(d, J = 6.2 Hz, 3H, 11i), 1.38 (d, J = 7.5 Hz, 3H, 10i), 1.35–1.28 (m, 2H), 1.25–1.16 
(m, 2H), 0.90 (d, J = 6.6 Hz, 6H, 11i), 0.89 (d, J = 6.6 Hz, 6H, 10i). 13C NMR (75 
MHz, CDCl3): δ 172.2 (10i), 171.5 (11i), 79.9 (10i), 74.7 (11i), 57.8 (11i), 50.8 (10i), 
35.9 (11i), 33.9 (10i), 32.2 (10i), 27.92 (11i), 27.86 (10i), 25.7 (11i), 22.51 (10i), 
22.48 (10i), 22.45 (11i), 22.45 (11i), 20.47 (11i), 12.7 (10i). 
 
rac-(3R,4R)-4-(2-((Tert-butyldimethylsilyl)oxy)ethyl)-3-methyloxetan-2-one (10j) 
and rac-(3R,4R)-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4-methyloxetan-2-one 
(11j) 
General procedure H was followed using 1d (13.2 mg, 0.0149 mmol, 7.49 mol 
%), THF (0.4 ml), and tert-butyldimethyl(2-((2S,3R)-3-methyloxiran-2-
yl)ethoxy)silane (9j, 43.0 mg, 0.199 mmol). After stirring at 22 °C for 21 h, the crude 
reaction mixture was subjected to flash column chromatography to give a mixture of 
10j and 11j (44.6 mg, 92%) as a colorless oil. Analytical data for 10j has previously 
been reported in the literature.66 1H NMR (500 MHz, CDCl3): δ 4.52 (qd, J = 6.1, 4.0 
Hz, 1H, 11j), 4.32 (td, J = 6.6, 4.0 Hz, 1H, 10j), 3.79–3.70 (m, 2H, 10j), 3.71–3.65 
(m, 2H, 11j), 3.35 (qd, J = 7.6, 4.0 Hz, 1H, 10j), 3.28 (ddd, J = 9.5, 5.4, 4.0 Hz, 1H, 
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11j), 2.07–1.91 (m, 2H + 2H, 10j + 11j), 1.55 (d, J = 6.1 Hz, 3H, 11j), 1.39 (d, J = 7.6 
Hz, 3H, 10j), 0.88 (s, 9H + 9H, 10j + 11j), 0.05 (s, 6H + 6H, 10j + 11j). 13C NMR 
(126 MHz, CDCl3): δ 172.3 (10j), 171.5 (11j), 77.6 (10j), 75.5 (11j), 61.0 (11j), 59.1 
(10j), 55.6 (11j), 51.1 (10j), 37.0 (10j), 30.9 (11j), 25.98 (11j), 25.97 (10j), 25.97 
(11j), 20.3 (11j), 18.4 (10j), 12.5 (10j), -5.37 (11j), -5.38 (10j). IR (neat, cm-1): 2955, 
2857, 1823, 1472, 1253, 1095, 830, 775. HRMS (ESI) m/z calculated for C12H25O3Si+ 
(M + H+) 245.1567, found 245.1564. 
 
rac-(3R,4R)-4-(3-((Tert-butyldimethylsilyl)oxy)propyl)-3-methyloxetan-2-one 
(10k) and rac-(3R,4R)-3-(3-((tert-butyldimethylsilyl)oxy)propyl)-4-methyloxetan-
2-one (11k) 
General procedure H was followed using 1d (8.9 mg, 0.0100 mmol, 5.00 mol %), 
THF (0.4 ml), and tert-butyldimethyl(3-((2S,3R)-3-methyloxiran-2-yl)propoxy)-
silane48 (9k, 46.0 mg, 0.200 mmol). After stirring at 22 °C for 21 h, the crude reaction 
mixture was subjected to flash column chromatography to give a mixture of 10k and 
11k (44.9 mg, 87%) as a colorless oil. Analytical data for 10k has previously been 
reported in the literature.67 1H NMR (500 MHz, CDCl3): δ 4.40 (qd, J = 6.1, 3.9 Hz, 
1H, 11k), 4.22 (td, J = 6.8, 4.0 Hz 1H, 10k), 3.68–3.61 (m, 2H + 2H, 10k + 11k), 
3.25–3.18 (m, 1H + 1H, 10k + 11k), 1.93–1.78 (m, 2H + 2H, 10k + 11k), 1.70–1.53 
(m, 2H + 2H, 10k + 11k), 1.54 (d, J = 6.1 Hz, 3H, 11k), 1.38 (d, J = 7.6 Hz, 3H, 10k), 
0.88 (s, 9H + 9H, 10k + 11k), 0.04 (s, 6H + 6H, 10k + 11k). 13C NMR (126 MHz, 
CDCl3): δ 172.1 (10k), 171.3 (11k), 79.6 (10k), 74.8 (11k), 62.35 (10k), 62.34 (11k), 
57.4 (11k), 50.9 (10k), 31.0 (10k), 29.9 (11k), 28.2 (10k), 26.03 (11k), 26.03 (10k), 
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24.5 (11k), 20.4 (11k), 18.42 (10k), 18.42(11k), 12.7 (10k), -5.23 (10k), -5.23(11k). 
IR (neat, cm-1): 2929, 2857, 1823, 1472, 1254, 1094, 832, 774. HRMS (ESI) m/z 
calculated for C13H27O3Si+ (M + H+) 259.1724, found 259.1724. 
2.5.2.8 Regioselective Carbonylation of cis-Epoxides Using Catalyst 7a 
rac-(2R,3R)-Methyl 2-ethyl-3-hydroxybutanoate (12b) 
General procedure I was followed using 7b (14.3 mg, 0.0149 mmol, 5.02 mol %), 
NaCo(CO)4 (3.3 mg, 0.017 mmol, 5.7 mol %), dioxane (0.3 ml), and rac-(2S,3R)-2-
ethyl-3-methyloxirane48 (9b, 0.990 M, dioxane, 300 µl, 0.297 mmol). After stirring at 
22 °C for 21 h, the reactor was carefully vented in a well-ventilated hood. The crude 
reaction mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 20.0 
mg, ca. 0.370 mmol), stirred for 5 minutes at 22 °C and then concentrated under 
reduced pressure. The residue was subjected to flash column chromatography to give 
12b (30.3 mg, 70%) as a colorless oil. The analytical data was in accordance with that 
reported in the literature.68 1H NMR (400 MHz, CDCl3): δ 3.91 (q, J = 5.5 Hz, 1H), 
3.70 (d, J = 0.6 Hz, 3H), 2.55 (d, J = 5.5 Hz, 1H), 2.31 (dt, J = 8.7, 6.1 Hz, 1H), 1.73–
1.59 (m, 2H), 1.21 (d, J = 6.3 Hz, 3H), 0.90 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, 
CDCl3): δ 176.0, 68.2, 54.4, 51.7, 22.7, 21.6, 11.8. 
 
rac-(R)-Methyl 2-((R)-1-hydroxyethyl)pentanoate (12c) 
General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.07 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.1 mol %) and rac-(2R,3S)-2-
methyl-3-propyloxirane48 (9c, 0.988 M, dioxane, 300 µl, 0.296 mmol). After stirring at 
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22 °C for 20 h, the reactor was carefully vented in a well-ventilated hood. The crude 
reaction mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 20.0 
mg, ca. 0.370 mmol), stirred for 5 minutes at 22 °C and then concentrated under 
reduced pressure. The residue was subjected to flash column chromatography to give 
12c (36.4 mg, 77%) as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 3.88 (h, J = 6.8 
Hz, 1H), 3.69 (s, 3H), 2.57 (d, J = 7.1 Hz, 1H), 2.38 (dt, J = 9.3, 5.7 Hz, 1H), 1.70–
1.45 (m, 2H), 1.29 (h, J = 7.3 Hz, 2H), 1.21 (d, J = 6.3 Hz, 3H), 0.89 (t, J = 7.3 Hz, 
3H). 13C NMR (75 MHz, CDCl3): δ 176.1, 68.5, 52.7, 51.7, 31.7, 21.7, 20.7, 14.1. IR 
(neat, cm-1): 3452, 2958, 2874, 1735, 1435, 1169, 1117, 938. HRMS (ESI) m/z 
calculated for C8H16NaO3+ (M + Na+) 183.0992, found 183.0998. 
 
rac-(3R,4R)-4-Butyl-3-methyloxetan-2-one (12a) and rac-(3R,4R)-3-butyl-4-
methyloxetan-2-one (11a) 
General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.00 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.0 mol %) and rac-(2R,3S)-2-
butyl-3-methyloxirane49 (9a, 1.00 M, dioxane, 300 µl, 0.300 mmol). After stirring at 
22 °C for 20 h, the reactor was carefully vented in a well-ventilated hood. The crude 
reaction mixture was subjected to bulb-to-bulb distillation to give a mixture of 12a and 
11a (29.4 mg, 69%) as a yellow oil. Analytical data for 12a61 and 11a48 has previously 
been reported. 
 
rac-(3R,4R)-3-Methyl-4-pentyloxetan-2-one (12d) and rac-(3R,4R)-4-methyl-3-
pentyloxetan-2-one (11d) 
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General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.00 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.0 mol %) and rac-(2R,3S)-2-
methyl-3-pentyloxirane48 (9d, 1.00 M, dioxane, 300 µl, 0.300 mmol). After stirring at 
22 °C for 20 h, the reactor was carefully vented in a well-ventilated hood. The crude 
reaction mixture was subjected to bulb-to-bulb distillation to give a mixture of 12d 
and 11d (34.7 mg, 74%) as a colorless oil. Analytical data for 12d64 and 11d48 has 
previously been reported. Only analytical data for 11d is provided: 1H NMR (400 
MHz, CDCl3): δ 4.39 (qd, J = 6.1, 4.0 Hz, 1H), 3.15 (ddd, J = 9.0, 6.5, 3.9 Hz, 1H), 
1.86–1.66 (m, 2H), 1.55 (d, J = 6.1 Hz, 3H), 1.47–1.27 (m, 6H), 0.88 (t, J = 6.8 Hz, 
3H). 13C NMR (75 MHz, CDCl3): δ 171.5, 74.8, 57.7, 31.5, 27.8, 26.7, 22.5, 20.5, 
14.1.  
 
rac-(3R,4R)-4-Hexyl-3-methyloxetan-2-one (12e) and rac-(3R,4R)-3-hexyl-4-
methyloxetan-2-one (11e) 
General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.03 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.0 mol %) and rac-(2S,3R)-2-
hexyl-3-methyloxirane48 (9e, 0.994 M, dioxane, 300 µl, 0.298 mmol). After stirring at 
22 °C for 22 h, the reactor was carefully vented in a well-ventilated hood. The crude 
reaction mixture was subjected to bulb-to-bulb distillation to give a mixture of 12e and 
11e (36.6 mg, 72%) as a colorless oil. Analytical data for 12e65 and 11e48 has 
previously been reported. Only analytical data for 11e is provided: 1H NMR (400 
MHz, CDCl3): δ 4.39 (qd, J = 6.1, 3.9 Hz, 1H), 3.15 (ddd, J = 8.8, 6.5, 3.9 Hz, 1H), 
1.86–1.66 (m, 2H), 1.55 (d, J = 6.2 Hz, 3H), 1.46–1.23 (m, 8H), 0.87 (t, J = 6.7 Hz, 
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3H). 13C NMR (75 MHz, CDCl3): δ 171.5, 74.7, 57.7, 31.6, 29.0, 27.8, 26.9, 22.6, 
20.4, 14.1.  
 
rac-(2R,3R)-Methyl 3-hydroxy-2-phenethylbutanoate (12h) 
General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.26 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.3 mol %) and rac-(2R,3S)-2-
methyl-3-phenethyloxirane (9h, 0.950 M, dioxane, 300 µl, 0.285 mmol). After stirring 
at 22 °C for 22 h, the reactor was carefully vented in a well-ventilated hood. The crude 
reaction mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 20.0 
mg, ca. 0.370 mmol), stirred for 5 minutes at 22 °C and then concentrated under 
reduced pressure. The residue was subjected to flash column chromatography to give 
12h (52.6 mg, 83%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.31–7.26 (m, 
2H), 7.21–7.17 (m, 3H), 3.94 (p, J = 6.4 Hz, 1H), 3.73 (s, 3H), 2.70–2.55 (m, 3H), 
2.45 (dddd, J = 9.4, 5.7, 4.8, 0.8 Hz, 1H), 2.09–1.99 (m, 1H), 1.90 (dddd, J = 14.0, 
9.7, 6.9, 4.9 Hz, 1H), 1.22 (d, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 175.7, 
141.3, 128.50, 128.48, 126.1, 68.5, 52.3, 51.7, 33.6, 31.1, 21.6. IR (neat, cm-1): 3440, 
2951, 1717, 1454, 1198, 1160, 1029, 749, 699. HRMS (ESI) m/z calculated for 
C13H18NaO3+ (M + Na+) 245.1148, found 245.1155. 
 
rac-(R)-Methyl 2-((R)-1-hydroxyethyl)-5-methylhexanoate (12i) 
General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.00 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.0 mol %) and rac-(2S,3R)-2-
isopentyl-3-methyloxirane48 (9i, 1.00 M, dioxane, 300 µl, 0.300 mmol). After stirring 
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at 22 °C for 20 h, the reactor was carefully vented in a well-ventilated hood. The crude 
reaction mixture was treated with methanol (0.4 ml) and sodium methoxide (ca. 20.0 
mg, ca. 0.370 mmol), stirred for 5 minutes at 22 °C and then concentrated under 
reduced pressure. The residue was subjected to flash column chromatography to give 
12i (44.1 mg, 78%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 3.89 (p, J = 6.3 
Hz, 1H), 3.69 (s, 3H), 2.54 (s, 1H), 2.33 (ddd, J = 9.3, 6.2, 5.2 Hz, 1H), 1.69–1.45 (m, 
3H), 1.20 (d, J = 6.3 Hz, 3H), 1.22–1.04 (m, 2H), 0.86 (d, J = 3.1 Hz, 3H), 0.84 (d, J = 
3.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 176.2, 68.5, 53.1, 51.7, 36.5, 28.2, 27.4, 
22.7, 22.4, 21.7. IR (neat, cm-1): 3453, 2954, 2871, 1736, 1435, 1168, 1116, 932. 
HRMS (ESI) m/z calculated for C10H20NaO3+ (M + Na+) 211.1305, found 211.1317. 
 
rac-(R)-Methyl 4-((tert-butyldimethylsilyl)oxy)-2-((R)-1-hydroxyethyl)butanoate 
(12j) 
General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.02 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.0 mol %) and rac-tert-
butyldimethyl(2-((2S,3R)-3-methyloxiran-2-yl)ethoxy)silane (9j, 0.998 M, dioxane, 
300 µl, 0.299 mmol). After stirring at 22 °C for 20 h, the reactor was carefully vented 
in a well-ventilated hood. The crude reaction mixture was treated with methanol (0.4 
ml) and sodium methoxide (ca. 20.0 mg, ca. 0.370 mmol), stirred for 5 minutes at 22 
°C and then concentrated under reduced pressure. The residue was subjected to flash 
column chromatography to give 12j (66.7 mg, 81%) as a colorless oil. 1H NMR (400 
MHz, CDCl3): δ 3.97–3.89 (m, 1H), 3.69 (s, 3H), 3.67 (dt, J = 11.6, 5.7 Hz, 1H), 3.58 
(ddd, J = 10.4, 7.5, 5.2 Hz, 1H), 2.79 (d, J = 7.5 Hz, 1H), 2.60 (dt, J = 8.4, 5.4 Hz, 
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1H), 1.95–1.78 (m, 2H), 1.22 (d, J = 6.4 Hz, 3H), 0.87 (s, 9H), 0.02 (s, 6H). 13C NMR 
(75 MHz, CDCl3): δ 175.7, 68.3, 61.2, 51.7, 49.5, 32.1, 26.0, 21.5, 18.4, -5.4, -5.3. IR 
(neat, cm-1): 3448, 2954, 2857, 1735, 1252, 1169, 1097, 832, 774. HRMS (ESI) m/z 
calculated for C13H29O4Si+ (M + H+) 277.1830, found 277.1837. 
 
rac-(R)-Methyl 5-((tert-butyldimethylsilyl)oxy)-2-((R)-1-hydroxyethyl)pentanoate 
(12k) 
General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.05 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.1 mol %) and rac-tert-
butyldimethyl(3-((2S,3R)-3-methyloxiran-2-yl)propoxy)silane48 (9k, 0.991 M, 
dioxane, 300 µl, 0.297 mmol). After stirring at 22 °C for 21 h, the reactor was 
carefully vented in a well-ventilated hood. The crude reaction mixture was treated 
with methanol (0.4 ml) and sodium methoxide (ca. 20.0 mg, ca. 0.370 mmol), stirred 
for 5 minutes at 22 °C and then concentrated under reduced pressure. The residue was 
subjected to flash column chromatography to give 12k (69.7 mg, 80%) as a colorless 
oil. 1H NMR (500 MHz, CDCl3): δ 3.92 (h, J = 6.4 Hz, 1H), 3.70 (s, 3H), 3.59 (t, J = 
6.2 Hz, 2H), 2.49 (d, J = 6.9 Hz, 1H), 2.40 (dt, J = 8.0, 6.4 Hz, 1H), 1.71–1.64 (m, 
2H), 1.52–1.46 (m, 2H), 1.22 (d, J = 6.4 Hz, 3H), 0.87 (s, 9H), 0.03 (s, 6H). 13C NMR 
(126 MHz, CDCl3): δ 176.1, 68.6, 62.7, 52.6, 51.7, 30.5, 26.1, 25.9, 21.7, 18.4, -5.2. 
IR (neat, cm-1): 3460, 2953, 2857, 1737, 1254, 1096, 833, 774. HRMS (ESI) m/z 
calculated for C14H31O4Si+ (M + H+) 291.1986, found 291.2000. 
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rac-3-((2R,3R)-2-Methyl-4-oxooxetan-3-yl)propyl acetate (10l) and rac-3-
((2R,3R)-3-methyl-4-oxooxetan-2-yl)propyl acetate (11l) 
General procedure I was followed using 7b (14.4 mg, 0.0150 mmol, 5.00 mol %), 
dioxane (0.3 ml), NaCo(CO)4 (3.0 mg, 0.015 mmol, 5.0 mol %) and rac-cis-1-
acetoxy-4,5-epoxyhexane51 (9l, 1.00 M, dioxane, 300 µl, 0.300 mmol). After stirring 
at 22 °C for 20 h, the reactor was carefully vented in a well-ventilated hood. The crude 
reaction mixture was concentrated under reduced pressure and then subjected to flash 
column chromatography to give a mixture of 10l and 11l (46.0 mg, 82%) as a colorless 
oil. Only analytical data for 11l is provided: 1H NMR (400 MHz, CDCl3): δ 4.38 (qd, 
J = 6.1, 4.0 Hz, 1H), 4.05 (t, J = 6.1 Hz, 2H), 3.18 (td, J = 7.5, 4.0 Hz, 1H), 2.01 (s, 
3H), 1.90–1.64 (m, 4H), 1.53 (d, J = 6.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 
171.0, 170.8, 74.5, 63.5, 57.0, 26.0, 24.4, 21.0, 20.3. IR (neat, cm-1): 2958, 1810, 
1733, 1388, 1232, 1127, 1019, 825. HRMS (ESI) m/z calculated for C9H14NaO4+ (M + 
Na+) 209.0784, found 209.0795. 
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2.5.2.9 Regioselective Chlorohydrin Formation From cis-Epoxides Using Catalyst 
7b 
rac-(2R,3R)-3-Chloroheptan-2-ol (14a) 
General procedure J was followed using 7b (14.8 mg, 0.0155 mmol, 5.20 mol %), 
THF (0.6 ml), 2,4,6-trimethylpyridine hydrochloride (52.3 mg, 0.332 mmol), and rac-
(2R,3S)-2-butyl-3-methyloxirane49 (9a, 34.0 mg, 0.298 mmol). The crude reaction 
mixture was subjected to bulb-to-bulb distillation to give 14a (30.5 mg, 68%) as a 
colorless oil. 1H NMR (500 MHz, CDCl3): δ 3.86–3.80 (m, 2H), 2.06 (d, J = 5.9 Hz, 
1H), 1.84–1.71 (m, 2H), 1.58–1.49 (m, 1H), 1.45–1.25 (m, 3H), 1.28 (d, J = 6.0 Hz, 
3H), 0.92 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 70.7, 70.5, 34.5, 28.8, 
22.4, 20.5, 14.1. IR (neat, cm-1): 3389, 2957, 2931, 2862, 1457, 1378, 1144, 1050, 
941, 835. Elemental analysis: C7H15ClO (150.65), calculated C 55.81, H 10.04, Cl 
23.53; found C 55.61, H 9.98, Cl 23.48. No molecular ion peak was observed when 
performing EI-MS or ESI-MS analysis, consequently no HRMS data was acquired. 
 
rac-(2R,3R)-3-Chlorooctan-2-ol (14d) 
General procedure J was followed using 7b (14.4 mg, 0.0150 mmol, 4.93 mol %), 
THF (0.6 ml), 2,4,6-trimethylpyridine hydrochloride (52.0 mg, 0.330 mmol), and rac-
(2R,3S)-2-methyl-3-pentyloxirane48 (9d, 39.0 mg, 0.304 mmol). The crude reaction 
mixture was subjected to flash column chromatography to give 14d (35.1 mg, 70%) as 
a colorless oil. 1H NMR (400 MHz, CDCl3): δ 3.86–3.78 (m, 2H), 2.13 (d, J = 5.4 Hz, 
1H), 1.83–1.69 (m, 2H), 1.61–1.50 (m, 1H), 1.47–1.22 (m, 5H), 1.27 (d, J = 6.0 Hz, 
3H), 0.89 (t, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 70.7, 70.5, 34.7, 31.4, 
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26.4, 22.6, 20.4, 14.1. IR (neat, cm-1): 3381, 2955, 2929, 2860, 1456, 1377, 1260, 
1143, 1061, 961, 852. Elemental analysis: C8H17ClO (164.67), calculated C 58.35, H 
10.41, Cl 21.53; found C 57.43, H 9.99, Cl 21.42. No molecular ion peak was 
observed when performing EI-MS or ESI-MS analysis, consequently no HRMS data 
was acquired. 
 
rac-(2R,3R)-3-Chlorononan-2-ol (14e) 
General procedure J was followed using 7b (14.3 mg, 0.0149 mmol, 5.03 mol %), 
THF (0.6 ml), 2,4,6-trimethylpyridine hydrochloride (52.0 mg, 0.330 mmol), and rac-
(2S,3R)-2-hexyl-3-methyloxirane48 (9e, 42.3 mg, 0.297 mmol). The crude reaction 
mixture was subjected to flash column chromatography to give 14e (40.8 mg, 77%) as 
a colorless oil. 1H NMR (500 MHz, CDCl3): δ 3.85–3.79 (m, 2H), 2.09 (d, J = 5.7 Hz, 
1H), 1.83–1.70 (m, 2H), 1.59–1.51 (m, 1H), 1.46–1.23 (m, 7H), 1.27 (d, J = 5.8 Hz, 
3H), 0.90–0.87 (m, 3H). 13C NMR (126 MHz, CDCl3): δ 70.7, 70.5, 34.7, 31.8, 28.9, 
26.7, 22.7, 20.5, 14.2. IR (neat, cm-1): 3384, 2925, 2857, 1457, 1377, 1259, 1142, 838. 
Elemental analysis: C9H19ClO (178.70), calculated C 60.49, H 10.72, Cl 19.84; found 
C 60.32, H 10.66, Cl 19.74. No molecular ion peak was observed when performing 
EI-MS or ESI-MS analysis, consequently no HRMS data was acquired. 
 
rac-(2R,3R)-3-Chloro-4-phenylbutan-2-ol (14g) 
General procedure J was followed using 7b (21.5 mg, 0.0225 mmol, 7.50 mol %), 
THF (0.6 ml), 2,4,6-trimethylpyridine hydrochloride (52.0 mg, 0.330 mmol), and rac-
(2S,3R)-2-benzyl-3-methyloxirane (9g, 44.5 mg, 0.300 mmol). The crude reaction 
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mixture was subjected to flash column chromatography to give 14g (30.7 mg, 55%) as 
a colorless oil. The analytical data was in accordance with that reported in the 
literature.69 1H NMR (400 MHz, CDCl3): δ 7.35–7.31 (m, 2H), 7.28–7.25 (m, 3H), 
4.05 (ddd, J = 8.2, 6.5, 3.2 Hz, 1H), 3.91–3.84 (m, 1H), 3.23 (dd, J = 14.0, 6.5 Hz, 
1H), 3.07 (dd, J = 14.0, 8.1 Hz, 1H), 1.97 (d, J = 8.1 Hz, 1H), 1.32 (d, J = 6.3 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 137.8, 129.5, 128.7, 127.0, 70.1, 68.6, 41.3, 21.1. 
 
rac-(2R,3R)-3-Chloro-5-phenylpentan-2-ol (14h) 
General procedure J was followed using 7b (14.4 mg, 0.0150 mmol, 4.95 mol %), 
THF (0.6 ml), 2,4,6-trimethylpyridine hydrochloride (52.0 mg, 0.330 mmol), and rac-
(2R,3S)-2-methyl-3-phenethyloxirane (9h, 49.2 mg, 0.303 mmol). The crude reaction 
mixture was subjected to flash column chromatography to give 14h (45.1 mg, 75%) as 
a colorless oil. 1H NMR (500 MHz, CDCl3): δ 7.33–7.30 (m, 2H), 7.23–7.21 (m, 3H), 
3.88–3.82 (m, 1H), 3.79 (ddd, J = 7.9, 6.1, 4.5 Hz, 1H), 2.94 (dt, J = 13.8, 6.9 Hz, 
1H), 2.77 (dt, J = 13.9, 8.2 Hz, 1H), 2.13–2.08 (m, 3H), 1.27 (d, J = 6.3 Hz, 3H). 13C 
NMR (126 MHz, CDCl3): δ 140.9, 128.64, 128.64, 126.3, 70.6, 69.3, 36.3, 32.8, 20.4. 
IR (neat, cm-1): 3390, 2931, 1454, 1375, 1126, 1029, 909, 749, 699. Elemental 
analysis: C11H15ClO (198.69), calculated C 66.49, H 7.61, Cl 17.84; found C 66.49, H 
7.67, Cl 17.92. No molecular ion peak was observed when performing EI-MS or ESI-
MS analysis, consequently no HRMS data was acquired. 
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rac-(2R,3R)-3-Chloro-6-methylheptan-2-ol (14i) 
General procedure J was followed using 7b (14.3 mg, 0.0149 mmol, 5.03 mol %), 
THF (0.6 ml), 2,4,6-trimethylpyridine hydrochloride (52.0 mg, 0.330 mmol), and rac-
(2S,3R)-2-isopentyl-3-methyloxirane48 (9i, 38.0 mg, 0.296 mmol). The crude reaction 
mixture was subjected to flash column chromatography to give 14i (33.1 mg, 68%) as 
a colorless oil. 1H NMR (500 MHz, CDCl3): δ 3.87–3.79 (m, 2H), 2.05 (d, J = 6.2 Hz, 
1H), 1.86–1.70 (m, 2H), 1.62–1.51 (m, 1H), 1.44 (dddd, J = 13.1, 10.7, 7.2, 4.7 Hz, 
1H), 1.35–1.25 (m, 1H), 1.28 (d, J = 6.1 Hz, 3H), 0.90 (t, J = 6.6 Hz, 6H). 13C NMR 
(126 MHz, CDCl3): δ 71.1, 70.5, 35.8, 32.7, 27.9, 22.9, 22.4, 20.5. IR (neat, cm-1): 
3391, 2955, 1468, 1367, 1253, 1147, 1110, 1025, 967, 777. Elemental analysis: 
C8H17ClO (164.67), calculated C 58.35, H 10.41, Cl 21.53; found C 58.49, H 10.50, 
Cl 21.62. No molecular ion peak was observed when performing EI-MS or ESI-MS 
analysis, consequently no HRMS data was acquired. 
2.5.2.10 Low Quality Crystal Data for Catalyst 1m 
To date, only low quality crystals of catalyst 1m could be obtained due to the 
pronounced propensity of 1m for crystal twinning when crystallized from a solution in 
THF that had been layered with a hydrocarbon solvent such as heptane. Use of other 
ethereal (Et2O, THP, DME) or hydrocarbon (pentane, hexanes, cyclohexane) solvents 
gave no / unsuitable crystals. 
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Table 2.13 Selected parameters of the low quality crystal data for catalyst 1m 
Empirical formula C58H72AlCoN2O8 
Formula weight 1011.09 
Crystal system Monoclinic 
Space group P2(1) 
Unit cell dimensions a = 15.8411(8) Å α = 90° 
 b = 53.450(3) Å β = 94.792(3)° 
 c = 16.2954(8) Å γ = 90° 
Volume 13749.1(12) Å3 
Z 8 
Final R indices [I>2sigma(I)] R1 = 0.0707, wR2 = 0.1832 
R indices (all data) R1 = 0.1038, wR2 = 0.2010 
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CHAPTER THREE 
Development of New Catalyst Frameworks for the Synthesis of Enantioenriched 
β-Lactones from Racemic or Meso cis-Disubstituted Epoxides 
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3.1 Introduction 
β-Lactones have a long-standing history as valuable and versatile compounds in 
chemical synthesis. Their usage includes areas such as the synthesis of natural 
products,1 pharmaceutical compounds,2 (biodegradable) polyesters,3 the labeling of 
proteins,4 and the use as precursors to value-added products with structural 
complexity.5 Moreover, the high intrinsic reactivity of the strained β-lactone ring 
allows reaction with a variety of nucleophiles to form products typically associated 
with aldol chemistry (Scheme 3.1).6,7 The resulting aldol moieties are also important 
motifs in natural products.8 
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Scheme 3.1 Common approaches to enantioenriched β-lactones, with epoxide 
carbonylation as an attractive alternative  
Although a variety of synthetic methodologies are available to access β-lactone 
products, methods for the direct, economical and enantioselective synthesis of β-
lactones are still limited,9 thus restricting their utility. In the past, aldol chemistry has 
often been used to access (enantioenriched) β-lactones (Scheme 3.1a).6 Many highly 
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diastereo- and enantioselective aldol reactions furnish suitable intermediates10 that can 
then be cyclized to the desired β-lactone.6 However, most aldol methodologies suffer 
from the requirements of preformed enolate-equivalents together with enantiopure 
auxiliaries or catalysts. Consequently, this route to β-lactones can be impractical and 
costly, although recent developments in the field of asymmetric direct aldol reactions 
may alleviate these concerns.11 
A more recent approach yielding enantioenriched β-lactones directly is based on 
(formal) [2+2]-cycloadditions of aldehydes with ketenes (Scheme 3.1b).12 These 
reactions routinely give cis-configured β-lactones with high stereoselectivity, but only 
a few catalytic systems for the synthesis of enantioenriched trans-β-lactones are 
reported.13,14 For example, Calter and coworkers described an organocatalytic 
approach showing excellent enantioselectivities, yet high catalyst loadings were 
needed and the scope was limited.13a Peters and coworkers disclosed a very elegant 
aluminum-catalyzed method yielding a broad variety of trans-β-lactones in good 
enantiomeric excess and yields.13b-d However, high catalyst loadings, low 
temperatures, and preparation of the catalyst with pyrophoric reagents just prior to use 
were required. In addition, diminished enantiomeric ratios for the important class of α-
methyl-substituted β-lactones were observed. 
Another direct approach to β-lactones is the carbonylation of epoxides using 
catalysts of the form [Lewis acid]+[Co(CO)4]- (Scheme 3.1c).15 This method is 
attractive because carbon monoxide and diastereopure epoxides are readily available. 
Furthermore, the reaction is proposed to follow by an SN2-mechanism,16 which 
reliably transforms stereochemistry already present in the epoxide. For example, cis-
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epoxides are cleanly converted into trans-β-lactones as shown in Scheme 3.1c. 
However, enantioselective variants of these reactions such as carbonylative kinetic 
resolution or meso desymmetrization of epoxides still have not reached synthetically 
useful levels, and were declared a major challenge for the field.17 Scheme 3.2 
summarizes the precedence from the literature.16a,18 
[Co(CO)4]
N N
O O
AltBu
tBu tBu
tBu
L
L
+
L = THF
(R,R)-1
O
Me Me
O
Me Me
O
49%
44% ee
(R,R)-1 
(1 mol %)
CO (800 psi)
neat, 0 °C
ref. 16a
(R,R)-2
(prepared in situ)
[Co(CO)4]
N N
O O
CrtBu
tBu tBu
tBu
+(R,R)-2 (5 mol %)
CO (500 psi)
DME, 70 °C
ref. 18c
93%
56% ee
O
O
O
O
O
[Co(CO)4]
+N OCr
N
Ph
(S,R)-3
(prepared in situ)
O
Me
O
Me
O
krel = 1.6
(S,R)-3 
(2 mol %)
CO (870 psi)
diglyme, 80 °C
ref. 18b
N
Ph
N
Ph
O[Rh(CO)2Cl]2 (5 mol %)
l - menthol (300 mol %)
CO (294 psi)
benzene, 90 °C
ref. 18a
tBu
tBu
44%
87% ee
a)
b)
d)
c)
racemic
racemic
meso
racemic
krel = 4.1
37%
19% ee
 
Scheme 3.2 Examples of previously reported catalytic systems for the asymmetric 
carbonylation of epoxides and aziridines  
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One of the best examples so far was reported by Ibrahim and coworkers (Scheme 
3.2b). Using catalyst (R,R)-2, they achieved moderate ee’s in the range of 11-56% in 
the carbonylative desymmetrization of a number of alicyclic meso epoxides.18c 
In an effort to advance the field of asymmetric epoxide carbonylation, we herein 
report two new enantiopure carbonylation catalysts. Both catalysts are active for 1) the 
carbonylative desymmetrization of aliphatic meso epoxides, and 2) the regiodivergent 
carbonylation of racemic cis-disubstituted epoxides. In both cases, the resulting α,β-
disubstituted β-lactones show high enantiomeric excess and trans-configuration, 
which makes these methods complementary to the advances in the field of [2+2]-
cycloadditions. Furthermore, the enantioenriched β-lactones can easily be converted 
into anti-aldol products. This transformation is important because aldol reactions 
giving rise to anti-β-hydroxycarbonyl moieties19 are less developed than those giving 
syn-aldol products.20 Consequently, enantioenriched anti-aldol products are less 
readily available than their syn-counterparts by either aldol reactions or [2+2]-cyclo-
additions, thus further underscoring the importance of this study. 
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3.2 Desymmetrization of Meso Epoxides 
3.2.1 Catalyst Development 
Initial efforts focused on the carbonylative desymmetrization of meso epoxides 
because only one product can arise from such epoxides in contrast to racemic cis- or 
trans-disubstituted epoxides (vide infra, Scheme 3). The precedence shown in Scheme 
3.2 guided the search for a suitable catalytic system. Salen-based ligands seemed an 
ideal platform for ligand development. Their highly modular nature and demonstrated 
ability to induce higher levels of enantioselectivity in comparison to porphyrin-
ligands18c made them very attractive. 
As a starting point, previously reported catalysts (S,S)-1 and (R,R)-2 were tested 
for the carbonylative desymmetrization of meso epoxide 4a (Table 3.1, entries 1 and 
2). Both catalysts gave unsatisfactory levels of enantioselectivity and activity. 
Interestingly, the aluminum-based system 1 performed slightly better than its 
chromium-analog 2, which made aluminum the metal of choice for future Lewis acids. 
In light of these results, we speculated that the flat geometry of the ligand framework 
in 1 and 2 was the main reason for the modest degree of enantioenrichment observed 
in lactone 5a. Salen-catalysts that bear aryl-moieties as substituents R2, on the other 
hand, deviate from this planarity, and the success of such catalysts in the 
regioselective carbonylation of trans-disubstituted epoxides21 made them promising 
candidates. Unfortunately, the results obtained with this class of catalysts were still not 
satisfactory in terms of activity and selectivity. Further inspiration for improvement 
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Table 3.1 Evaluation of enantiopure [Lewis acid]+ [Co(CO)4]--catalysts and 
reaction parameters for the carbonylative desymmetrization of meso epoxidesa 
N N
R1
R2
OAl+OR
1
R2 L L
[Co(CO)4]
L = THF
R1
tBu
Me
2,6-Me2Ph
R2
tBu
2,4,6-Me3Ph
2,6-Me2Ph
(R)-6a
(R)-6b
(R)-6c
CO (900 psi)
solvent
catalyst 
(5 mol %)O
nPr nPr
O
nPr nPr
4a 5a
O
(R)
6
 
entry catalystb solvent 
β-lactone 5ac 
conv. (%) conv. (%) 
1c (S,S)-1 THF >43 -16 
2d (R,R)-2 THF >05 -12 
3d (R)-6a THF >89 -58 
4d (R)-6b THF >70 -94 
5d (R)-6c THF >42 -97 
6d (R)-6b THP >78 -73 
7d (R)-6b 1,4-dioxane >98 -70 
8d (R)-6b DME >07 -24 
9d (R)-6b toluene >98 -43 
10d (R)-6b THF >68 -94 
11e (R)-6b THF >65 -94 
12f (R)-6b THF >95 -87 
aReaction conditions: [4a] = 0.5 M, 22 °C, 12 h. bCatalyst generated in situ (LnAlCl + NaCo(CO)4), 
except for entry 1. cConversion to β-lactone and enantiomeric excess determined by GC analysis. d450 
psi CO used. e5 mol % NaCo(CO)4 added. fRun at 40 °C. 
came from work in our group that used salen-catalysts based on 1,1’-binaphthyl-2,2’-
diamine (DABN).22 The DABN-unit twists the salen-ligand, thus decreasing its 
planarity. Moreover, DABN-based catalysts have been used successfully in other 
asymmetric transformations, and also make other coordination geometries such as cis-
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α or cis-β more accessible.23 Indeed, use of DABN in the form of (R)-6a gave good 
initial results (entry 3). Combining the DABN-unit contained in (R)-6a with 
salicylaldehydes bearing aryl-moieties as substituents R2 then yielded catalyst (R)-6b, 
which finally showed good activity and excellent enantioselectivity (entry 4). 
Increasing the steric hindrance around the Lewis acid improved selectivity even 
further (catalyst (R)-6c, entry 5), but at the same time decreased activity. Attempts to 
improve the activity of (R)-6b by using solvents other than THF were successful yet 
the degree of enantiomeric excess suffered greatly (entries 6-9). Variation of CO 
pressure, reaction temperature, or addition of excess Na[CO(CO)4] showed no further 
benefit (entries 10-13). Lastly, it should be noted that catalysts (R)-6a-c were 
generated in situ for all experiments by mixing the corresponding aluminum chloride 
precursor with Na[CO(CO)4] just prior to the reaction. This approach was taken 
because (R)-6b and c upon isolation showed a degree of solvation that was hard to 
quantify, and consequently made weighing out defined amounts of catalyst difficult. In 
situ generation of carbonylation catalysts has also been used successfully by others.24 
3.2.2 Scope of the Carbonylative Desymmetrization of Meso Epoxides 
With competent catalytic systems in hand, the scope of the carbonylative 
desymmetrization of meso epoxides 4 was explored (Table 3.2). So far, only aliphatic 
meso epoxides have been found to be active with catalysts (R)-6b and (R)-6c at 22 °C. 
This is remarkable because the majority of reported desymmetrization reactions for 
meso epoxides are geared towards alicyclic meso epoxides.25 Of the meso epoxides 
tested with (R)-6b, all showed yields greater than 70% and good to excellent levels of 
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enantioenrichment. Moreover, an inverse correlation between the steric size of the 
substrate and the activity of (R)-6b was noted, with bulkier epoxides requiring higher 
catalyst loadings and slightly elevated reaction temperatures (cf. entries 1 and 5). 
Interestingly, increasing the steric size of the epoxide also led to larger amounts of 
ketone side-products, which stem from rearrangement reactions of the epoxide.16b In 
addition, a trend in terms of enantioselectivity manifested itself, with epoxides such as 
4a and c giving the best results (entries 2 and 3). 
Table 3.2 Scope of the carbonylative desymmetrization of meso epoxides 4 using 
catalysts (R)-6b and (R)-6ca 
catalyst 
(x mol %)O
R R
O
R R
CO (900 psi)
THF
4a-e 5a-e
O
meso
 
entry R catalyst 
mol % 
catalyst 
isol. 
product 
isol. 
yield (%) 
%eeb 
1d Me (R)-6b 2.5 5b 95c 83 
2d Et  (R)-6b 4 5c 70a 95 
3d nPr  (R)-6b 7 5a 77a 94 
4d nBu (R)-6b 8 5d 72a 92 
5d (CH2)3OCH2CF3  (R)-6b 12.5 5e 79a 84 
6d Me (R)-6c 2.5 5b 94c 83 
7d Et  (R)-6c 6 5c 74a 98 
8e nPr  (R)-6c 10 5a 76a 97 
9d nBu (R)-6c 12 5d 72a 91 
aReaction conditions: [4] = 0.5 M, 22 °C, 24 h. All reactions gave full conversion by GC analysis. 
bEnantiomeric excess determined by GC analysis. cYield determined by GC analysis using method of 
standard addition. dRun at 33 °C. Catalysts (R)-6b and (R)-6c were generated in situ (LnAlCl + 
NaCo(CO)4). 
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Use of the bulkier catalyst (R)-6c gave results and trends similar to those seen 
with (R)-6b. In the case of epoxide 4b, the same enantiomeric excess was observed 
with either catalyst (entries 1 and 6). This substrate is apparently too small to be 
affected by the additional steric bulk of (R)-6c. In other cases, improved enantiomeric 
excess of the β-lactone product was obtained, which however occurred at the expense 
of higher catalyst loadings (entries 7 and 8). All in all, catalysts (R)-6b and (R)-6c 
were well suited for the carbonylative desymmetrization of aliphatic meso epoxides, 
which nicely complements analogous work on alicyclic meso epoxides carried out by 
Ibrahim and coworkers.18c 
3.2.3 Solid State Structure of Catalyst (R)-6b 
Single crystals of (R)-6b were obtained and subjected to X-ray analysis to further 
understand the mode of action of this catalyst (Figure 3.1). 
  
Figure 3.1 ORTEP-representations of catalyst (R)-6b with thermal ellipsoids 
drawn at 40% probability. Hydrogen atoms, cobaltate counterion and solvent 
molecules omitted / truncated for clarity. 
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The solid state structure shows the expected ion pair composed of [Lewis acid]+ 
and [Co(CO)4]-. More interestingly, the ligand around the aluminum-ion adopts cis-α 
geometry, which is a departure from the trans-planar structures of previously reported 
salen-based carbonylation catalysts.15 The strong twist imposed by the DABN-unit in 
combination with the steric interaction of the mesityl-groups are most likely the main 
causes for this arrangement of the ligand. In support of this, an analog of (R)-6a shows 
cis-β geometry,26 whereas use of a more flexible diamine-unit gives a trans-planar 
coordinated salen-complex.27 Nonetheless, this cis-α geometry allows for formation of 
a rigid and C2-symmetric chiral pocket occupied by two THF-molecules. This 
structure also explains why DME was a particularly poor solvent for (R)-6b (Table 
3.1, entry 8). DME can act as a bidentate ligand, thus occupying both cis-coordination 
sites. Due to the chelate effect, it would then be able to compete with epoxide 
molecules for binding to the Lewis acid. 
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3.3 Regiodivergent Carbonylation of Racemic cis-Disubstituted Epoxides 
3.3.1 Background 
Given the strong performance of (R)-6b and (R)-6c in the carbonylation of meso 
epoxides, a logical extension was to investigate the carbonylation of racemic cis-
disubstituted epoxides. However, achieving synthetically useful asymmetric reactions 
with this class of epoxides is much more challenging. A nucleophile reacting with 
such epoxides has to differentiate not only between the two different epoxide 
enantiomers, but also between the two different epoxy-methine-carbons within each 
enantiomer. Consequently, even reacting such epoxides with achiral catalysts and 
reagents can be difficult, resulting in a mixture of two regioisomeric products. As was 
mentioned in Chapter 1, potential solutions to this problem include 1) installation of a 
strong steric/electronic bias in the epoxide, or 2) use of a catalyst that promotes 
formation of only one of the two regioisomers. The second approach is undoubtedly 
more elegant, but catalytic systems that give high levels of regioselectivity in SN2-
reactions of unbiased racemic cis- or trans-disubstituted epoxides are exceedingly rare 
(cf. Chapter 2). The general idea behind the regioselective reaction of a racemic 
epoxide is shown in Scheme 3.3A. Each enantiomer of the carbonylation catalyst 
reacts preferentially with only one enantiomer of the epoxide, and selectively inserts 
CO next to epoxide-substituent R1. The result is a racemic mixture of only one of the 
two possible β-lactone regioisomers. 
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Scheme 3.3 Range of possible β-lactone products from the carbonylation of 
racemic cis-disubstituted epoxides. Use of a regioselective carbonylation catalyst that is 
racemic or achiral results in Regioselective Carbonylation (A). If the same catalyst is 
enantiopure and only consumes 7, Carbonylative Kinetic Resolution (B) ensues. A 
regioselective, enantiopure catalyst that consumes both 7 and ent-7 with opposing 
regioselectivities gives Regiodivergent Carbonylation (C). Catalyst* denotes an enantiopure 
carbonylation catalyst. CO = carbon monoxide. 
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If an enantiopure version of the same catalyst is employed, and if it converts one 
enantiomer of the epoxide much faster than the other, one obtains a classical kinetic 
resolution (Scheme 3.3B).28,30c The resulting product would now be an enantio-
enriched β-lactone, and if the regioselectivity of the catalyst is still high, one obtains 
only one of the two possible enantioenriched regioisomers. In practice, however, both 
enantiomers of the epoxide tend to react with comparable rates, and one still obtains a 
mixture of regioisomers and only modest enantiomeric enrichment. As a result, 
efficient kinetic resolutions of racemic cis- or trans-disubstituted epoxides have 
largely remained elusive.29 
A possible third scenario, shown in Scheme 3.3C, belongs to the recently 
burgeoning field of (regio-)divergent reactions.30 Here, both enantiomers of the 
epoxide react with an enantiopure catalyst, but the catalyst displays opposing 
regioselectivities for each epoxide enantiomer. The outcome of such a reaction would 
be the formation of two regioisomeric β-lactones that both are highly enantioenriched. 
Consequently, the requirements of a successful catalyst would be that its 
regiopreference must be stronger than any steric or electronic bias contained in 
substituents R1 and R2 of the epoxide. Furthermore, the catalyst must still be able to 
distinguish between the two epoxide enantiomers. Unsurprisingly, few regiodivergent 
reactions based on an SN2-reaction have been reported so far outside the realm of 
enzyme-catalysis, especially with epoxides as substrates.31 
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3.3.2 Catalyst Evaluation 
When testing catalyst (R)-6b with racemic cis-disubstituted epoxide 7a, the 
formation of two regioisomeric trans-β-lactones 8a and 9a was observed, the 
enantiomeric excess of which were excellent and good respectively (Table 3.3, entry 
1). A kinetic resolution could not account for this observation, whereas invoking the 
occurrence of a regiodivergent reaction30 could (Scheme 3.3C).  
Table 3.3 Evaluation of enantiopure [Lewis acid]+[Co(CO)4]--catalysts and 
solvents for the regiodivergent carbonylation of cis-epoxidesa 
O
Me nBu
catalyst 
(5 mol %)
CO (900 psi)
solvent
O
O
Me nBu
O
Me nBu
+
O
8a7a 9a
O
Me nBu
ent-7a
+
 
entry catalyst solvent 
lactone 8ab lactone 9ab 
conv. (%), %ee conv. (%), %ee 
1b (R)-6b THF 43 94 53 83 
2b (R)-6b toluene 44 86 54 73 
3b (R)-6b Et2O 46 87 53 77 
4b (R)-6b DME 11 58 17 79 
5b (R)-6b THP 43 87 54 72 
6b (R)-6b 1,4-dioxane 44 85 55 72 
7b (R)-6c THF 49 90 51 91 
8c (R,R)-1 THF 72 <1 26 08 
9b (R)-6a THF 61 30 33 49 
aReaction conditions: [epoxide] = 0.5 M, 22 °C, 16 h. bConversion to respective β-lactone and 
enantiomeric excess determined by GC analysis. Catalysts (R)-6a-c were generated in situ (LnAlCl + 
NaCo(CO)4). 
Regiodivergent carbonylation of methyl-cis-disubstituted epoxides such as 7a are 
especially attractive because the resulting trans-β-lactones 8 and 9 are both potentially 
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useful. Lactone 8 can be transformed into enantioenriched propionate aldol units with 
anti-configuration. Such compounds are often used in the synthesis of natural 
products.8c β-Lactone 9, on the other hand, represents aldol products based on 
acetaldehyde, which is a troublesome electrophile for aldol reactions because of its 
suspected carcinogenicity and propensity to hydrate or oligomerize. 
Given the good initial results with catalyst (R)-6b, further attempts were made to 
increase the enantiomeric excess for 9a by using different solvents. None of the 
solvents tested surpassed the results obtained with THF (entries 2-6). However, it was 
found that (R)-6c yielded both β-lactones with very good enantiomeric excess (entry 
7). (R)-6b and (R)-6c are nonetheless complementary, with (R)-6b showing the best 
enantiomeric excess for 8a, whereas (R)-6c gave slightly lower but still excellent 
values for both 8a and 9a. As expected, previously reported catalysts such as (R,R)-1 
or (R)-6a failed to reach similar levels of selectivity (entries 8 and 9). 
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3.3.3 Scope of the Regiodivergent Carbonylation of Racemic cis-Epoxides 
Encouraged by the screening results, the scope of this reaction using a variety of 
racemic cis-disubstituted epoxides 7 and catalyst (R)-6b was investigated next (Table 
3.4). The resulting lactones 8 and 9 all showed high levels of enantioenrichment, but 
none of them could be separated quantitatively using flash column chromatography. 
Table 3.4 Scope of the regiodivergent carbonylation of racemic cis-epoxides using 
catalyst (R)-6ba 
(R)-6b
(5 mol %)
CO (900 psi)
THF
O
R2 R1
O
R2 R1
O
R1 R2
+
O
O
R1 R2
7a-i
+
O
then 
separation
OMeR2
O
Me
OH
OMeMe
O
R2
OH
10a-e,h-i
isolated
8a-i
9a-i
<86% ee
(discarded)ent-7a-i
for 8a-e,h-i:
NaOMe/
MeOH
 
entry R1 R2 isol. product isol. yield (%) %eeb 
1 Me Et 10b 38a 94 
2 Me nPr 10c 32a 93 
3 Me nBu 10a 36a 94 
4 Me nPent 10d 36a 94 
5 Me nHex 10e 33a 95 
6 Et nPr 8f + 9f 61c 
96 (8f), 
93 (9f) 
7 Et nBu 8g + 9g 73c 
96 (8g), 
90 (9g) 
8 Me (CH2)2iPr 10h 36a 94 
9 Me (CH2)3OTBS 10i 35a 92 
aReaction conditions: [rac-7] = 0.5 M, 22 °C, 20 h. All reactions gave full conversion by GC analysis. 
bEnantiomeric excess determined by GC analysis. cIsolated yield of combined β-lactones 8 and 9. TBS 
= tBuMe2Si. Catalyst (R)-6b was generated in situ (LnAlCl + NaCo(CO)4). 
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However, this inseparability is of little concern if one is interested in the resulting 
aldol-type products, because ring-opening of lactones 8a-e,h-i and 9a-e,h-i to the 
corresponding methyl-esters enabled facile separation of the two species. Using this 
approach, lactones 8a-e,h-i were converted into methyl-esters 10a-e,h-i via a one-pot 
procedure, and isolated as such. Lactones 9a-e,h-i (with R1 = Me) generally showed 
less than 86% ee, which did not warrant isolation of their ester-derivatives. 
Good yields and excellent enantioselectivities of 93% ee or better were achieved 
for methyl-esters 10a-e bearing linear alkyl-chains of varying length as R2 (entries 1-
5). Epoxides with branching in R2 performed equally well and produced esters 10h-i 
with comparable yields and enantioenrichment (entries 8 and 9). Ethyl-substituted 
epoxides 7f and 7g also gave good enantiomeric excess for 8 and 9 (entries 6 and 7), 
but even their ester-derivatives were difficult to separate. Therefore, a mixture of the 
two lactones was isolated in both cases. Overall, (R)-6b proved to be an excellent 
catalyst for the production of highly enantioenriched lactones 8 and the corresponding 
esters 10 from racemic epoxides 7. Consequently, (R)-6b is the catalyst of choice if 
highly enantioenriched propionate aldol-type products are desired. 
Given the good performance of (R)-6c in the carbonylative meso 
desymmetrization reaction (Table 3.2, entries 6-9) and in the screen with cis-
disubstituted epoxides (Table 3.3, entry 7), its behavior in the regiodivergent 
carbonylation of racemic cis-epoxides was also investigated. Consequently, a variety 
of racemic cis-epoxides 7 were carbonylated using (R)-6c (Table 3.5) using the same 
conditions as before in Table 3.4. In all cases, the formation of two regioisomeric 
trans-β-lactones 8 and 9 in a ratio of approximately 1 : 1 was observed. More 
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Table 3.5 Scope of the regiodivergent carbonylation of cis-epoxides using catalyst 
(R)-6ca  
O
R1 R2
(R)-6c 
(5 mol %)
CO (900 psi)
THF
O
O
R1 R2
O
R1 R2
+
O
8a-h7a-h 9a-h
+
O
R1 R2
ent-7a-h
inseparable  
entry R1 R2 
isol.  
product 
isol. 
yield (%) 
ratiob 
8 : 9 
%eec 
1d Me Et 
ent-8b +  
ent-9b 
66 49 : 51 
94 (ent-8b), 
91 (ent-9b), 
2d Me nPr 8c + 9c 74 49 : 51 
94 (8c), 
92 (9c), 
3d Me nBu 8a + 9a 73 49 : 51 
90 (8a), 
91 (9a), 
4e Me nPent 8d + 9d 71 49 : 51 
90 (8d), 
92 (9d), 
5d Me nHex 8e + 9e 67 49 : 51 
90 (8e), 
92 (9e), 
6e Et nPr 8f + 9f 66 49 : 51 
98 (8f), 
97 (9f), 
7e Et nBu 8g + 9g 67 49 : 51 
96 (8g), 
95 (9g), 
8d Me (CH2)2iPr 8h + 9h 66 52 : 48 
83 (8h), 
91 (9h), 
aReaction conditions: [epoxide] = 0.5 M, 22 °C, 20 h. Yields are of isolated, combined β-lactones 8 and 
9. All reactions gave full conversion by GC analysis. bDetermined via GC analysis from crude reaction 
mixture. cEnantiomeric excess determined by GC analysis. d(S)-6c was used. e(R)-6c (8 mol %) used. 
Catalysts (R)- and (S)-6c were generated in situ (LnAlCl + NaCo(CO)4). 
importantly, 8 and 9 both showed excellent levels of enantioenrichment in the case of 
methyl-substituted epoxides (R1 = Me) bearing linear or branched alkyl-groups as R2 
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(entries 1-5, and 8). Racemic ethyl-substituted epoxides 7f and 7g (R1 = Et) required 
slightly higher catalyst loadings, but also formed β-lactones 8 and 9 with exceptionally 
high degrees of enantiomeric excess (entries 6 and 7). 
Overall, the results obtained with (R)-6c (Table 3.5) were reminiscent of those 
seen before with (R)-6b (Table 3.4). A significant difference, however, is that (R)-6c 
forms the two trans-β-lactone products 8 and 9 in a ratio of approximately 1 : 1, and 
both β-lactones show excellent enantiomeric excess exceeding 90% ee (β-lactone 8h 
being the only exception). With catalyst (R)-6b, the less desired lactone 9 was the 
prevailing product and generally showed <86% ee. Nevertheless, catalysts (R)-6b and 
(R)-6c are complementary. (R)-6b is the catalyst of choice if highly enantioenriched 
lactones 8 (>94% ee) and the corresponding propionate aldol-type products 10 are 
desired. (R)-6b, on the other hand, provides access to both β-lactones in highly 
enantioenriched form (usually > 90% ee). These two lactones can also be transformed 
into enantioenriched aldol-type compounds (vide infra). 
As before, the resulting lactones 8 and 9 were not readily separable via silica gel 
column chromatography. Consequently, mixtures of the two lactones were isolated in 
all cases in good yield. This, however, is of little concern if one is interested in the 
corresponding aldol-type products. Methyl-substituted β-lactones 8 a-e,h-i and 9a-e,h-
i can still be separated from one another by converting them into the corresponding 
methyl-ester derivatives. One example for this is given in Equation 3.1 for racemic 
epoxide 7i. 
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7i
OMe
O
Me
OH
OMeMe
OOH
10i
38%
91% ee
11
40%
94% ee
(R)-6c (5 mol %)
CO (900 psi)
THF, 22 °C, 20 h
2. NaOMe, then
3. flash column 
    chromatography
1.
ent-7i
+
O
Me
O
Me
TBSO
OTBS
3
TBSO
TBSO
3
3
3
+
 
(3.1) 
Epoxide 7i first underwent regiodivergent carbonylation using (R)-6c. Using a one-pot 
sequence, the resulting β-lactones were ring-opened to the corresponding methyl-ester 
10i and 11, which subsequently were isolated individually. As a result, two highly 
enantioenriched anti-aldol-type products were obtained from a single substrate using 
(R)-6c. 
3.3.4 Detailed Investigation of the Regiodivergent Carbonylation of Racemic cis-
Epoxides Using Catalyst (R)-6b 
Having established the scope of this transformation for a variety of racemic cis-
epoxides, the course of the reaction and factors responsible for its outcome were 
investigated next. As mentioned before, a regiodivergent reaction would explain the 
results obtained. A prerequisite for such a reaction would be that (R)-6b carbonylates 
both enantiomers of a given epoxide 7 with high and opposing regioselectivities. To 
confirm this hypothesis, highly enantioenriched 7a was synthesized and carbonylated 
with either enantiomer of catalyst 6b (Scheme 3.4). 
As Scheme 3.4 shows, carbonylation of enantioenriched 7a occurred with high 
and opposing regioselectivities when using (R)- and (S)-6b. Interestingly, the two 
enantiomers of 6b showed some degree of a matched/mismatched pair with 7a. (R)-6b 
carbonylated 7a only with a regioselectivity of 8.2 : 1 with regard to 8a and ent-9a.
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Me nBu
catalyst
 (5 mol %)
CO (900 psi)
THF
22 °C, 16 h
O
O
Me nBu
O
Me nBu
+
O
8a7a(99% ee) ent-9a
ratiob
 8a : ent-9a
89.1 10.9
2.4 97.6
catalyst
(R)-6b
(S)-6b
 
Scheme 3.4 Regioselectivity in the carbonylation of enantioenriched epoxide 7a 
using catalysts (R)- and (S)-6b Both reactions gave >95% conversion (GC analysis), and 
ratios were determined via 1H NMR analysis of crude reaction mixture. Catalysts (R)- and (S)-
6b were generated in situ (LnAlCl + NaCo(CO)4). 
carbonylated 7a only with a regioselectivity of 8.2 : 1 with regard to 8a and ent-9a. 
Contrary to that, (S)-6b gave a much better ratio of 1 : 41 in favor of ent-9a. The same 
result, namely a ratio of 1 : 41 favoring 9a, should be obtained if (R)-6b were to react 
with enantiopure ent-7a. Consequently, (R)-6b fulfills the requirement necessary for a 
regiodivergent reaction, namely providing high and opposing regioselectivities. 
The experiments performed in Scheme 3.4 also revealed that (R)-6b displayed 
different levels of chemoselectivity when reacting with 7a vs. ent-7a. The reaction 
with 7a produced circa twice as much ketone side products, 2- and 3-heptanone, as the 
one with ent-7a. The formation of ketone is a consequence of unproductive 
isomerization reactions of the epoxide.15d In addition, 7a produced 2- and 3-heptanone 
in approximately a 1 : 1 ratio, whereas ent-7a gave a ratio of circa 1 : 4. These 
findings explain the observed accumulation of 3-heptanone relative to 2-heptanone in 
the reaction of racemic 7a with (R)-6b (vide infra, Figure 3.3). Moreover, these results 
seem to indicate that ketone formation is an inherent property of catalysts such as (R)-
6b, and less the result of catalyst degradation. 
The results from Scheme 3.4 also allow for two more conclusions. First, (R)-6b 
can be used to regioselectively carbonylate enantioenriched cis-epoxides 7. Secondly, 
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the data in Scheme 3.4 allows calculation of the theoretically expected ratio of 
regioisomers and enantiomeric ratios for 8a and 9a in the regiodivergent carbonylation 
of racemic 7a using (R)-6b (Figure 3.2).  
O
Me nBu
89.1 10.9
 
7a 
O
Me nBu
2.4 97.6
 
ent-7a 
Regioselectivity of (R)-6b in 
the carbonylation of 7a and 
ent-7a 
(data taken from Scheme 3.4) 
Theoretical er for 8a when using (R)-6b: 89.1 : 2.4 = 97.4 : 2.6 (94.8% ee) 
Theoretical er for 9a when using (R)-6b: 97.6 : 10.9 = 90.0 : 10.0 (80.0% ee) 
Calculation of theoretical ratio of regioisomers 8a : 9a when using (R)-6b: 
ratio of 8a : 9a is (89.1 + 2.4) : (97.6 + 10.9) = 45.8 : 54.2 
Figure 3.2 Calculation of the theoretical enantiomeric ratio (er) and ratio of 
regioisomers for the reaction of racemic epoxide 7a with catalyst (R)-6b 
The thus obtained theoretical values were then compared to the experimental data 
(Scheme 3.5). Good agreement between theoretically predicted and experimentally 
observed results was noted as far as the ratio of regioisomers 8a and 9a and  
O
Me nBu
ent-7a
CO
O
O
Me nBu
O
Me nBu
+
O
8a 9a
O
Me nBu
7a
+
(R)-6b
theoretical ratio 8a : 9a 45.8 : 54.2
experimentally observed ratio 8a : 9a 44.7 : 55.3
theoretical er of 8a
experimentally observed er of 8a
theoretical er of 9a
experimentally observed er of 9a
97.4 : 2.6
97.3 : 2.7
90.0 : 10.0
91.6 : 8.4  
Scheme 3.5 Predicted and experimentally observed values for enantiomeric ratio 
(er) and ratio of regioisomers in the regiodivergent carbonylation of racemic 
epoxide 7a using catalyst (R)-6b Predicted values taken from Figure 3.2 
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enantiomeric ratio of 8a are concerned. The enantiomeric ratio of 9a deviates from the 
predicted value to a greater extent, and is higher than expected. This deviation can be 
attributed to the small amounts of ketone side product formed during the reaction. 
Since both enantiomers of the epoxide give rise to different amounts of ketone, it 
seems plausible that this can affect the enantiomeric ratios of 8a and 9a to different 
extents, and lead to deviations from the theoretically predicted values. 
In a next step, the carbonylation of racemic 7a with (R)-6b was monitored in 
detail using GC analysis. The resulting data (Figure 3.3) showed that (R)-6b consumed 
both enantiomers of the epoxide with comparable activity, with ent-7a reacting faster 
than 7a by a factor of approximately 4 (vide infra). This observation rules out a 
transient kinetic resolution of the epoxide. Small amounts of ketone side products 
were also detected, and steadily increased as the reaction progressed. Interestingly, the 
two ketone products, 2- and 3-heptanone, are formed in unequal amounts, with 3-
heptanone being the major species especially at later stages of the reaction. Different 
levels of chemoselectivity in the carbonylation reactions of 7a and ent-7a with (R)-6b 
rationalize this observation, i.e. one enantiomer of the epoxide is more prone to giving 
ketone side-products than the other (vide supra).  
Moreover, the collected data indicated that 9a, the β-lactone preferentially formed 
by (R)-6b from ent-7a (Scheme 3.4 and Figure 3.4), is the lactone that is formed 
fastest and initially in >90% ee. Lactone 8a, on the other hand, is produced slower and 
at first only with <80% ee. However, as the reaction progressed more of the other 
epoxide enantiomer 7a was consumed, which causes the enantiomeric ratio of 9a to 
slowly deteriorate. As shown in Figure 3.4, this is due to the fact that 3a gives rise to 
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Figure 3.3 Reaction profiles of major species present in the regiodivergent 
carbonylation of racemic epoxide 7a using catalyst (R)-6b  
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Figure 3.3 (continued) 
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8a and small amounts of ent-9a. Consequently, the %ee of 8a steadily improves as 
that of 9a declines, until 8a reaches the excellent %ee that is observed upon 
completion of the reaction. Figure 3.4 summarizes most of the data discussed so far 
for the regiodivergent carbonylation of racemic 7a using (R)-6b. 
ent-7a consumed 
faster than 7a
9a produced faster,
er deteriorates as
reaction progresses
8a produced slower,
er improves as
reaction progresses
predicted er
for 8a: 97.4 : 2.6
observed er
for 8a: 97.3 : 2.7
predicted er
for 9a: 90.0 : 10.0
observed er
for 9a: 91.6 : 8.4
(1st order, krel ~ 4)
O
nBu Me
O
nBu Me
O
Me nBu
O
8a
9a
O
Me nBu
7a
O
ent-7a
O
nBuMe
O
O
MenBu
O
ent-8a
ent-9a
Co(CO)4-Co(CO)4-
Co(CO)4-Co(CO)4-
(R)-6b
89.1%
10.9% 97.6%
2.4%
(R)-6b
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major product
LnAl+ +AlLn
Me nPent
O
nBu
O
ketone 
side-products
Me
continuously 
formed in 
small amounts
conditions:
900 psi CO
THF, 22 °C
 
Figure 3.4 Detailed analysis of the regiodivergent carbonylation of racemic 
epoxide 7a with catalyst (R)-6b 
Monitoring the reaction of racemic 7a with (R)-6b also allowed for an 
approximation of the selectivity factor s with regard to the epoxide. These data can be 
estimated by plotting conversion of epoxide against its enantiomeric excess over the 
course of the reaction. The distribution of the data points in the resulting plot varies in 
a characteristic way depending on the selectivity factor s and the reaction order in 
substrate in the selectivity-determining step.32 In case of the reaction of racemic 7a 
with (R)-6b (Figure 3.5), the experimental plot resembled graphs that are associated 
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with a first order dependence in substrate. This is an interesting observation because 
previous mechanistic studies16b showed that salen-based carbonylation catalysts 
convert terminal epoxides with zero order dependence in the rate law. Moreover, a 
simulated curve representing a first order dependence and a selectivity factor s of ca. 4 
adequately reproduced the experimental data points. Consequently, it seems 
reasonable to assume that the order in epoxide in the selectivity-determining step is 1 
Plot conversion vs. ee
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0.1
0.2
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0.4
0.5
0.6
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conv. (%)
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Figure 3.5 Experimentally determined data points for the variation of ee of 
unreacted epoxide relative to its conversion, and comparison to theoretical 
graphs for (a) zeroth-, (b) first-, and (c) second-order reactions in epoxide. The 
data points were aquired from the reaction of racemic 7a with (R)-6b. The simulated graphs 
were calculated using the equations given in reference 32. 
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throughout most of the reaction, and that (R)-6b displays a selectivity factor s (krel) of 
approximately 4 in the regiodivergent carbonylation of racemic 7a. 
Lastly, this finding indicates again that an efficient classical kinetic resolution is not 
feasible with (R)-6b for racemic epoxides 7. 
3.3.5 Application of Regiodivergent Carbonylation to the Synthesis of Fragment A 
of Globomycin 
Lastly, to demonstrate the applicability of the regiodivergent carbonylation 
methodology catalyst (R)-6b was used to synthesize Fragment A (12) of Globomycin33 
starting from racemic epoxide 7e (Scheme 3.6). Globomycin is a promising antibiotic 
against Gram-negative bacteria and also shows the ability to act as a specific inhibitor 
of certain signal peptidases.33 Furthermore, it was found that the activity of 
Globomycin depends strongly on the actual length of the alkyl chain in Fragment A.34 
H
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Scheme 3.6 Synthesis of Fragment A (12) of Globomycin using regiodivergent 
carbonylation  
The desired fragment 12 was obtained in 30% yield starting from 7e, and its 
enantiomeric excess of 95% ee compared favorably to the 92% ee reported in the 
literature for this compound.33 What is even more important is that regiodivergent 
carbonylation is well suited to deliver derivatives of 12 with comparable 
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enantioselectivities as was seen in Encouraged by the screening results, the scope of 
this reaction using a variety of racemic cis-disubstituted epoxides 7 and catalyst (R)-
6b was investigated next (Table 3.4). The resulting lactones 8 and 9 all showed high 
levels of enantioenrichment, but none of them could be separated quantitatively using 
flash column chromatography. 
Table 3.4 and Table 3.5. The literature procedure comes short in this regard.34 
Moreover, regiodivergent carbonylation can deliver two highly enantioenriched 
derivatives of Fragment A in just one step if catalyst (R)-6c is used. This subsequently 
would allow for the rapid assembly of a library of Fragment A-analogs for structure-
activity relationship studies. Overall, this application showcases the strength of 
regiodivergent carbonylation as a fast and economical means to generate molecular 
diversity, which is often needed in medicinal chemistry. 
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3.4 Conclusion 
In conclusion, two new enantiopure carbonylation catalysts (R)-6b and (R)-6c 
based on salen-frameworks were reported. (R)-6b and (R)-6c were applied to the 
enantioselective desymmetrization of aliphatic meso epoxides and the regiodivergent 
carbonylation of racemic cis-disubstituted epoxides (Figure 3.6).  
O
R R
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R R
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Figure 3.6 Catalysts and carbonylation reactions investigated for the synthesis of 
enantioenriched trans-β-lactones from either meso (a) or racemic cis-epoxides (b) 
In both transformations, the two catalysts showed excellent levels of enantiomeric 
induction for a large variety of epoxides. The products are highly enantioenriched 
trans-β-lactones, which can be further elaborated to the corresponding anti-aldol-type 
products in a one-pot sequence. Both classes of compounds are not readily accessible 
with other methodologies. The effectiveness of (R)-6b and (R)-6c in inducing 
enantioenrichment was attributed to the cis-α coordination geometry of the ligand 
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around the Lewis acidic metal ion. Given that regiodivergent reactions based on SN2-
reactions are exceedingly rare, the occurrence and progression of the regiodivergent 
carbonylation reaction using racemic epoxide 7a and catalyst (R)-6b was studied in 
detail. The two enantiomers of 7a were shown to react with comparable rates, but 
were carbonylated with opposing regioselectivities. This finding was independently 
confirmed by carbonylating enantiopure 7a with either enantiomer of catalyst 6b. 
Lastly, regiodivergent carbonylation was applied to the synthesis of an important 
fragment of Globomycin. This example demonstrated the potential of regiodivergent 
carbonylation to generate a variety of derivatives for structure-activity relationship 
studies with comparatively little synthetic effort. 
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3.5 Experimental Procedures 
3.5.1 General Considerations 
Methods and instruments 
Unless stated otherwise all synthetic manipulations were carried out using 
standard Schlenk techniques under a nitrogen atmosphere or in an MBraun Unilab 
glovebox under an atmosphere of purified nitrogen. Reactions were carried out in 
oven-dried glassware cooled under vacuum. High-pressure reactions were performed 
in a custom-designed and -fabricated, six-chamber, stainless steel, high-pressure 
reactor.35 The reactor design allowed for incorporation of six 2 fluid dram glass vials. 
IR spectra were recorded on a Nicolet 380 FT-IR spectrometer. 1H NMR and 13C 
NMR spectra were recorded on a Varian 300, 400 or 500 MHz instrument at 22° C 
(unless indicated otherwise) with shifts reported relative to the residual solvent peak 
(CDCl3: 7.26 ppm (1H), and 77.16 ppm (13C); C6D6: 7.16 ppm (1H) and 128.06 ppm 
(13C); THF-d8: 3.58 ppm (1H) and 67.57 ppm (13C)). 19F NMR spectra were recorded 
on a Varian 400 MHz instrument with shifts referenced to an external standard of neat 
CFCl3 (0 ppm). NMR solvents were purchased from Cambridge Isotope Laboratories 
and stored over activated 4Å molecular sieves (C6D6) or K2CO3 (CDCl3). Optical 
rotations were measured on a Perkin-Elmer 241 polarimeter. GC analyses were 
performed on a Hewlett Packard 6890 gas chromatograph equipped with a Supelco b-
Dex120 and a Supelco b-Dex225 column, and a flame ionization detector. Helium 
(Airgas, UHP grade) was used as carrier gas. HRMS analyses were performed at the 
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Mass Spectrometry Laboratory at the University of Illinois at Urbana-Champaign. 
Elemental analyses were performed at Midwest Microlab, LLC. 
 
Chemicals 
Anhydrous 1,4-dioxane, 1,2-dimethoxyethane (DME) and tetrahydropyran (THP) 
were purchased from Sigma-Aldrich and degassed via three freeze-pump-thaw cycles 
prior to use. Anhydrous toluene, dichloromethane, hexanes and tetrahydrofuran were 
purchased from Fischer Scientific and sparged vigorously with nitrogen for 40 minutes 
prior to first use. The solvents were further purified by passing them under nitrogen 
pressure through two packed columns of neutral alumina (tetrahydrofuran was also 
passed through a third column packed with activated 4Å molecular sieves) or through 
neutral alumina and copper(II) oxide (for toluene and hexanes). Tetrahydrofuran and 
dichloromethane were degassed via three freeze-pump-thaw cycles prior to use. 
Diethylether was dried over sodium/benzophenone and degassed via three freeze-
pump-thaw cycles prior to use. Pentane and cyclohexane were dried over 
phosphor(V)oxide and degassed via three freeze-pump-thaw cycles prior to use. 
Triethylamine was dried over calcium hydride and degassed via three freeze-pump-
thaw cycles prior to use. n-Dodecane and all epoxides used in this study were dried 
over calciumhydride and degassed via three freeze-pump-thaw cycles prior to use. All 
non-dried solvents used were reagent grade or better and used as received.  
Carbon monoxide (Airgas, 99.99% min. purity) was used as received. All other 
chemicals were purchased from Aldrich, Alfa-Aesar or GFS Chemicals, and used as 
received. Flash column chromatography was performed with silica gel (particle size 
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40-64 µm, 230-400 mesh) using either mixtures of ethyl acetate and hexanes or 
mixtures of diethylether and pentane as eluent. 
[(S,S)-salcyAl(THF)2]+[Co(CO)4]- ((S,S)-1, (S,S)-salcy = (S,S)-N,N'-bis(3,5-di-
tert-butyl-salicyl-idene)-1,2-cyclohexanediamine),16 (R)-tBuBinamAlCl (precursor to 
2a, (R)-tBuBinam = (R)-N,N'-bis(2-hydroxy-3,5-di-tert-butylbenzylidene)-1,1'-
binaphthyl-2,2'-diamine),26 NaCo(CO)4,36 rac-(2R,3S)-2,3-diethyloxirane (rac-4c),37 
rac-(2R,3S)-2,3-dipropyloxirane (rac-4a),38 rac-(2R,3S)-2,3-dibutyloxirane (rac-4d),39 
(Z)-oct-4-ene-1,8-diylbis(4-methylbenzenesulfonate) (rac-SM1),40 rac-(2R,3S)-2-
butyl-3-methyloxirane (rac-7a),41 rac-(2R,3S)-2-ethyl-3-propyloxirane (rac-7f),42 rac-
(2R,3S)-2-butyl-3-ethyloxirane (rac-7g),43 and the precursors to (S,S)-15a,21 (S,S)-
15b,21 (S,S)-15c21 were prepared according to literature procedures. 
Racemic mixtures of β-lactones 8a-i and 9a-i were synthesized using 
[ClTPPAl(THF)2]+[Co(CO)4]- (ClTPP = meso tetra(4-chlorophenyl)porphyrinato).44 
3.5.2 Synthetic Procedures 
3.5.2.1 General Procedures 
General procedure A: Epoxidation of alkenes to epoxides using mCPBA 
mCPBA (Aldrich, ≤ 77%) was added in portions at 0 °C to a solution of the 
corresponding alkene in DCM and the resulting mixture was stirred at the same 
temperature until TLC analysis indicated complete consumption of the alkene. After 
destroying excess mCPBA by adding aqueous NaHSO3 at 0 °C, the reaction mixture 
was filtered, the organic phase washed with NaHCO3 (sat., aq., 3x), dried with sodium 
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sulfate, filtered and concentrated under reduced pressure. The residue was purified 
either via distillation or flash column chromatography. 
 
General procedure B: Carbonylation of epoxides using (R)-6b and (R)-6c 
In a glove box, a 2 fluid dram glass vial equipped with a Teflon-coated magnetic 
stir bar was charged with the appropriate pre-catalyst, NaCo(CO)4, and the appropriate 
solvent. After 1 minute of stirring at 22 °C, the vial was placed in a custom-made 6-
well high-pressure reactor which itself was placed in a glove box freezer (-34 °C) for 
30 minutes. The appropriate epoxide (also cooled to -34 °C) was then added to the 
vial, the reactor removed from the freezer, subsequently sealed, taken out of the glove 
box, placed in a well-ventilated hood and pressurized with carbon monoxide (900 psi). 
It is important to keep the temperature of the reactor below 0 °C once it is removed 
from the freezer to minimize isomerization of the epoxide to ketone products. The 
reactor was then sealed again, placed in a 22 °C water bath (unless noted otherwise) 
and the reaction mixture stirred for the time indicated. The reactor was then carefully 
vented in a well-ventilated hood and the product isolated as indicated. 
 
General procedure C: Derivatization of β-hydroxymethylesters with 
trifluoroacetic anhydride for GC analysis 
The corresponding β-hydroxymethylester (ca. 5-10 mg) was dissolved in DCM (1 
ml). Three equivalents of pyridine were added, followed by slow addition of three 
equivalents of trifluoroacetic anhydride at 0 °C, and the resulting reaction mixture was 
stirred at 22 °C. Hydrochloric acid (1M, aq.) was added as soon as TLC analysis 
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indicated full conversion of starting material. The resulting phases were separated, the 
organic phase dried with sodium sulfate, and subsequently passed through a short plug 
of silica gel using diethylether as eluent. The eluate was then subjected to GC analysis. 
3.5.2.2 Synthesis of Starting Materials 
(Z)-1,8-Bis(2,2,2-trifluoroethoxy)oct-4-ene (SM1) 
2,2,2-Trifluoroethanol (1.51 g, 15.1 mmol) was added dropwise to a mixture of 
sodium hydride (Aldrich, 95%, dry, 0.480 g, 20.0 mmol) and THF (10 ml) at 0 °C. 
After stirring for 1 h at 22 °C, a solution of (Z)-oct-4-ene-1,8-diylbis(4-
methylbenzene-sulfonate)8 in THF (5 ml) was added at 0 °C, and the resulting mixture 
refluxed for 12 h. The reaction mixture was then cooled to 22 °C, H2O was added, 
followed by extraction of the aqueous phase with Et2O (3x). The combined organic 
layers were washed with brine, dried with sodium sulfate, filtered and concentrated 
under reduced pressure. The residue was purified via flash column chromatography to 
afford SM1 (1.38 g, 85%) as a colorless liquid. 1H NMR (400 MHz, CDCl3): δ 5.38 
(ddd, J = 5.7, 4.4, 1.1 Hz, 2H), 3.79 (q, J = 8.8 Hz, 4H), 3.59 (t, J = 6.4 Hz, 4H), 2.12 
(td, J = 7.2, 5.4 Hz, 4H), 1.67 (dt, J = 7.8, 6.5 Hz, 4H). 13C NMR (101 MHz, CDCl3): 
δ 129.7, 124.3 (d, J = 281.4 Hz), 72.2, 68.4 (q, J = 33.8 Hz), 29.5, 23.4. 19F NMR 
(376 MHz, CDCl3): δ -74.4 (t, J = 8.8 Hz). IR (neat, cm-1): 2935, 1441, 1275, 1133, 
966, 827. HRMS (ESI) m/z calculated for C12H18F6NaO2+ (M + Na+) 331.1103, found 
331.1110. 
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2,3-Bis(3-(2,2,2-trifluoroethoxy)propyl)oxirane (4e) 
Following general procedure A, (Z)-1,8-bis(2,2,2-trifluoroethoxy)oct-4-ene (SM1, 
1.28 g, 4.15 mmol) was reacted with mCPBA (1.41 g) in DCM (10 ml) to give 4e 
(1.19 g, 88%) as a colorless liquid. 1H NMR (400 MHz, C6D6): δ 3.23 (q, J = 8.8 Hz, 
4H), 3.16–3.05 (m, 4H), 2.62–2.57 (m, 2H), 1.52–1.28 (m, 8H). 13C NMR (101 MHz, 
C6D6): δ 124.7 (d, J = 279.6 Hz), 72.0, 68.1 (q, J = 33.4 Hz), 56.2, 27.0, 24.6. 19F 
NMR (376 MHz, C6D6): δ -74.2 (t, J = 8.9 Hz). IR (neat, cm-1): 2935, 1444, 1275, 
1131, 966, 826. HRMS (ESI) m/z calculated for C12H19F6O3+ (M + H+) 325.1233, 
found 325.1245. 
 
rac-(2S,3R)-2-Ethyl-3-methyloxirane (rac-7b) 
Following general procedure A, (Z)-pent-2-ene (7.00 g, 99.8 mmol) was reacted 
with mCPBA (27.5 g) in DCM (100 ml) to give rac-7b (0.992 g, 12%) as a colorless 
liquid. The analytical data was in accordance with that reported in the literature.45 1H 
NMR (400 MHz, CDCl3): δ 3.02 (qd, J = 5.5, 4.2 Hz, 1H), 2.84 (td, J = 6.4, 4.2 Hz, 
1H), 1.61–1.52 (m, 1H), 1.54–1.42 (m, 1H), 1.25 (d, J = 5.5 Hz, 3H), 1.01 (t, J = 7.6 
Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 58.3, 52.8, 21.0, 13.1, 10.5. 
 
rac-(2R,3S)-2-Methyl-3-propyloxirane (rac-7c) 
Following general procedure A, (Z)-hex-2-ene (5.12 g, 60.8 mmol) was reacted 
with mCPBA (17.0 g) in DCM (135 ml) to give rac-7c (1.74 g, 29%) as a colorless 
liquid. The analytical data was in accordance with that reported in the literature.46 1H 
NMR (300 MHz, CDCl3): δ 3.01 (qd, J = 5.5, 4.3 Hz, 1H), 2.87 (td, J = 5.9, 4.1 Hz, 
 176 
1H), 1.54–1.39 (m, 4H), 1.24 (d, J = 5.6 Hz, 3H), 0.96–0.93 (m, 3H). 13C NMR (126 
MHz, CDCl3): δ 57.0, 52.6, 29.6, 19.8, 14.1, 13.3. 
 
rac-(2R,3S)-2-Methyl-3-pentyloxirane (rac-7d) 
Following general procedure A, (Z)-oct-2-ene (5.00 g, 44.6 mmol) was reacted 
with mCPBA (12.6 g) in DCM (100 ml) to give rac-7d (3.47 g, 61%) as a colorless 
liquid. The analytical data was in accordance with that reported in the literature.47 1H 
NMR (300 MHz, CDCl3): δ 2.99 (qd, J = 5.5, 4.4 Hz, 1H), 2.86–2.83 (m, 1H), 1.52–
1.25 (m, 8H), 1.22 (d, J = 5.5 Hz, 3H), 0.87–0.85 (m, 3H). 13C NMR (126 MHz, 
CDCl3): δ 57.2, 52.7, 31.8, 27.6, 26.20, 22.7, 14.0, 13.2. 
 
rac-(2S,3R)-2-Hexyl-3-methyloxirane (rac-7e) 
Following general procedure A, (Z)-non-2-ene17 (1.19 g, 9.43 mmol) was reacted 
with mCPBA (2.40 g) in DCM (18 ml) to give rac-7e (1.05 g, 78%) as a colorless 
liquid. The analytical data was in accordance with that reported in the literature.48 1H 
NMR (300 MHz, CDCl3): δ 3.04 (qd, J = 5.5, 4.3 Hz, 1H), 2.90 (td, J = 5.9, 4.2 Hz, 
1H), 1.58–1.24 (m, 10H), 1.27 (d, J = 5.4 Hz, 3H), 0.91–0.87 (m, 3H). 13C NMR (126 
MHz, CDCl3): δ 57.3, 52.7, 31.9, 29.3, 27.7, 26.5, 22.7, 14.2, 13.3. 
 
rac-(2S,3R)-2-Isopentyl-3-methyloxirane (rac-7h) 
6-Methylhept-2-yne (4.41 g, 40.0 mmol), Lindlar catalyst (Aldrich, 1.50 g), 
pentane (30 ml) and quinoline (freshly distilled, 1.65 g, 12.7 mmol) were placed in a 
Fisher-Porter tube, and the contents of the tube purged with nitrogen for 5 minutes. A 
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H2-pressure of 32 psi was applied to the tube and the reaction mixture stirred at 22 °C 
until TLC analysis indicated complete disappearance of starting material (during this 
process the tube was repressurized with H2-gas as necessary). The Fisher-Porter tube 
was carefully vented, then HCl (1 M, aq.) was carefully added and the reaction 
mixture filtered through a pad of celite. The organic phase was washed with HCl (1 M, 
aq., 2x), then dried with sodium sulfate, filtered and concentrated under reduced 
pressure. 
Following general procedure A, the residue was reacted with mCPBA (12.2 g) in 
DCM (80 ml) to give rac-7h (1.22 g, 24%) as a colorless liquid. 1H NMR (300 MHz, 
CDCl3): δ 3.04 (qd, J = 5.5, 4.2 Hz, 1H), 2.88 (td, J = 6.1, 4.2 Hz, 1H), 1.64–1.35 (m, 
4H), 1.32–1.23 (m, 1H), 1.27 (d, J = 5.5 Hz, 3H), 0.91 (d, J = 6.6 Hz, 6H). 13C NMR 
(75 MHz, CDCl3): δ 57.4, 52.8, 35.5, 28.0, 25.6, 22.7, 22.5, 13.3. IR (neat, cm-1): 
2957, 1468, 1389, 1065, 982, 804, 790. HRMS (ESI) m/z calculated for C8H17O+ (M + 
H+) 129.1274, found 129.1276. 
 
(Z)-Tert-butyl(hex-4-en-1-yloxy)dimethylsilane (SM2) 
(Z)-Hex-4-en-1-ol (0.955 g, 9.53 mmol) and 1-methyl-1H-imidazole (2.47 g, 30.1 
mmol) were added to a solution of tert-butylchlorodimethylsilane (1.80 g, 11.9 mmol) 
in DCM (24 ml) at 0 °C. The reaction mixture was stirred for 24 h at 22 °C, then 
washed with water, dried with sodium sulfate, filtered and concentrated under reduced 
pressure. The residue was purified via flash column chromatography to give SM2 
(1.76 g, 86%) as a colorless liquid. 1H NMR (400 MHz, CDCl3): δ 5.49–5.35 (m, 2H), 
3.61 (t, J = 6.5 Hz, 2H), 2.12–2.06 (m, 2H), 1.61–1.54 (m, 5H), 0.90 (s, 9H), 0.05 (s, 
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6H). 13C NMR (101 MHz, CDCl3): δ 130.3, 124.3, 62.8, 32.8, 26.1, 23.3, 18.5 12.9, -
5.1. IR (neat, cm-1): 2929, 2857, 1472, 1254, 1098, 833, 773. Elemental analysis: 
C12H26OSi (214.42), calculated C 67.22, H 12.22; found C 67.04, H 11.97. No 
molecular ion peak was observed when performing EI-MS or ESI-MS analysis, 
consequently no HRMS data was acquired. 
 
rac-Tert-butyldimethyl(3-((2S,3R)-3-methyloxiran-2-yl)propoxy)silane (rac-7i)  
Following general procedure A, (Z)-tert-butyl(hex-4-en-1-yloxy)dimethylsilane 
(SM2) (1.60 g, 7.46 mmol) was reacted with mCPBA (1.86 g) in DCM (20 ml) to give 
rac-7i (1.61 g, 94%) as a colorless liquid. 1H NMR (300 MHz, CDCl3): δ 3.71–3.59 
(m, 2H), 3.04 (td, J = 5.6, 4.3 Hz, 1H), 2.92 (td, J = 6.0, 4.1 Hz, 1H), 1.92–1.49 (m, 
4H), 1.26 (d, J = 5.4 Hz, 3H), 0.88 (s, 9H), 0.04 (s, 6H). 13C NMR (75 MHz, CDCl3): 
δ 62.8, 57.0, 52.8, 29.8, 26.1, 24.3, 18.5, 13.3, -5.2. IR (neat, cm-1): 2955, 2857, 1472, 
1253, 1097, 833, 773. HRMS (ESI) m/z calculated for C12H27O2Si+ (M + H+) 
231.1775, found 231.1777. 
 
(S)-2-(Benzyloxy)heptan-3-one (SM3)  
(S)-2-(Benzyloxy)-1-(pyrrolidin-1-yl)propan-1-one49 (4.66 g, 20.0 mmol) was 
added to THF (70 ml), and the resulting mixture cooled to -78 °C. n-Butyllithium 
(Acros, 1.6 M, hexanes, 14.5 ml, 23 mmol) was added dropwise at -78 °C under 
vigorous stirring, and then the reaction mixture was stirred for 6 minutes at -78 °C. 
Ammonium chloride (sat., aq.) was added, and the aqueous layer extracted with Et2O 
(2x). The combined organic layers were dried with sodium sulfate, filtered and 
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concentrated under reduced pressure. The residue was purified via flash column chro-
matography to give SM3 (3.17 g, 72%) as a colorless liquid. 1H NMR (300 MHz, 
CDCl3): δ 7.31–7.14 (m, 5H), 4.45 (d, J = 11.7 Hz, 1H), 4.42 (d, J = 11.7 Hz, 1H), 
3.85 (q, J = 6.9 Hz, 1H), 2.56–2.38 (m, 2H), 1.52–1.42 (m, 2H), 1.29–1.17 (m, 2H), 
1.24 (d, J = 6.8 Hz, 3H), 0.82 (t, J = 7.3 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 
213.2, 137.8, 128.6, 128.0, 127.9, 80.8, 72.0, 37.2, 25.5, 22.5, 17.6, 14.0. IR (neat, 
cm-1): 2958, 2933, 2872, 1716, 1454, 1368, 1113, 734. HRMS (ESI) m/z calculated 
for C14H20O2Na+ (M + Na+) 243.1356, found 243.1358. Specific rotation: [α]22D = -
49.7 (c = 1.1, CHCl3). 
 
(2S,3S)-2-(Benzyloxy)heptan-3-ol (SM4) 
L-Selectride (Aldrich, 1.0 M, THF, 4.5 ml, 4.5 mmol) was added to a solution of 
(S)-2-(benzyloxy)heptan-3-one (SM3, 0.783 g, 3.55 mmol) in THF (12 ml) dropwise 
at -78 °C. After stirring for 2 h at -78 °C, ammonium chloride (sat., aq.) was added, 
and the aqueous layer extracted with Et2O (2x). The combined organic layers were 
washed with NaHCO3 (sat., aq.), dried with sodium sulfate, filtered and concentrated 
under reduced pressure. The residue was purified via flash column chromatography to 
give SM4 (0.483 g, 61%) as a colorless liquid. 1H NMR (400 MHz, CDCl3): δ 7.29–
7.19 (m, 5H), 4.57 (d, J = 11.5 Hz, 1H), 4.37 (d, J = 11.5 Hz, 1H), 3.38–3.34 (m, 1H), 
3.31 (q, J = 6.1 Hz, 1H), 2.47 (s, 1H), 1.43–1.22 (m, 6H), 1.12 (d, J = 6.0 Hz, 3H), 
0.83 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 138.5, 128.6, 128.0, 127.9, 
78.6, 75.1, 71.1, 32.7, 27.9, 22.9, 15.7, 14.2. IR (neat, cm-1): 2932, 2860, 1454, 1375, 
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1072, 1027, 733. HRMS (ESI) m/z calculated for C14H23O2+ (M + H+) 223.1693, 
found 223.1699. Specific rotation: [α]22D = +27.2 (c = 0.90, CHCl3). 
 
(2S,3S)-2-(Benzyloxy)heptan-3-yl 4-methylbenzenesulfonate (SM5) 
(2S,3S)-2-(Benzyloxy)heptan-3-ol (SM4, 0.416 g, 1.87 mmol), 4-methylbenzene-
1-sulfonyl chloride (1.00 g, 5.25 mmol), and pyridine (1.96 g, 24.7 mmol) were mixed 
and stirred at 40 °C for 5 h. The reaction mixture was allowed to cool to 22 °C, Et2O 
was added and the organic phase was washed with HCl (1 M, aq., 2x). The organic 
layer was then dried with sodium sulfate, filtered and concentrated under reduced 
pressure. The residue was purified via flash column chromatography to give SM5 
(0.632 g, 90%) as a colorless liquid, which was stored at -15 °C to prevent 
discoloration of the product. 1H NMR (300 MHz, CDCl3): δ 7.72 (d, J = 8.2 Hz, 2H), 
7.34–7.23 (m, 7H), 4.53 (qu, J = 4.2 Hz, 1H), 4.49 (d, J = 12.0 Hz, 1H), 4.40 (d, J = 
12.0 Hz, 1H), 3.66 (qd, J = 6.4, 4.4 Hz, 1H), 2.40 (s, 3H), 1.68 (dddd, J = 13.9, 9.9, 
5.9, 3.8 Hz, 1H), 1.57–1.45 (m, 1H), 1.21–1.10 (m, 3H), 1.12 (d, J = 6.4 Hz, 3H), 
1.06–0.93 (m, 1H), 0.77 (t, J = 6.9 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 144.6, 
138.4, 134.4, 129.7, 128.4, 127.9, 127.8, 127.7, 84.4, 74.6, 71.4, 28.7, 27.3, 22.5, 21.7, 
14.6, 13.9. IR (neat, cm-1): 2956, 2871, 1598, 1362, 1174, 1096, 904, 813. HRMS 
(ESI) m/z calculated for C21H28O4NaS+ (M + Na+) 399.1603, found 399.1601. Specific 
rotation: [α]22D = -22.1 (c = 0.60, CHCl3). 
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(2S,3S)-2-Hydroxyheptan-3-yl 4-methylbenzenesulfonate (SM6) 
Palladium on carbon (Strem, 5% Pd, 0.352 g), methanol (15 ml), and (2S,3S)-2-
(benzyloxy)heptan-3-yl 4-methylbenzenesulfonate (SM5, 0.498 g, 1.32 mmol) were 
placed in a Fisher-Porter tube and the contents of the tube purged with nitrogen for 5 
minutes. A H2-pressure of 32 psi was applied to the tube and the reaction mixture 
stirred at 22 °C until TLC analysis indicated complete disappearance of starting 
material (during this process the tube was repressurized with H2-gas as necessary). 
The Fisher-Porter tube was carefully vented, Et2O was added, and the resulting 
mixture filtered through celite. The filtrate was concentrated under reduced pressure 
and the residue purified via flash column chromatography to give SM6 (0.309 g, 82%) 
as a colorless liquid. 1H NMR (400 MHz, CDCl3): δ 7.79 (d, J = 8.2 Hz, 2H), 7.34 (d, 
J = 8.2 Hz, 2H), 4.45 (dt, J = 7.3, 5.1 Hz, 1H), 3.84 (qd, J = 6.4, 5.1 Hz, 1H), 2.43 (s, 
3H), 2.24 (s, 1H), 1.65 (dddd, J = 15.4, 7.8, 6.5, 4.9 Hz, 1H), 1.57–1.48 (m, 1H), 
1.26–1.12 (m, 4H), 1.15 (d, J = 6.5 Hz, 3H), 0.80 (t, J = 7.0 Hz, 3H). 13C NMR (75 
MHz, CDCl3): δ 144.9, 134.2, 129.9, 127.9, 87.7, 68.2, 30.2, 26.9, 22.5, 21.7, 18.9, 
13.9. IR (neat, cm-1): 3531, 2957, 2872, 1356, 1173, 1096, 894, 813. HRMS (ESI) 
m/z calculated for C14H23O4S+ (M + H+) 287.1317, found 287.1312. Specific rotation: 
[α]22D = +4.4 (c = 3.9, CHCl3). 
 
(2R,3S)-2-Butyl-3-methyloxirane (7a) 
A solution of (2S,3S)-2-hydroxyheptan-3-yl 4-methylbenzenesulfonate (SM6, 
4.46 g, 15.6 mmol) in Et2O (10 ml) was added to a suspension of sodium hydride 
(Aldrich, 95%, dry, 0.560 g, 23.3 mmol) in Et2O (40 ml), and refluxed for 3 days. 
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Upon cooling to 0 °C, H2O was added and the aqueous phase extracted with Et2O 
(2x). The combined organic layers were dried with sodium sulfate, filtered and 
concentrated under reduced pressure. Distillation of the crude product mixture 
provided 7a (0.861 g, 43%) as a colorless liquid. The analytical data was in 
accordance with that reported for rac-(2R,3S)-2-butyl-3-methyloxirane in the 
literature.50 1H NMR (300 MHz, CDCl3): δ 3.04 (qd, J = 5.5, 4.2 Hz, 1H), 2.90 (td, J 
= 5.8, 4.0 Hz, 1H), 1.56–1.32 (m, 6H), 1.26 (d, J = 5.5 Hz, 3H), 0.94 (d, J = 6.8 Hz, 
3H). 13C NMR (126 MHz, CDCl3): δ 57.1, 52.6, 28.7, 27.3, 22.6, 14.1, 13.2. Specific 
rotation: [α]22D = -8.1 (c = 0.53, CHCl3). 
The enantiomeric ratio (er) was determined to be >99 : 1 by GC analysis (b-
Dex225 column) in comparison to authentic racemic material. 
 
2',4',5,6'-Tetramethyl-[1,1'-biphenyl]-2-ol (SM7) 
2-Bromo-4-methylphenol (freshly distilled, 2.33 g, 12.4 mmol) was added 
dropwise to a mixture of sodium hydride (Aldrich, 95%, dry, 0.380 g, 15.8 mmol) and 
THF (20 ml) at 0 °C, followed by stirring at 22 °C for 10 minutes. Pd(acac)2 (0.170 g, 
0.558 mmol, 4.50 mol %) was added, followed by mesitylmagnesium bromide 
(Aldrich, 1.0 M, THF, 18 ml), and the resulting mixture was refluxed for 12 h. Upon 
cooling to 0 °C, H2O and then HCl (2 M, aq.) were added, and the resulting mixture 
was filtered through a pad of celite. The resulting phases were separated and the 
aqueous phase extracted with Et2O (3x). The combined organic layers were washed 
with brine, dried with sodium sulfate, filtered and concentrated under reduced 
pressure. The residue was purified via flash column chromatography to give SM7 
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(2.78 g, 99%) as an off-white solid. MP 66–67 °C. 1H NMR (300 MHz, CDCl3): δ 
7.08 (d, J = 8.4 Hz, 1H), 7.00 (s, 2H), 6.90 (d, J = 8.1 Hz, 1H), 6.83 (s, 1H), 4.49 (d, J 
= 0.9 Hz, 1H), 2.35 (s, 3H), 2.32 (s, 3H), 2.04 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 
150.3, 138.0, 137.8, 132.0, 130.5, 129.9, 129.5, 128.8, 126.3, 114.9, 21.2, 20.7, 20.4. 
IR (neat, cm-1): 3477, 2917, 1478, 1436, 1272, 1230, 1161, 1031, 819. HRMS (ESI) 
m/z calculated for C16H18NaO+ (M + Na+) 249.1250, found 249.1259.  
 
2-Hydroxy-2',4',5,6'-tetramethyl-[1,1'-biphenyl]-3-carbaldehyde (SM8) 
Methylmagnesium bromide (Acros, 3 M, Et2O, 6.5 ml, 20 mmol) is added slowly 
to 2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol (SM7, 3.78 g, 16.7 mmol) in THF (40 ml) 
at 0 °C. After warming to 22 °C, toluene (80 ml), triethylamine (2.76 g, 27.3 mmol) 
and paraformaldehyde (1.28 g, 42.6 mmol) were added, and the resulting reaction 
mixture stirred at 80 °C for 12 h. After cooling to 0 °C, H2O and then HCl (2 M, aq.) 
were added, and the resulting phases were separated. The aqueous phase was extracted 
with Et2O (2x). The combined organic layers were washed with brine, dried with 
sodium sulfate, filtered and concentrated under reduced pressure. The residue was 
purified via flash column chromatography to afford SM8 (3.32 g, 78%) as an off-
white solid. MP 105–106 °C. 1H NMR (300 MHz, CDCl3): δ 10.95 (s, 1H), 9.93 (s, 
1H), 7.37 (d, J = 2.3 Hz, 1H), 7.18 (d, J = 2.2 Hz, 1H), 6.97 (s, 2H), 2.39 (s, 3H), 2.34 
(s, 3H), 2.03 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 196.8, 156.9, 139.5, 137.4, 136.6, 
132.9, 132.8, 129.8, 129.2, 128.3, 120.6, 21.3, 20.45, 20.44. IR (neat, cm-1): 2917, 
1643, 1454, 1320, 1224, 1103, 971, 850, 798, 742. HRMS (ESI) m/z calculated for 
C17H19O+ (M + H+) 255.1380, found 255.1383.  
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2,2'',6,6''-Tetramethyl-[1,1':3',1''-terphenyl]-4'-ol (SM9) 
A solution of 2,4-dibromophenol (freshly sublimed, 3.80 g, 15.1 mmol) in THF 
(10 ml) was added dropwise to a mixture of sodium hydride (Aldrich, 95%, dry, 0.518 
g, 21.6 mmol) and THF (38 ml) at 0 °C, followed by stirring at 22 °C for 10 minutes. 
Pd(OAc)2 (0.277 g, 1.23 mmol, 8.17 mol %) was added, followed by 2,6-dimethyl-
phenylmagnesium bromide (Aldrich, 1.0 M, THF, 40 ml), and the resulting mixture 
was refluxed for 12 h. Upon cooling to 0 °C, H2O and then HCl (2 M, aq.) were 
added, and the resulting mixture was filtered through a pad of celite. The resulting 
phases were separated and the aqueous phase extracted with Et2O (2x). The combined 
organic layers were washed with brine, dried with sodium sulfate, filtered and 
concentrated under reduced pressure. The residue was purified via flash column chro-
matography to give SM9 (3.17 g, 70%) as a thick yellow oil. 1H NMR (400 MHz, 
CDCl3): δ 7.29–7.12 (m, 8H), 6.85 (t, J = 1.3 Hz, 1H), 4.68 (s, 1H), 2.16 (s, 6H), 2.15 
(s, 6H). 13C NMR (101 MHz, CDCl3): δ 151.2, 141.6, 137.9, 136.5, 134.8, 133.6, 
130.4, 129.8, 128.5, 128.1, 127.4, 127.0, 126.5, 115.4, 21.1, 20.4. IR (neat, cm-1): 
3486, 2917, 1463, 1219, 1161, 828, 768. HRMS (ESI) m/z calculated for C22H22NaO+ 
(M + Na+) 325.1563, found 325.1563. 
 
4'-Hydroxy-2,2'',6,6''-tetramethyl-[1,1':3',1''-terphenyl]-5'-carbaldehyde (SM10)  
Methylmagnesium bromide (Acros, 3 M, Et2O, 4.0 ml, 12.0 mmol) is added 
slowly to 2,2'',6,6''-tetramethyl-[1,1':3',1''-terphenyl]-4'-ol (SM9, 2.80 g, 9.26 mmol) 
in THF (20 ml) at 0 °C. After warming to 22 °C, toluene (39 ml), triethylamine (1.60 
g, 15.8 mmol) and paraformaldehyde (0.810 g, 27.0 mmol) were added, and the 
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resulting reaction mixture stirred at 80 °C for 12 h. After cooling to 0 °C, H2O and 
then HCl (2 M, aq.) were added, and the resulting phases were separated. The aqueous 
phase was extracted with Et2O (2x). The combined organic layers were washed with 
brine, dried with sodium sulfate, filtered and concentrated under reduced pressure. The 
residue was purified via flash column chromatography followed by recrystallization 
from methanol to afford SM10 (1.90 g, 62%) as a colorless solid. MP 111–112 °C 
(methanol). 1H NMR (400 MHz, CDCl3): δ 11.16 (s, 1H), 9.98 (s, 1H), 7.41 (d, J = 
2.1 Hz, 1H), 7.23–7.13 (m, 7H), 2.12 (s, 12H). 13C NMR (101 MHz, CDCl3): δ 196.9, 
157.6, 139.9, 139.44, 139.44, 136.6, 136.4, 135.7, 133.3, 132.9, 130.2, 128.0, 127.7, 
127.5, 120.9, 21.1, 20.6. IR (neat, cm-1): 2917, 1651, 1451, 1266, 1197, 1082, 934, 
767. HRMS (ESI) m/z calculated for C23H23O2+ (M + H+) 331.1693, found 331.1688.  
3.5.2.3 Synthesis and Metallation of Salen-Compounds 
(R)-3,3''-(([1,1'-Binaphthalene]-2,2'-diylbis(azanylylidene))bis(methanylylidene))-
bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) ((R)-MesBinam, L1)  
2-Hydroxy-2',4',5,6'-tetramethyl-[1,1'-biphenyl]-3-carbaldehyde (SM8, 254 mg, 
0.999 mmol), (R)-[1,1'-binaphthalene]-2,2'-diamine (142 mg, 0.499 mmol) and 
methanol (8 ml) were mixed and then refluxed for 12 h. After allowing the reaction 
mixture to reach 22 °C, the resulting precipitate was isolated by filtration, washed with 
a small amount of cold methanol and then dried in vacuo at 70 °C to give L1 (289 mg, 
76%) as a powder of orange color. MP >200 °C. 1H NMR (300 MHz, CDCl3): δ 
11.91 (s, 2H), 8.26 (s, 2H), 7.99 (d, J = 8.7 Hz, 2H), 7.89 (d, J = 8.2 Hz, 2H), 7.41–
7.33 (m, 4H), 7.24–7.17 (m, 4H), 6.93 (s, 2H), 6.89 (m, 4H), 6.72 (d, J = 2.2 Hz, 2H), 
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2.31 (s, 6H), 2.25 (s, 6H), 2.04 (s, 6H), 1.87 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 
164.6, 155.8, 146.4, 136.8, 136.51, 136.45, 135.3, 134.2, 133.2, 132.3, 131.7, 130.2, 
128.6, 128.4, 128.2, 128.1, 127.5, 127.0, 126.9, 126.8, 125.5, 119.1, 118.7, 21.2, 
20.51, 20.46, 20.45. IR (neat, cm-1): 2917, 1582, 1451, 1260, 1181, 1110, 820, 745. 
HRMS (ESI) m/z calculated for C54H49N2O2+ (M + H+) 757.3789, found 757.3783. 
Specific rotation: [α]22D = -172.5 (c = 0.97, CHCl3).  
 
(R)-MesBinamAlCl (ML1, (R)-MesBinam = (R)-3,3''-(([1,1'-binaphthalene]-2,2'-diyl-
bis(azanylylidene))bis(methanylylidene))bis(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-
olate))  
Et2AlCl (Aldrich, 1.0 M, hexanes, 1.05 ml, 1.05 mmol) was added to a solution of 
(R)-3,3''-(([1,1'-binaphthalene]-2,2'-diylbis(azanylylidene))bis(methanylylidene))bis-
(2',4',5,6'-tetramethyl-[1,1'-biphenyl]-2-ol) ((R)-MesBinam, L1, 724 mg, 0.957 mmol) 
in DCM (12 ml) at 0 °C. The resulting solution was stirred at 22 °C for 12 h, followed 
by removal of volatiles in vacuo. The residue was suspended in boiling cyclohexane, 
and filtered through celite while still hot. The filtrate was allowed to slowly reach 22 
°C. The resulting precipitate was isolated by filtration, washed twice with pentane and 
subsequently dried in vacuo at 80 °C to give (R)-MesBinamAlCl (ML1, 394 mg, 
50%) as a bright yellow solid. MP >200 °C. 1H NMR (500 MHz, CDCl3, -55 °C): δ 
8.40 (s, 1H), 8.25 (s, 1H), 8.04 (d, J = 8.6 Hz, 1H), 7.98 (d, J = 8.2 Hz, 1H), 7.92 (d, J 
= 8.8 Hz, 2H), 7.62 (d, J = 8.6 Hz, 1H), 7.51 (dt, J = 9.9, 7.2 Hz, 2H), 7.42 (d, J = 8.6 
Hz, 1H), 7.32–7.26 (m, 2H), 7.14 (d, J = 8.5 Hz, 1H), 7.10 (s, 1H), 7.08–7.03 (m, 3H), 
6.98 (s, 1H), 6.96 (s, 1H), 6.92 (s, 1H), 6.86 (s, 1H), 6.79 (s, 1H), 2.47 (s, 3H), 2.39 (s, 
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3H), 2.19 (s, 3H), 2.15 (s, 3H), 2.06 (s, 3H), 1.93 (s, 3H), 1.89 (s, 3H), 1.65 (s, 3H). 
13C NMR (126 MHz, CDCl3, -55 °C): δ 174.0, 169.1, 163.3, 159.3, 144.2, 143.9, 
141.1, 139.9, 138.9, 137.6, 136.9, 135.8, 135.7, 135.2, 135.1, 133.9, 133.7, 132.7, 
132.5, 132.4, 132.3, 132.2, 131.91, 131.90, 129.99, 129.47, 128.5, 128.2, 127.9, 127.8, 
127.75, 127.6, 127.03, 126.97, 126.85, 126.5, 126.3, 126.23, 126.22, 126.19, 126.0, 
125.8, 125.5, 125.2, 119.0, 118.6, 21.7, 21.44, 21.35, 21.27, 20.5, 20.41, 20.36, 19.15. 
IR (neat, cm-1): 2916, 1551, 1456, 1218, 977, 821, 749. HRMS (ESI) m/z calculated 
for C54H46AlN2O2+ (M - Cl)+ 781.3369, found 781.3375.  
Note: NMR spectra collected in CDCl3 at 22 °C displayed very broad resonances. 
 
[(R)-MesBinamAl]+[Co(CO)4]- ((R)-6b, (R)-MesBinam = (R)-3,3''-(([1,1'-
binaphthalene]-2,2'-diylbis(azanylylidene))bis(methanylylidene))bis(2',4',5,6'-tetra-
methyl-[1,1'-biphenyl]-2-olate)) 
NaCo(CO)4 (17.8 mg, 91.8 µmol), (R)-MesBinamAlCl (ML1, 75.0 mg, 91.8 
µmol) and THF (4 ml) were mixed and stirred for 12 h at 22 °C. The reaction mixture 
was filtered through a 0.45 µm teflon syringe filter, carefully layered with hexane and 
then placed in a freezer at -34 °C for two days to give brown crystals of (R)-6b. A 
yield could not be obtained due to the unknown solvation state of (R)-6b upon 
isolation and drying in vacuo. 1H NMR (300 MHz, C6D6 + THF-d8): δ 8.00 (s, 4H), 
7.64 (d, J = 8.0 Hz, 4H), 7.12–7.02 (m, 6H), 6.96–6.91 (m, 2H), 6.88 (s, 2H), 6.66 (s, 
2H), 6.53 (s, 2H), 2.29 (s, 6H), 1.92 (s, 6H), 1.86 (s, 6H), 1.79 (s, 6H). 13C NMR (126 
MHz, THF-d8): δ 173.2, 161.5, 146.8, 141.0, 138.8, 137.5, 135.9, 135.7, 134.2, 133.4, 
133.3, 132.9, 131.6, 129.5, 129.2, 128.8, 128.0, 127.7, 127.5, 127.4, 126.9, 123.3, 
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120.7, 22.4, 21.2, 20.4, 20.3. IR (neat, cm-1): 2916, 1878 ν(C=O), 1616, 1588, 1551, 
1440, 1218, 822. 
Neither MS nor elemental analysis could be obtained to a satisfactory degree due to 
the unknown solvation state of (R)-6b in isolated form. 
 
(R)-5',5''''-((1E,1'E)-([1,1'-Binaphthalene]-2,2'-diylbis(azanylylidene))-
bis(methanylylidene))bis(2,2'',6,6''tetramethyl-[1,1':3',1''-terphenyl]-4'-ol) ((R)-
Xyl2Binam, L2) 
4'-Hydroxy-2,2'',6,6''-tetramethyl-[1,1':3',1''-terphenyl]-5'-carbaldehyde (SM10, 
662 mg, 2.00 mmol), (R)-[1,1'-binaphthalene]-2,2'-diamine (285 mg, 1.00 mmol) and 
ethanol (14 ml) were mixed and then refluxed for 12 h. After allowing the reaction 
mixture to reach 22 °C, the resulting precipitate was isolated by filtration, washed with 
ethanol, then pentane, and then dried in vacuo at 70 °C. The obtained powder was 
dissolved in DCM, layered with hexane, and left standing open to the atmosphere until 
most of the solvent had evaporated. The resulting precipitate was isolated by filtration, 
washed with pentane, and then dried in vacuo at 70 °C to give L2 (596 mg, 66%) as a 
powder of orange color. MP 177 °C (decomp.). 1H NMR (400 MHz, CDCl3): δ 12.25 
(s, 2H), 8.45 (s, 2H), 7.99 (d, J = 8.8 Hz, 2H), 7.90 (d, J = 8.2 Hz, 2H), 7.47 (d, J = 8.8 
Hz, 2H), 7.40 (dt, J = 8.1, 3.9 Hz, 2H), 7.25 (d, J = 3.4 Hz, 4H), 7.16 (t, J = 7.4 Hz, 
2H), 7.11–7.05 (m, 6H), 7.00 (t, J = 7.8 Hz, 4H), 6.87 (d, J = 2.1 Hz, 2H), 6.82 (d, J = 
2.1 Hz, 2H), 2.03 (s, 6H), 1.96 (s, 6H), 1.93 (s, 6H), 1.89 (s, 6H). 13C NMR (101 
MHz, CDCl3): δ 163.7, 156.8, 145.3, 140.7, 137.0, 136.7, 136.6, 136.5, 136.4, 135.4, 
133.4, 132.4, 131.7, 131.3, 130.0, 129.0, 128.3, 127.7, 127.6, 127.4, 127.3, 127.2, 
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127.11, 127.10, 126.9, 126.7, 125.7, 119.2, 118.6, 21.1, 20.9, 20.46, 20.46. IR (neat, 
cm-1): 2915, 1580, 1447, 1195, 971, 765, 744. HRMS (ESI) m/z calculated for 
C66H57N2O2+ (M + H+) 909.4415, found 909.4410. Specific rotation: [α]22D = -352.1 
(c = 0.45, CHCl3).  
 
(R)-Xyl2BinamAlCl (ML2, (R)-Xyl2Binam = (R)-5',5''''-((1E,1'E)-([1,1'-
binaphthalene]-2,2'-diylbis(azanylylidene))bis(methanylylidene))bis(2,2'',6,6''-
tetramethyl-[1,1':3',1''-terphenyl]-4'-olate) 
Et2AlCl (Aldrich, hexanes, 1.0 M, 400 µl, 0.400 mmol) was added to a solution of 
(R)-5',5''''-((1E,1'E)-([1,1'-binaphthalene]-2,2'-diylbis(azanylylidene))bis(methanylyli-
dene))bis(2,2'',6,6''tetramethyl-[1,1':3',1''-terphenyl]-4'-ol) ((R)-Xyl2Binam, L2, 327 
mg, 0.360 mmol) in DCM (2 ml) at 0 °C. The reaction mixture was stirred at 22 °C for 
12 h, and the resulting precipitate was isolated by filtration, washed with a small 
amount of DCM, and subsequently dried in vacuo at 80 °C to give (R)-
Xyl2BinamAlCl (ML2, 172 mg, 49%) as a bright yellow solid. MP >200 °C. 1H 
NMR (500 MHz, CDCl3, -55 °C): δ 8.49 (s, 1H), 8.29 (s, 1H), 8.13 (d, J = 8.6 Hz, 
1H), 8.06–8.01 (m, 3H), 7.73 (d, J = 8.6 Hz, 1H), 7.58–7.52 (m, 3H), 7.37–7.28 (m, 
4H), 7.20–7.03 (m, 14H), 6.99 (d, J = 2.3 Hz, 1H), 6.95 (d, J = 2.3 Hz, 1H), 2.13 (s, 
3H), 2.09 (s, 3H), 2.06 (s, 3H), 2.05 (s, 3H), 2.01 (s, 3H), 2.00 (s, 3H), 1.97 (s, 3H), 
1.72 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 174.9, 169.5, 163.9, 160.1, 144.3, 144.2, 
140.56, 140.56, 140.27, 140.25, 139.5, 139.1, 137.9, 137.6, 136.9, 136.79, 136.78, 
136.7, 136.4, 135.7, 134.1, 133.31, 133.31, 133.17, 133.17, 132.64, 132.63, 132.3, 
132.1, 132.03, 132.00, 130.3, 129.9, 129.8, 129.1, 128.6, 127.9, 127.5, 127.3, 127.23, 
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127.17, 127.08, 127.05, 126.97, 126.95, 126.94, 126.86, 126.8, 126.53, 126.53, 126.4, 
126.24, 126.19, 126.07, 126.07, 125.3, 119.4, 119.1, 21.74, 21.69, 21.5, 21.33, 21.25, 
21.2, 20.8, 19.1. IR (neat, cm-1): 2917, 1543, 1439, 1279, 1192, 1137, 881, 769, 746. 
HRMS (ESI) m/z calculated for C66H54AlN2O2+ (M - Cl)+ 933.3995, found 933.4019.  
Note: NMR spectra collected in CDCl3 at 22 °C displayed very broad resonances. 
3.5.2.4 Carbonylative Desymmetrization of Meso Epoxides Using Catalyst (R)-6b 
(3R,4R)-3,4-Dimethyloxetan-2-one (5b) 
General procedure B was followed using (R)-ML1 (0.025 M, THF, 400 µl, 0.010 
mmol, 2.5 mol %), NaCo(CO)4 (0.0250 M, THF, 400 µl, 0.010 mmol, 2.5 mol %) and 
meso (2R,3S)-2,3-dimethyloxirane (28.7 mg, 0.398 mmol). The reaction mixture was 
stirred for 24 h at 22 °C. The volatility of 5b interfered with its quantitative isolation, 
thus the yield of the reaction was determined using the method of standard addition. 
To this end, the crude reaction mixture was filtered through a short plug of silica gel 
using THF as eluent. The eluate was placed in a volumetric flask and diluted with 
THF to a total volume of 5 ml. A 0.5 ml aliquot of this solution was then analyzed via 
GC analysis. Additional 0.5 ml aliquots from this stock solution were subsequently 
treated with increasing amounts of independently isolated 5b, and the resulting 
mixtures also analyzed via GC analysis. The observed increase in signal for 5b was 
then used to determine tha the yield of 5b was approximately 37.8 mg (95%). 
Analytical data for 5b has previously been reported.14c 1H NMR (400 MHz, 
CDCl3): δ 4.35 (qd, J = 6.1, 4.0 Hz, 1H), 3.22 (qd, J = 7.5, 4.0 Hz, 1H), 1.56 (d, J = 
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6.3 Hz, 3H), 1.39 (d, J = 7.7 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 171.9, 76.2, 
52.3, 20.1, 12.4. Specific rotation: [α]22D = +43.7 (c = 0.22, CHCl3). 
The enantiomeric ratio (er) was determined to be 91.5 : 8.5 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. 
 
Stereochemical assignment of 5b: 
The stereochemical identity of 5b was determined by two methods. First, the 
specific rotation of 5b was compared under identical conditions to that reported in the 
literature for (3S,4S)-3,4-dimethyloxetan-2-one14c and found to be of the opposite sign. 
Second, a racemic mixture of trans-3,4-dimethyloxetan-2-one was kinetically resolved 
to enantiopure (3R,4R)-3,4-dimethyloxetan-2-one by adapting a published procedure51 
using Lipase PS and benzyl alcohol. The β-lactone isolated from this reaction was 
identical with 5b with regard to the sign of its specific rotation and its GC retention 
time. 
 
(3R,4R)-3,4-Diethyloxetan-2-one (5c) 
General procedure B was followed using (R)-ML1 (8.2 mg, 0.010 mmol, 3.9 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 3.91 mol %) and meso 
(2R,3S)-2,3-diethyloxirane37 (1.28 M, THF, 200 µl, 0.256 mmol). After stirring at 22 
°C for 24 h, the crude reaction mixture was subjected to bulb-to-bulb distillation to 
give 5c (23.0 mg, 70%) as a yellow oil. 1H NMR (400 MHz, CDCl3): δ 4.17 (td, J = 
6.6, 3.9 Hz, 1H), 3.12 (ddd, J = 8.5, 6.5, 4.0 Hz, 1H), 1.93–1.69 (m, 4H), 1.02 (t, J = 
7.5 Hz, 3H), 0.99 (t, J = 7.4 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 171.5, 78.8, 57.2, 
 192 
27.6, 21.2, 11.4, 9.2. IR (neat, cm-1): 2969, 2939, 2880, 1812, 1461, 1386, 1120, 1062, 
954. HRMS (ESI) m/z calculated for C7H13O2+ (M + H+) 129.0916, found 129.0922. 
Specific rotation: [α]22D = +19.9 (c = 0.26, CHCl3). 
The enantiomeric ratio (er) was determined to be 97.8 : 2.2 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. 
 
Stereochemical assignment of 5c: 
The stereochemical identity of 5c was determined by comparing the order of 
elution of the two enantiomers during GC analysis with that of 5b and 5a. 
 
(3R,4R)-3,4-Dipropyloxetan-2-one (5a) 
Using (R)-6b:  
General procedure B was followed using (R)-ML1 (14.3 mg, 0.0175 mmol, 7.00 
mol %), NaCo(CO)4 (0.100 M, THF, 175 µl, 0.018 mmol, 7.0 mol %) and meso 
(2R,3S)-2,3-dipropyloxirane38 (1.00 M, THF, 250 µl, 0.250 mmol). After stirring at 22 
°C for 24 h, the crude reaction mixture was subjected to bulb-to-bulb distillation to 
give 5a (30.1 mg, 77%) as a yellow oil. Analytical data for 5a has previously been 
reported.50 1H NMR (400 MHz, CDCl3): δ 4.22 (ddd, J = 7.4, 5.9, 4.0 Hz, 1H), 3.17 
(ddd, J = 8.8, 6.6, 4.0 Hz, 1H), 1.88–1.77 (m, 2H), 1.75–1.64 (m, 2H), 1.51–1.37 (m, 
4H), 0.97 (t, J = 7.4 Hz, 3H), 0.94 (t, J = 7.3 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 
171.7, 78.1, 56.1, 36.6, 30.1, 20.4, 18.5, 13.86, 13.86. Specific rotation: [α]22D = 
+19.1 (c = 0.77, CHCl3). 
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The enantiomeric ratio (er) was determined to be 96.9 : 3.1 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. 
Using (R)-6c:  
General procedure B was followed using (R)-ML2 (9.7 mg, 0.0100 mmol, 10 mol 
%), NaCo(CO)4 (1.00 M, THF, 100 µl, 0.0100 mmol, 10.0 mol %) and meso (2R,3S)-
2,3-dipropyloxirane38 (1.00 M, THF, 100 µl, 0.100 mmol). After stirring at 22 °C for 
24 h, the crude reaction mixture was subjected to bulb-to-bulb distillation to give 5a 
(11.9 mg, 76%) as a yellow oil. 
The enantiomeric ratio (er) was determined to be 98.6 : 1.4 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. 
 
Stereochemical assignment of 5a: 
The stereochemical identity of 5a was determined by comparing the specific 
rotation of 5a under identical conditions to that reported in the literature for (3R,4R)-
3,4-dipropyloxetan-2-one.50 The literature known compound and 5a displayed the 
same sign of rotation. 
 
(3R,4R)-3,4-Dibutyloxetan-2-one (5d) 
General procedure B was followed using (R)-ML1 (13.1 mg, 0.0160 mmol, 8.04 
mol %), NaCo(CO)4 (0.0800 M, THF, 200 µl, 0.016 mmol, 8.0 mol %) and meso 
(2R,3S)-2,3-dibutyloxirane7 (0.994 M, THF, 200 µl, 0.199 mmol). After stirring at 22 
°C for 24 h, the crude reaction mixture was subjected to bulb-to-bulb distillation to 
give 5d (26.7 mg, 72%) as a yellow oil. 1H NMR (400 MHz, CDCl3): δ 4.20 (ddd, J = 
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7.4, 6.0, 4.0 Hz, 1H), 3.15 (ddd, J = 8.7, 6.6, 3.9 Hz, 1H), 1.89–1.65 (m, 4H), 1.44–
1.29 (m, 8H), 0.91 (t, J = 7.0 Hz, 3H), 0.90 (t, J = 7.0 Hz, 3H). 13C NMR (75 MHz, 
CDCl3): δ 171.8, 78.3, 56.2, 34.2, 29.2, 27.7, 27.2, 22.50, 22.46, 14.0, 13.9. IR (neat, 
cm-1): 2957, 2931, 2861, 1817, 1466, 1125, 1064, 838. HRMS (ESI) m/z calculated 
for C11H21O2+ (M + H+) 185.1542, found 185.1543. Specific rotation: [α]22D = +21.1 
(c = 0.32, CHCl3). 
The enantiomeric ratio (er) was determined to be 95.9 : 4.1 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. 
 
Stereochemical assignment of 5d: 
The stereochemical identity of 5d was determined by comparing the order of 
elution of the two enantiomers during GC analysis with that of 5b and 5a. 
 
(3R,4R)-3,4-Bis(3-(2,2,2-trifluoroethoxy)propyl)oxetan-2-one (5e) 
General procedure B was followed using (R)-ML1 (25.5 mg, 0.0312 mmol, 12.5 
mol %), NaCo(CO)4 (0.0624 M, THF, 500 µl, 0.0312 mmol, 12.5 mol %) and meso 
2,3-bis(3-(2,2,2-trifluoroethoxy)propyl)oxirane (SM2, 80.4 mg, 0.248 mmol). After 
stirring at 33 °C for 24 h, the crude reaction mixture was subjected to flash column 
chromatography to give 5e (68.6 mg, 79%) as a yellow oil. 1H NMR (300 MHz, 
CDCl3): δ 4.29 (td, J = 6.6, 4.1 Hz, 1H), 3.81 (qd, J = 8.7, 2.5 Hz, 4H), 3.70–3.60 (m, 
4H), 3.25 (td, J = 7.6, 4.0 Hz, 1H), 1.98–1.65 (m, 8H). 13C NMR (75 MHz, CDCl3): δ 
171.1, 124.0 (q, J = 279.6 Hz), 77.7, 72.02, 71.95, 68.45 (q, J = 34.0 Hz), 68.44 (q, J = 
34.0 Hz), 55.9, 31.2, 27.0, 25.4, 24.7. Note: The two CF3-groups are 
 195 
pseudohomotopic, thus only one signal was observed. 19F NMR (376 MHz, CDCl3): δ 
-74.3 (td, J = 8.9, 2.6 Hz). IR (neat, cm-1): 2923, 2853, 1816, 1445, 1275, 1121, 966, 
826. HRMS (ESI) m/z calculated for C13H19F6O4+ (M + H+) 353.1182, found 
353.1197. Specific rotation: [α]22D = +21.2 (c = 0.32, CHCl3). 
The enantiomeric ratio (er) was determined to be 92.0 : 8.0 by GC analysis (b-
Dex225 column) in comparison to authentic racemic material. 
 
Stereochemical assignment of 5e: 
The stereochemical identity of 5e was determined by comparing the order of 
elution of the two enantiomers during GC analysis with that of 5b and 5a. 
3.5.2.5 Regiodivergent Carbonylation of cis-Epoxides Using Catalyst (R)-6b 
(2R,3R)-Methyl 3-hydroxy-2-methylpentanoate (10b)  
General procedure B was followed using (R)-ML1 (8.3 mg, 0.010 mmol, 5.0 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2S,3R)-
2-ethyl-3-methyloxirane (rac-7b, 0.998 M, THF, 200 µl, 0.200 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was treated with methanol (0.4 ml) and 
sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), stirred for 5 minutes at 22 °C and 
then concentrated under reduced pressure. The residue was subjected to flash column 
chromatography to give 10b (11.1 mg, 38%) as a yellow oil. Analytical data for this 
compound has previously been reported.52 1H NMR (400 MHz, CDCl3): δ 3.71 (s, 
3H), 3.59 (dtd, J = 8.5, 6.5, 3.9 Hz, 1H), 2.56 (d, J = 6.7 Hz, 1H), 2.55 (td, J = 7.2, 6.5 
Hz, 1H), 1.54 (dtt, J = 14.1, 7.5, 4.0 Hz, 1H), 1.47–1.36 (m, 1H), 1.21 (d, J = 7.2 Hz, 
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3H), 0.98 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 176.6, 74.8, 51.83, 
44.9, 27.7, 14.4, 9.9. Specific rotation: [α]22D = -3.7 (c = 0.17, CHCl3). 
The enantiomeric ratio (er) was determined to be 2.7 : 97.3 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
ester 10b was derivatized following general procedure C. 
 
Stereochemical assignment of 10b: 
The stereochemical identity of 10b was determined by comparing the specific 
rotation of 10b under identical conditions to that reported in the literature for (2R,3R)-
methyl 3-hydroxy-2-methylpentanoate.52 The literature known compound and 10b 
displayed the same sign of rotation. 
 
(2R,3R)-Methyl 3-hydroxy-2-methylhexanoate (10c)  
General procedure B was followed using (R)-ML1 (8.4 mg, 0.010 mmol, 5.1 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.08 mol %) and rac-(2R,3S)-
2-methyl-3-propyloxirane (rac-7c, THF, 0.983 M, 200 µl, 0.197 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was treated with methanol (0.4 ml) and 
sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), stirred for 5 minutes at 22 °C and 
then concentrated under reduced pressure. The residue was subjected to flash column 
chromatography to give 10c (10.1 mg, 32%) as a yellow oil. Analytical data for this 
compound has previously been reported.53 1H NMR (400 MHz, CDCl3): δ 3.71 (s, 
3H), 3.69–3.65 (m, 1H), 2.56–2.49 (m, 1H), 2.48 (broad s, 1H), 1.56–1.36 (m, 4H), 
1.21 (d, J = 7.2 Hz, 3H), 0.93 (t, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 
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176.6, 73.3, 51.9, 45.4, 37.1, 18.9, 14.5, 14.2. Specific rotation: [α]22D = -3.4 (c = 1.6, 
CHCl3). 
The enantiomeric ratio (er) was determined to be 2.9 : 97.1 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
ester 10c was derivatized following general procedure C. 
 
Stereochemical assignment of 10c: 
The stereochemical identity of 10c was determined by comparing the specific 
rotation of 10c under identical conditions to that reported in the literature for (2R,3R)-
methyl 3-hydroxy-2-methylhexanoate.53 The literature known compound and 10c 
displayed the same sign of rotation. 
 
(3R,4R)-3-Ethyl-4-propyloxetan-2-one (8f) and (3R,4R)-4-ethyl-3-propyloxetan-2-
one (9f) 
General procedure B was followed using (R)-ML1 (8.4 mg, 0.010 mmol, 5.1 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.08 mol %) and rac-(2R,3S)-
2-ethyl-3-propyloxirane42 (rac-7f, 0.985 M, THF, 200 µl, 0.197 mmol). After stirring 
at 22 °C for 18.5 h, the crude reaction mixture was subjected to bulb-to-bulb 
distillation to give a mixture of 8f and 9f (17.0 mg, 61%) as a yellow oil. Analytical 
data for 8f54 and 9f50 has previously been reported. 1H NMR (300 MHz, CDCl3): δ 
4.22 (ddd, J = 7.3, 6.1, 4.0 Hz, 1H, 8f), 4.15 (td, J = 6.6, 4.0 Hz, 1H, 9f), 3.20–3.09 
(m, 2), 1.94–1.62 (m, 8H), 1.51–1.35 (m, 4H), 1.01 (t, J = 7.6 Hz, 3H, 8f), 0.99 (t, J = 
7.5 Hz, 3H, 9f), 0.96 (t, J = 7.7 Hz, 3H, 8f), 0.93 (t, J = 7.4 Hz, 3H, 9f). 13C NMR (75 
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MHz, CDCl3): δ 171.7 (8f), 171.6 (9f), 79.3 (9f), 77.5 (8f), 57.6 (8f), 55.6 (9f), 36.6 
(8f), 30.0 (9f), 27.6 (9f), 21.1 (8f), 20.4 (9f), 18.5 (8f), 13.83 (8f), 13.83 (9f), 11.3 (8f), 
9.2 (9f). IR (neat, cm-1): 2964, 2936, 2877, 1814, 1463, 1383, 1124, 868, 821. HRMS 
(ESI) m/z calculated for C8H15O2+ (M + H+) 143.1067, found 143.1074. Specific 
rotation: [α]22D = +11.6 (c = 0.26, CHCl3). 
The enantiomeric ratio (er) was determined to be 98.0 : 2.0 for 8f, and 96.5 : 3.5 
for 9f by GC analysis (b-Dex120 column) in comparison to authentic racemic 
material. 
 
Stereochemical assignment of 8f and 9f: 
The stereochemical identity of 8f and 9f was determined by first identifying the 
main component in the corresponding racemic β-lactone mixture as racemic 9f based 
on previously reported data.50,54 As is explained for the carbonylation of rac-(2R,3S)-
2-butyl-3-methyloxirane (7a, vide infra), (R)-6b preferentially forms (3R,4R)-4-alkyl-
3-methyloxetan-2-one (8) and (3R,4R)-3-alkyl-4-methyloxetan-2-one (9). Assuming 
that this preference is not altered by substituting the methyl-group with an ethyl-group, 
and given that the elution profile of 8f and 9f in the GC trace resembles those of 8a-i 
and 9a-e (i.e. the major enantiomer elutes first for both regiosiomers), the major 
enantiomers of the two regioisomers should be (3R,4R)-3-ethyl-4-propyloxetan-2-one 
(8f) and (3R,4R)-4-ethyl-3-propyloxetan-2-one (9f). The sign of the specific rotation 
further supports this assignment, because it is identical to that of the mixtures of 8 and 
9 a-e. 
 
 199 
(2R,3R)-Methyl 3-hydroxy-2-methylheptanoate (10a)  
General procedure B was followed using (R)-ML1 (8.2 mg, 0.010 mmol, 5.0 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2R,3S)-
2-butyl-3-methyloxirane41 (rac-7a, 1.00 M, THF, 200 µl, 0.200 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was treated with methanol (0.4 ml) and 
sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), stirred for 5 minutes at 22 °C and 
then concentrated under reduced pressure. The residue was subjected to flash column 
chromatography to give 10a (12.5 mg, 36%) as a yellow oil. Analytical data for this 
compound has previously been reported.55 1H NMR (400 MHz, CDCl3): δ 3.71 (s, 
3H), 3.65 (ddd, J = 8.4, 6.3, 3.0 Hz, 1H), 2.56–2.49 (m, 1H), 2.49 (broad s, 1H). 1.52–
1.25 (m, 6H), 1.21 (d, J = 7.2 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, 
CDCl3): δ 176.6, 73.5, 51.9, 45.3, 34.6, 27.8, 22.8, 14.5, 14.2. Specific rotation: 
[α]22D = -2.7 (c = 0.19, CHCl3). 
The enantiomeric ratio (er) was determined to be 2.7 : 97.3 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
ester 10a was derivatized following general procedure C. 
 
Stereochemical assignment of 10a: 
The stereochemical identity of 10a was determined by comparing the specific 
rotation of 10a under identical conditions to that reported in the literature for (2R,3R)-
methyl 3-hydroxy-2-methylheptanoate.55 The literature known compound and 10a 
displayed the same sign of rotation. 
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(3R,4R)-4-Butyl-3-ethyloxetan-2-one (8g) and (3R,4R)-3-butyl-4-ethyloxetan-2-
one (9g)  
General procedure B was followed using (R)-ML1 (8.4 mg, 0.010 mmol, 5.0 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2R,3S)-
2-butyl-3-ethyloxirane43 (rac-7g, 1.00 M, THF, 200 µl, 0.200 mmol). After stirring at 
22 °C for 18.5 h, the crude reaction mixture was subjected to bulb-to-bulb distillation 
to give a mixture of 8g and 9g (22.8 mg, 73%) as a yellow oil. Analytical data for 
racemic 8g has previously been reported.56 1H NMR (300 MHz, CDCl3): δ 4.22–4.17 
(m, 1H, 8g), 4.17–4.11 (m, 1H, 9g), 3.17–3.07 (m, 2H), 1.92–1.62 (m, 8H), 1.44–1.26 
(m, 8H), 1.00 (t, J = 7.4 Hz, 3H), 0.98 (t, J = 7.5 Hz, 3H), 0.90–0.86 (m, 6H). 13C 
NMR (75 MHz, CDCl3): δ 171.6 (8g), 171.5 (9g), 79.2 (9g), 77.7 (8g), 57.5 (8g), 55.7 
(9g), 34.2 (8g), 29.2 (9g), 27.6 (9g), 27.5 (9g), 27.1 (8g), 22.41 (8g), 22.38 (9g), 21.1 
(8g), 13.9 (8g), 13.8 (9g), 11.3 (8g), 9.1 (9g). IR (neat, cm-1): 2960, 2993, 2863, 1816, 
1462, 1382, 1123, 851. HRMS (ESI) m/z calculated for C9H17O2+ (M + H+) 157.1223, 
found 157.1233. Specific rotation: [α]22D = +5.2 (c = 0.35, CHCl3). 
The enantiomeric ratio (er) was determined to be 98.6 : 1.4 for 8g, and 95.0 : 5.0 
for 9g by GC analysis (b-Dex225 column) in comparison to authentic racemic 
material. 
 
Stereochemical assignment of 8g and 9g: 
The stereochemical identity of 8g and 9g was determined by first identifying the 
main component in the corresponding racemic β-lactone mixture as racemic 9g based 
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on previously reported data.56 The identity of 8g and 9g was then further assigned 
based on the assignment made for 8f and 9f. 
 
(2R,3R)-Methyl 3-hydroxy-2-methyloctanoate (10d)  
General procedure B was followed using (R)-ML1 (8.4 mg, 0.010 mmol, 5.0 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2R,3S)-
2-methyl-3-pentyloxirane (rac-7d, 1.00 M, THF, 200 µl, 0.200 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was treated with methanol (0.4 ml) and 
sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), stirred for 5 minutes at 22 °C and 
then concentrated under reduced pressure. The residue was subjected to flash column 
chromatography to give 10d (12.9 mg, 34%) as a yellow oil. Analytical data for this 
compound has previously been reported.57 1H NMR (400 MHz, CDCl3): δ 3.71 (s, 
3H), 3.66 (dt, J = 6.6, 4.1 Hz, 1H), 2.57–2.50 (m, 1H), 2.48 (broad s, 1H), 1.52–1.25 
(m, 8H), 1.22 (d, J = 7.2 Hz, 3H), 0.91–0.87 (m, 3H). 13C NMR (126 MHz, CDCl3): δ 
176.6, 73.5, 51.8, 45.3, 34.8, 31.9, 25.3, 22.7, 14.5, 14.2. Specific rotation: [α]22D = -
6.1 (c = 0.20, CHCl3). 
The enantiomeric ratio (er) was determined to be 2.8 : 97.2 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
ester 10d was derivatized following general procedure C. 
 
Stereochemical assignment of 10d: 
The stereochemical identity of 10d was determined by comparing the specific 
rotation of 10d under identical conditions to that reported in the literature for (2R,3R)-
 202 
methyl 3-hydroxy-2-methyloctanoate.57 The literature known compound and 10d 
displayed the same sign of rotation. 
 
(2R,3R)-Methyl 3-hydroxy-2-methylnonanoate (10e)  
General procedure B was followed using (R)-ML1 (8.4 mg, 0.010 mmol, 5.0 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2R,3S)-
2-hexyl-3-methyloxirane (rac-7e, 0.991 M, THF, 200 µl, 0.198 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was treated with methanol (0.4 ml) and 
sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), stirred for 5 minutes at 22 °C and 
then concentrated under reduced pressure. The residue was subjected to flash column 
chromatography to give 10e (13.3 mg, 33%) as a yellow oil. Analytical data for this 
compound has previously been reported.58 1H NMR (400 MHz, CDCl3): δ 3.71 (s, 
3H), 3.65 (td, J = 7.2, 6.1, 2.8 Hz, 1H), 2.57–2.49 (m, 1H), 2.48 (broad s, 1H), 1.52–
1.24 (m, 10H), 1.21 (d, J = 7.3 Hz, 3H), 0.90–0.86 (m, 3H). 13C NMR (126 MHz, 
CDCl3): δ 176.7, 73.5, 51.9, 45.3, 34.9, 31.9, 29.4, 25.6, 22.8, 14.5, 14.2. Specific 
rotation: [α]22D = -1.5 (c = 0.20, CHCl3). 
The enantiomeric ratio (er) was determined to be 2.5 : 97.5 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
ester 10e was derivatized following general procedure C. 
 
Stereochemical assignment of 10e: 
The stereochemical identity of 10e was determined by comparing the specific 
rotation of 10e under identical conditions to that reported in the literature for (2R,3R)-
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methyl 3-hydroxy-2-methylnonanoate.58 The literature known compound and 10e 
displayed the same sign of rotation. 
 
(2R,3R)-Methyl 3-hydroxy-2,6-dimethylheptanoate (10h)  
General procedure B was followed using (R)-ML1 (8.3 mg, 0.010 mmol, 5.1 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.08 mol %) and rac-(2S,3R)-
2-isopentyl-3-methyloxirane (rac-7h, 0.983 M, THF, 200 µl, 0.197 mmol). After 
stirring at 22 °C for 20 h, the crude reaction mixture was treated with methanol (0.4 
ml) and sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), stirred for 5 minutes at 22 
°C and then concentrated under reduced pressure. The residue was subjected to flash 
column chromatography to give 10h (13.4 mg, 36%) as a yellow oil. 1H NMR (300 
MHz, CDCl3): δ 3.69 (s, 3H), 3.62 (ddd, J = 8.1, 6.3, 3.8 Hz, 1H), 2.53 (p, J = 7.0 Hz, 
1H), 2.50 (broad s, 1H), 1.60–1.16 (m, 5H), 1.19 (d, J = 7.2 Hz, 3H), 0.88 (d, J = 2.7 
Hz, 3H), 0.86 (d, J = 2.8 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 176.6, 73.7, 51.8, 
45.2, 34.7, 32.7, 28.1, 22.8, 22.5, 14.5. IR (neat, cm-1): 3458, 2953, 2870, 1720, 1460, 
1196, 1169, 1025. HRMS (ESI) m/z calculated for C10H20NaO3+ (M + Na+) 211.1305, 
found 211.1307. Specific rotation: [α]22D = -3.3 (c = 0.11, CHCl3). 
The enantiomeric ratio (er) was determined to be 3.1 : 96.9 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
ester 10h was derivatized following general procedure C. 
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Stereochemical assignment of 10h: 
The stereochemical identity of 10h was determined by comparing the order of 
elution of the two enantiomers during GC analysis with that of 10a-e. 
 
(2R,3R)-Methyl 6-((tert-butyldimethylsilyl)oxy)-3-hydroxy-2-methylhexanoate 
(10i)  
General procedure B was followed using (R)-ML1 (8.4 mg, 0.010 mmol, 5.1 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.05 mol %) and rac-tert-
butyldimethyl(3-((2S,3R)-3-methyloxiran-2-yl)propoxy)silane (rac-7i, 0.991 M, THF, 
200 µl, 0.198 mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was 
treated with methanol (0.4 ml) and sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), 
stirred for 5 minutes at 22 °C and then concentrated under reduced pressure. The 
residue was subjected to flash column chromatography to give 10i (20.0 mg, 35%) as 
a yellow oil. 1H NMR (300 MHz, CDCl3): δ 3.73–3.63 (m, 1H), 3.69 (s, 3H), 3.65 (t, 
J = 5.8 Hz, 2H), 3.13 (broad s, 1H), 2.54 (p, J = 7.1 Hz, 1H), 1.71–1.60 (m, 3H), 1.52–
1.39 (m, 1H), 1.18 (d, J = 7.1 Hz, 3H), 0.88 (s, 9H), 0.05 (s, 6H). 13C NMR (75 MHz, 
CDCl3): δ 176.4, 73.1, 63.3, 51.8, 45.5, 31.6, 29.0, 26.1, 18.4, 14.1, -5.2. IR (neat, cm-
1): 2952, 2857, 1739, 1462, 1254, 1093, 833, 774. HRMS (ESI) m/z calculated for 
C14H31O4Si+ (M + H+) 291.1986, found 291.1991. Specific rotation: [α]22D = -5.9 (c = 
0.31, CHCl3). 
The enantiomeric ratio (er) was determined to be 3.6 : 96.4 by GC analysis (b-
Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
ester 10i was derivatized following general procedure C. 
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Stereochemical assignment of 10i: 
The stereochemical identity of 10i was determined by comparing the order of 
elution of the two enantiomers during GC analysis with that of 10a-e. 
3.5.2.6 Regiodivergent Carbonylation of cis-Epoxides Using Catalyst (R)-6c 
(3S,4S)-4-Ethyl-3-methyloxetan-2-one (ent-8b) and (3S,4S)-3-ethyl-4-methyl-
oxetan-2-one (ent-9b)  
General procedure B was followed using (S)-6c (9.8 mg, 0.010 mmol, 5.0 mol %), 
NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2R,3S)-2-
ethyl-3-methyloxirane (rac-7b, 0.998 M, THF, 200 µl, 0.200 mmol). After stirring at 
22 °C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb distillation to 
give a mixture of ent-8b and ent-9b (15.1 mg, 66%) as a yellow oil. Analytical data 
for ent-8b50 and ent-9b14c has previously been reported. 1H NMR (400 MHz, CDCl3): 
δ 4.41 (qd, J = 6.1, 4.0 Hz, 1H, ent-9b), 4.13 (td, J = 6.6, 4.0 Hz, 1H, ent-8b), 3.22 
(qd, J = 7.5, 4.0 Hz, 1H, ent-8b), 3.13 (ddd, J = 8.4, 6.7, 4.0 Hz, 1H, ent-9b), 1.98–
1.68 (m, 4H), 1.55 (d, J = 6.1 Hz, 3H, ent-9b), 1.39 (d, J = 7.5 Hz, 3H, ent-8b), 1.03 
(t, J = 7.5 Hz, 3H, ent-8b), 1.00 (t, J = 7.6 Hz, 3H, ent-9b). 13C NMR (126 MHz, 
CDCl3): δ 172.1 (ent-8b), 171.2 (ent-9b), 80.6 (ent-8b), 74.2 (ent-9b), 59.0 (ent-9b), 
50.4 (ent-8b), 27.3 (ent-8b), 21.0 (ent-9b), 20.4 (ent-9b), 12.7 (ent-8b), 11.2 (ent-9b), 
9.1 (ent-8b). Specific rotation: [α]22D = -16.0 (c = 0.23, CHCl3). 
The enantiomeric ratio (er) was determined to be 2.7 : 97.3 for ent-8b, and 4.5 : 
95.5 for ent-9b by GC analysis (b-Dex225 column) in comparison to authentic 
racemic material. 
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Stereochemical assignment of ent-8b and ent-9b: 
The stereochemical identity of ent-8b and ent-9b was determined by first 
identifying the main component in the corresponding racemic β-lactone mixture as 
racemic 8b based on previously reported data.14c,50 As is explained for the 
carbonylation of rac-(2R,3S)-2-butyl-3-methyloxirane (7a), (R)-6b preferentially 
forms (3R,4R)-4-alkyl-3-methyloxetan-2-one (8) and (3R,4R)-3-alkyl-4-methyloxetan-
2-one (9). Consequently, (S)-6b should preferentially form (3S,4S)-4-ethyl-3-
methyloxetan-2-one (ent-8b) and (3S,4S)-3-ethyl-4-methyloxetan-2-one (ent-9b). 
 
(3R,4R)-3-Methyl-4-propyloxetan-2-one (8c) and (3R,4R)-4-methyl-3-
propyloxetan-2-one (9c)  
General procedure B was followed using (R)-6c (9.7 mg, 0.010 mmol, 5.0 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2R,3S)-
2-methyl-3-propyloxirane (rac-7c, 0.997 M, THF, 200 µl, 0.199 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb distillation 
followed by flash column chromatography to give a mixture of 8c and 9c (19.0 mg, 
74%) as a yellow oil. Analytical data for 8c50 and 9c51 has previously been reported. 
1H NMR (300 MHz, CDCl3): δ 4.40 (qd, J = 6.1, 3.9 Hz, 1H, 9c), 4.18 (ddd, J = 7.3, 
6.2, 4.0 Hz, 1H, 8c), 3.26–3.14 (m, 2H), 1.90–1.65 (m, 4H), 1.55 (d, J = 6.1 Hz, 3H, 
9c), 1.50–1.34 (m, 4H), 1.38 (d, J = 7.5 Hz, 3H, 8c), 0.98 (t, J = 7.5 Hz, 3H, 8c), 0.95 
(t, J = 7.3 Hz, 3H, 9c). 13C NMR (126 MHz, CDCl3): δ 172.2 (8c), 171.4 (9c), 79.5 
(8c), 74.7 (9c), 57.5 (9c), 50.8 (8c), 36.2 (8c), 29.8 (9c), 20.4 (9c), 20.3 (9c), 18.5 (8c), 
13.80 (8c), 13.79 (9c), 12.6 (8c). Specific rotation: [α]22D = +9.9 (c = 0.29, CHCl3). 
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The enantiomeric ratio (er) was determined to be 97.2 : 2.8 for 8c, and 95.9 : 4.1 
for 9c by GC analysis (b-Dex120 column) in comparison to authentic racemic 
material. 
 
Stereochemical assignment of 8c and 9c: 
The stereochemical identity of 8c and 9c was determined by first identifying the 
main component in the corresponding racemic β-lactone mixture as racemic 8c based 
on previously reported data.50,51 As is explained for the carbonylation of rac-(2R,3S)-
2-butyl-3-methyloxirane (7a), (R)-6b preferentially forms (3R,4R)-4-alkyl-3-
methyloxetan-2-one (8) and (3R,4R)-3-alkyl-4-methyloxetan-2-one (9). Consequently, 
the major enantiomers of the two regioisomers should be (3R,4R)-3-methyl-4-
propyloxetan-2-one (8c) and (3R,4R)-4-methyl-3-propyloxetan-2-one (9c). 
 
(3R,4R)-3-Ethyl-4-propyloxetan-2-one (8f) and (3R,4R)-4-ethyl-3-propyloxetan-2-
one (9f)  
General procedure B was followed using (R)-6c (15.5 mg, 0.0160 mmol, 8.08 mol 
%), NaCo(CO)4 (0.0800 M, THF, 200 µl, 0.0160 mmol, 8.08 mol %) and rac-(2R,3S)-
2-ethyl-3-propyloxirane10 (rac-7f, 0.992 M, THF, 200 µl, 0.198 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb distillation 
followed by flash column chromatography to give a mixture of 8f and 9f (18.7 mg, 
66%) as a yellow oil. 
For analytical data and stereochemical assignment see the analogous reaction using 
catalyst (R)-6b in Section 3.5.2.5. 
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The enantiomeric ratio (er) was determined to be 99.2 : 0.8 for 8f, and 98.4 : 1.6 
for 9f by GC analysis (b-Dex120 column) in comparison to authentic racemic 
material. 
 
(3R,4R)-4-Butyl-3-methyloxetan-2-one (8a) and (3R,4R)-3-butyl-4-methyloxetan-
2-one (9a)  
General procedure B was followed using (R)-6c (9.7 mg, 0.010 mmol, 5.0 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.00 mol %) and rac-(2R,3S)-
2-butyl-3-methyloxirane9 (rac-7a, 1.00 M, THF, 200 µl, 0.200 mmol). After stirring at 
22 °C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb distillation 
followed by flash column chromatography to give a mixture of 8a and 9a (20.9 mg, 
73%) as a yellow oil. Analytical data for 8a50 has previously been reported. 1H NMR 
(300 MHz, CDCl3): δ 4.40 (qd, J = 6.1, 4.0 Hz, 1H, 9a), 4.17 (td, J = 6.7, 4.0 Hz, 1H, 
8a), 3.26–3.13 (m, 2H), 1.92–1.66 (m, 4H), 1.56 (d, J = 6.2 Hz, 3H, 9a), 1.48–1.31 
(m, 8H), 1.38 (d, J = 7.5 Hz, 3H, 8a), 0.95–0.89 (m, 6H). 13C NMR (75 MHz, 
CDCl3): δ 172.2 (8a), 171.5 (9a), 79.7 (8a), 74.7 (9a), 57.6 (9a), 50.8 (8a), 33.9 (8a), 
29.1 (9a), 27.5 (9a), 27.1 (8a), 22.43 (9a), 22.40 (8a), 20.4 (9a), 14.0 (8a), 13.9 (9a), 
12.6 (8a). IR (neat, cm-1): 2959, 2933, 2863, 1816, 1457, 1386, 1124, 828. HRMS 
(ES) m/z calculated for C8H14O2+ (M+) 142.0994, found 142.0990. Specific rotation: 
[α]22D = +15.4 (c = 0.28, CHCl3). 
The enantiomeric ratio (er) was determined to be 95.1 : 4.9 for 8a, and 95.6 : 4.4 
for 9a by GC analysis (b-Dex120 column) in comparison to authentic racemic 
material. 
 209 
 
Stereochemical assignment of 8a and 9a: 
The stereochemical identity of 8a and 9a was determined using a combination of 
1H NMR and GC analysis. First, rac-(2R,3S)-2-butyl-3-methyloxirane was 
carbonylated using [ClTPPAl(THF)2]+[Co(CO)4]- to give a corresponding racemic 
mixture of rac-8a and rac-9a. The major component in this β-lactone mixture was 
identified as rac-8a based on previously reported data.50 Consequently, the two main 
peaks in the GC trace below (b-Dex225 column) can be attributed to rac-8a, whereas 
the two minor peaks stem from rac-9a.  
 
Next, enantioenriched (2R,3S)-2-butyl-3-methyloxirane (7a) was carbonylated 
using (R)-6c, and the resulting β-lactone mixture analyzed by 1H NMR and GC (cf. 
Scheme 3.4). The main component was (3R,4R)-4-butyl-3-methyloxetan-2-one (8a), 
which allowed for identification of the main peak in the corresponding GC trace as 8a, 
and the minor peak as (3S,4S)-3-butyl-4-methyloxetan-2-one (ent-9a).  
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Carbonylation of enantioenriched 7a using (S)-6c yielded ent-9a as the main 
product and 8a as the minor component as can be seen in the following GC trace.  
 
In analogy, carbonylation of (2S,3R)-2-butyl-3-methyloxirane (ent-7a) using (R)-
6c should give (3R,4R)-3-butyl-4-methyloxetan-2-one (9a) as the major product and 
(3S,4S)-4-butyl-3-methyloxetan-2-one (ent-8a) as the minor product. Consequently, 
carbonylation of racemic 7a using (R)-6c should yield (3R,4R)-4-butyl-3-
methyloxetan-2-one (8a) and (3R,4R)-3-butyl-4-methyloxetan-2-one (9a) as the main 
products. Generally speaking, carbonylation of racemic cis-epoxides 7 using (R)-6c 
yields (3R,4R)-4-alkyl-3-methyloxetan-2-ones (8) and (3R,4R)-3-alkyl-4-
methyloxetan-2-ones (9) as the main products, and (3S,4S)-4-alkyl-3-methyloxetan-2-
ones (ent-8) and (3S,4S)-3-alkyl-4-methyloxetan-2-ones (ent-9) as the minor products. 
 
(3R,4R)-4-Butyl-3-ethyloxetan-2-one (8g) and (3R,4R)-3-butyl-4-ethyloxetan-2-
one (9g)  
General procedure B was followed using (R)-6c (15.5 mg, 0.0160 mmol, 8.00 mol 
%), NaCo(CO)4 (0.0800 M, THF, 200 µl, 0.0160 mmol, 8.00 mol %) and rac-(2R,3S)-
2-butyl-3-ethyloxirane43 (rac-7g, 1.00 M, THF, 200 µl, 0.200 mmol). After stirring at 
22 °C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb distillation 
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followed by flash column chromatography to give a mixture of 8g and 9g (21.0 mg, 
67%) as a yellow oil. 
For analytical data and stereochemical assignment see the analogous reaction using 
catalyst (R)-6b in Section 3.5.2.5. 
The enantiomeric ratio (er) was determined to be 98.2 : 1.8 for 8g, and 97.5 : 2.5 
for 9g by GC analysis (b-Dex225 column) in comparison to authentic racemic 
material. 
 
(3R,4R)-3-Methyl-4-pentyloxetan-2-one (8d) and (3R,4R)-4-methyl-3-pentyl-
oxetan-2-one (9d) 
General procedure B was followed using (R)-6c (15.5 mg, 0.0160 mmol, 8.04 mol 
%), NaCo(CO)4 (0.0800 M, THF, 200 µl, 0.0160 mmol, 8.04 mol %) and rac-(2R,3S)-
2-methyl-3-pentyloxirane (rac-7d, 0.993 M, THF, 200 µl, 0.199 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb distillation 
followed by flash column chromatography to give a mixture of 8d and 9d (22.2 mg, 
71%) as a yellow oil. Analytical data for racemic 8d59 has previously been reported. 
1H NMR (400 MHz, CDCl3): δ 4.40 (qd, J = 6.1, 3.9 Hz, 1H, 9d), 4.17 (td, J = 6.7, 
4.0 Hz, 1H, 8d), 3.22 (qd, J = 7.6, 4.0 Hz, 1H, 8d), 3.16 (ddd, J = 8.9, 6.5, 3.9 Hz, 1H, 
9d), 1.90–1.67 (m, 4H), 1.55 (d, J = 6.0 Hz, 3H), 1.49–1.25 (m, 12H), 1.38 (d, J = 7.5 
Hz, 3H), 0.91–0.87 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 172.2 (8d), 171.5 (9d), 
79.7 (8d), 74.8 (9d), 57.7 (9d), 50.8 (8d), 34.2 (8d), 31.50 (9d), 31.46 (8d), 27.7 (9d), 
26.6 (9d), 24.7 (8d), 22.54 (8d), 22.46 (9d), 20.4 (9d), 14.04 (9d), 14.02 (8d), 12.6 
(8d). IR (neat, cm-1): 2931, 2860, 1817, 1458, 1125, 863, 830. HRMS (ESI) m/z 
 212 
calculated for C9H17O2+ (M + H+) 157.1223, found 157.1220. Specific rotation: [α]22D 
= +10.5 (c = 0.34, CHCl3). 
The enantiomeric ratio (er) was determined to be 95.1 : 4.9 for 8d, and 96.1 : 3.9 
for 9d by GC analysis (b-Dex120 column) in comparison to authentic racemic 
material. 
 
Stereochemical assignment of 8d and 9d: 
The stereochemical identity of 8d and 9d was assigned in analogy to the 
procedure used for 8c and 9c. 
 
(3R,4R)-4-Hexyl-3-methyloxetan-2-one (8e) and (3R,4R)-3-hexyl-4-methyloxetan-
2-one (9e)  
General procedure B was followed using (R)-6c (9.7 mg, 0.010 mmol, 5.0 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.03 mol %) and rac-(2R,3S)-
2-hexyl-3-methyloxirane (rac-7e, 0.994 M, THF, 200 µl, 0.199 mmol). After stirring 
at 22 °C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb distillation 
followed by flash column chromatography to give a mixture of 8e and 9e (22.8 mg, 
67%) as a yellow oil. Analytical data for racemic 8e60 has previously been reported. 
1H NMR (300 MHz, CDCl3): δ 4.40 (qd, J = 6.1, 4.0 Hz, 1H, 9e), 4.17 (td, J = 6.6, 3.9 
Hz, 1H, 8e), 3.26–3.13 (m, 2H), 1.92–1.66 (m. 4H), 1.55 (d, J = 6.1 Hz, 3H), 1.47–
1.22 (m, 16H), 1.38 (d, J = 7.6 Hz, 3H), 0.90–0.86 (m, 6H). 13C NMR (75 MHz, 
CDCl3): δ 172.2 (8e), 171.5 (9e), 79.7 (8e), 74.7 (9e), 57.7 (9e), 50.8 (8e), 34.2 (8e), 
31.7 (8e), 31.6 (9e), 29.00 (9e), 28.96 (8e), 27.8 (9e), 26.9 (9e), 25.0 (8e), 22.60 (9e), 
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22.57 (8e), 20.4 (9e), 14.11 (9e), 14.11 (8e), 12.6 (8e). IR (neat, cm-1): 2929, 2858, 
1819, 1458, 1124, 828. HRMS (EI) m/z calculated for C10H18O2+ (M+) 170.1307, 
found 170.1311. Specific rotation: [α]22D = +12.4 (c = 0.35, CHCl3). 
The enantiomeric ratio (er) was determined to be 94.8 : 5.2 for 8e, and 96.0 : 4.0 
for 9e by GC analysis (b-Dex120 column) in comparison to authentic racemic 
material. 
 
Stereochemical assignment of 8e and 9e: 
The stereochemical identity of 8e and 9e was assigned in analogy to the procedure 
used for 8c and 9c. 
 
(3R,4R)-4-Isopentyl-3-methyloxetan-2-one (8h) and (3R,4R)-3-isopentyl-4-methyl-
oxetan-2-one (9h)  
General procedure B was followed using (R)-6c (9.7 mg, 0.010 mmol, 5.1 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.08 mol %) and rac-(2S,3R)-
2-isopentyl-3-methyloxirane (rac-7h, 0.983M, THF, 200 µl, 0.197 mmol). After 
stirring at 22 °C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb 
distillation followed by flash column chromatography to give a mixture of 8h and 9h 
(20.7 mg, 66%) as a yellow oil. 1H NMR (400 MHz, CDCl3): δ 4.40 (qd, J = 6.1, 3.9 
Hz, 1H, 9h), 4.15 (td, J = 6.7, 4.0 Hz, 1H, 8h), 3.21 (qd, J = 7.5, 4.0 Hz, 1H, 8h), 3.14 
(ddd, J = 8.9, 6.5, 3.9 Hz, 1H, 9h), 1.91–1.67 (m, 4H), 1.62–1.51 (m, 2H), 1.55 (d, J = 
6.2 Hz, 3H, 9h), 1.38 (d, J = 7.5 Hz, 3H, 8h), 1.36–1.28 (m, 2H), 1.27–1.16 (m, 2H), 
0.91 (d, J = 6.6 Hz, 6H, 9h), 0.90 (d, J = 6.6 Hz, 6H, 8h). 13C NMR (75 MHz, 
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CDCl3): δ 172.2 (8h), 171.5 (9h), 79.9 (8h), 74.7 (9h), 57.8 (9h), 50.8 (8h), 35.9 (9h), 
33.9 (8h), 32.2 (8h), 27.92 (9h), 27.86 (8h), 25.7 (9h), 22.51 (8h), 22.48 (8h), 22.45 
(9h), 22.45 (9h), 20.47 (9h), 12.7 (8h). IR (neat, cm-1): 2956, 2872, 1816, 1457, 1122, 
829. MS (ESI) m/z calculated for C9H17O2+ (M + H+) 157.1, found 157.1. Specific 
rotation: [α]22D = +10.0 (c = 0.22, CHCl3). 
The enantiomeric ratio (er) was determined to be 91.6 : 8.4 for 8h, and 95.4 : 4.6 
for 9h by GC analysis (b-Dex120 column) in comparison to authentic racemic 
material.  
 
Stereochemical assignment of 8h and 9h: 
The stereochemical identity of 8h and 9h was assigned in analogy to the 
procedure used for 8c and 9c. Regioisomer 8h was assumed to be the major 
regioisomer in the corresponding racemic β-lactone mixture in analogy to the 
observations made with 8a-e. 
 
(2R,3R)-Methyl 6-((tert-butyldimethylsilyl)oxy)-3-hydroxy-2-methylhexanoate 
(10i) and (R)-Methyl 5-((tert-butyldimethylsilyl)oxy)-2-((R)-1-hydroxyethyl)pen-
tanoate (11) 
General procedure B was followed using (R)-6c (9.7 mg, 0.010 mmol, 5.1 mol 
%), NaCo(CO)4 (0.0500 M, THF, 200 µl, 0.0100 mmol, 5.05 mol %) and rac-tert-
butyldimethyl(3-((2S,3R)-3-methyloxiran-2-yl)propoxy)silane (rac-7i, 0.991 M, THF, 
200 µl, 0.198 mmol). After stirring at 22 °C for 20 h, the crude reaction mixture was 
treated with methanol (0.4 ml) and sodium methoxide (ca. 14.0 mg, ca. 0.259 mmol), 
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stirred for 5 minutes at 22 °C and then concentrated under reduced pressure. The 
residue was subjected to flash column chromatography to give 10i (21.8 mg, 38%) and 
11 (23.0 mg, 40%) as two separate yellow oils.  
Analytical data and stereochemical assignment for 10i was given before when using 
catalyst (R)-6b in Section 3.5.2.5. 
The enantiomeric ratio (er) for 10i was determined to be 4.6 : 95.4 by GC analysis 
(b-Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
ester 10i was derivatized following general procedure C. 
 
Analytical data for 11: 
1H NMR (300 MHz, CDCl3): δ 3.92 (h, J = 6.4 Hz, 1H), 3.72 (s, 3H), 3.60 (t, J = 
6.2 Hz, 2H), 2.51 (d, J = 5.9 Hz, 1H), 2.40 (dt, J = 7.5, 6.4 Hz, 1H), 1.73–1.65 (m, 
2H), 1.56–1.46 (m, 2H), 1.23 (d, J = 6.3 Hz, 3H), 0.88 (s, 9H), 0.04 (s, 6H). 13C NMR 
(126 MHz, CDCl3): δ 176.1, 68.6, 62.7, 52.6, 51.7, 30.5, 26.1, 25.9, 21.7, 18.4, -5.2. 
IR (neat, cm-1): 3460, 2953, 2857, 1737, 1254, 1096, 833, 774. HRMS (ESI) m/z 
calculated for C14H30O4NaSi+ (M + Na+) 313.1806, found 313.1815. Specific 
rotation: [α]22D = -5.8 (c = 0.20, CHCl3). 
The enantiomeric ratio (er) for 11 was determined to be 96.9 : 3.1 by GC analysis 
(b-Dex120 column) in comparison to authentic racemic material. Prior to GC analysis, 
the TBS-protecting group was removed using two equivalents of para-toluenesulfonic 
acid monohydrate in THF at 60 °C for 2.5 hours to give the corresponding lactone, 3-
(1-hydroxyethyl)tetrahydro-2H-pyran-2-one. (1H NMR (300 MHz, CDCl3): δ 4.32 (t, 
J = 6.0 Hz, 2H), 4.07 (s, 1H), 4.04–3.92 (m, 1H), 2.40 (dt, J = 11.9, 8.0 Hz, 1H), 2.08 
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(dq, J = 13.8, 7.2 Hz, 1H), 1.99–1.69 (m, 2H), 1.59–1.48 (m, 1H), 1.24 (d, J = 6.5 Hz, 
3H). MS (ESI) m/z calculated for C7H13O2+ (M + H+) 145.1, found 145.1). This 
lactone was then derivatized following general procedure C and subjected to GC 
analysis. 
 
Stereochemical assignment of 11: 
The stereochemical identity of 11 was assigned based on the observation that (R)-
6b preferentially forms (3R,4R)-3-alkyl-4-methyloxetan-2-ones (9). Since (3R,4R)-3-
(3-((tert-butyldimethylsilyl)oxy)propyl)-4-methyloxetan-2-one (9i) is the precursor to 
13 and stereochemistry is preserved in the ring-opening reaction using sodium 
methoxide, the product should be (R)-methyl 5-((tert-butyldimethylsilyl)oxy)-2-((R)-
1-hydroxyethyl)pentanoate (11). 
 
(2R,3R)-3-Hydroxy-2-methylnonanoic acid (12) 
(2R,3R)-Methyl 3-hydroxy-2-methylnonanoate (10e) was converted to 14 using a 
previously published method.61 Ester 10e (12 mg, 0.059 mmol) was dissolved in a 
mixture of THF, methanol and water (1:1:1, 0.9 ml), and lithium hydroxide 
monohydrate (13 mg, 0.31 mmol) was added. The mixture was stirred at 22 °C until 
no more starting material was detected by TLC. Water was added and the reaction 
mixture extracted with DCM once. The aqueous phase was acidified using 
hydrochloric acid (1 M, aq.), and then extracted with Et2O (3x). The organic phase 
was dried with sodium sulfate and subsequently concentrated under reduced pressure 
to give 12 as a colorless oil (10 mg, 90%). The analytical data matched that reported in 
 217 
the literature.61 1H NMR (300 MHz, CDCl3): δ 6.68 (broad s, 1H), 3.70 (m, 1H), 2.56 
(p, J = 7.1 Hz, 1H), 1.71–1.11 (m, 11H), 1.24 (d, J = 7.2 Hz, 3H), 0.96–0.81 (m, 3H). 
13C NMR (126 MHz, CDCl3): δ 181.2, 73.5, 45.4, 34.7, 31.9, 29.3, 25.5, 22.8, 14.4, 
14.2. 
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3.5.2.7 Crystallographic Data for Catalyst (R)-6b 
Table 3.6 Crystal data and structure refinement for catalyst (R)-6b 
Identification code (R)-6b 
Empirical formula C78H86AlCoN2O11 
Formula weight 1313.40 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group P2(1)2(1)2(1) 
Unit cell dimensions a = 11.5495(11) Å α = 90° 
 b = 21.268(2) Å β = 90° 
 c = 28.170(3) Å γ = 90° 
Volume 6919.5(12) Å3 
Z 4 
Density (calculated) 1.261 Mg/m3 
Absorption coefficient 0.323 mm-1 
F(000) 2784 
Crystal size 0.35 x 0.20 x 0.15 mm3 
Theta range for data collection 1.45 to 23.26° 
Index ranges -7<=h<=12, -19<=k<=23, -29<=l<=31 
Reflections collected 21630 
Independent reflections 9927 [R(int) = 0.0435] 
Completeness to theta = 23.26° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9532 and 0.8954 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9927 / 12 / 843 
Goodness-of-fit on F2  1.043 
Final R indices [I>2sigma(I)] R1 = 0.0677, wR2 = 0.1659 
R indices (all data) R1 = 0.0988, wR2 = 0.1836 
Absolute structure parameter 0.00(3) 
Largest diff. peak and hole 0.301 and -0.415 e.Å-3 
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Table 3.7 Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for catalyst (R)-6b 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
_____________________________________________________________________ 
 x y z U(eq) 
_____________________________________________________________________ 
Al(1) 724(1)  5441(1) -2037(1) 30(1) 
O(1) 148(3)  5973(2) -2481(1) 32(1) 
O(2) 1485(3) 4893(2) -1662(1) 33(1) 
O(3) 2236(3) 5842(2) -2186(1) 36(1) 
O(4) 942(3)  4807(2) -2540(1) 34(1) 
N(1) -925(4) 5146(2) -1913(2) 32(1) 
N(2) 507(4)  5990(2) -1461(2) 32(1) 
C(1) -1262(4) 4962(3) -1446(2) 34(1) 
C(2) -1320(5) 4320(3) -1319(2) 44(2) 
C(3) -1695(6) 4156(3) -871(2) 5 2(2) 
C(4) -1986(5) 4613(3) -532(2) 44(2) 
C(5) -2307(6) 4449(4) -71(3)  67(2) 
C(6) -2530(7) 4896(4) 269(3)  67(2) 
C(7) -2403(6) 5525(4) 146(3)  59(2) 
C(8) -2113(5) 5700(3) -298(2) 45(2) 
C(9) -1895(5) 5253(3) -662(2) 39(2) 
C(10) -1568(5) 5421(2) -1127(2) 33(1) 
C(11) -1552(5) 6102(3) -1281(2) 34(1) 
C(12) -2573(6) 6485(2) -1271(2) 41(1) 
C(13) -3685(5) 6225(3) -1205(2) 43(2) 
C(14) -4633(6) 6606(3) -1213(3) 56(2) 
C(15) -4535(7) 7249(3) -1288(3) 61(2) 
C(16) -3484(6) 7522(3) -1353(3) 56(2) 
C(17) -2472(6) 7139(3) -1350(2) 43(2) 
C(18) -1360(6) 7399(3) -1435(2) 50(2) 
C(19) -409(5) 7030(2) -1485(2) 39(2) 
C(20) -509(5) 6375(2) -1411(2) 37(1) 
C(21) -1777(5) 5222(2) -2210(2) 36(1) 
C(22) -1720(5) 5545(2) -2659(2) 33(1) 
C(23) -2676(5) 5532(3) -2957(2) 43(2) 
C(24) -2743(5) 5872(3) -3360(2) 43(2) 
C(25) -1778(6) 6238(2) -3477(2) 44(2) 
C(26) -795(5) 6284(2) -3197(2) 36(1) 
C(27) -761(5) 5936(2) -2767(2) 34(1) 
C(28) -3797(6) 5871(4) -3675(3) 58(2) 
C(29) 234(5)  6647(2) -3357(2) 37(2) 
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C(30) 599(6)  7205(2) -3120(2) 39(2) 
C(31) 1574(6) 7511(3) -3280(3) 51(2) 
C(32) 2216(6) 7309(3) -3656(3) 51(2) 
C(33) 1834(6) 6774(3) -3900(3) 54(2) 
C(34) 838(6)  6461(3) -3759(2) 44(2) 
C(35) -53(6)  7447(3) -2698(2) 46(2) 
C(36) 3337(7) 7633(4) -3798(3) 78(2) 
C(37) 474(6)  5899(3) -4055(2) 52(2) 
C(38) 1189(5) 5992(2) -1104(2) 33(1) 
C(39) 2159(5) 5567(3) -1036(2) 37(1) 
C(40) 2243(5) 5011(2) -1312(2) 33(1) 
C(41) 3127(5) 4585(3) -1205(2) 40(2) 
C(42) 3889(5) 4716(3) -840(3) 53(2) 
C(43) 3810(6) 5275(3) -557(2) 50(2) 
C(44) 2910(6) 5677(3) -668(2) 48(2) 
C(45) 4636(6) 5384(3) -155(3) 65(2) 
C(46) 3306(5) 3993(2) -1482(2) 37(2) 
C(47) 4254(5) 3895(3) -1778(2) 43(2) 
C(48) 4337(5) 3357(3) -2048(3) 51(2) 
C(49) 3529(6) 2869(3) -2016(3) 48(2) 
C(50) 2627(6) 2950(2) -1691(2) 43(2) 
C(51) 2474(5) 3495(2) -1433(2) 39(1) 
C(52) 5217(6) 4381(3) -1825(3) 62(2) 
C(53) 3645(7) 2278(3) -2305(3) 71(2) 
C(54) 1481(5) 3553(3) -1104(2) 45(2) 
C(55) 2399(7) 6508(3) -2306(3) 71(2) 
C(56) 3536(8) 6591(4) -2453(4) 106(4) 
C(57) 4056(7) 5954(4) -2537(4) 96(3) 
C(58) 3327(5) 5531(3) -2248(3) 53(2) 
C(59) 1173(6) 4910(3) -3036(2) 47(2) 
C(60) 1815(7) 4342(3) -3203(3) 63(2) 
C(61) 1398(13) 3843(4) -2867(4) 147(6) 
C(62) 961(7)  4132(2) -2454(3) 60(2) 
Co(1) 7533(1) 6396(1) 1570(1) 69(1) 
O(5) 9858(9) 5891(4) 1432(5) 214(6) 
O(6) 7194(7) 6207(2) 2574(2) 97(2) 
O(7) 7498(5) 7679(3) 1219(3) 96(2) 
O(8) 5713(8) 5682(4) 1109(3) 161(4) 
C(63) 8898(9) 6084(5) 1466(4) 119(4) 
C(64) 7335(8) 6308(3) 2169(3) 69(2) 
C(65) 7500(7) 7171(3) 1367(3) 70(2) 
C(66) 6479(10) 5957(5) 1285(3) 115(4) 
O(1S) 3495(9) 2080(4) -69(4)  177(5) 
C(1S) 4629(14) 2143(7) 68(7)  210(10) 
C(2S) 5039(9) 2757(6) 27(5)  121(4) 
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C(3S) 4097(11) 3028(5) -318(5) 122(4) 
C(4S) 3302(15) 2506(7) -370(6) 191(8) 
O(2S) 5856(17) 8130(4) 156(4)  182(5) 
C(5S) 4741(18) 7929(8) 21(7)  218(11) 
C(6S) 4808(14) 7275(10) 79(6)  178(8) 
C(7S) 5880(20) 7124(6) 127(8)  198(10) 
C(8S) 6539(13) 7681(16) 27(7)  227(12) 
O(3S) -6063(17) 5457(12) -4947(6) 302(10) 
C(9S) -5767(12) 4754(7) -4760(5) 143(5) 
C(10S) -6658(13) 4663(10) -4405(5) 160(6) 
C(11S) -6622(15) 5228(12) -4188(7) 179(8) 
C(12S) -6473(16) 5707(7) -4483(8) 182(9) 
_____________________________________________________________________
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Table 3.8 Bond lengths [Å] and angles [°] for catalyst (R)-6b 
_____________________________________________________________________
Al(1)-O(2)  1.802(4) 
Al(1)-O(1)  1.814(4) 
Al(1)-O(4)  1.971(4) 
Al(1)-O(3)  1.988(4) 
Al(1)-N(2)  2.015(5) 
Al(1)-N(1)  2.035(5) 
O(1)-C(27)  1.326(7) 
O(2)-C(40)  1.342(7) 
O(3)-C(58)  1.434(7) 
O(3)-C(55)  1.468(7) 
O(4)-C(59)  1.440(7) 
O(4)-C(62)  1.457(6) 
N(1)-C(21)  1.302(7) 
N(1)-C(1)  1.426(7) 
N(2)-C(38)  1.277(7) 
N(2)-C(20)  1.438(7) 
C(1)-C(10)  1.374(8) 
C(1)-C(2)  1.413(8) 
C(2)-C(3)  1.378(9) 
C(3)-C(4)  1.405(9) 
C(4)-C(5)  1.394(9) 
C(4)-C(9)  1.413(8) 
C(5)-C(6)  1.373(11) 
C(6)-C(7)  1.389(10) 
C(7)-C(8)  1.345(9) 
C(8)-C(9)  1.422(9) 
C(9)-C(10)  1.407(8) 
C(10)-C(11)  1.513(8) 
C(11)-C(20)  1.386(8) 
C(11)-C(12)  1.433(8) 
C(12)-C(17)  1.415(8) 
C(12)-C(13)  1.411(9) 
C(13)-C(14)  1.362(9) 
C(14)-C(15)  1.389(9) 
C(15)-C(16)  1.358(10) 
C(16)-C(17)  1.425(9) 
C(17)-C(18)  1.418(10) 
C(18)-C(19)  1.358(8) 
C(19)-C(20)  1.413(7) 
C(21)-C(22)  1.440(8) 
C(22)-C(27)  1.419(8) 
C(22)-C(23)  1.388(8) 
C(23)-C(24)  1.348(8) 
C(24)-C(25)  1.398(9) 
C(24)-C(28)  1.507(8) 
C(25)-C(26)  1.387(8) 
C(26)-C(27)  1.418(8) 
C(26)-C(29)  1.487(8) 
C(29)-C(34)  1.388(8) 
C(29)-C(30)  1.427(8) 
C(30)-C(31)  1.377(9) 
C(30)-C(35)  1.495(8) 
C(31)-C(32)  1.363(9) 
C(32)-C(33)  1.401(9) 
C(32)-C(36)  1.521(10) 
C(33)-C(34)  1.387(9) 
C(34)-C(37)  1.518(8) 
C(38)-C(39)  1.453(8) 
C(39)-C(44)  1.372(8) 
C(39)-C(40)  1.418(8) 
C(40)-C(41)  1.398(8) 
C(41)-C(42)  1.381(9) 
C(41)-C(46)  1.498(8) 
C(42)-C(43)  1.434(9) 
C(43)-C(44)  1.381(9) 
C(43)-C(45)  1.499(9) 
C(46)-C(47)  1.391(9) 
C(46)-C(51)  1.436(8) 
C(47)-C(48)  1.377(9) 
C(47)-C(52)  1.524(8) 
C(48)-C(49)  1.398(9) 
C(49)-C(50)  1.397(9) 
C(49)-C(53)  1.504(9) 
C(50)-C(51)  1.380(8) 
C(51)-C(54)  1.479(8) 
C(55)-C(56)  1.388(11) 
C(56)-C(57)  1.502(11) 
C(57)-C(58)  1.477(10) 
C(59)-C(60)  1.493(8) 
C(60)-C(61)  1.503(11) 
C(61)-C(62)  1.410(10) 
Co(1)-C(64)  1.714(8) 
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Co(1)-C(66)  1.732(9) 
Co(1)-C(63)  1.735(10) 
Co(1)-C(65)   1.746(7) 
O(5)-C(63)   1.187(10) 
O(6)-C(64)   1.171(8) 
O(7)-C(65)   1.156(7) 
O(8)-C(66)   1.170(9) 
O(1S)-C(4S)   1.260(12) 
O(1S)-C(1S)   1.372(14) 
C(1S)-C(2S)   1.394(14) 
C(2S)-C(3S)   1.569(16) 
C(3S)-C(4S)   1.448(16) 
O(2S)-C(8S)   1.29(2) 
O(2S)-C(5S)   1.41(2) 
C(5S)-C(6S)   1.40(2) 
C(6S)-C(7S)   1.29(2) 
C(7S)-C(8S)   1.43(3) 
O(3S)-C(9S)   1.62(2) 
O(3S)-C(12S)   1.49(2) 
C(9S)-C(10S)   1.448(17) 
C(10S)-C(11S)   1.35(2) 
C(11S)-C(12S)   1.33(2) 
 
O(2)-Al(1)-O(1)  170.8(2) 
O(2)-Al(1)-O(4)  85.26(17) 
O(1)-Al(1)-O(4)  88.68(17) 
O(2)-Al(1)-O(3)  88.48(16) 
O(1)-Al(1)-O(3)  84.73(16) 
O(4)-Al(1)-O(3)  91.66(17) 
O(2)-Al(1)-N(2)  87.93(18) 
O(1)-Al(1)-N(2)  98.51(18) 
O(4)-Al(1)-N(2)  172.29(18) 
O(3)-Al(1)-N(2)  91.77(17) 
O(2)-Al(1)-N(1)  99.02(18) 
O(1)-Al(1)-N(1)  88.12(18) 
O(4)-Al(1)-N(1)  91.85(17) 
O(3)-Al(1)-N(1)  171.96(17) 
N(2)-Al(1)-N(1)  85.65(19) 
C(27)-O(1)-Al(1)  132.3(3) 
C(40)-O(2)-Al(1)  128.8(3) 
C(58)-O(3)-C(55) 107.7(4) 
C(58)-O(3)-Al(1)  126.9(3) 
C(55)-O(3)-Al(1)  125.1(4) 
C(59)-O(4)-C(62) 108.0(4) 
C(59)-O(4)-Al(1)  128.1(3) 
C(62)-O(4)-Al(1)  123.7(4) 
C(21)-N(1)-C(1)  114.8(5) 
C(21)-N(1)-Al(1)  124.0(4) 
C(1)-N(1)-Al(1)  119.9(4) 
C(38)-N(2)-C(20) 115.1(5) 
C(38)-N(2)-Al(1)  124.0(4) 
C(20)-N(2)-Al(1)  120.7(4) 
C(10)-C(1)-N(1)  118.7(5) 
C(10)-C(1)-C(2)  120.5(6) 
N(1)-C(1)-C(2)  120.8(5) 
C(3)-C(2)-C(1)  119.5(6) 
C(2)-C(3)-C(4)  121.5(6) 
C(5)-C(4)-C(9)  120.2(6) 
C(5)-C(4)-C(3)  121.6(6) 
C(9)-C(4)-C(3)  118.1(6) 
C(6)-C(5)-C(4)  121.7(7) 
C(5)-C(6)-C(7)  118.2(7) 
C(8)-C(7)-C(6)  121.6(7) 
C(7)-C(8)-C(9)  122.0(6) 
C(4)-C(9)-C(10)  120.4(5) 
C(4)-C(9)-C(8)  116.3(6) 
C(10)-C(9)-C(8)  123.3(5) 
C(1)-C(10)-C(9)  119.9(5) 
C(1)-C(10)-C(11) 119.3(5) 
C(9)-C(10)-C(11) 120.8(5) 
C(20)-C(11)-C(12) 118.9(5) 
C(20)-C(11)-C(10) 119.2(5) 
C(12)-C(11)-C(10) 121.9(5) 
C(17)-C(12)-C(13) 118.8(6) 
C(17)-C(12)-C(11) 119.2(6) 
C(13)-C(12)-C(11) 122.0(5) 
C(14)-C(13)-C(12) 119.7(6) 
C(13)-C(14)-C(15) 121.6(7) 
C(16)-C(15)-C(14) 121.0(6) 
C(15)-C(16)-C(17) 119.2(6) 
C(18)-C(17)-C(12) 119.0(6) 
C(18)-C(17)-C(16) 121.3(5) 
C(12)-C(17)-C(16) 119.7(6) 
C(19)-C(18)-C(17) 121.7(6) 
C(20)-C(19)-C(18) 119.2(6) 
C(19)-C(20)-C(11) 121.5(5) 
C(19)-C(20)-N(2) 118.6(5) 
C(11)-C(20)-N(2) 119.9(5) 
N(1)-C(21)-C(22) 126.0(5) 
C(27)-C(22)-C(23) 120.1(5) 
C(27)-C(22)-C(21) 120.3(5) 
C(23)-C(22)-C(21) 119.1(5) 
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C(24)-C(23)-C(22) 123.0(6) 
C(23)-C(24)-C(25) 116.9(6) 
C(23)-C(24)-C(28) 122.8(6) 
C(25)-C(24)-C(28) 120.3(6) 
C(26)-C(25)-C(24) 123.8(6) 
C(25)-C(26)-C(27) 118.2(6) 
C(25)-C(26)-C(29) 121.2(5) 
C(27)-C(26)-C(29) 120.5(5) 
O(1)-C(27)-C(22) 121.5(5) 
O(1)-C(27)-C(26) 120.6(5) 
C(22)-C(27)-C(26) 117.9(5) 
C(34)-C(29)-C(30) 118.1(5) 
C(34)-C(29)-C(26) 120.1(5) 
C(30)-C(29)-C(26) 121.8(6) 
C(31)-C(30)-C(29) 118.8(6) 
C(31)-C(30)-C(35) 120.7(5) 
C(29)-C(30)-C(35) 120.6(5) 
C(30)-C(31)-C(32) 123.4(6) 
C(31)-C(32)-C(33) 117.9(6) 
C(31)-C(32)-C(36) 121.6(7) 
C(33)-C(32)-C(36) 120.5(7) 
C(34)-C(33)-C(32) 120.6(6) 
C(29)-C(34)-C(33) 121.0(6) 
C(29)-C(34)-C(37) 122.3(5) 
C(33)-C(34)-C(37) 116.7(6) 
N(2)-C(38)-C(39) 125.2(5) 
C(44)-C(39)-C(40) 120.9(5) 
C(44)-C(39)-C(38) 118.7(5) 
C(40)-C(39)-C(38) 120.0(5) 
O(2)-C(40)-C(41) 120.9(5) 
O(2)-C(40)-C(39) 121.0(5) 
C(41)-C(40)-C(39) 118.1(5) 
C(40)-C(41)-C(42) 119.8(6) 
C(40)-C(41)-C(46) 122.2(5) 
C(42)-C(41)-C(46) 118.0(5) 
C(41)-C(42)-C(43) 122.6(6) 
C(44)-C(43)-C(42) 115.8(6) 
C(44)-C(43)-C(45) 123.7(6) 
C(42)-C(43)-C(45) 120.4(6) 
C(43)-C(44)-C(39) 122.8(6) 
C(47)-C(46)-C(51) 118.3(5) 
C(47)-C(46)-C(41) 123.2(5) 
C(51)-C(46)-C(41) 118.5(5) 
C(46)-C(47)-C(48) 120.6(5) 
C(46)-C(47)-C(52) 121.6(5) 
C(48)-C(47)-C(52) 117.7(6) 
C(47)-C(48)-C(49) 122.3(6) 
C(50)-C(49)-C(48) 116.7(6) 
C(50)-C(49)-C(53) 121.5(6) 
C(48)-C(49)-C(53) 121.8(6) 
C(51)-C(50)-C(49) 122.9(5) 
C(50)-C(51)-C(46) 118.9(6) 
C(50)-C(51)-C(54) 119.9(5) 
C(46)-C(51)-C(54) 121.2(5) 
C(56)-C(55)-O(3) 108.2(6) 
C(55)-C(56)-C(57) 108.1(7) 
C(58)-C(57)-C(56) 103.6(6) 
O(3)-C(58)-C(57) 106.7(5) 
O(4)-C(59)-C(60) 105.9(5) 
C(61)-C(60)-C(59) 102.4(6) 
C(62)-C(61)-C(60) 109.1(6) 
C(61)-C(62)-O(4) 107.3(6) 
C(64)-Co(1)-C(66) 107.7(4) 
C(64)-Co(1)-C(63) 104.3(5) 
C(66)-Co(1)-C(63) 110.7(6) 
C(64)-Co(1)-C(65) 115.0(4) 
C(66)-Co(1)-C(65) 110.0(5) 
C(63)-Co(1)-C(65) 109.0(4) 
O(5)-C(63)-Co(1) 174.3(12) 
O(6)-C(64)-Co(1) 175.7(6) 
O(7)-C(65)-Co(1) 177.8(8) 
O(8)-C(66)-Co(1) 175.6(11) 
C(4S)-O(1S)-C(1S) 106.8(11) 
O(1S)-C(1S)-C(2S) 113.1(11) 
C(1S)-C(2S)-C(3S) 99.2(9) 
C(4S)-C(3S)-C(2S) 102.8(9) 
O(1S)-C(4S)-C(3S) 111.8(11) 
C(8S)-O(2S)-C(5S) 104.9(12) 
C(6S)-C(5S)-O(2S) 102.7(11) 
C(5S)-C(6S)-C(7S) 108.2(15) 
C(6S)-C(7S)-C(8S) 106.4(16) 
O(2S)-C(8S)-C(7S) 103.5(15) 
C(9S)-O(3S)-C(12S) 96.4(10) 
O(3S)-C(9S)-C(10S) 101.4(13) 
C(9S)-C(10S)-C(11S) 99.9(16) 
C(12S)-C(11S)-C(10S) 113.8(18) 
C(11S)-C(12S)-O(3S) 108.5(14) 
_________________________________ 
Symmetry transformations used to 
generate equivalent atoms. 
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Table 3.9 Anisotropic displacement parameters (Å2 x 103) for catalyst (R)-6b 
The anisotropic displacement factor exponent takes the form: -2π2 [h2 a*2U11 + ... + 2 
h k a* b* U12] 
_____________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
_____________________________________________________________________ 
Al(1) 26(1)  18(1) 47(1)  1(1) -1(1)  1(1) 
O(1) 27(2)  21(2) 47(2)  2(2) -5(2)  -1(2) 
O(2) 31(2)  18(2) 50(3)  3(2) -6(2)  0(2) 
O(3) 25(2)  23(2) 61(3)  7(2) 3(2)  -2(2) 
O(4) 37(2)  18(2) 48(2)  0(2) 3(2)  4(2) 
N(1) 35(3)  16(2) 46(3)  0(2) 1(3)  1(2) 
N(2) 26(3)  24(2) 45(3)  2(2) 1(2)  -2(2) 
C(1) 14(3)  36(3) 53(4)  7(3) 3(3)  0(2) 
C(2) 36(4)  27(3) 68(5)  8(3) 0(3)  -2(3) 
C(3) 49(4)  41(4) 65(5)  26(4) 3(4)  -1(3) 
C(4) 32(3)  47(4) 52(4)  22(3) 2(3)  11(3) 
C(5) 58(5)  73(5) 71(5)  39(4) 5(4)  17(4) 
C(6) 57(5)  84(6) 59(5)  25(4) 2(4)  12(5) 
C(7) 46(4)  77(5) 54(5)  1(4) -5(4)  11(4) 
C(8) 38(4)  48(4) 49(4)  9(3) -4(3)  6(3) 
C(9) 29(3)  43(3) 46(4)  11(3) 0(3)  3(3) 
C(10) 29(3)  29(3) 42(4)  3(3) 1(3)  8(3) 
C(11) 31(3)  33(3) 39(4)  4(2) 2(3)  -2(3) 
C(12) 42(4)  35(3) 45(4)  4(3) 1(3)  16(3) 
C(13) 23(3)  49(4) 57(4)  9(3) 4(3)  2(3) 
C(14) 29(4)  65(5) 74(5)  13(4) 5(3)  11(3) 
C(15) 47(5)  53(4) 83(6)  17(4) 8(4)  23(4) 
C(16) 50(5)  47(4) 71(5)  16(3) 18(4)  23(3) 
C(17) 44(4)  37(3) 49(4)  5(3) 5(3)  3(3) 
C(18) 66(5)  23(3) 62(5)  -1(3) 6(4)  17(3) 
C(19) 38(4)  22(3) 56(4)  4(3) -1(3)  -2(3) 
C(20) 41(4)  25(3) 43(4)  7(3) -4(3)  8(3) 
C(21) 27(3)  23(3) 56(4)  1(3) 3(3)  -2(2) 
C(22) 31(3)  16(3) 52(4)  -2(2) -3(3)  2(2) 
C(23) 38(4)  35(3) 55(4)  -2(3) -1(3)  6(3) 
C(24) 32(4)  41(3) 55(4)  -7(3) -6(3)  7(3) 
C(25) 58(4)  24(3) 48(4)  -3(3) -11(3)  11(3) 
C(26) 43(4)  18(3) 46(4)  2(2) 2(3)  5(3) 
C(27) 40(4)  21(3) 41(4)  -7(2) -5(3)  8(3) 
C(28) 32(4)  83(5) 60(5)  1(4) -14(3)  7(4) 
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C(29) 45(4)  19(3) 47(4)  5(3) -3(3)  1(2) 
C(30) 51(4)  21(3) 44(4)  9(3) 2(3)  4(3) 
C(31) 67(5)  23(3) 64(5)  4(3) -6(4)  -7(3) 
C(32) 46(4)  49(4) 59(5)  14(3) 4(4)  -11(3) 
C(33) 64(5)  41(4) 55(5)  0(3) 13(4)  1(3) 
C(34) 51(4)  31(3) 50(4)  3(3) 4(3)  -5(3) 
C(35) 49(4)  28(3) 61(5)  -3(3) -4(3)  6(3) 
C(36) 57(5)  80(5) 96(7)  11(5) 13(5)  -14(4) 
C(37) 58(5)  36(3) 63(5)  -8(3) 7(4)  -3(3) 
C(38) 29(3)  27(3) 44(4)  1(3) 0(3)  3(2) 
C(39) 24(3)  36(3) 50(4)  6(3) -4(3)  -6(3) 
C(40) 27(3)  20(3) 52(4)  9(2) 1(3)  0(2) 
C(41) 30(3)  28(3) 62(4)  5(3) -4(3)  -7(3) 
C(42) 31(4)  41(4) 88(5)  17(4) -15(4)  -8(3) 
C(43) 44(4)  35(3) 70(5)  9(3) -22(4)  -5(3) 
C(44) 45(4)  37(3) 61(4)  6(3) -11(3)  -4(3) 
C(45) 49(4)  53(4) 92(6)  13(4) -38(4)  -8(3) 
C(46) 22(3)  26(3) 63(4)  9(3) -12(3)  3(2) 
C(47) 20(3)  27(3) 81(5)  10(3) -4(3)  6(3) 
C(48) 29(3)  42(4) 83(5)  6(3) 5(4)  6(3) 
C(49) 47(4)  27(3) 70(5)  11(3) 0(4)  8(3) 
C(50) 39(4)  24(3) 66(4)  12(3) -1(4)  -6(3) 
C(51) 28(3)  25(3) 64(4)  8(3) -4(3)  -2(3) 
C(52) 32(4)  42(4) 112(6)  15(4) 5(4)  -7(3) 
C(53) 57(5)  41(4) 114(7)  -4(4) 22(5)  0(4) 
C(54) 37(4)  27(3) 71(5)  9(3) -1(3)  -3(3) 
C(55) 53(5)  29(3) 131(7)  13(4) 10(5)  -10(3) 
C(56) 64(6)  58(5) 198(11) 53(6) 34(7)  10(4) 
C(57) 42(5)  70(5) 176(10) 22(6) 45(6)  -4(4) 
C(58) 21(3)  47(4) 90(5)  8(4) 17(3)  8(3) 
C(59) 66(5)  28(3) 47(4)  4(3) 3(4)  2(3) 
C(60) 81(5)  42(4) 65(5)  -8(3) 25(4)  11(4) 
C(61) 291(17) 31(4) 118(8)  9(5) 118(10) 32(7) 
C(62) 89(6)  13(3) 77(5)  2(3) 15(4)  3(3) 
Co(1) 67(1)  56(1) 84(1)  -15(1) 27(1)  -17(1) 
O(5) 166(9)  116(6) 361(17) -6(8) 142(10) 68(6) 
O(6) 148(6)  58(3) 84(4)  -7(3) 21(4)  31(4) 
O(7) 64(4)  64(4) 159(6)  14(4) 4(4)  7(3) 
O(8) 177(8)  192(8) 114(6)  -46(6) 49(6)  -138(8) 
C(63) 135(10) 77(6) 144(10) -33(6) 67(8)  0(6) 
C(64) 81(6)  49(4) 78(6)  -16(4) 7(5)  8(4) 
C(65) 39(4)  60(5) 111(7)  0(4) 8(5)  2(4) 
C(66) 160(11) 101(7)84(7)  -29(6) 37(7)  -83(8) 
O(1S) 143(8)  110(6) 279(12) 105(7)-86(8)  -43(6) 
C(1S) 146(13) 135(12)350(30) 133(14)-141(16) -57(10) 
228 
C(2S) 88(8)  143(10)132(10) -51(8)24(7)  -13(8) 
C(3S) 127(10) 70(7) 171(12) 39(7) -4(9)  15(7) 
C(4S) 219(17) 129(11) 226(16) 104(12) -131(14) -57(11) 
O(2S) 299(18) 66(5) 183(10) -28(5) -36(12) -39(8) 
C(5S) 225(19) 125(11) 300(20) -133(14) -150(17)  127(13) 
C(6S) 102(11) 290(30) 141(13) -67(15) -2(10) -51(14) 
C(7S) 230(20) 76(8) 290(20) -20(10)-150(20) 14(11) 
C(8S) 86(11)  440(40) 154(15) -100(20) 25(10) -40(18) 
O(3S) 310(20) 400(20) 201(14) 114(16) 5(14) -148(19) 
C(9S) 113(10) 180(13) 134(11) -38(10) 36(9) -14(10) 
C(10S) 103(11) 270(20) 107(11) 12(12) 0(9) 15(13) 
C(11S) 118(12) 260(20) 159(17) -60(18) 10(11) 43(15) 
C(12S) 225(19) 101(10) 221(19) 14(11) 117(16) 94(11) 
_____________________________________________________________________
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Table 3.10 Hydrogen coordinates (x 104) and isotropic displacement parameters 
(Å2 x 103) for catalyst (R)-6b 
_____________________________________________________________________ 
 x  y  z  U(eq) 
_____________________________________________________________________ 
H(2A) -1102 4004 -1540 53 
H(3A) -1758 3723 -791 62 
H(5A) -2373 4017 10 81 
H(6A) -2765 4779 579 80 
H(7A) -2523 5839 380 71 
H(8A) -2052 6135 -369 54 
H(13A) -3773 5785 -1155 52 
H(14A) -5378 6428 -1166 67 
H(15A) -5213 7502 -1294 73 
H(16A) -3425 7963 -1401 67 
H(18A) -1279 7842 -1457 60 
H(19A) 316 7209 -1569 46 
H(21A) -2504 5047 -2123 43 
H(23A) -3313 5272 -2874 51 
H(25A) -1798 6469 -3766 52 
H(28A) -4388 5594 -3540 87 
H(28B) -3583 5720 -3992 87 
H(28C) -4105 6299 -3700 87 
H(31A) 1813 7882 -3120 62 
H(33A) 2261 6623 -4165 64 
H(35A) 475 7484 -2427 69 
H(35B) -679 7154 -2620 69 
H(35C) -380 7860 -2773 69 
H(36A) 3469 7997 -3592 117 
H(36B) 3282 7774 -4129 117 
H(36C) 3984 7338 -3766 117 
H(37A) -240 5720 -3925 78 
H(37B) 1087 5581 -4049 78 
H(37C) 340 6033 -4383 78 
H(38A) 1050 6296 -863 40 
H(42A) 4489 4423 -773 64 
H(44A) 2806 6044 -481 57 
H(45A) 4489 5798 -15 97 
H(45B) 5433 5368 -275 97 
H(45C) 4527 5058 86 97 
H(48A) 4966 3315 -2263 61 
H(50A) 2096 2614 -1646 52 
H(52A) 5047 4741 -1619 93 
230 
H(52B) 5268 4522 -2155 93 
H(52C) 5955 4192 -1729 93 
H(53A) 4050 1957 -2118 106 
H(53B) 4086 2368 -2594 106 
H(53C) 2873 2123 -2390 106 
H(54A) 981 3899 -1208 67 
H(54B) 1766 3638 -783 67 
H(54C) 1038 3160 -1104 67 
H(55A) 1860 6632 -2562 85 
H(55B) 2239 6773 -2024 85 
H(56A) 3980 6818 -2206 128 
H(56B) 3556 6842 -2749 128 
H(57A) 4020 5839 -2878 115 
H(57B) 4873 5941 -2431 115 
H(58A) 3218 5124 -2412 63 
H(58B) 3695 5451 -1937 63 
H(59A) 1648 5293 -3081 57 
H(59B) 440 4960 -3215 57 
H(60A) 1614 4238 -3536 75 
H(60B) 2662 4403 -3178 75 
H(61A) 782 3590 -3020 176 
H(61B) 2045 3559 -2783 176 
H(62A) 1463 4035 -2178 72 
H(62B) 170 3977 -2385 72 
H(1SA) 5116 1863 -130 252 
H(1SB) 4706 2005 402 252 
H(2SA) 5823 2772 -114 145 
H(2SB) 5042 2978 337 145 
H(3SA) 3707 3399 -178 147 
H(3SB) 4441 3148 -627 147 
H(4SA) 2499 2660 -331 230 
H(4SB) 3376 2329 -694 230 
H(5SA) 4139 8113 229 262 
H(5SB) 4572 8042 -313 262 
H(6SA) 4476 7061 -201 214 
H(6SB) 4365 7145 363 214 
H(7SA) 6092 6784 -97 237 
H(7SB) 6036 6978 455 237 
H(8SA) 7268 7688 212 272 
H(8SB) 6725 7711 -315 272 
H(9SA) -4983 4732 -4618 171 
H(9SB) -5829 4440 -5018 171 
H(10A) -6464 4317 -4184 192 
H(10B) -7424 4582 -4551 192 
H(11A) -7353 5291 -4011 215 
231 
H(11B) -5981 5227 -3954 215 
H(12A) -5896 6003 -4352 219 
H(12B) -7213 5935 -4527 219 
_____________________________________________________________________ 
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CHAPTER FOUR 
A Catalytic Route to Ampakines and Their Derivatives Using Hydroformylation 
 
 
 
 
 
Reprinted adapted with permission from Mulzer, M.; Coates, G. W. Org. Lett. 2011, 
13, 1426–1428. Copyright © 2011 by the American Chemical Society.
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4.1 Introduction 
Neurodegenerative diseases such as Alzheimer’s or Parkinson’s are on the rise 
globally and will lead to substantial financial and societal costs if effective treatments 
are not found in the near future.1 One promising therapy currently under investigation 
is the administration of ampakines.2 These compounds allow positive allosteric 
modulation of AMPA receptors and could help alleviate the symptoms of these 
diseases by restoring diminished glutamatergic neurotransmission.2b,d Important 
examples of ampakines are CX-5543 and CX-6144 (Figure 4.1), and their effects on 
cell receptors and potential medicinal applications are well documented. Structurally 
related to CX-614, 3-substituted-[1,2,3]-benzotriazinones (Figure 4.1) also show 
potential for the treatment of neurodegenerative diseases by modulating AMPA recep-
tors at nanomolar concentrations.5a 
O
O O
N
O
O
NNN
NR
O
O
3-substituted-[1,2,3]-
benzotriazinones
O
N
Me
O
n
n = 0: CX-554
n = 1: CX-614 precursor  
Figure 4.1 Examples of ampakines 
As part of research efforts focused on the use of carbon monoxide as a feedstock 
for the preparation of synthetically useful intermediates,6 our group recently reported 
the carbonylative ring-expansion of 2-substituted oxazolines to oxazinones7,8 and 
hydroformylation of 2-oxazolines to N-acylated aminoaldehydes.9 Based on these 
findings we proposed that the in situ generation of an aminoaldehyde moiety followed 
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by cyclization could produce the desired ampakine targets or synthetic precursors 
shown in Figure 4.1. This methodology would be very atom economical, as opposed 
to current synthetic routes, which use hard-to-obtain precursors,5 suffer from low 
yields,10 or require stoichiometric,11 toxic,12 or expensive13 reagents. In this report we 
describe a domino reaction14 that readily yields the desired ampakine framework while 
using simple starting materials and Co2(CO)8 as an inexpensive precatalyst. 
4.2 Reaction Development 
We hypothesized that a dihydrooxazine bearing an ortho-substituted phenol 
would give the desired ampakine structure following stepwise hydroformylation and 
cyclization. To test this theory, a model substrate was synthesized and subjected to 
hydroformylation conditions in the presence of catalytic amounts of Co2(CO)8 (Table 
4.1). Solvents of different polarities and Lewis-basicities were investigated as these 
parameters are crucial in related carbonylation reactions.15 Toluene proved to be the 
best solvent (entry 9), yielding the desired product in 81% isolated yield. Highly polar 
and completely non-polar solvents both impeded the reaction (entries 1-3). Benzene as 
solvent gave results similar to those obtained with toluene (entry 8), but was not 
pursued further due to its higher toxicity. Lowering the reaction temperature or the 
overall pressure decreased the yield (entries 10 and 11). Furthermore, adding 
molecular sieves (3Å) to the reaction mixture led to no improvement, suggesting that 
the water produced in the reaction has no deleterious effect. 
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Table 4.1 Influence of solvent, pressure, and temperaturea 
N
O
OH
Co2(CO)8 (4 mol %)
O
N
O
1a 2a
H2 / CO (1 : 1)
solvent
 
entry solvent pressure (psi) temperature (°C) isol. yield (%) 
1 DMF 1000 80 <1b 
2 MeCN 1000 80 <1b 
3 hexanes 1000 80 <1b 
4 THF 1000 80 50a 
5 MTBE 1000 80 58a 
6 EtOAc 1000 80 65a 
7 1,4-Dioxane 1000 80 70a 
8 benzene 1000 80 79a 
9 toluene 1000 80 81a 
10 toluene 1000 60 23b 
11 toluene 800 80 61b 
aReaction conditions: [1a] = 0.25 M, 20 h. Isolated yield for reactions carried out on a 0.5 mmol scale. 
bDetermined by 1H NMR spectroscopy. 
4.3 Scope of the Reaction 
Next, we subjected a variety of substituted dihydrooxazines to the optimized con-
ditions (Table 4.2). The introduction of either electron-withdrawing (entry 2) or 
electron-donating (entries 3, 4, 6, 7, 9, and 10) substituents onto the aryl-moiety of the 
dihydrooxazine decreased the isolated yield in comparison to the unsubstituted 
substrate (entry 1), despite complete consumption of the corresponding starting 
materials.16 The decrease in yield in entry 2 is consistent with observations made by 
Jia and coworkers for the carbonylative ring-expansion of aryl-substituted 2- 
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Table 4.2 Hydroformylation of substituted 2-aryl-dihydrooxazinesa 
N
O
OH O
N
O
Co2(CO)8 (4 mol %)
R1
R2
R3
R2
R1
R3
1b-k 2b-k
H2 / CO (1 : 1) 
(1000 psi)
toluene
 
entry R1 R2 R3 isol. product isol. yield (%) 
1 H H H 2a 81, 81b 
2 H H F 2b 65 
3 H H Me 2c 70, 73c 
4 H H OMe 2d 68, 87c 
5 H H Ph 2e 72c 
6 H Me H 2f 72c 
7 H OMe H 2g 43, 73c, 74d 
8 Br H H 2h 79 
9 H (-OCH2O-) 2i 76c 
10 H (-OCH2CH2O-) 2j 40, 71c 
11 H (-CH=CH-)2 2k 64, 80c 
aReaction conditions: [1] = 0.25 M, 80 °C, 20 h. Isolated yield for reactions carried out on a 0.5 mmol 
scale. b7.5 mmol scale. c[1] = 0.12 M, 0.4 mmol scale. d8 mol % Co2(CO)8, [1] = 0.12 M, 0.4 mmol 
scale. 
oxazolines.8 In entries 3, 4, 6, 7, 9, and 10 the electron-donating substituents should 
increase the nucleophilicity of the dihydrooxazine, which could facilitate initiation of 
unproductive ring-opening polymerization, a well-known reaction of oxazolines and 
oxazines.17 Initiation of polymerization requires the attack of a substrate molecule on 
an already activated substrate molecule (Scheme 4.1, path A: SN2 attack by 1a in the 
place of Co(CO)4-; and path B: attack by 1a at Co-acyl C).17a Consequently, we 
decided to decrease the overall substrate concentration to favor the desired hydrofor-
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mylation pathway. This modification of the reaction conditions led to a pronounced 
increase in yield for substrates with electron-donating substituents (entries 4, 6, and 
11), and furnished CX-5543 (entry 9), CX-6144 (entry 10) and the intermediate needed 
for the synthesis of benzotriazinones (entry 6) in good yield. Lastly, our methodology 
scales very well as can be seen in entry 1. Increasing the scale of the reaction by more 
than an order of magnitude had no impact on the quantity or quality of the product 2a. 
Table 4.3 Hydroformylation of alkylsubstituted 2-dihydrooxazines 
O
O
R3N
R2R1
N
O
OH
R1
R2
R3
1l-o 2l-o
Co2(CO)8 (4 mol %)
H2 / CO (1 : 1) 
(1000 psi)
toluene
 
entry R1 R2 R3 isol. product isol. yield (%)a drc 
1 Me H H 2l 66, 90b 1.6 : 1 
2 Ph H H 2m 80 2.9 : 1 
3 Me Me H 2n 93 - 
4 H H Me 2o 80 1.3 : 1 
aReaction conditions: [1] = 0.25 M, 80 °C, 20 h. Isolated yield for reactions carried out on a 0.5 mmol 
scale. b[1] = 0.12 M, 0.4 mmol scale. cDiastereomeric ratio (cis : trans). 
Modifications to the dihydrooxazine backbone were well tolerated (Table 4.3, 
entries 1-4).18 The observed diastereomeric ratios in favor of cis-configuration were 
relatively small, possibly due to the flexibility of the five-membered ring and the dis-
tance between the existing and the newly formed stereocenter. The position of the sub-
stituent had little effect on the ratio (entries 1 and 4), whereas changing the size of the 
substituent from methyl to phenyl roughly doubled the stereoselectivity (entries 1 and 
2). Furthermore, the diastereomeric ratios seem to be primarily kinetically controlled. 
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For example, in entry 1 the cis-isomer forms in 23% excess; a pure sample of this dia-
stereomer is recovered unchanged when resubjected to our hydroformylation 
conditions, but epimerizes to approximately a 1 : 1 mixture when exposed to p-to-
luenesulfonic acid at 40 °C. Consequently, the two diastereomers of a given substrate 
seemingly do not interconvert under our reaction conditions. Lastly, the cis-
configuration in the major isomer of 2m was confirmed crystallographically (Figure 
4.2), and presumably is analogous for the major isomers of products 2l and 2o. 
 
Figure 4.2 ORTEP-representation of 2m with thermal ellipsoids drawn at 50% 
probability 
Although our methodology turned out to be quite general as was seen in Table 4.2 
and Table 4.3, some substrates did not furnish the desired products when using 
standard reaction conditions. For example, 1p and 1q (Figure 4.3) both gave low 
conversions to a multitude of products. For these substrates, one may have hoped for 
clean conversion to an amido-aldehyde containing product analogous to that seen in  
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N
O
MeO
MeO
partial conversion 
to multiple products
for both substrates
N
O
1p 1q  
Figure 4.3 Substrates that were not amenable to hydroformylation reactions 
Equation 4.1,9 or a Friedel-Crafts-type reaction of the postulated intermediary acyl-
cobalt species C (Scheme 4.1). In addition, oxazolin 1r gave the expected product 3 
(equation 4.1),9 and no further ring-closing reaction was observed. 
Co2(CO)8 (4 mol %)N
O
OH OH
N
H
O
H
O
1r
(0.4 M)
3
H2 / CO (1 : 1) 
(1000 psi)
toluene
80 °C, 20 h
 
(4.1) 
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4.4 Proposed Catalytic Cycle 
Based on previous literature reports,7,8,13 we expect the first part of the domino 
reaction to proceed by the catalytic cycle depicted in Scheme 4.1. 
O
N
H
Ar
(CO)4Co-
CO
O
N
O
N
O
OH
Co2(CO)8
H2
O
N
H
Ar
O
N
H
O Co(CO)4
HCo(CO)4
Ar
H2
Ar N
H
O
O
initiation of 
polymerization
1a 1a
1a 2a
path A path B
(CO)4Co
+
initiation of 
polymerization
A
B
C
D
 
Scheme 4.1 Proposed catalytic cycle for the conversion of dihydrooxazine 1a to 2a 
First, activation of the dihydrooxazine 1a through protonation and subsequent 
ring-opening via an SN2-type pathway (A) should give rise to a transient cobalt-alkyl 
species B. Insertion of CO,19 followed by hydrogenolysis of the resulting cobalt-acyl 
intermediate C20,21 produces an N-acylaminoaldehyde D. The presence of the Brøn-
sted-acid HCo(CO)4 should then facilitate isomerization to the corresponding 
hemiaminal and subsequent formation of an iminium ion by loss of water. A fast se-
cond cyclization to the final product 2a is likely given the close vicinity of the phenol-
group to the iminium ion. 
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4.5 Conclusion 
In conclusion, we have developed an atom economical route to an important am-
pakine framework via hydroformylation of dihydrooxazines. Our methodology pro-
vides quick access to the pharmaceutically interesting compound CX-614 (Table 4.2, 
entry 10) and to a central building block for the synthesis of 3-substituted-[1,2,3]-
benzotriazinones (Table 4.2, entry 6). In both cases, the modular nature of the starting 
materials allows for the synthesis of a wide range of derivatives. 
4.6 Experimental Procedures  
4.6.1 General Considerations 
Unless stated otherwise all synthetic manipulations were carried out using 
standard Schlenk techniques under a nitrogen atmosphere or in an MBraun Unilab 
glovebox under an atmosphere of purified nitrogen. Reactions were carried out in 
oven-dried glassware cooled under vacuum. Anhydrous toluene, hexanes and 
tetrahydrofuran were purchased from Fischer Scientific and sparged vigorously with 
nitrogen for 40 minutes prior to first use. The solvents were further purified by passing 
them under nitrogen pressure through two packed columns of neutral alumina (tetra-
hydrofuran was also passed through a third column packed with activated 4Å 
molecular sieves) or through neutral alumina and copper(II) oxide (for toluene and 
hexanes). Chlorobenzene was distilled from phosphorus pentoxide and degassed via 
three freeze-pump-thaw cycles prior to use. All non-dried solvents used were reagent 
grade or better and used as received.  
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IR spectra were recorded on a Nicolet 380 FT-IR spectrometer. 1H NMR and 13C 
NMR spectra were recorded on a Varian 400 MHz instrument with shifts reported 
relative to the residual solvent peak. 19F NMR spectra were recorded on a Varian 400 
MHz instrument with shifts referenced to an external standard of neat CFCl3 (0 ppm). 
NMR solvents were purchased from Cambridge Isotope Laboratories and used as re-
ceived. 
Carbon monoxide (Matheson, 99.99% min. purity) and hydrogen (Airgas, 
99.999% min. purity) were used as received. Dicobalt octacarbonyl (Strem Chemicals, 
stabilized with 1-5% hexanes) was stored at –35 °C in a glove box freezer and used as 
received. Zinc chloride (Strem Chemicals, anhydrous) was stored in a glove box and 
used as received. All other chemicals were purchased from Aldrich or Alfa-Aesar and 
used as received. Flash column chromatography was performed with silica gel 
(particle size 40-64 µm, 230-400 mesh) using mixtures of ethyl acetate and hexanes as 
eluent unless stated otherwise. 
The starting materials 3-hydroxy-2-naphthonitrile,22 6-hydroxybenzo[d][1,3]di-
oxole-5-carbaldehyde,23 dihydro-2,3-formyl-7-hydroxy-6-benzodioxane-1,4,24 3-
amino-3-phenylpropan-1-ol,25 3-amino-3-methylbutanoic acid,26 3-amino-2-
methylpropan-1-ol,27 2-(5,6-dihydro-4H-1,3-oxazin-2-yl)phenol (1a),28 2-phenyl-5,6-
dihydro-4H-1,3-oxazine (1p),29 and 2-(4,5-dihydrooxazol-2-yl)phenol (1r)30 were 
prepared according to literature procedures. The following previously synthesized 
amino alcohols were obtained by reduction of the corresponding amino acids with 
lithium aluminum hydride according to a published procedure,4 and their analytical 
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data compared to that found in the literature: 3-aminobutan-1-ol31 and 3-amino-3-
methylbutan-1-ol.32 
4.6.2 Synthetic Procedures 
4.6.2.1 Preparation of 2-Hydroxybenzonitriles 
General Procedure A: Synthesis of 2-Hydroxybenzonitriles from the 
corresponding 2-Hydroxybenzaldehydes 
2-Hydroxybenzonitriles were synthesized from the corresponding 2-hydroxybenz-
aldehydes using a modified published procedure:33 A round-bottom flask was charged 
with the appropriate 2-hydroxybenzaldehyde (7.0 mmol), nitroethane (14.0 mmol), 
glacial acetic acid (1.5 ml) and anhydrous sodium acetate (14.0 mmol) and the 
resulting mixture was refluxed until TLC analysis indicated complete consumption of 
the 2-hydroxybenzaldehyde. Upon cooling the reaction mixture for five minutes water 
and ethyl acetate were added and the resulting layers separated. The aqueous layer was 
extracted two times with ethyl acetate and the combined organic layers were washed 
two times with saturated aqueous sodium bicarbonate solution, then with brine, then 
dried with sodium sulfate, filtered and concentrated under reduced pressure. The 
residue was then purified via flash column chromatography. 
Using this procedure the following 2-hydroxybenzonitriles were obtained and 
their analytical data compared to that found in the literature: 2-hydroxy-5-methyl-
benzonitrile,34 2-hydroxy-5-methoxybenzonitrile,35 2-hydroxy-4-methoxy-
benzonitrile,36 4-hydroxy-[1,1'-biphenyl]-3-carbonitrile.37 2-Hydroxy-4-methyl-
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benzonitrile contained an inseparable impurity after flash column chromatography and 
thus was used for the next reaction without further purification. 
 
5-Fluoro-2-hydroxybenzonitrile  
Lithium chloride (0.636 g, 15.0 mmol) was placed in a Schlenk flask and heated 
to 200 °C for 15 minutes under vacuum. Upon cooling to ambient temperature 5-
fluoro-2-methoxybenzonitrile (0.756 g, 5.00 mmol), a Teflon-coated magnetic stir bar 
and anhydrous DMSO (9 ml) were added to the flask and the resulting mixture stirred 
at 155 °C for 6 h. The reaction mixture was cooled to room temperature, water was 
added and the resulting layer extracted three times with ethyl acetate. The combined 
organic layers were washed with water and brine, dried with sodium sulfate, filtered 
and concentrated under reduced pressure to give a colorless solid. The analytical data 
of the product 5-fluoro-2-hydroxybenzonitrile (0.352 g, 25%) obtained after 
purification via flash column chromatography was in accordance with that found in 
the literature.38 
 
7-Hydroxy-2,3-dihydrobenzo[b][1,4]dioxine-6-carbonitrile  
Following general procedure A 5.53 g (30.7 mmol) dihydro-2,3-formyl-7-
hydroxy-6-benzodioxane-1,4, 4.5 ml (4.7 g, 63 mmol) nitroethane and 5.17 g (63.0 
mmol) sodium acetate were refluxed in 6.3 ml glacial acetic acid. After concentrating 
the organic layers under reduced pressure the residue was suspended in 
dichloromethane, filtered and washed with dichloromethane to afford the title 
compound as a faintly red solid (2.84 g, 52%, mp 210 °C (decomp.)). 1H NMR (d6-
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acetone): δ 7.01 (s, 1H), 6.49 (s, 1H), 4.33-4.30 (m, 2H), 4.23-4.21 (m, 2H). 13C NMR 
(d6-acetone): δ 155.8, 150.0, 138.4, 121.2, 117.3, 105.4, 93.0, 66.1, 65.0. IR (neat, cm-
1): 3312, 3082, 2951, 2219, 1595, 1513, 1432, 1291, 1193, 1061, 882, 843. HRMS 
(ESI) m/z calculated for C9H8NO3+ (M + H+) 178.0504, found 178.0506. 
 
6-Hydroxybenzo[d][1,3]dioxole-5-carbonitrile  
Following general procedure A 1.89 g (11.4 mmol) 6-hydroxyben-
zo[d][1,3]dioxole-5-carbaldehyde, 1.7 ml (1.8 g, 24 mmol) nitroethane and 1.94 g 
(23.6 mmol) sodium acetate were refluxed in 4 ml glacial acetic acid. After 
concentrating the organic layers under reduced pressure the residue was purified via 
flash column chromatography using mixtures of diethylether and n-pentane as eluent 
to afford the title compound as an orange-colored solid (0.666 g, 36%, mp 216 °C 
(decomp.)). 1H NMR (d6-acetone): δ 6.98 (s, 1H), 6.59 (s, 1H), 6.07 (s, 2H). 13C 
NMR (d6-acetone): δ 158.2, 153.7, 142.1, 117.5, 110.8, 103.5, 98.8, 91.3. IR (neat, 
cm-1): 3237, 2917, 1627, 1493, 1439, 1311, 1182, 1032, 928, 738. HRMS (ESI) m/z 
calculated for C8H6NO3+ (M + H+) 164.0348, found 164.0350. 
4.6.2.2 Preparation of Dihydrooxazines 
General Procedure B: Synthesis of Dihydrooxazines from the corresponding 2-
Hydroxybenzonitriles 
Dihydrooxazines were synthesized using a modified published procedure.39 A 
round-bottom flask was charged with the appropriate 2-hydroxybenzonitrile (10.0 
mmol), zinc chloride (1.0 mmol, 10 mol %) and the appropriate aminoalcohol (if solid, 
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15.8 mmol) in a glove box. Upon removal of the flask from the glove box 
chlorobenzene (30 ml) and the appropriate aminoalcohol (if liquid, 15.8 mmol) were 
added and the resulting mixture refluxed for 24-36 h. The reaction mixture was then 
cooled to ambient temperature and volatiles removed in vacuo. The resulting residue 
was dissolved in ethyl acetate and washed three times with water and the combined 
aqueous layers reextracted with ethyl acetate. The combined organic layers were 
washed with brine, dried with sodium sulfate, filtered and concentrated under reduced 
pressure. The resulting crude dihydrooxazine was then purified via flash column 
chromatography. 
2-(5,6-Dihydro-4H-1,3-oxazin-2-yl)-4-fluorophenol (1b)  
Following general procedure B using 155 mg (1.13 mmol) 5-fluoro-2-hydroxy-
benzonitrile, 16 mg (0.12 mmol, 10 mol %) ZnCl2, 0.16 ml (0.16 g, 2.1 mmol) 3-
aminopropan-1-ol and 4.5 ml chlorobenzene afforded the title compound as a colorless 
solid (172 mg, 78%, mp 34-35 °C). 1H NMR (CDCl3): δ 13.81 (s, 1H), 7.32 (dd, J = 
9.5 Hz, J = 3.2 Hz, 1H), 6.99 (ddd, J = 8.9 Hz, J = 8.1 Hz, J = 3.2 Hz, 1H), 6.84 (dd, J 
= 9.0 Hz, J = 4.7 Hz, 1H), 4.37 (t, J = 5.5 Hz, 2H), 3.58 (t, J = 5.9 Hz, 2H), 2.04-1.99 
(m, 2H). 13C NMR (CDCl3): δ 158.7 (d, J = 2.6 Hz), 157.1 (d, J = 1.6 Hz), 154.9 (d, J 
= 234.8 Hz), 119.5 (d, J = 23.4 Hz), 118.1 (d, J = 7.4 Hz), 114.8 (d, J = 7.8 Hz), 112.6 
(d, J = 24.5 Hz), 65.7, 41.1, 21.7. 19F NMR (CDCl3): δ -126.43. IR (neat, cm-1): 2938, 
2870, 1640, 1614, 1497, 1359, 1259, 1181, 1090, 965, 770. HRMS (ESI) m/z 
calculated for C10H11FNO2+ (M + H+) 196.0774, found 196.0774. 
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2-(5,6-Dihydro-4H-1,3-oxazin-2-yl)-4-methylphenol (1c)  
Following general procedure B using 450 mg (3.38 mmol) 2-hydroxy-5-methyl-
benzonitrile, 44 mg (0.32 mmol, 10 mol %) ZnCl2, 0.41 ml (0.41 g, 5.4 mmol) 3-
aminopropan-1-ol and 10 ml chlorobenzene afforded the title compound as a yellow 
solid (500 mg, 77%, mp 35-37 °C). 1H NMR (CDCl3): δ 13.90 (s, 1H), 7.45 (d, J = 
2.5 Hz, 1H), 7.09, (dd, J = 8.4 Hz, J = 2.5 Hz, 1H), 6.81 (d, J = 8.4 Hz, 1H), 4.36 (t, J 
= 5.5 Hz, 2H), 3.57 (t, J = 5.9 Hz, 2H), 2.24 (s, 3H), 2.03-1.97 (m, 2H). 13C NMR 
(CDCl3): δ 159.4, 158.8, 133.3, 126.8, 126.8, 117.0, 114.3, 65.5, 41.1, 21.8, 20.7. IR 
(neat, cm-1): 2942, 1638, 1493, 1357, 1257, 1194, 1100, 844, 764. HRMS (ESI) m/z 
calculated for C11H14NO2+ (M + H+) 192.1025, found 192.1026. 
 
2-(5,6-Dihydro-4H-1,3-oxazin-2-yl)-4-methoxyphenol (1d)  
Following general procedure B using 370 mg (2.48 mmol) 2-hydroxy-5-methoxy-
benzonitrile, 30 mg (0.22 mmol, 9 mol %) ZnCl2, 0.30 ml (0.30 g, 3.9 mmol) 3-
aminopropan-1-ol and 7.5 ml chlorobenzene afforded the title compound as an off-
white solid (424 mg, 83%, mp 70-71 °C). 1H NMR (CDCl3): δ 13.62 (s, 1H), 7.16 (d, 
J = 3.1 Hz, 1H), 6.90 (dd, J = 8.9 Hz, J = 3.1 Hz, 1H), 6.83 (d, J = 8.9 Hz, 1H), 4.37 
(t, J = 5.4 Hz, 2H), 3.74 (s, 3H), 3.58 (t, J = 5.9 Hz, 2H), 2.04-1.98 (m, 2H). 13C NMR 
(CDCl3): δ 159.1, 155.3, 151.4, 120.1, 118.0, 114.4, 110.3, 65.6, 56.1, 41.1, 21.8. IR 
(neat, cm-1): 2932, 1602, 1208, 1360, 1280, 1180, 1032, 817, 766. HRMS (ESI) m/z 
calculated for C11H14NO3+ (M + H+) 208.0974, found 208.0979. 
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3-(5,6-Dihydro-4H-1,3-oxazin-2-yl)-[1,1'-biphenyl]-4-ol (1e)  
Following general procedure B using 300 mg (1.54 mmol) 4-hydroxy-[1,1'-
biphenyl]-3-carbonitrile, 21 mg (0.15 mmol, 10 mol %) ZnCl2, 0.20 ml (0.20 g, 2.6 
mmol) 3-aminopropan-1-ol and 5 ml chlorobenzene afforded the title compound as an 
off-white solid (294 mg, 75%, mp 84-86 °C). 1H NMR (CDCl3): δ 14.26 (s, 1H), 7.94 
(d, J = 2.4 Hz, 1H), 7.56-7.53 (m, 3H), 7.41-7.37 (m, 2H), 7.27 (t, J = 7.4 Hz, 1H), 
6.99 (d, J = 8.6 Hz, 1H), 4.41 (t, J = 5.4 Hz, 2H), 3.61 (t, J = 5.9 Hz, 2H), 2.07-2.01 
(m, 2H). 13C NMR (CDCl3): δ 160.8, 159.6, 141.0, 131.3, 130.9, 128.9, 126.8, 126.7, 
125.4, 117.8, 114.8, 65.6, 41.1, 21.8. IR (neat, cm-1): 2950, 1634, 1591, 1479, 1359, 
1238, 1101, 832, 761, 689. HRMS (ESI) m/z calculated for C16H16NO2+ (M + H+) 
254.1181, found 254.1179. 
 
2-(5,6-Dihydro-4H-1,3-oxazin-2-yl)-5-methylphenol (1f)  
Following general procedure B using 192 mg of crude 2-hydroxy-4-
methylbenzonitrile, 38 mg (0.28 mmol) ZnCl2, 0.18 ml (0.18 g, 2.4 mmol) 3-
aminopropan-1-ol and 6.5 ml chlorobenzene afforded the title compound as a colorless 
solid (128 mg, 19% (over two steps), mp 58-59 °C). 1H NMR (CDCl3): δ 14.12 (s, 
1H), 7.51 (d, J = 8.1 Hz, 1H), 6.72 (s, 1H), 6.58 (d, J = 8.1 Hz, 1H), 4.36 (t, J = 5.4 
Hz, 2H), 3.57 (t, J = 5.9 Hz, 2H), 2.29 (s, 3H), 2.03-1.97 (m, 2H). 13C NMR (CDCl3): 
δ 161.1, 159.5, 143.2, 126.7, 119.0, 117.7, 112.2, 65.4, 41.0, 21.9, 21.8. IR (neat, cm-
1): 2939, 2904, 1635, 1610, 1514, 1359, 1242, 1151, 913, 811, 686. HRMS (ESI) m/z 
calculated for C11H14NO2+ (M + H+) 192.1025, found 192.1024. 
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2-(5,6-Dihydro-4H-1,3-oxazin-2-yl)-5-methoxyphenol (1g)  
Following general procedure B using 315 mg (2.07 mmol) 2-hydroxy-4-methoxy-
benzonitrile, 29 mg (2.1 mmol, 10 mol %) ZnCl2, 0.26 ml (0.26 g, 3.4 mmol) 3-
aminopropan-1-ol and 6 ml chlorobenzene afforded the title compound as a colorless 
solid (157 mg, 37%, mp 62-64 °C). 1H NMR (CDCl3): δ 14.61 (s, 1H), 7.52 (d, J = 
8.8 Hz, 1H), 6.41 (d, J = 2.6 Hz, 1H), 6.32 (dd, J = 8.8 Hz, J = 2.6 Hz, 1H), 4.35 (t, J 
= 5.5 Hz, 2H), 3.77 (s, 3H), 3.55 (t, J = 6.0 Hz, 2H), 2.03-1.97 (m, 2H). 13C NMR 
(CDCl3): δ 163.5, 163.3, 159.8, 128.0, 107.8, 105.5, 101.2, 65.5, 55.4, 40.7, 21.9. IR 
(neat, cm-1): 2940, 2859, 1607, 1443, 1359, 1263, 1141, 1035, 913, 947, 805. HRMS 
(ESI) m/z calculated for C11H14NO3+ (M + H+) 208.0974, found 208.0976. 
 
2-Bromo-6-(5,6-dihydro-4H-1,3-oxazin-2-yl)phenol (1h)  
Following general procedure B using 596 mg (3.01 mmol) 3-bromo-2-hydroxy-
benzonitrile, 42 mg (0.31 mmol, 10 mol %) ZnCl2, 0.38 ml (0.38 g, 5.0 mmol) 3-
aminopropan-1-ol and 10 ml chlorobenzene afforded the title compound as a yellow 
solid (391 mg, 51%, mp 100-101 °C). 1H NMR (CDCl3): δ 15.58 (s, 1H), 7.58 (dd, J 
= 8.0 Hz, J = 1.7 Hz, 1H), 7.53 (dd, J = 7.8 Hz, J = 1.7 Hz, 1H), 6.61 (t, J = 7.9 Hz, 
1H), 4.39 (t, J = 5.5 Hz, 2H), 3.58 (t, J = 6.0 Hz, 2H), 2.06-2.00 (m, 2H). 13C NMR 
(CDCl3): δ 160.0, 159.9, 136.0, 126.1, 118.0, 115.1, 111.7, 65.9, 40.6, 21.5. IR (neat, 
cm-1): 2963, 1635, 1590, 1435, 1381, 1265, 1152, 1034, 952, 833, 753. HRMS (ESI) 
m/z calculated for C10H11BrNO2+ (M + H+) 255.9973, found 255.9974. 
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6-(5,6-Dihydro-4H-1,3-oxazin-2-yl)benzo[d][1,3]dioxol-5-ol (1i)  
Following general procedure B using 0.576 mg (3.53 mmol) 6-hydro-
xybenzo[d][1,3]dioxole-5-carbonitrile, 48 mg (0.35 mmol) ZnCl2, 0.43 ml (0.42 g, 5.7 
mmol) 3-aminopropan-1-ol and 11 ml chlorobenzene afforded the title compound as a 
faintly yellow solid (0.461 mg, 59%, mp 94-95 °C). 1H NMR (CDCl3): δ 14.65 (br s, 
1H), 7.04 (s, 1H), 6.42 (s, 1H), 5.87 (s, 2H), 4.35 (t, J = 5.3 Hz, 2H), 3.55 (t, J = 5.9 
Hz, 2H), 2.04-1.98 (m, 2H). 13C NMR (CDCl3): δ 159.9, 159.6, 151.1, 139.4, 105.9, 
104.9, 101.2, 98.7, 65.5, 40.5, 21.8. IR (neat, cm-1): 3063, 2890, 1630, 1452, 1430, 
1391, 1248, 1128, 1039, 837, 691. HRMS (ESI) m/z calculated for C11H12NO4+ (M + 
H+) 222.0766, found 222.0767. 
 
7-(5,6-Dihydro-4H-1,3-oxazin-2-yl)-2,3-dihydrobenzo[b][1,4]dioxin-6-ol (1j) 
Following general procedure B using 451 mg (2.54 mmol) 7-hydroxy-2,3-
dihydrobenzo[b][1,4]dioxine-6-carbonitrile, 35 mg (0.26 mmol, 10 mol %) ZnCl2, 
0.33 ml (0.33 g, 4.3 mmol) 3-aminopropan-1-ol and 8.5 ml chlorobenzene afforded the 
title compound as a faintly orange-colored colorless solid (236 mg, 40%, mp 105-108 
°C). 1H NMR (CDCl3): δ 13.82 (s, 1H), 7.14 (s, 1H), 6.40 (s, 1H), 4.34 (t. J = 5.5 Hz, 
2H), 4.25-4.22 (m, 2H), 4.18-4.15 (m, 2H), 3.55 (t, J = 5.9 Hz, 2H), 2.02-1.97 (m, 
2H). 13C NMR (CDCl3): δ 159.1, 156.3, 147.2, 135.6, 114.7, 108.2, 104.7, 65.5, 65.0, 
64.2, 40.9, 21.9. IR (neat, cm-1): 2976, 2864, 1640, 1593, 1504, 1359, 1302, 1245, 
1065, 894, 854. HRMS (ESI) m/z calculated for C12H14NO4+ (M + H+) 236.0923, 
found 236.0920. 
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3-(5,6-Dihydro-4H-1,3-oxazin-2-yl)naphthalen-2-ol (1k)  
Following general procedure B using 678 mg (4.01 mmol) 3-hydroxy-2-
naphthonitrile, 55 mg (0.40 mmol, 10 mol %) ZnCl2, 0.5 ml (0.49 g, 6.6 mmol) 3-
aminopropan-1-ol and 12 ml chlorobenzene afforded the title compound as a colorless 
solid (715 mg, 79%, mp 74-76 °C). 1H NMR (CDCl3): δ 13.81 (s, 1H), 8.30 (s, 1H), 
7.81 (d, J = 8.2 Hz, 1H), 7.71 (d, J = 8.3 Hz, 1H), 7.47 (ddd, J = 8.1 Hz, J = 6.9 Hz, J 
= 1.2 Hz, 1H), 7.33-7.29 (m, 2H), 4.45 (t, J = 5.5 Hz, 2H), 3.66 (t, J = 5.9 Hz, 2H), 
2.10-2.04 (m, 2H). 13C NMR (CDCl3): δ 159.0, 157.0, 136.4, 126.9, 128.2, 127.8, 
126.8, 126.1, 123.1, 117.0, 110.9, 65.6, 41.3, 21.7. IR (neat, cm-1): 2969, 1644, 1516, 
1470, 1354, 1288, 1122, 904, 841, 756, 622. HRMS (ESI) m/z calculated for 
C14H14NO2+ (M + H+) 228.1025, found 228.1024. 
 
2-(4-Methyl-5,6-dihydro-4H-1,3-oxazin-2-yl)phenol (1l)  
Following general procedure B using 456 mg (3.83 mmol) 2-hydroxybenzonitrile, 
53 mg (0.39 mmol, 10 mol %) ZnCl2, 550 mg (6.17 mmol) 3-aminobutan-1-ol and 10 
ml chlorobenzene afforded the title compound as a yellow solid (500 mg, 77%, mp 35-
37 °C). 1H NMR (CDCl3): δ 14.38 (s, 1H), 7.65 (dd, J = 7.9 Hz, J = 1.7 Hz, 1H), 7.27 
(ddd, J = 8.3 Hz, J = 7.2 Hz, J = 1.7 Hz, 1H), 6.90 (dd, J = 8.3 Hz, J = 1.2 Hz, J = 0.4 
Hz, 1H), 6.77 (ddd, J = 7.2 Hz, J = 7.9 Hz, J = 1.2 Hz, 1H), 4.42 (dt, J = 11.0 Hz, J = 
4.3 Hz, 1H), 4.30 (td, J = 10.4 Hz, J = 3.2 Hz, 1H), 3.73-3.64 (m, 1H), 2.09-2.02 (m, 
1H), 1.75-1.66 (m, 1H), 1.32 (d, J = 6.8 Hz, 3H). 13C NMR (CDCl3): δ 161.3, 158.5, 
132.6, 127.0, 117.8, 117.4, 114.6, 64.6, 46.4, 29.3, 23.2. IR (neat, cm-1): 2969, 2886, 
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1630, 1497, 1358, 1265, 1193, 1106, 759, 690. HRMS (ESI) m/z calculated for 
C11H14NO2+ (M + H+) 192.1025, found 192.1023. 
 
2-(4-Phenyl-5,6-dihydro-4H-1,3-oxazin-2-yl)phenol (1m)  
Following general procedure B using 397 mg (3.33 mmol) 2-hydroxybenzonitrile, 
45 mg (0.33 mmol, 10 mol %) ZnCl2, 756 mg (5.00 mmol) 3-amino-3-phenylpropan-
1-ol and 10 ml chlorobenzene afforded the title compound as a colorless solid (720 
mg, 85%, mp 60-61 °C). 1H NMR (CDCl3): δ 14.17 (br s, 1H), 7.75 (dd, J = 7.9 Hz, J 
= 1.7 Hz, 1H), 7.38-7.24 (m, 6H), 6.95 (d, J = 8.3 Hz, 1H), 6.83 (td, J = 7.6 Hz, J = 
1.2 Hz, 1H), 4.83 (dd, J = 8.1 Hz, J = 5.1 Hz, 1H), 4.46-4.36 (m, 2H), 2.38-2.31 (m, 
1H), 2.05-1.96 (m, 1H). 13C NMR (CDCl3): δ 161.3, 160.0, 143.2, 132.9, 128.8, 
127.4, 127.3, 126.5, 118.0, 117.5, 114.6, 64.3, 54.3, 30.4. IR (neat, cm-1): 2969, 1630, 
1603, 1494, 1454, 1257, 771, 702, 572. HRMS (ESI) m/z calculated for C16H16NO2+ 
(M + H+) 254.1181, found 254.1179. 
 
2-(4,4-Dimethyl-5,6-dihydro-4H-1,3-oxazin-2-yl)phenol (1n)  
Following general procedure B using 834 mg (7.00 mmol) 2-hydroxybenzonitrile, 
100 mg (0.33 mmol, 10 mol %) ZnCl2, 1.18 g (11.4 mmol) 3-amino-3-methylbutan-1-
ol and 21 ml chlorobenzene afforded the title compound as an off-white solid (1.30 g, 
91%, mp 31-32 °C). 1H NMR (CDCl3): δ 14.44 (s, 1H), 7.65 (dd, J = 7.9 Hz, J = 1.8 
Hz, 1H), 7.27 (ddd, J = 9.0 Hz, J = 7.2 Hz, J = 1.8 Hz, 1H), 6.90 (dd, J = 8.3 Hz, J = 
1.2 Hz, 1H), 6.77 (ddd, J = 9.0 Hz, J = 8.3 Hz, J = 1.2 Hz, 1H), 4.35 (t, J = 5.7 Hz, 
2H), 1.86 (t, J = 5.7 Hz, 2H), 1.32 (s, 6H). 13C NMR (CDCl3): δ 161.2, 157.5, 132.5, 
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127.1, 117.8, 117.3, 114.7, 62.7, 48.7, 34.2, 30.1. IR (neat, cm-1): 2961, 2919, 1625, 
1599, 1497, 1384, 1326, 1245, 1088, 854, 751. HRMS (ESI) m/z calculated for 
C12H16NO2+ (M + H+) 206.1181, found 206.1181. 
 
2-(5-Methyl-5,6-dihydro-4H-1,3-oxazin-2-yl)phenol (1o)  
Following general procedure B using 271 mg (2.28 mmol) 2-hydroxybenzonitrile, 
33 mg (0.33 mmol, 11 mol %) ZnCl2, 341 mg (3.83 mmol) 3-amino-2-methylpropan-
1-ol and 7 ml chlorobenzene afforded the title compound as a colorless solid (349 mg, 
80%, mp 66-67 °C). 1H NMR (CDCl3): δ 14.20 (s, 1H), 7.66 (dd, J = 8.0 Hz, J = 1.7 
Hz, 1H), 7.28 (ddd, J = 8.3 Hz, J = 7.2 Hz, J = 1.8 Hz, 1H), 6.91 (ddd, J = 8.3 Hz, J = 
1.2 Hz, J = 0.4 Hz, 1H), 6.77 (ddd, J = 7.9 Hz, J = 7.2 Hz, J = 1.2 Hz, 1H), 4.34 (ddd, 
J = 10.6 Hz, J = 4.1 Hz, J = 2.5 Hz, 1H), 3.86 (t, J = 10.3 Hz, 1H), 3.63 (ddd, J = 16.2 
Hz, J = 5.0 Hz, J = 2.5 Hz, 1H), 3.13 (dd, J = 16.2 Hz, J = 9.4 Hz, 1H), 2.19-2.06 (m, 
1H), 1.00 (d, J = 6.8 Hz, 3H). 13C NMR (CDCl3): δ 161.1, 159.1, 132.6, 127.0, 117.8, 
117.3, 114.6, 70.7, 48.4, 26.2, 15.0. IR (neat, cm-1): 2963, 2926, 1637, 1603, 1500, 
1455, 1345, 1206, 932, 757, 688. HRMS (ESI) m/z calculated for C11H14NO2+ (M + 
H+) 192.1025, found 192.1024. 
 
2-(3,4-Dimethoxyphenyl)-5,6-dihydro-4H-1,3-oxazine (1q)  
Following general procedure B using 1.63 g (10.0 mmol) 3,4-dimethoxybenzo-
nitrile, 10 mg (0.70 mmol, 7 mol %) ZnCl2, 1.18 mg (15.7 mmol) 3-aminopropan-1-ol 
and 30 ml chlorobenzene afforded the title compound as a colorless solid (987 mg, 
45%). 1H NMR (400 MHz, C6D6): δ 7.96 (d, J = 2.0 Hz, 1H), 7.93 (dd, J = 8.4, 2.0 
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Hz, 1H), 6.58 (d, J = 8.4 Hz, 1H), 3.78 (t, J = 5.4 Hz, 2H), 3.47 (s, 3H), 3.41 (t, J = 5.9 
Hz, 2H), 3.32 (s, 3H), 1.33 (p, J = 5.8 Hz, 2H). 
4.6.2.3 Hydroformylation of Dihydrooxazines 
General Procedure C: Hydroformylation of Dihydrooxazines 
In a glove box, vials equipped with Teflon-coated magnetic stir bars were charged 
with Co2(CO)8, the appropriate dihydrooxazine and toluene. The vials were then 
placed in a custom-made 6-well high-pressure reactor40 which was subsequently 
closed, taken out of the glove box and pressured with carbon monoxide (500 psi 
partial pressure) and hydrogen (500 psi partial pressure). The reactor was then sealed 
and the reaction mixtures were stirred for 20 h at 80 °C. The reactor was then cooled 
to ambient temperature and carefully vented in a well-ventilated hood. The crude 
reaction mixtures were concentrated in vacuo and then purified by flash column 
chromatography. 
 
3,3a-Dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2a)  
Following general procedure C using 88.6 mg (0.500 mmol) 2-(5,6-dihydro-4H-
1,3-oxazin-2-yl)phenol (1a), 7.0 mg (0.020 mmol, 4.0 mol %) Co2(CO)8 and 2 ml 
toluene afforded the title compound as a colorless solid (77.0 mg, 81%, mp 68-70 °C). 
The analytical data was in accordance with that in the literature.41 
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7-Fluoro-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2b)  
Following general procedure C using 79.0 mg (0.405 mmol) 2-(5,6-dihydro-4H-
1,3-oxazin-2-yl)-4-fluorophenol (1b), 5.5 mg (0.016 mmol, 4.0 mol %) Co2(CO)8 and 
1.6 ml toluene afforded the title compound as a colorless solid (54.7 mg, 65%, mp 77-
80 °C). 1H NMR (CDCl3): δ 7.56 (dd, J = 8.2 Hz, J = 3.1 Hz, 1H), 7.09 (ddd, J = 8.9 
Hz, J = 8.1 Hz, J = 3.2 Hz, 1H), 6.90 (dd, J = 8.9 Hz, J = 4.2 Hz, 1H), 5.40 (t, J = 5.8 
Hz, 1H), 3.80 (dt, J = 11.6 Hz, J = 7.3 Hz, 1H), 3.58 (ddd, J = 11.8 Hz, J = 8.0 Hz, J = 
5.0 Hz, 1H), 2.44-2.37 (m, 1H), 2.26-2.17 (m, 1H), 2.13-2.04 (m, 1H), 1.97-1.86 (m, 
1H). 13C NMR (CDCl3): δ 160.2, 158.2 (d, J = 242.0 Hz), 153.5 (d, J = 2.0 Hz), 
121.0, 120.9 (d, J = 24.1 Hz), 118.1 (d, J = 7.6 Hz), 114.0 (d, J = 24.5 Hz), 88.9, 44.6, 
32.0, 21.5. 19F NMR (CDCl3): δ -119.88. IR (neat, cm-1): 3039, 2980, 2883, 1667, 
1590, 1482, 1349, 1256, 1078, 963, 767. HRMS (ESI) m/z calculated for 
C11H11FNO2+ (M + H+) 208.0774, found 208.0772. 
 
7-Methyl-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2c)  
Following general procedure C using 77.0 mg (0.403 mmol) 2-(5,6-dihydro-4H-
1,3-oxazin-2-yl)-4-methylphenol (1c), 5.5 mg (0.016 mmol, 4.0 mol %) Co2(CO)8 and 
3.3 ml toluene afforded the title compound as an off-white solid (60.0 mg, 73%, mp 
95-97 °C). 1H NMR (CDCl3): δ 7.68 (d, J = 2.3 Hz, 1H), 7.18 (dd, J = 8.3 Hz, J = 2.4 
Hz, 1H), 6.82 (d, J = 8.3 Hz, 1H), 5.41 (t, J = 5.8 Hz, 1H), 3.80 (dt, J = 11.6 Hz, J = 
7.4 Hz, 1H), 3.57 (ddd, J = 11.7 Hz, J = 8.0 Hz, J = 5.0 Hz, 1H), 2.43-2.35 (m, 1H), 
2.29 (s, 3H), 2.24-2.15 (m, 1H), 2.13-2.01 (m, 1H), 1.93-1.84 (m, 1H). 13C NMR 
(CDCl3): δ 161.3, 155.3, 134.7, 132.3, 128.0, 120.0, 116.3, 88.6, 44.4, 32.1, 21.5, 
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20.6. IR (neat, cm-1): 3047, 2942, 2891, 1658, 1611, 1434, 1338, 1182, 1074, 827. 
HRMS (ESI) m/z calculated for C12H14NO2+ (M + H+) 204.1025, found 204.1023. 
 
7-Methoxy-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2d)  
Following general procedure C using 84.0 mg (0.405 mmol) 2-(5,6-dihydro-4H-
1,3-oxazin-2-yl)-4-methoxyphenol (1d), 5.5 mg (0.016 mmol, 4.0 mol %) Co2(CO)8 
and 3.3 ml toluene afforded the title compound as a colorless solid (77.1 mg, 87%, mp 
90-92 °C). 1H NMR (CDCl3): δ 7.37 (d, J = 3.1 Hz, 1H), 6.96 (dd, J = 8.9 Hz, J = 3.1 
Hz, 1H), 6.86 (d, J = 8.9 Hz, 1H), 5.42 (t, J = 5.8 Hz, 1H), 3.80 (dt, J = 11.6 Hz, J = 
7.4 Hz, 1H), 3.79 (s, 3H), 3.59 (ddd, J = 11.7 Hz, J = 8.0 Hz, J = 4.9 Hz, 1H), 2.43-
2.35 (m, 1H), 2.25-2.16 (m, 1H), 2.13-2.04 (m, 1H), 1.96-1.84 (m, 1H). 13C NMR 
(CDCl3): δ 160.9, 155.0, 151.3, 121.5, 120.0, 117.5, 110.0, 88.5, 55.8, 44.3, 31.9, 
21.4. IR (neat, cm-1): 2896, 2838, 1663, 1619, 1484, 1272, 1179, 1078, 905, 817, 756. 
HRMS (ESI) m/z calculated for C12H14NO3+ (M + H+) 220.0974, found 220.0973. 
 
7-Phenyl-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2e)  
Following general procedure C using 126 mg (0.497 mmol) 3-(5,6-dihydro-4H-
1,3-oxazin-2-yl)-[1,1'-biphenyl]-4-ol (1e), 7.0 mg (0.020 mmol, 4.0 mol %) Co2(CO)8 
and 4.0 ml toluene afforded the title compound as a colorless solid (95.2 mg, 72%, mp 
135-138 °C). 1H NMR (CDCl3): δ 8.15 (d, J = 2.3 Hz, 1H), 7.64 (dd, J = 8.5 Hz, J = 
2.4 Hz, 1H), 7.58-7.56 (m, 2H), 7.43-7.39 (m, 2H), 7.31 (t, J = 7.3 Hz, 1H), 7.01 (d, J 
= 8.5 Hz, 1H), 5.49 (t, J = 5.8 Hz, 1H), 3.84 (dt, J = 11.6 Hz, J = 7.3 Hz, 1H), 3.62 
(ddd, J = 11.6 Hz, J = 8.0 Hz, J = 5.0 Hz, 1H), 2.46-2.39 (m, 1H), 2.29-2.20 (m, 1H), 
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2.13-2.05 (m, 1H), 1.98-1.87 (m, 1H). 13C NMR (CDCl3): δ 161.0, 156.8, 139.9, 
136.0, 132.5, 129.0, 127.5, 127.0, 126.4, 120.1, 117.1, 88.8, 44.5, 32.1, 21.5. IR (neat, 
cm-1): 2996, 2895, 1674, 1614, 1439, 1342, 1063, 832, 764, 699. HRMS (ESI) m/z 
calculated for C17H16NO2+ (M + H+) 266.1181, found 266.1181. 
 
6-Methyl-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2f)  
Following general procedure C using 77.0 mg (0.403 mmol) 2-(5,6-dihydro-4H-
1,3-oxazin-2-yl)-5-methylphenol (1f), 5.5 mg (0.016 mmol, 4.0 mol %) Co2(CO)8 and 
3.3 ml toluene afforded the title compound as a colorless solid (58.9 mg, 72%, mp 81-
84 °C). 1H NMR (CDCl3): δ 7.77 (d, J = 7.9 Hz, 1H), 6.9 (d, J = 7.8 Hz, 1H), 6.72 (s, 
1H), 5.42 (t, J = 5.8 Hz, 1H), 3.79 (dt, J = 11.5 Hz, J = 7.3 Hz, 1H), 3.57 (ddd, J = 
11.6 Hz, J = 8.0 Hz, J = 5.1 Hz, 1H), 2.43-2.35 (m, 1H), 2.32 (s, 3H), 2.24-2.15 (m, 
1H), 2.11-2.02 (m, 1H), 1.95-1.84 (m, 1H). 13C NMR (CDCl3): δ 161.3, 157.5, 145.0, 
127.9, 123.8, 117.3, 116.9, 88.6, 44.4, 32.1, 21.9, 21.5. IR (neat, cm-1): 2980, 2891, 
1657, 1617, 1428, 1347, 1112, 1074, 935, 772. HRMS (ESI) m/z calculated for 
C12H14NO2+ (M + H+) 204.1025, found 204.1024. 
 
6-Methoxy-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2g)  
Following general procedure C using 83.0 mg (0.401 mmol) 2-(5,6-dihydro-4H-
1,3-oxazin-2-yl)-5-methoxyphenol (1g), 5.5 mg (0.016 mmol, 4.0 mol %) Co2(CO)8 
and 3.3 ml toluene afforded the title compound as a colorless solid (64.2 mg, 73%, mp 
119-122 °C). 1H NMR (CDCl3): δ 7.81 (d, J = 8.7 Hz, 1H), 6.61 (dd, J = 8.7 Hz, J = 
2.4 Hz, 1H), 6.41 (d, J = 2.4 Hz, 1H), 5.45 (t, J = 5.8 Hz, 1H), 3.81-3.75 (m, 1H), 3.78 
267 
 
(s, 3H), 3.59-3.53 (m, 1H), 2.43-2.35 (m, 1H), 2.24-2.16 (m, 1H), 2.11-2.02 (m, 1H), 
1.95-1.84 (m, 1H). 13C NMR (CDCl3): δ 164.3, 161.2, 159.2, 129.5, 112.9, 109.7, 
101.0, 88.9, 55.7, 44.4, 21.1, 21.6. IR (neat, cm-1): 2971, 2895, 1665, 1607, 1438, 
1349, 1268, 1102, 1023, 855, 769. HRMS (ESI) m/z calculated C12H14NO3+ (M + H+) 
220.0974, found 220.0974. 
 
5-Bromo-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2h)  
Following general procedure C using 128 mg (0.500 mmol) 2-bromo-6-(5,6-
dihydro-4H-1,3-oxazin-2-yl)phenol (1h), 7.0 mg (0.02 mmol, 4.0 mol %) Co2(CO)8 
and 2 ml toluene afforded the title compound as a colorless solid (106 mg, 79%, mp 
85-88 °C). 1H NMR (CDCl3): δ 7.85 (dd, J = 7.7 Hz, J = 1.6 Hz, 1H), 7.61 (dd, J = 
7.9 Hz, J = 1.6 Hz, 1H), 6.96 (t, J = 7.8 Hz, 1H), 5.52 (t, J = 5.7 Hz, 1H), 3.83 (dt, J = 
11.6 Hz, J = 7.3 Hz, 1H), 3.59 (ddd, J = 11.7 Hz, J = 8.0 Hz, J = 5.3 Hz, 1H), 2.51-
2.43 (m, 1H), 2.39-2.30 (m, 1H), 2.17-2.07 (m, 1H), 2.01-1.88 (m, 1H). 13C NMR 
(CDCl3): δ 160.3, 154.4, 137.3, 127.4, 123.6, 121.4, 110.4, 89.2, 44.7, 32.1, 21.6. IR 
(neat, cm-1): 2982, 2887, 1668, 1597, 1429, 1336, 1067, 854, 757, 684. HRMS (ESI) 
m/z calculated for C11H11NO2Br+ (M + H+) 267.9973, found 267.9974. 
 
7,8-Dihydro-5aH-[1,3]dioxolo[4',5':4,5]benzo[1,2-e]pyrrolo[2,1-b][1,3]oxazin-10-
(6H)-one (2i)  
Following general procedure C using 87.5 mg (0.396 mmol) 6-(5,6-dihydro-4H-
1,3-oxazin-2-yl)benzo[d][1,3]dioxol-5-ol (1i), 5.5 mg (0.016 mmol, 4.0 mol %) 
Co2(CO)8 and 3.3 ml toluene afforded the title compound as a colorless solid (70.6 
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mg, 76%, mp 162-164 °C). 1H NMR (CDCl3): δ 7.25 (s, 1H), 6.39 (s, 1H), 5.94-5.93 
(m, 2H), 5.38 (t, J = 5.7 Hz, 1H), 3.75 (dt, J = 11.4 Hz, J = 7.2 Hz, 1H), 3.53 (ddd, J = 
11.4 Hz, J = 7.9 Hz, J = 5.2 Hz, 1H), 2.39-2.31 (m, 1H), 2.21-2.12 (m, 1H), 2.09-2.00 
(m, 1H), 1.93-18.2 (m, 1H). 13C NMR (CDCl3): δ 161.0, 154.2, 152.1, 143.5, 112.8, 
106.2, 102.0, 98.0, 88.9, 44.4, 32.0, 21.7. IR (neat, cm-1): 2979, 2914, 1650, 1455, 
1251, 1135, 1031, 932, 769. HRMS (ESI) m/z calculated for C12H12NO4+ (M + H+) 
234.0766, found 234.0767. The analytical data was in accordance with that found in 
the literature.42 
 
6a,7,8,9-Tetrahydro-2H-[1,4]dioxino[2',3':4,5]benzo[1,2-e]pyrrolo[2,1-
b][1,3]oxazin-11(3H)-one (2j)  
Following general procedure C using 93.5 mg (0.397 mmol) 7-(5,6-dihydro-4H-
1,3-oxazin-2-yl)-2,3-dihydrobenzo[b][1,4]dioxin-6-ol (1j), 5.5 mg (0.016 mmol, 4.0 
mol %) Co2(CO)8 and 3.3 ml toluene afforded the title compound as a colorless solid 
(70.1 mg, 71%, mp 155-158 °C). 1H NMR (CDCl3): δ 7.37 (s, 1H), 6.41 (s, 1H), 5.38 
(t, J = 5.8 Hz, 1H), 4.25-4.23 (m, 2H), 4.19-4.17 (m, 2H), 3.76 (dt, J = 11.5 Hz, J = 
7.3 Hz, 1H), 3.55 (ddd, J = 11.5 Hz, J = 8.0 Hz, J = 5.0 Hz, 1H), 2.40-2.32 (m, 1H), 
2.21-2.12 (m, 1H), 2.08-2.00 (m, 1H), 1.93-1.82 (m, 1H). 13C NMR (CDCl3): δ 160.9, 
152.3, 148.2, 140.0, 115.9, 113.4, 104.7, 88.8, 65.0, 64.0, 44.4, 32.1, 21.6. IR (neat, 
cm-1): 2986, 2879, 1652, 1623, 1448, 1299, 1149, 1058, 897, 760. HRMS (ESI) m/z 
calculated for C13H14NO4+ (M + H+) 248.0923, found 248.0925. The analytical data 
was in accordance with that found in the literature.19 
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3,3a-Dihydro-1H-Naphtho[2,3-e]pyrrolo[2,1-b][1,3]oxazin-11(2H)-one (2k)  
Following general procedure C using 94.0 mg (0.414 mmol) 3-(5,6-dihydro-4H-
1,3-oxazin-2-yl)naphthalen-2-ol (1k), 5.5 mg (0.016 mmol, 4.0 mol %) Co2(CO)8 and 
3.3 ml toluene afforded the title compound as a colorless solid (79.5 mg, 80%, mp 
118-121 °C). 1H NMR (CDCl3): δ 8.48 (s, 1H), 7.87 (d, J = 8.2 Hz, 1H), 7.70 (d, J = 
8.3 Hz, 1H), 7.48 (dd, J = 8.2 Hz, J = 7.0 Hz, 1H), 7.37 (dd, J = 8.2 Hz, J = 7.0 Hz, 
1H), 7.30 (s, 1H), 5.48 (t, J = 5.9 Hz, 1H), 3.88-3.83 (m, 1H), 3.68-3.62 (m, 1H), 2.47-
2.40 (m, 1H), 2.28-2.19 (m, 1H), 2.14-2.06 (m, 1H), 1.97-1.88 (m, 1H). 13C NMR 
(CDCl3): δ 161.1, 153.6, 136.4, 129.53, 129.49, 129.47, 128.6, 127.0, 125.2, 120.2, 
112.2, 88.7, 44.6, 32.2, 21.3. IR (neat, cm-1): 2958, 2892, 1662, 1630, 1434, 1337, 
1101, 1071, 876, 749, 639. HRMS (ESI) m/z calculated for C15H14NO2+ (M + H+) 
240.1025, found 240.1024. 
 
1-Methyl-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2l)  
Following general procedure C using 76.7 mg (0.401 mmol) 2-(4-methyl-5,6-
dihydro-4H-1,3-oxazin-2-yl)phenol (1l), 5.5 mg (0.016 mmol, 4.0 mol %) Co2(CO)8 
and 3.3 ml toluene afforded the title compound as two diastereomers (90% overall 
yield, dr 1.6:1). 
 
Major diastereomer (44.4 mg, mp 80-82 °C, colorless solid): 1H NMR (CDCl3): δ 
7.93 (dd, J = 7.8 Hz, J = 1.6 Hz, 1H), 7.40 (td, J = 7.7 Hz, J = 1.5 Hz, 1H), 7.08 (t, J = 
7.8 Hz, 1H), 6.94 (d, J = 8.1 Hz, 1H), 5.42 (dd, J = 8.0 Hz, J = 5.8 Hz, 1H), 4.26 
(quint, J = 6.8 Hz, 1H), 2.38-2.25 (m, 2H), 2.09 (tt, J = 12.9 Hz, J = 7.6 Hz, 1H), 1.76 
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(dd, J = 12.9 Hz, J = 7.5 Hz, 1H), 1.38 (d, J = 6.4 Hz, 3H). 13C NMR (CDCl3): δ 
161.3, 157.9, 133.9, 128.1, 122.8, 120.1, 116.6, 89.5, 51.8, 29.6, 28.5, 20.4. IR (neat, 
cm-1): 2975, 1662, 1650, 1607, 1470, 1432, 1352, 1179, 1071, 770. HRMS (ESI) m/z 
calculated for C12H14NO2+ (M + H+) 204.1025, found 204.1027. 
 
Minor diastereomer (28.7 mg, mp 115-118 °C, colorless solid): 1H NMR 
(CDCl3): δ 7.89 (dd, J = 7.7 Hz, J = 1.5 Hz, 1H), 7.38 (td, J = 7.6 Hz, J = 1.6 Hz, 1H), 
7.07 (td, J = 7.5 Hz, J = 0.9 Hz, 1H), 6.91 (d, J = 8.1 Hz, 1H), 5.53 (dd, J = 6.6 Hz, J 
= 3.6 Hz, 1H), 4.45-4.39 (m, 1H), 2.49-2.41 (m, 1H), 2.29-2.18 (m, 2H), 1.62-1.57 (m, 
1H), 1.35 (d, J = 6.5 Hz, 3H). 13C NMR (CDCl3): δ 160.9, 157.3, 133.8, 128.1, 122.8, 
120.5, 116.6, 88.5, 54.0, 30.6, 29.6, 20.7. IR (neat, cm-1): 2974, 2902, 1654, 1608, 
1423, 1332, 1171, 1073, 769. HRMS (ESI) m/z calculated for C12H14NO2+ (M + H+) 
204.1025, found 204.1026. 
 
1-Phenyl-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2m)  
Following general procedure C using 126 mg (0.497 mmol) 2-(4-phenyl-5,6-
dihydro-4H-1,3-oxazin-2-yl)phenol (1m), 7.0 mg (0.07 mmol, 4.0 mol %) Co2(CO)8 
and 2.0 ml toluene afforded the title compound as two diastereomers (80% overall 
yield, dr 2.9:1). 
Major diastereomer (78.3 mg, mp 194-197 °C, colorless solid): 1H NMR 
(CDCl3): δ 7.91 (dd, J = 7.7 Hz, J = 1.8 Hz, 1H), 7.43 (ddd, J = 8.1 Hz, J = 7.4 Hz, J = 
1.7 Hz, 1H), 7.28-7.22 (m, 4H), 7.19-7.16 (m, 1H), 7.08 (td, J = 7.5 Hz, J = 1.0 Hz, 
1H), 7.02 (dd, J = 8.2 Hz, J = 1.0 Hz, 1H), 5.62-5.59 (m, 1H), 5.26-5.25 (m, 1H), 
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2.43-2.29 (m, 3H), 2.00-1.94 (m, 1H). 13C NMR (CDCl3): δ 161.1, 158.2, 141.9, 
134.2, 128.8, 128.5, 127.3, 125.9, 122.9, 119.9, 116.8, 89.7, 59.2, 30.8, 29.0. IR (neat, 
cm-1): 3078, 2985, 1668, 1603, 1491, 1464, 1344, 1229, 1065, 855, 768, 698. HRMS 
(ESI) m/z calculated for C17H16NO2+ (M + H+) 266.1181, found 266.1180. 
 
Minor diastereomer (26.8 mg, mp 87-89 °C, colorless solid): 1H NMR (CDCl3): δ 
7.90 (dd, J = 7.7 Hz, J = 1.6 Hz, 1H), 7.43 (ddd, J = 8.3 Hz, J = 7.5 Hz, J = 1.7 Hz, 
1H), 7.35-7.31 (m, 2H), 7.26-7.22 (m, 3H), 7.11 (td, J = 7.6 Hz, J = 1.0 Hz, 1H), 6.98 
(dd, J = 8.2 Hz, J = 0.9 Hz, 1H), 5.77 (dd, J = 6.2 Hz, J = 2.8 Hz, 1H), 5.47 (dd, J = 
7.6 Hz, J = 2.8 Hz, 1H), 2.62-2.52 (m, 1H), 2.42-2.27 (m, 2H), 2.04-1.98 (m, 1H). 13C 
NMR (CDCl3): δ 160.9, 157.4, 141.5, 134.1, 128.9, 128.5, 127.4, 125.7, 123.0, 120.2, 
116.7, 89.1, 81.2, 31.6, 30.7. IR (neat, cm-1): 2971, 2928, 1660, 1608, 1465, 1418, 
1433, 1220, 1051, 960, 760, 722. HRMS (ESI) m/z calculated for C17H16NO2+ (M + 
H+) 266.1181, found 266.1181. 
 
1,1-Dimethyl-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2n)  
Following general procedure C using 101.6 mg (0.495 mmol) 2-(4,4-dimethyl-
5,6-dihydro-4H-1,3-oxazin-2-yl)phenol (1n), 7.0 mg (0.02 mmol, 4.0 mol %) 
Co2(CO)8 and 2.0 ml toluene afforded the title compound as a colorless solid (100.3 
mg, 93%, mp 105-106 °C). 1H NMR (CDCl3): δ 7.88 (d, J = 7.7 Hz, 1H), 7.36 (dd, J 
= 8.2 Hz, J = 7.2 Hz, 1H), 7.06 (dd, J = 7.7 Hz, J = 7.2 Hz, 1H), 6.89 (d, J = 8.2 Hz, 
1H), 5.46 (t, J = 6.5 Hz, 1H), 2.36-2.29 (m, 1H), 2.25-2.15 (m, 1H), 1.97-1.90 (m, 
1H), 1.83-1.75 (m, 1H), 1.59 (s, 3H), 1.53 (s, 3H). 13C NMR (CDCl3): δ 161.0, 157.5, 
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133.7, 128.0, 121.0, 116.3, 89.66, 89.64, 62.4, 37.3, 29.1, 28.0, 26.3. IR (neat, cm-1): 
3070, 2966, 1658, 1608, 1418, 1341, 1071, 786, 720, 598. HRMS (ESI) m/z 
calculated for C13H16NO2+ (M + H+) 218.1181, found 218.1181. 
 
2-Methyl-3,3a-dihydro-1H-benzo[e]pyrrolo[2,1-b][1,3]oxazin-9(2H)-one (2o)  
Following general procedure C using 95.4 mg (0.499 mmol) 2-(5-methyl-5,6-
dihydro-4H-1,3-oxazin-2-yl)phenol (1o), 7.0 mg (0.07 mmol, 4.0 mol %) Co2(CO)8 
and 2.0 ml toluene afforded the title compound as two diastereomers (80% overall 
yield, dr 1:1.3). 
 
Major diastereomer (45.2 mg, mp 69-72 °C, colorless solid): 1H NMR (CDCl3): δ 
7.91 (dd, J = 7.8 Hz, J = 1.7 Hz, 1H), 7.40 (ddd, J = 8.2 Hz, J = 7.3 Hz, J = 1.7 Hz, 
1H), 7.09 (ddd, J = 7.7 Hz, J = 7.4 Hz, J = 1.1 Hz, 1H), 6.94 (dd, J = 8.2 Hz, J = 1.1 
Hz, 1H), 5.49 (dd, J = 7.2 Hz, J = 5.7 Hz, 1H), 3.83 (dd, J = 11.5 Hz, J = 7.8 Hz, 1H), 
3.31 (dd, J = 11.5 Hz, J = 8.6 Hz, 1H), 2.55-2.49 (m, 1H), 2.44-2.30 (m, 1H), 1.91 
(ddd, J = 12.6 Hz, J = 10.4 Hz, J = 7.2 Hz, 1H), 1.19 (d, J = 6.7 Hz, 3H). 13C NMR 
(CDCl3): δ 160.9, 157.5, 133.9, 128.0, 122.8, 119.9, 116.6, 88.7, 50.9, 40.0, 29.5, 
18.3. IR (neat, cm-1): 2969, 2843, 1659, 1610, 1463, 1430, 1347, 1190, 1057, 760, 
696. HRMS (ESI) m/z calculated for C12H14NO2+ (M + H+) 204.1025, found 
204.1026. 
 
Minor diastereomer (35.9 mg, colorless oil): 1H NMR (CDCl3): δ 7.90 (d, J = 7.6 
Hz, 1H), 7.42-7.38 (m, 1H), 7.08 (t, J = 7.5 Hz, 1H), 6.93 (d, J = 8.3 Hz, 1H), 5.52 
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(dd, J = 6.4 Hz, J = 3.5 Hz, 1H), 4.06 (dd, J = 11.5 Hz, J = 6.8 Hz, 1H), 3.08 (dd, J = 
11.4 Hz, J = 7.3 Hz, 1H), 2.56-2.47 (m, 1H), 2.43-2.37 (m, 1H), 2.05-1.98 (m, 1H), 
1.11 (d, J = 6.8 Hz, 3H). 13C NMR (CDCl3): δ 161.0, 157.7, 133.9, 128.2, 122.7, 
120.0, 116.6, 88.5, 52.1, 39.8, 30.6, 18.4. IR (neat, cm-1): 2959, 2873, 1664, 1610, 
1466, 1427, 1355, 1222, 1075, 757, 696. HRMS (ESI) m/z calculated for C12H14NO2+ 
(M + H+) 204.1025, found 204.1023. 
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4.6.2.4 Crystallographic Data for Major Diastereomer of 2m 
Table 4.4 Crystal data and structure refinement for major diastereomer of 2m 
Identification code  2m 
Empirical formula  C17H15NO2 
Formula weight  265.30 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 8.4225(4) Å α = 90° 
 b = 13.7700(7) Å β = 104.075(2)° 
 c = 11.5762(5) Å γ = 90° 
Volume 1302.28(11) Å
3
 
Z 4 
Density (calculated) 1.353 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 560 
Crystal size 0.30 x 0.25 x 0.20 mm3 
Theta range for data collection 2.34 to 28.39° 
Index ranges -11<=h<=11, -18<=k<=17, -11<=l<=15 
Reflections collected 10431 
Independent reflections 3251 [R(int) = 0.0273] 
Completeness to theta = 28.39° 99.4%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9824 and 0.9738 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3251 / 0 / 241 
Goodness-of-fit on F2 1.074 
Final R indices [I>2sigma(I)] R1 = 0.0401, wR2 = 0.0962 
R indices (all data) R1 = 0.0523, wR2 = 0.1032 
Largest diff. peak and hole 0.281 and -0.217 e/Å-3 
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Table 4.5 Atomic coordinates (x104) and equivalent isotropic displacement 
parameters (Å2x103) for major diastereomer of 2m 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
___________________________________________________________________  
O(1) -57(1) 8667(1) 688(1) 25(1) 
O(2) 1644(1) 5926(1) 1091(1) 32(1) 
N(1) -353(1) 6991(1) 241(1) 22(1) 
C(1) 1596(2) 8533(1) 1105(1) 22(1) 
C(2) 2535(2) 9321(1) 1603(1) 28(1) 
C(3) 4192(2) 9196(1) 2066(1) 33(1) 
C(4) 4913(2) 8291(1) 2043(1) 32(1) 
C(5) 3963(2) 7501(1) 1580(1) 27(1) 
C(6) 2286(1) 7613(1) 1106(1) 21(1) 
C(7) 1202(2) 6753(1) 793(1) 22(1) 
C(8) -1752(2) 6331(1) 62(1) 23(1) 
C(9) -3116(2) 6944(1) -736(1) 28(1) 
C(10) -2622(2) 7996(1) -430(1) 29(1) 
C(11) -775(2) 7969(1) -190(1) 24(1) 
C(12) -2148(1) 6036(1) 1220(1) 20(1) 
C(13) -1647(2) 6567(1) 2264(1) 25(1) 
C(14) -2072(2) 6273(1) 3294(1) 29(1) 
C(15) -3017(2) 5456(1) 3290(1) 30(1) 
C(16) -3531(2) 4924(1) 2252(1) 29(1) 
C(17) -3089(2) 5209(1) 1227(1) 24(1) 
________________________________________________________________________________ 
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Table 4.6 Bond lengths [Å] and angles [°] for major diastereomer of 2m 
_____________________________________________________________________
O(1)-C(1)  1.3703(14) 
O(1)-C(11)  1.4228(14) 
O(2)-C(7)  1.2215(14) 
N(1)-C(7)  1.3504(15) 
N(1)-C(11)  1.4504(15) 
N(1)-C(8)  1.4623(15) 
C(1)-C(2)  1.3841(17) 
C(1)-C(6)  1.3932(16) 
C(2)-C(3)  1.3791(19) 
C(2)-H(2)  0.968(15) 
C(3)-C(4)  1.389(2) 
C(3)-H(3)  0.974(17) 
C(4)-C(5)  1.3793(18) 
C(4)-H(4)  0.988(16) 
C(5)-C(6)  1.3935(17) 
C(5)-H(5)  0.979(15) 
C(6)-C(7)  1.4855(16) 
C(8)-C(12)  1.5128(16) 
C(8)-C(9)  1.5393(18) 
C(8)-H(8)  0.951(15) 
C(9)-C(10)  1.5251(18) 
C(9)-H(9B)  0.976(15) 
C(9)-H(9A)  0.982(15) 
C(10)-C(11)  1.5126(17) 
C(10)-H(10B)  0.991(16) 
C(10)-H(10A)  0.995(16) 
C(11)-H(11)  1.011(14) 
C(12)-C(13)  1.3879(16) 
C(12)-C(17)  1.3889(16) 
C(13)-C(14)  1.3867(18) 
C(13)-H(13)  0.978(15) 
C(14)-C(15)  1.3771(19) 
C(14)-H(14)  0.988(16) 
C(15)-C(16)  1.3836(19) 
C(15)-H(15)  0.971(16) 
C(16)-C(17)  1.3844(18) 
C(16)-H(16)  0.958(17) 
C(17)-H(17)  0.965(14) 
 
C(1)-O(1)-C(11) 112.27(9) 
C(7)-N(1)-C(11) 121.09(10) 
C(7)-N(1)-C(8) 124.85(10) 
C(11)-N(1)-C(8) 114.01(10) 
O(1)-C(1)-C(2) 117.97(11) 
O(1)-C(1)-C(6) 120.77(10) 
C(2)-C(1)-C(6) 121.10(11) 
C(3)-C(2)-C(1) 119.04(12) 
C(3)-C(2)-H(2) 121.7(8) 
C(1)-C(2)-H(2) 119.3(8) 
C(2)-C(3)-C(4) 120.70(12) 
C(2)-C(3)-H(3) 119.4(10) 
C(4)-C(3)-H(3) 119.9(10) 
C(5)-C(4)-C(3) 120.02(12) 
C(5)-C(4)-H(4) 120.4(10) 
C(3)-C(4)-H(4) 119.5(10) 
C(4)-C(5)-C(6) 120.12(12) 
C(4)-C(5)-H(5) 120.8(9) 
C(6)-C(5)-H(5) 119.0(9) 
C(1)-C(6)-C(5) 118.95(11) 
C(1)-C(6)-C(7) 119.49(10) 
C(5)-C(6)-C(7) 120.77(11) 
O(2)-C(7)-N(1) 123.63(11) 
O(2)-C(7)-C(6) 123.15(11) 
N(1)-C(7)-C(6) 112.97(10) 
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N(1)-C(8)-C(12) 112.67(9) 
N(1)-C(8)-C(9) 101.65(9) 
C(12)-C(8)-C(9) 112.72(10) 
N(1)-C(8)-H(8) 109.5(9) 
C(12)-C(8)-H(8) 107.5(9) 
C(9)-C(8)-H(8) 112.8(8) 
C(10)-C(9)-C(8) 105.07(10) 
C(10)-C(9)-H(9B) 113.0(9) 
C(8)-C(9)-H(9B) 111.5(9) 
C(10)-C(9)-H(9A) 111.0(9) 
C(8)-C(9)-H(9A) 108.4(9) 
H(9B)-C(9)-H(9A) 107.8(12) 
C(11)-C(10)-C(9) 103.27(11) 
C(11)-C(10)-H(10B) 112.2(9) 
C(9)-C(10)-H(10B) 111.8(9) 
C(11)-C(10)-H(10A) 108.7(9) 
C(9)-C(10)-H(10A) 110.8(9) 
H(10B)-C(10)-H(10A) 109.9(13) 
O(1)-C(11)-N(1) 110.83(9) 
O(1)-C(11)-C(10) 110.75(10) 
N(1)-C(11)-C(10) 103.95(10) 
O(1)-C(11)-H(11) 106.9(8) 
N(1)-C(11)-H(11) 109.5(8) 
C(10)-C(11)-H(11) 114.9(7) 
C(13)-C(12)-C(17) 118.71(11) 
C(13)-C(12)-C(8) 122.96(11) 
C(17)-C(12)-C(8) 118.31(10) 
C(14)-C(13)-C(12) 120.49(12) 
C(14)-C(13)-H(13) 120.1(8) 
C(12)-C(13)-H(13) 119.4(8) 
C(15)-C(14)-C(13) 120.41(12) 
C(15)-C(14)-H(14) 120.3(9) 
C(13)-C(14)-H(14) 119.3(9) 
C(14)-C(15)-C(16) 119.56(12) 
C(14)-C(15)-H(15) 121.1(9) 
C(16)-C(15)-H(15) 119.4(9) 
C(15)-C(16)-C(17) 120.16(12) 
C(15)-C(16)-H(16) 119.6(9) 
C(17)-C(16)-H(16) 120.2(9) 
C(16)-C(17)-C(12) 120.66(11) 
C(16)-C(17)-H(17) 119.7(8) 
C(12)-C(17)-H(17) 119.6(8) 
_____________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms. 
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Table 4.7 Anisotropic displacement parameters (Å2x103) for major diastereomer 
of 2m  
The anisotropic displacement factor exponent takes the form: -2π2[h2 a*2U11 + ... + 2 h 
k a* b* U12] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_________________________________________________________________  
O(1) 25(1)  18(1) 31(1)  -4(1) 5(1)  1(1) 
O(2) 32(1)  18(1) 45(1)  0(1) 8(1)  2(1) 
N(1) 24(1)  17(1) 24(1)  -1(1) 7(1)  -3(1) 
C(1) 24(1)  20(1) 21(1)  1(1) 7(1)  -1(1) 
C(2) 33(1)  19(1) 33(1)  -3(1) 9(1)  -3(1) 
C(3) 33(1)  28(1) 37(1)  -4(1) 6(1)  -9(1) 
C(4) 24(1)  34(1) 36(1)  1(1) 5(1)  -4(1) 
C(5) 26(1)  26(1) 29(1)  1(1) 9(1)  1(1) 
C(6) 25(1)  20(1) 20(1)  -1(1) 8(1)  -1(1) 
C(7) 26(1)  19(1) 23(1)  -2(1) 10(1)  0(1) 
C(8) 25(1)  19(1) 23(1)  -4(1) 6(1)  -4(1) 
C(9) 29(1)  30(1) 23(1)  1(1) 1(1)  -6(1) 
C(10) 27(1)  26(1) 31(1)  4(1) 1(1)  0(1) 
C(11) 29(1)  19(1) 23(1)  1(1) 5(1)  -2(1) 
C(12) 19(1)  18(1) 23(1)  1(1) 3(1)  1(1) 
C(13) 25(1)  23(1) 26(1)  -4(1) 7(1)  -4(1) 
C(14) 31(1)  31(1) 25(1)  -5(1) 8(1)  -1(1) 
C(15) 32(1)  32(1) 28(1)  3(1) 12(1)  0(1) 
C(16) 28(1)  25(1) 34(1)  1(1) 9(1)  -5(1) 
C(17) 24(1)  23(1) 25(1)  -3(1) 3(1)  -3(1) 
__________________________________________________________________ 
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Table 4.8 Hydrogen coordinates (x104) and isotropic displacement parameters 
(Å2x103) for major diastereomer of 2m 
_____________________________________________________________________ 
 x  y  z  U(eq) 
_____________________________________________________________________ 
H(2) 2010(17) 9943(11) 1631(12) 28(4) 
H(3) 4860(20) 9748(12) 2417(14) 41(4) 
H(4) 6100(20) 8211(12) 2401(14) 40(4) 
H(5) 4445(18) 6852(11) 1599(13) 31(4) 
H(8) -1519(17) 5755(11) -317(12) 27(4) 
H(9B) -4188(19) 6783(11) -607(13) 29(4) 
H(9A) -3142(18) 6801(11) -1572(14) 35(4) 
H(10B) -3116(19) 8443(12) -1091(14) 37(4) 
H(10A) -2931(18) 8200(11) 310(14) 33(4) 
H(11) -322(16) 8097(10) -908(12) 21(3) 
H(13) -986(17) 7152(10) 2269(12) 25(3) 
H(14) -1685(19) 6653(11) 4033(14) 35(4) 
H(15) -3327(19) 5245(12) 4006(14) 38(4) 
H(16) -4180(19) 4353(13) 2251(14) 40(4) 
H(17) -3423(17) 4823(11) 512(12) 28(4) 
__________________________________________________________________ 
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